Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency, 19230-19292 [2020-06990]
Download as PDF
<![CDATA[
19230
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Parts 400, 405, 409, 410, 412,
414, 415, 417, 418, 421, 422, 423, 425,
440, 482, and 510
[CMS–1744–IFC]
RIN 0938–AU31
Medicare and Medicaid Programs;
Policy and Regulatory Revisions in
Response to the COVID–19 Public
Health Emergency
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Interim final rule with comment
period.
AGENCY:
This interim final rule with
comment period (IFC) gives individuals
and entities that provide services to
Medicare beneficiaries needed
flexibilities to respond effectively to the
serious public health threats posed by
the spread of the 2019 Novel
Coronavirus (COVID–19). Recognizing
the urgency of this situation, and
understanding that some pre-existing
Medicare payment rules may inhibit
innovative uses of technology and
capacity that might otherwise be
effective in the efforts to mitigate the
impact of the pandemic on Medicare
beneficiaries and the American public,
we are changing Medicare payment
rules during the Public Health
Emergency (PHE) for the COVID–19
pandemic so that physicians and other
practitioners, home health and hospice
providers, inpatient rehabilitation
facilities, rural health clinics (RHCs),
and federally qualified health centers
(FQHCs) are allowed broad flexibilities
to furnish services using remote
communications technology to avoid
exposure risks to health care providers,
patients, and the community. We are
also altering the applicable payment
policies to provide specimen collection
fees for independent laboratories
collecting specimens from beneficiaries
who are homebound or inpatients (not
in a hospital) for COVID–19 testing. We
are also expanding, on an interim basis,
the list of destinations for which
Medicare covers ambulance transports
under Medicare Part B. In addition, we
are making programmatic changes to the
Medicare Diabetes Prevention Program
(MDPP) and the Comprehensive Care for
Joint Replacement (CJR) Model in light
of the PHE, and program-specific
requirements for the Quality Payment
Program to avoid inadvertently creating
jbell on DSKJLSW7X2PROD with RULES2
SUMMARY:
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
incentives to place cost considerations
above patient safety. This IFC will
modify the calculation of the 2021 and
2022 Part C and D Star Ratings to
address the expected disruption to data
collection and measure scores posed by
the COVID–19 pandemic and also to
avoid inadvertently creating incentives
to place cost considerations above
patient safety. This rule also amends the
Medicaid home health regulations to
allow other licensed practitioners to
order home health services, for the
period of this PHE for the COVID–19
pandemic in accordance with state
scope of practice laws. We are also
modifying our under arrangements
policy during the PHE for the COVID–
19 pandemic so that hospitals are
allowed broader flexibilities to furnish
inpatient services, including routine
services outside the hospital.
DATES:
Effective date: These regulations are
effective on March 31, 2020.
Applicability date: These regulations
are applicable beginning on March 1,
2020.
Comment date: To be assured
consideration, comments must be
received at one of the addresses
provided below, no later than 5 p.m. on
June 1, 2020.
ADDRESSES: In commenting, please refer
to file code CMS–1744–IFC. Comments,
including mass comment submissions,
must be submitted in one of the
following three ways (please choose
only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–1744–IFC, P.O. Box 8016,
Baltimore, MD 21244–8016.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–1744–IFC,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Jamie Hermansen, (410) 786–2064, for
general information, contact one of the
following:
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
HAPG_COVID-19@cms.hhs.gov, for
issues related to telehealth services, and
communication technology-based
services; frequency limits on subsequent
care services in inpatient and nonfacility settings, critical care
consultations, required ‘‘hands-on’’
visits for ESRD monthly capitation
payments; removal of restrictions on
technology, and supervision of
interactive telecommunications
technology; clinical laboratory fee
schedule; services furnished by opioid
treatment programs; payment under
Medicare Part B for teaching physician
services and resident moonlighting;
remote physiologic monitoring;
physician supervision flexibility for
outpatient hospital services; payment
for office/outpatient evaluation and
management visits; counting of resident
time at alternate locations; Ambulance
Fee Schedule; rural health clinic
services; federally qualified health
center services; and inpatient hospital
services furnished under arrangements
outside of the hospital. (Note this email
address has an underscore ‘‘_’’ between
‘‘HAPG’’ and ‘‘COVID–19’’.)
IRFCoverage@cms.hhs.gov, for issues
related to the Medicare inpatient
rehabilitation facility benefits.
NCDsPublicHealthEmergency@
cms.hhs.gov, for issues related to
national coverage determination and
local coverage determination
requirements.
PartCandDStarRatings@cms.hhs.gov,
for issues related to Medicare Parts C
and D quality rating system.
MedicaidHomeHealthRule@
cms.hhs.gov, for issues related to
Medicaid home health provider
flexibility.
Hillary Loeffler, (410) 786–0456,
HomeHealthPolicy@cms.hhs.gov, or
HospicePolicy@cms.hhs.gov, for issues
related to the Medicare home health and
hospice benefits.
Megan Hyde, (410) 786–3247, and
Rebecca Cole, (410) 786–1589, for issues
related to Innovation Center Models,
and alternative payment model
treatment under the Quality Payment
Program.
Kim Spalding Bush, (410) 786–3232,
and Fiona Larbi, (410) 786–7224, for
issues related to the Medicare Shared
Savings Program.
Molly MacHarris, (410) 786–4461, for
issues related to the Merit-based
Incentive Payment System (MIPS).
Heather Holsey, (410) 786–0028, for
Comprehensive Care for Joint
Replacement model.
Amanda Rhee, (410) 786–3888, and
Elizabeth Matthews, (410) 786–5433, for
Medicare Diabetes Prevention Program
expanded model.
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
Brittany LaCouture, (410) 786–0481,
for Alternative Payment Model
provisions of the Quality Payment
Program.
CAPT Scott Cooper, USPHS, (410)
786–9496, for issues related to special
requirements for psychiatric hospitals.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
regulations.gov. Follow the search
instructions on that website to view
public comments.
jbell on DSKJLSW7X2PROD with RULES2
Table of Contents
I. Background
II. Provisions of the Interim Final Rule
A. Payment for Medicare Telehealth
Services Under Section 1834(m) of the
Act
B. Frequency Limitations on Subsequent
Care Services in Inpatient and Nursing
Facility Settings, and Critical Care
Consultations and Required ‘‘Hands-on’’
Visits for ESRD Monthly Capitation
Payments
C. Telehealth Modalities and Cost-sharing
D. Communication Technology-Based
Services (CTBS)
E. Direct Supervision by Interactive
Telecommunications Technology
F. Clarification of Homebound Status
Under the Medicare Home Health
Benefit
G. The Use of Telecommunications
Technology Under the Medicare Home
Health Benefit During the PHE for the
COVID–19 Pandemic
H. The Use of Technology Under the
Medicare Hospice Benefit
I. Telehealth and the Medicare Hospice
Face-to-Face Encounter Requirement
J. Modification of the Inpatient
Rehabilitation Facility (IRF) Face-to-Face
Requirement for the PHE During the
COVID–19 Pandemic
K. Removal of the IRF Post-Admission
Physician Evaluation Requirement for
the PHE for the COVID–19 Pandemic and
Clarification Regarding the ‘‘3-Hour’’
Rule
L. Rural Health Clinics (RHCs) and
Federally Qualified Health Centers
(FQHCs)
M. Medicare Clinical Laboratory Fee
Schedule: Payment for Specimen
Collection for Purposes of COVID–19
Testing
N. Requirements for Opioid Treatment
Programs (OTP)
O. Application of Teaching Physician and
Moonlighting Regulations During the
PHE for the COVID–19 pandemic During
the PHE for COVID–19
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
P. Special Requirements for Psychiatric
Hospitals (§ 482.61(d))
Q. Innovation Center Models
R. Remote Physiologic Monitoring
S. Telephone Evaluation and Management
(E/M) Services
T. Physician Supervision Flexibility for
Outpatient Hospitals—Outpatient
Hospital Therapeutic Services Assigned
to the Non-Surgical Extended Duration
Therapeutic Services (NSEDTS) Level of
Supervision
U. Application of Certain National
Coverage Determination and Local
Coverage Determination Requirements
During the PHE for the COVID–19
Pandemic
V. Change to Medicare Shared Savings
Program Extreme and Uncontrollable
Circumstances Policy
W. Level Selection for Office/Outpatient E/
M Visits When Furnished Via Medicare
Telehealth
X. Counting of Resident Time During the
PHE for the COVID–19 Pandemic
Y. Addressing the Impact of COVID–19 on
Part C and Part D Quality Rating Systems
Z. Changes to Expand Workforce Capacity
for Ordering Medicaid Home Health
Services, Medical Equipment, Supplies
and Appliances and Physical Therapy,
Occupational Therapy or Speech
Pathology and Audiology Services
AA. Origin and Destination Requirements
Under the Ambulance Fee Schedule
BB. Merit-Based Incentive Payment System
Updates
CC. Inpatient Hospital Services Furnished
Under Arrangements Outside the
Hospital During the Public Health
Emergency (PHE) for the COVID–19
Pandemic
DD. Advance Payments to Suppliers
Furnishing Items and Services Under
Part B
III. Waiver of Proposed Rulemaking
IV. Collection of Information Requirements
V. Response to Comments
VI. Regulatory Impact Analysis
Regulations Text
Addenda Available Only Through the
Internet on the CMS Website
The Addenda along with other
supporting documents and tables
referenced in this interim final rule with
comment period (IFC) are available
through the internet on the CMS website
at https://www.cms.gov/. For this IFC,
refer to item CMS–1744–IFC. Readers
who experience any problems accessing
any of the Addenda or other documents
referenced in this IFC and posted on the
CMS website identified above should
contact HAPG_COVID-19@cms.hhs.gov.
CPT (Current Procedural Terminology)
Copyright Notice
Throughout this IFC, we use CPT
codes and descriptions to refer to a
variety of services. We note that CPT
codes and descriptions are copyright
2019 American Medical Association. All
Rights Reserved. CPT is a registered
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
19231
trademark of the American Medical
Association (AMA). Applicable Federal
Acquisition Regulations (FAR) and
Defense Federal Acquisition Regulations
(DFAR) apply.
I. Background
The United States is responding to an
outbreak of respiratory disease caused
by a novel (new) coronavirus that was
first detected in China and which has
now been detected in more than 190
locations internationally, including in
all 50 States and the District of
Columbia. The virus has been named
‘‘SARS–CoV–2’’ and the disease it
causes has been named ‘‘coronavirus
disease 2019’’ (abbreviated ‘‘COVID–
19’’).
On January 30, 2020, the International
Health Regulations Emergency
Committee of the World Health
Organization (WHO) declared the
outbreak a ‘‘Public Health Emergency of
international concern’’ (PHEIC). On
January 31, 2020, Health and Human
Services Secretary, Alex M. Azar II,
declared a PHE for the United States to
aid the nation’s healthcare community
in responding to COVID–19 (hereafter
referred to as the PHE for the COVID–
19 pandemic). On March 11, 2020, the
WHO publicly characterized COVID–19
as a pandemic. On March 13, 2020 the
President of the United States declared
the COVID–19 outbreak a national
emergency.
Coronaviruses are a large family of
viruses that are common in people and
many different species of animals,
including camels, cattle, cats, and bats.
Rarely, animal coronaviruses can infect
people and then spread between people
such as with MERS-CoV, SARS-CoV,
and now with this new virus (COVID–
19).
The complete clinical picture with
regard to COVID–19 is not fully known.
Reported illnesses have ranged from
very mild (including some with no
reported symptoms) to severe, including
illness resulting in death. While
information so far suggests that most
COVID–19 illness is mild, a report out
of China suggests serious illness occurs
in 16 percent of cases. Older people and
people of all ages with severe chronic
medical conditions—like heart disease,
lung disease and diabetes, for
example—seem to be at higher risk of
developing serious COVID–19 illness.1
A pandemic is a global outbreak of
disease. Pandemics happen when a new
virus emerges to infect people and can
spread between people sustainably.
Because there is little to no pre-existing
1 https://www.cdc.gov/coronavirus/2019-ncov/
cases-updates/summary.html.
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19232
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
immunity against the new virus, it
spreads worldwide. The virus that
causes COVID–19 is infecting people
and spreading easily from person-toperson. This is the first pandemic
known to be caused by the emergence
of a new coronavirus.2
People in places where ongoing
community spread of the virus that
causes COVID–19 has been reported are
at elevated risk of exposure, with the
level of risk dependent on the location.
Healthcare workers caring for patients
with COVID–19 are at elevated risk of
exposure. Close contacts of persons with
COVID–19 also are at elevated risk of
exposure.
Early information out of China, where
COVID–19 first started, shows that some
people are at higher risk of getting very
sick from this illness. This includes:
• Older adults, with risk increasing
by age.
• People who have serious chronic
medical conditions like:
++ Heart disease.
++ Diabetes.
++ Lung disease.
The Centers for Disease Control and
Prevention (CDC) has developed
guidance to help in the risk assessment
and management of people with
potential exposures to COVID–19,
including recommending that health
care professionals make every effort to
interview a person under investigation
for infection by telephone, text
monitoring system, or video
conference.3
As the healthcare community works
to implement and establish
recommended infection prevention and
control practices, regulatory agencies
under appropriate waiver authority
granted by the PHE for the COVID–19
pandemic declaration are also working
to revise and implement regulations that
work in concert with healthcare
community infection prevention and
treatment practices. Based on the
current and projected increase in rate of
incidence of the COVID–19 disease in
the US population, and observed
fatalities in the elderly population, who
are particularly vulnerable due to age
and co-morbidities, and additionally,
impact on health workers that are at
increased risk due to treating the
population, we believe that certain
Medicare and Medicaid regulations that
may offer providers flexibilities in
furnishing services to combat the
COVID–19 pandemic should be
reviewed and revised as appropriate.
2 https://www.cdc.gov/coronavirus/2019-ncov/
cases-updates/summary.html.
3 https://www.cdc.gov/coronavirus/2019-ncov/
cases-updates/summary.html.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
We are addressing some of these
regulations in this interim final rule
with comment period (IFC) to ensure
that sufficient health care items and
services are available to meet the needs
of individuals enrolled in the programs
under Title XVIII (Medicare) and Title
XIX (Medicaid) of the Social Security
Act (the Act).
In this extraordinary circumstance,
we recognize that public exposure
greatly increases the overall risk to
public health. We believe that this
increased risk produces an immediate
change, not only in the circumstances
under which services can safely occur,
but also results in an immediate change
to the business relationships between
providers, suppliers, and practitioners.
By increasing access to services
delivered using telecommunications
technology, increasing access to testing
in a patient’s home, and improving
infection control, this IFC will provide
the necessary flexibility for Medicare
beneficiaries to be able to receive
medically necessary services without
jeopardizing their health or the health of
those who are providing those services,
while minimizing the overall risk to
public health.
II. Provisions of the Interim Final Rule
In this IFC, we are defining the term,
‘‘Public Health Emergency,’’ in the
regulation at 42 CFR 400.200, which
contains definitions that apply under
the entirety of chapter 400 of title 42 of
the CFR. The definition identifies the
PHE determined to exist nationwide by
the Secretary of Health and Human
services under section 319 of the Public
Health Service Act on January 31, 2020,
as a result of confirmed cases of COVID–
19, including any subsequent renewals.
A. Payment for Medicare Telehealth
Services Under Section 1834(m) of the
Act
Section 1834(m) of the Act specifies
the payment amounts and
circumstances under which Medicare
makes payment for a discrete set of
services, all of which must ordinarily be
furnished in-person, when they are
instead furnished using interactive, realtime telecommunication technology.
When furnished under the telehealth
rules, many of these specified Medicare
telehealth services are still reported
using codes that describe ‘‘face-to-face’’
services but are furnished using audio/
video, real-time communication
technology instead of in-person. The list
of these eligible telehealth services is
published on the CMS website at
https://www.cms.gov/Medicare/
Medicare-General-Information/
Telehealth/.
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
In contrast, Medicare pays separately
for other professional services that are
commonly furnished remotely using
telecommunications technology, but
that do not usually require the patient
to be present in-person with the
practitioner when they are furnished.
These services, including remote
physician interpretation of diagnostic
tests, care management services and
virtual check-ins among many others,
are considered physicians’ services in
the same way as services that are
furnished in-person without the use of
telecommunications technology. They
are covered and paid in the same way
as services delivered without the use of
telecommunications technology, but are
not considered Medicare telehealth
services and are not subject to the
conditions of payment under section
1834(m) of the Act.
On March 17, 2020, we announced
the expansion of telehealth services on
a temporary and emergency basis
pursuant to waiver authority added
under section 1135(b)(8) of the Act by
the Coronavirus Preparedness and
Response Supplemental Appropriations
Act, 2020 (Pub. L. 116–123, March 6,
2020). Starting on March 6, 2020,
Medicare can pay for telehealth
services, including office, hospital, and
other visits furnished by physicians and
other practitioners to patients located
anywhere in the country, including in a
patient’s place of residence. In the
context of the PHE for the COVID–19
pandemic, we recognize that physicians
and other health care professionals are
faced with new challenges regarding
potential exposure risks, for people with
Medicare, for health care providers, and
for members of the community at large.
For example, the CDC has urged health
care professionals to make every effort
to interview persons under investigation
for infection by telephone, text
messaging system, or video conference
instead of in-person. To facilitate the
use of telecommunications technology
as a safe substitute for in-person
services, we are, on an interim basis,
adding many services to the list of
eligible Medicare telehealth services,
eliminating frequency limitations and
other requirements associated with
particular services furnished via
telehealth, and clarifying several
payment rules that apply to other
services that are furnished using
telecommunications technologies that
can reduce exposure risks.
As discussed in this IFC and in prior
rulemaking, several conditions must be
met for Medicare to make payment for
telehealth services under the Physician
Fee Schedule (PFS). For further details,
see the full discussion of the scope of
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
Medicare telehealth services in the
‘‘Medicare Program; Revisions to
Payment Policies Under the Physician
Fee Schedule and Other Revisions to
Part B for CY 2018; Medicare Shared
Savings Program Requirements; and
Medicare Diabetes Prevention Program’’
final rule (82 FR 53006, November 17,
2017) (hereinafter referred to as the CY
2018 PFS final rule) and in our
regulations at 42 CFR 410.78 and
414.65.
1. Site of Service Differential for
Medicare Telehealth Services
Under the PFS, there are two payment
rates for many physicians’ services: The
facility rate; and the non-facility, or
office, rate. The PFS non-facility rate is
the single amount paid to a physician or
other practitioner for services furnished
in their office. The PFS facility rate is
the amount generally paid to a
professional when a service is furnished
in a setting of care, like a hospital,
where Medicare is making a separate
payment to an entity in addition to the
payment to the billing physician or
practitioner. This separate payment,
often referred to as a ‘‘facility fee’’
reflects the facility’s costs associated
with the service (clinical staff, supplies
and equipment) and is paid in addition
to what is paid to the professional
through the PFS.
We note that, in accordance with
section 1834(m)(2)(B) of the Act, a
facility fee is, in most cases, paid to the
‘‘originating site’’ where the beneficiary
is located at the time a telehealth service
is furnished. The payment amount for
the telehealth originating site facility fee
is a nationally applicable flat fee, paid
without geographic or site of service
adjustments that generally apply to
payments for different kinds of services
furnished by Medicare providers and
suppliers.
For Medicare telehealth services, we
currently make payment to the billing
physician or practitioner at the PFS
facility rate since the facility costs
(clinical staff, supplies, and equipment)
associated with furnishing the service
would generally be incurred by the
originating site, where the patient is
located, and not by the practitioner at
the distant site; and because the statute
requires Medicare to pay an originating
site facility fee to the site that hosts the
patient.
When a physician or practitioner
submits a claim for their services,
including claims for telehealth services,
they include a place of service (POS)
code that is used to determine whether
a service is paid using the facility or
non-facility rate. Currently, CMS
requires that claims for Medicare
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
telehealth services include the POS
code 02, which is specific to telehealth
services.
Under the waiver authority exercised
by the Secretary in response to the PHE
for the COVID–19 pandemic, Medicare
telehealth services can be furnished to
patients wherever they are located,
including in the patient’s home. As
provided by the amendments to section
1135(b)(8) of the Act, when telehealth
services are furnished under the waiver
to beneficiaries located in places that
are not identified as permissible
originating sites in section
1834(m)(4)(C)(ii)(I) through (IX) of the
Act, no originating site facility fee is
paid. We also recognize that as
physician practices suddenly transition
a potentially significant portion of their
services from in-person to telehealth
visits in the context of the PHE for the
COVID–19 pandemic, the relative
resource costs of furnishing these
services via telehealth may not
significantly differ from the resource
costs involved when these services are
furnished in person. For example, we
expect that physician offices will
continue to employ nursing staff to
engage with patients during telehealth
visits or to coordinate pre- or post-visit
care, regardless of whether or not the
visit takes place in person, as it would
have outside of the PHE for the COVID–
19 pandemic, or through telehealth in
the context of the PHE for the COVID–
19 pandemic. Consequently, the
assumptions that have supported
payment of telehealth services at the
PFS facility rate would not apply in
many circumstances for services
furnished during the PHE for the
COVID–19 pandemic. Instead, we
believe that, as more telehealth services
are furnished to patients wherever they
are located rather than in statutory
originating sites, it would be
appropriate to assume that the relative
resource costs of services furnished
through telehealth should be reflected
in the payment to the furnishing
physician or practitioner as if they
furnished the services in person, and to
assign the payment rate that ordinarily
would have been paid under the PFS
were the services furnished in-person.
For example, a physician practicing in
an office setting who, under the PHE for
the COVID–19 pandemic, sees patients
via telehealth instead of in person
would be paid at the non-facility, or
office, rate for these services. Similarly,
a physician who typically sees patients
in an outpatient provider-based clinic of
a hospital would be paid the facility rate
for services newly furnished via
telehealth.
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
19233
To implement this change on an
interim basis, we are instructing
physicians and practitioners who bill
for Medicare telehealth services to
report the POS code that would have
been reported had the service been
furnished in person. This will allow our
systems to make appropriate payment
for services furnished via Medicare
telehealth which, if not for the PHE for
the COVID–19 pandemic, would have
been furnished in person, at the same
rate they would have been paid if the
services were furnished in person.
Given the potential importance of using
telehealth services as means of
minimizing exposure risks for patients,
practitioners, and the community at
large, we believe this interim change
will maintain overall relativity under
the PFS for similar services and
eliminate potential financial deterrents
to the clinically appropriate use of
telehealth. Because we currently use the
POS code on the claim to identify
Medicare telehealth services, we are
finalizing on an interim basis the use of
the CPT telehealth modifier, modifier
95, which should be applied to claim
lines that describe services furnished
via telehealth. We note that we are
maintaining the facility payment rate for
services billed using the general
telehealth POS code 02, should
practitioners choose, for whatever
reason, to maintain their current billing
practices for Medicare telehealth during
the PHE for the COVID–19 pandemic.
2. Adding Services to the List of
Medicare Telehealth Services
In the ‘‘Medicare Program; Revisions
to Payment Policies Under the
Physician Fee Schedule for Calendar
Year 2003 and Inclusion of Registered
Nurses in the Personnel Provision of the
Critical Access Hospital Emergency
Services Requirement for Frontier Areas
and Remote Locations’’ final rule with
comment period (67 FR 79988,
December 31, 2002) (hereinafter referred
to the CY 2003 PFS final rule with
comment period), we established a
process for adding services to or
deleting services from the list of
Medicare telehealth services in
accordance with section
1834(m)(4)(F)(ii) of the Act. This
process provides the public with an
ongoing opportunity to submit requests
for adding services, which we then
review. We have also routinely
reviewed potential services for addition
to the list of telehealth services and
sought comment on any such proposed
additions. Under this process, we assign
any potential addition to the list of
telehealth services to one of the
following two categories:
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19234
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
• Category 1: Services that are similar
to professional consultations, office
visits, and office psychiatry services that
are currently on the list of telehealth
services. In reviewing these requests, we
look for similarities between the
requested and existing telehealth
services for the roles of, and interactions
among, the beneficiary, the physician
(or other practitioner) at the distant site
and, if necessary, the telepresenter, a
practitioner who is present with the
beneficiary in the originating site. We
also look for similarities in the
telecommunications system used to
deliver the service; for example, the use
of interactive audio and video
equipment.
• Category 2: Services that are not
similar to those on the current list of
telehealth services. Our review of these
requests includes an assessment of
whether the service is accurately
described by the corresponding code
when furnished via telehealth and
whether the use of a
telecommunications system to furnish
the service produces demonstrated
clinical benefit to the patient. Submitted
evidence should include both a
description of relevant clinical studies
that demonstrate the service furnished
by telehealth to a Medicare beneficiary
improves the diagnosis or treatment of
an illness or injury or improves the
functioning of a malformed body part,
including dates and findings, and a list
and copies of published peer reviewed
articles relevant to the service when
furnished via telehealth. Our
evidentiary standard of clinical benefit
does not include minor or incidental
benefits.
Some examples of clinical benefit
include the following:
• Ability to diagnose a medical
condition in a patient population
without access to clinically appropriate
in-person diagnostic services.
• Treatment option for a patient
population without access to clinically
appropriate in-person treatment options.
• Reduced rate of complications.
• Decreased rate of subsequent
diagnostic or therapeutic interventions
(for example, due to reduced rate of
recurrence of the disease process).
• Decreased number of future
hospitalizations or physician visits.
• More rapid beneficial resolution of
the disease process treatment.
• Decreased pain, bleeding, or other
quantifiable symptom.
• Reduced recovery time.
The list of telehealth services,
including the additions described later
in this section, can be located on the
CMS website at https://www.cms.gov/
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
Medicare/Medicare-GeneralInformation/Telehealth/.
On an interim basis, we are adding
the following services to the Medicare
telehealth list on a Category 2 basis for
the duration of this PHE for the COVID–
19 pandemic, for telehealth services
with dates of service beginning March 1,
2020 through the end of the declared
PHE including any subsequent
renewals. When we previously
considered adding these services to the
list of telehealth services, either through
a public request or through our own
internal review, we considered whether
or not these services met the category 1
or category 2 criteria. In many cases we
reviewed requests to add these services
on a category 1 basis but did not receive
or identify information that allowed us
to review the services on a category 2
basis. While we do not believe the
context of this PHE for the COVID–19
pandemic changes the assessment of
these services as category 1, we have
reassessed all of these services on a
category 2 basis in the context of the
widespread presence of COVID–19 in
the community. Given the exposure
risks for beneficiaries, the health care
work force, and the community at large,
in-person interaction between
professionals and patients poses an
immediate potential risk that would not
have been present when we previously
reviewed these services. This new risk
creates a unique circumstance where
health care professionals need to weigh
the risks associated with disease
exposure so they can bill Medicare for
the service. For example, certain
persons, especially older adults who are
particularly vulnerable to this specific
virus, those considered at risk because
of underlying health conditions, and
those known to be recently exposed or
diagnosed, and therefore, likely to
spread the virus to others, are often
being directed by local public health
officials to self-isolate as much as
possible. At the same time, we note that
the risks to medical professionals
treating patients is high and we consider
it likely that medical professionals will
try to treat patients as effectively as
possible without exposing themselves or
their patients unnecessarily. In some
cases, use of telecommunication
technology could mitigate the exposure
risk, and in such cases, there is a clear
clinical benefit of using such technology
in furnishing the service. In other
words, patients who should not be seen
by a professional in-person due to the
exposure risk are highly likely to be
without access to clinically appropriate
treatment or diagnostic options unless
they have access to services furnished
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
through interactive communication
technology. Therefore, in the context of
the PHE for the COVID–19 pandemic,
we believe all of the following services
meet the category 2 criteria to be added
to the list of telehealth services on the
basis that there is a patient population
that would otherwise not have access to
clinically appropriate treatment. We
note that, as with other services on the
Medicare telehealth list, it may not be
clinically appropriate or possible to use
telecommunications technology to
furnish these particular services to every
person or in every circumstance.
However, in the context of the PHE for
the COVID–19 pandemic with specific
regard to the exposure risks noted
above, we recognize the clinical benefit
of access to medically reasonable and
necessary services furnished using
telecommunications technology as
opposed to the potential lack of access
that could occur to mitigate the risk of
disease exposure. In light of the PHE for
the COVID–19 pandemic, the demand
for physicians in areas heavily impacted
by COVID–19 or under served by
clinicians may intensify, resulting in a
need for critical care services for
patients with suspected or diagnosed
COVID–19 and those who are in acute
care settings due to other conditions.
These practitioners may be working
with nurses, consulting with other
healthcare professionals, writing orders,
looking at images, communicating with
family members for patients with a
number of acute conditions. The CPT
codes describing E/M services reflect an
assumption that the nature of the work
involved in evaluation and management
visits varies, in part, based on the
setting of care and the patient’s status.
Consequently, there are separate sets of
E/M codes for different settings of care,
such as office/outpatient codes, nursing
facility codes, or emergency department
codes. We expect physicians and other
practitioners to use the E/M code that
best describes the nature of the care they
are providing, regardless of the physical
location or status of the patient. Under
ordinary circumstances, we would
expect the kind of E/M code reported to
generally align with the physical
location or status of the patient. In the
context of the PHE, we recognize that
the relationship among the setting of
care, patient status, and kind of E/M
code reported may depend on the needs
of local communities and the capacity of
local health care institutions.
Consequently, we are reiterating that
practitioners should report the E/M
code that best describes the nature of
the care they are providing.
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
We are adding the following codes to
the existing list of telehealth services on
a Category 2 basis for the PHE for the
COVID–19 pandemic:
jbell on DSKJLSW7X2PROD with RULES2
3. Emergency Department Visits: CPT
Codes
• 99281 (Emergency department visit
for the evaluation and management of
a patient, which requires these 3 key
components: A problem focused history;
A problem focused examination; and
Straightforward medical decision
making. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are self limited or minor.)
• 99282 (Emergency department visit
for the evaluation and management of
a patient, which requires these 3 key
components: An expanded problem
focused history; An expanded problem
focused examination; and Medical
decision making of low complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the
presenting problem(s) are of low to
moderate severity.)
• 99283 (Emergency department visit
for the evaluation and management of
a patient, which requires these 3 key
components: An expanded problem
focused history; An expanded problem
focused examination; and Medical
decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of moderate severity.)
• 99284 (Emergency department visit
for the evaluation and management of
a patient, which requires these 3 key
components: A detailed history; A
detailed examination; and Medical
decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of high severity, and
require urgent evaluation by the
physician, or other qualified health care
professionals but do not pose an
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
immediate significant threat to life or
physiologic function.)
• 99285 (Emergency department visit
for the evaluation and management of
a patient, which requires these 3 key
components within the constraints
imposed by the urgency of the patient’s
clinical condition and/or mental status:
A comprehensive history; A
comprehensive examination; and
Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of high severity and pose
an immediate significant threat to life or
physiologic function.)
4. Initial and Subsequent Observation,
and Observation Discharge Day
Management: CPT Codes
• 99217 (Observation care discharge
day management (This code is to be
utilized to report all services provided to
a patient on discharge from outpatient
hospital ‘‘observation status’’ if the
discharge is on other than the initial
date of ‘‘observation status.’’ To report
services to a patient designated as
‘‘observation status’’ or ‘‘inpatient
status’’ and discharged on the same
date, use the codes for Observation or
Inpatient Care Services [including
Admission and Discharge Services,
99234–99236 as appropriate.])
• 99218 (Initial observation care, per
day, for the evaluation and management
of a patient which requires these 3 key
components: A detailed or
comprehensive history; A detailed or
comprehensive examination; and
Medical decision making that is
straightforward or of low complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the
problem(s) requiring admission to
outpatient hospital ‘‘observation status’’
are of low severity. Typically, 30
minutes are spent at the bedside and on
the patient’s hospital floor or unit.)
• 99219 (Initial observation care, per
day, for the evaluation and management
of a patient, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
19235
problem(s) and the patient’s and/or
family’s needs. Usually, the problem(s)
requiring admission to outpatient
hospital ‘‘observation status’’ are of
moderate severity. Typically, 50 minutes
are spent at the bedside and on the
patient’s hospital floor or unit.)
• 99220 (Initial observation care, per
day, for the evaluation and management
of a patient, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the problem(s)
requiring admission to outpatient
hospital ‘‘observation status’’ are of high
severity. Typically, 70 minutes are spent
at the bedside and on the patient’s
hospital floor or unit.)
• 99224 (Subsequent observation
care, per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: Problem focused interval
history; Problem focused examination;
Medical decision making that is
straightforward or of low complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the patient is
stable, recovering, or improving.
Typically, 15 minutes are spent at the
bedside and on the patient’s hospital
floor or unit.)
• 99225 (Subsequent observation
care, per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: An expanded problem
focused interval history; An expanded
problem focused examination; Medical
decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the patient is
responding inadequately to therapy or
has developed a minor complication.
Typically, 25 minutes are spent at the
bedside and on the patient’s hospital
floor or unit.)
• 99226 (Subsequent observation
care, per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: A detailed interval history;
A detailed examination; Medical
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19236
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
decision making of high complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the patient is
unstable or has developed a significant
complication or a significant new
problem. Typically, 35 minutes are
spent at the bedside and on the patient’s
hospital floor or unit.)
• 99234 (Observation or inpatient
hospital care, for the evaluation and
management of a patient including
admission and discharge on the same
date, which requires these 3 key
components: A detailed or
comprehensive history; A detailed or
comprehensive examination; and
Medical decision making that is
straightforward or of low complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually the
presenting problem(s) requiring
admission are of low severity. Typically,
40 minutes are spent at the bedside and
on the patient’s hospital floor or unit.)
• 99235 (Observation or inpatient
hospital care, for the evaluation and
management of a patient including
admission and discharge on the same
date, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually the presenting
problem(s) requiring admission are of
moderate severity. Typically, 50 minutes
are spent at the bedside and on the
patient’s hospital floor or unit.)
• 99236 (Observation or inpatient
hospital care, for the evaluation and
management of a patient including
admission and discharge on the same
date, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually the presenting
problem(s) requiring admission are of
high severity. Typically, 55 minutes are
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
spent at the bedside and on the patient’s
hospital floor or unit.)
5. Initial Hospital Care and Hospital
Discharge Day Management: CPT Codes
• 99221 (Initial hospital care, per
day, for the evaluation and management
of a patient, which requires these 3 key
components: A detailed or
comprehensive history; A detailed or
comprehensive examination; and
Medical decision making that is
straightforward or of low complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the
problem(s) requiring admission are of
low severity. Typically, 30 minutes are
spent at the bedside and on the patient’s
hospital floor or unit.)
• 99222 (Initial hospital care, per
day, for the evaluation and management
of a patient, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the problem(s)
requiring admission are of moderate
severity. Typically, 50 minutes are spent
at the bedside and on the patient’s
hospital floor or unit.)
• 99223 (Initial hospital care, per
day, for the evaluation and management
of a patient, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the problem(s)
requiring admission are of high severity.
Typically, 70 minutes are spent at the
bedside and on the patient’s hospital
floor or unit.)
• 99238 (Hospital discharge day
management; 30 minutes or less)
• 99239 (Hospital discharge day
management; more than 30 minutes)
6. Initial Nursing Facility Visits and
Nursing Facility Discharge Day
Management: CPT Codes
• 99304 (Initial nursing facility care,
per day, for the evaluation and
management of a patient, which
requires these 3 key components: A
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
detailed or comprehensive history; A
detailed or comprehensive examination;
and Medical decision making that is
straightforward or of low complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the
problem(s) requiring admission are of
low severity. Typically, 25 minutes are
spent at the bedside and on the patient’s
facility floor or unit.)
• 99305 (Initial nursing facility care,
per day, for the evaluation and
management of a patient, which
requires these 3 key components: A
comprehensive history; A
comprehensive examination; and
Medical decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the problem(s)
requiring admission are of moderate
severity. Typically, 35 minutes are spent
at the bedside and on the patient’s
facility floor or unit.)
• 99306 (Initial nursing facility care,
per day, for the evaluation and
management of a patient, which
requires these 3 key components: A
comprehensive history; A
comprehensive examination; and
Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the problem(s)
requiring admission are of high severity.
Typically, 45 minutes are spent at the
bedside and on the patient’s facility
floor or unit.)
• 99315 (Nursing facility discharge
day management; 30 minutes or less)
• 99316 (Nursing facility discharge
day management; more than 30
minutes)
7. Critical Care Services: CPT Codes
• 99291 (Critical care, evaluation and
management of the critically ill or
critically injured patient; first 30–74
minutes)
• 99292 (Critical care, evaluation and
management of the critically ill or
critically injured patient; each
additional 30 minutes (List separately in
addition to code for primary service))
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
8. Domiciliary, Rest Home, or Custodial
Care Services: CPT Codes
• 99327 (Domiciliary or rest home
visit for the evaluation and management
of a new patient, which requires these
3 key components: A comprehensive
history; A comprehensive examination;
and Medical decision making of
moderate complexity. Counseling and/
or coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of high severity.
Typically, 60 minutes are spent with the
patient and/or family or caregiver.)
• 99328 (Domiciliary or rest home
visit for the evaluation and management
of a new patient, which requires these
3 key components: A comprehensive
history; A comprehensive examination;
and Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the patient is
unstable or has developed a significant
new problem requiring immediate
physician attention. Typically, 75
minutes are spent with the patient and/
or family or caregiver.)
• 99334 (Domiciliary or rest home
visit for the evaluation and management
of an established patient, which requires
at least 2 of these 3 key components: A
problem focused interval history; A
problem focused examination;
Straightforward medical decision
making. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are self-limited or minor.
Typically, 15 minutes are spent with the
patient and/or family or caregiver.)
• 99335 (Domiciliary or rest home
visit for the evaluation and management
of an established patient, which requires
at least 2 of these 3 key components: An
expanded problem focused interval
history; An expanded problem focused
examination; Medical decision making
of low complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of low to moderate
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
severity. Typically, 25 minutes are spent
with the patient and/or family or
caregiver.)
• 99336 (Domiciliary or rest home
visit for the evaluation and management
of an established patient, which requires
at least 2 of these 3 key components: A
detailed interval history; A detailed
examination; Medical decision making
of moderate complexity. Counseling
and/or coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of moderate to high
severity. Typically, 40 minutes are spent
with the patient and/or family or
caregiver.)
• 99337 (Domiciliary or rest home
visit for the evaluation and management
of an established patient, which requires
at least 2 of these 3 key components: A
comprehensive interval history; A
comprehensive examination; Medical
decision making of moderate to high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of moderate to high
severity. The patient may be unstable or
may have developed a significant new
problem requiring immediate physician
attention. Typically, 60 minutes are
spent with the patient and/or family or
caregiver.)
9. Home Visits: CPT Codes
• 99341 (Home visit for the
evaluation and management of a new
patient, which requires these 3 key
components: A problem focused history;
A problem focused examination; and
Straightforward medical decision
making. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of low severity. Typically,
20 minutes are spent face-to-face with
the patient and/or family.)
• 99342 (Home visit for the
evaluation and management of a new
patient, which requires these 3 key
components: An expanded problem
focused history; An expanded problem
focused examination; and Medical
decision making of low complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
19237
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the
presenting problem(s) are of moderate
severity. Typically, 30 minutes are spent
face-to-face with the patient and/or
family.)
• 99343 (Home visit for the
evaluation and management of a new
patient, which requires these 3 key
components: A detailed history; A
detailed examination; and Medical
decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of moderate to high
severity. Typically, 45 minutes are spent
face-to-face with the patient and/or
family.)
• 99344 (Home visit for the
evaluation and management of a new
patient, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of high severity.
Typically, 60 minutes are spent face-toface with the patient and/or family.)
• 99345 (Home visit for the
evaluation and management of a new
patient, which requires these 3 key
components: A comprehensive history;
A comprehensive examination; and
Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the patient is
unstable or has developed a significant
new problem requiring immediate
physician attention. Typically, 75
minutes are spent face-to-face with the
patient and/or family.)
• 99347 (Home visit for the
evaluation and management of an
established patient, which requires at
least 2 of these 3 key components: A
problem focused interval history; A
problem focused examination;
Straightforward medical decision
making. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
E:\FR\FM\06APR2.SGM
06APR2
19238
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are self limited or minor.
Typically, 15 minutes are spent face-toface with the patient and/or family.)
• 99348 (Home visit for the
evaluation and management of an
established patient, which requires at
least 2 of these 3 key components: An
expanded problem focused interval
history; An expanded problem focused
examination; Medical decision making
of low complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of low to moderate
severity. Typically, 25 minutes are spent
face-to-face with the patient and/or
family.)
• 99349 (Home visit for the
evaluation and management of an
established patient, which requires at
least 2 of these 3 key components: A
detailed interval history; A detailed
examination; Medical decision making
of moderate complexity. Counseling
and/or coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are moderate to high
severity. Typically, 40 minutes are spent
face-to-face with the patient and/or
family.)
• 99350 (Home visit for the
evaluation and management of an
established patient, which requires at
least 2 of these 3 key components: A
comprehensive interval history; A
comprehensive examination; Medical
decision making of moderate to high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the presenting
problem(s) are of moderate to high
severity. The patient may be unstable or
may have developed a significant new
problem requiring immediate physician
attention. Typically, 60 minutes are
spent face-to-face with the patient and/
or family.)
10. Inpatient Neonatal and Pediatric
Critical Care: CPT Codes
• 99468 (Initial inpatient neonatal
critical care, per day, for the evaluation
and management of a critically ill
neonate, 28 days of age or younger)
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
• 99469 (Subsequent inpatient
neonatal critical care, per day, for the
evaluation and management of a
critically ill neonate, 28 days of age or
younger)
• 99471 (Initial inpatient pediatric
critical care, per day, for the evaluation
and management of a critically ill infant
or young child, 29 days through 24
months of age)
• 99472 (Subsequent inpatient
pediatric critical care, per day, for the
evaluation and management of a
critically ill infant or young child, 29
days through 24 months of age)
• 99473 (Self-measured blood
pressure using a device validated for
clinical accuracy; patient education/
training and device calibration)
• 99475 (Initial inpatient pediatric
critical care, per day, for the evaluation
and management of a critically ill infant
or young child, 2 through 5 years of age)
• 99476 (Subsequent inpatient
pediatric critical care, per day, for the
evaluation and management of a
critically ill infant or young child, 2
through 5 years of age)
staging of dementia (eg, functional
assessment staging test [FAST], clinical
dementia rating [CDR]); Medication
reconciliation and review for high-risk
medications; Evaluation for
neuropsychiatric and behavioral
symptoms, including depression,
including use of standardized screening
instrument(s); Evaluation of safety (eg,
home), including motor vehicle
operation; Identification of caregiver(s),
caregiver knowledge, caregiver needs,
social supports, and the willingness of
caregiver to take on caregiving tasks;
Development, updating or revision, or
review of an Advance Care Plan;
Creation of a written care plan,
including initial plans to address any
neuropsychiatric symptoms, neurocognitive symptoms, functional
limitations, and referral to community
resources as needed (eg, rehabilitation
services, adult day programs, support
groups) shared with the patient and/or
caregiver with initial education and
support. Typically, 50 minutes are spent
face-to-face with the patient and/or
family or caregiver.)
11. Initial and Continuing Intensive
Care Services: CPT Codes
• 99477 (Initial hospital care, per
day, for the evaluation and management
of the neonate, 28 days of age or
younger, who requires intensive
observation, frequent interventions, and
other intensive care services)
• 99478 (Subsequent intensive care,
per day, for the evaluation and
management of the recovering very low
birth weight infant (present body weight
less than 1500 grams))
• 99479 (Subsequent intensive care,
per day, for the evaluation and
management of the recovering low birth
weight infant (present body weight of
1500–2500 grams))
• 99480 (Subsequent intensive care,
per day, for the evaluation and
management of the recovering infant
(present body weight of 2501–5000
grams))
13. Group Psychotherapy: CPT Code
12. Care Planning for Patients With
Cognitive Impairment: CPT Code
• 99483 (Assessment of and care
planning for a patient with cognitive
impairment, requiring an independent
historian, in the office or other
outpatient, home or domiciliary or rest
home, with all of the following required
elements: Cognition-focused evaluation
including a pertinent history and
examination; Medical decision making
of moderate or high complexity;
Functional assessment (eg, basic and
instrumental activities of daily living),
including decision-making capacity;
Use of standardized instruments for
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
• 90853 (Group psychotherapy (other
than of a multiple-family group))
14. End-Stage Renal Disease (ESRD)
Services: CPT Codes
• 90952 (End-stage renal disease
(ESRD) related services monthly, for
patients younger than 2 years of age to
include monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 2–3 face-to-face visits by a
physician or other qualified health care
professional per month)
• 90953 (End-stage renal disease
(ESRD) related services monthly, for
patients younger than 2 years of age to
include monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 1 face-to-face visit by a physician
or other qualified health care
professional per month)
• 90959 (End-stage renal disease
(ESRD) related services monthly, for
patients 12–19 years of age to include
monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 1 face-to-face visit by a physician
or other qualified health care
professional per month)
• 90962 (End-stage renal disease
(ESRD) related services monthly, for
patients 20 years of age and older; with
1 face-to-face visit by a physician or
other qualified health care professional
per month)
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
15. Psychological and
Neuropsychological Testing: CPT Codes
• 96130 (Psychological testing
evaluation services by physician or
other qualified health care professional,
including integration of patient data,
interpretation of standardized test
results and clinical data, clinical
decision making, treatment planning
and report, and interactive feedback to
the patient, family member(s) or
caregiver(s), when performed; first hour)
• 96131 (Psychological testing
evaluation services by physician or
other qualified health care professional,
including integration of patient data,
interpretation of standardized test
results and clinical data, clinical
decision making, treatment planning
and report, and interactive feedback to
the patient, family member(s) or
caregiver(s), when performed; each
additional hour (List separately in
addition to code for primary procedure))
• 96132 (Neuropsychological testing
evaluation services by physician or
other qualified health care professional,
including integration of patient data,
interpretation of standardized test
results and clinical data, clinical
decision making, treatment planning
and report, and interactive feedback to
the patient, family member(s) or
caregiver(s), when performed; first hour)
• 96133 (Neuropsychological testing
evaluation services by physician or
other qualified health care professional,
including integration of patient data,
interpretation of standardized test
results and clinical data, clinical
decision making, treatment planning
and report, and interactive feedback to
the patient, family member(s) or
caregiver(s), when performed; each
additional hour (List separately in
addition to code for primary procedure))
• 96136 (Psychological or
neuropsychological test administration
and scoring by physician or other
qualified health care professional, two
or more tests, any method; first 30
minutes)
• 96137 (Psychological or
neuropsychological test administration
and scoring by physician or other
qualified health care professional, two
or more tests, any method; each
additional 30 minutes (List separately in
addition to code for primary procedure))
• 96138 (Psychological or
neuropsychological test administration
and scoring by technician, two or more
tests, any method; first 30 minutes)
• 96139 (Psychological or
neuropsychological test administration
and scoring by technician, two or more
tests, any method; each additional 30
minutes (List separately in addition to
code for primary procedure))
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
16. Therapy Services
We have received a number of
requests, most recently for CY 2018 PFS
rulemaking, that we add therapy
services to the Medicare telehealth list.
In the CY 2018 PFS final rule, we noted
that section 1834(m)(4)(E) of the Act
specifies the types of practitioners who
may furnish and bill for Medicare
telehealth services as those practitioners
under section 1842(b)(18)(C) of the Act.
Physical therapists, occupational
therapists and speech-language
pathologists are not among the
practitioners identified in section
1842(b)(18)(C) of the Act. We stated in
the Medicare Program; Revisions to
Payment Policies under the Physician
Fee Schedule and Other Revisions to
Part B for CY 2017; Medicare Advantage
Bid Pricing Data Release; Medicare
Advantage and Part D Medical Loss
Ratio Data Release; Medicare Advantage
Provider Network Requirements;
Expansion of Medicare Diabetes
Prevention Program Model; Medicare
Shared Savings Program Requirements’’
final rule (81 FR 80198, November 15,
2016) (hereinafter referred to as the CY
2017 PFS final rule) that because these
services are predominantly furnished by
physical therapists, occupational
therapists and speech-language
pathologists, we did not believe it
would be appropriate to add them to the
list of telehealth services at this time. In
a subsequent request to consider adding
these services for 2018, the original
requester suggested that we might
propose these services to be added to
the list so that they can be furnished via
telehealth when furnished by eligible
distant site practitioners. Since the
majority of the codes are furnished over
90 percent of the time by therapy
professionals, who are not included on
the statutory list of eligible distant site
practitioners, we stated that we believed
that adding therapy services to the
telehealth list could result in confusion
about who is authorized to furnish and
bill for these services when furnished
via telehealth.
In light of the PHE for the COVID–19
pandemic, we believe that the risks
associated with confusion are
outweighed by the potential benefits for
circumstances when these services
might be furnished via telehealth by
eligible distant site practitioners. We
believe this is sufficient clinical
evidence to support the addition of
therapy services to the Medicare
telehealth list on a category 2 basis.
However, we note that the statutory
definition of distant site practitioners
under section 1834(m) of the Act does
not include physical therapists,
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
19239
occupational therapists, or speechlanguage pathologists, meaning that it
does not provide for payment for these
services as Medicare telehealth services
when furnished by physical therapists,
occupational therapists, or speechlanguage pathologists.
CPT codes:
• 97161 (Physical therapy evaluation:
low complexity, requiring these
components: A history with no personal
factors and/or comorbidities that impact
the plan of care; An examination of
body system(s) using standardized tests
and measures addressing 1–2 elements
from any of the following: body
structures and functions, activity
limitations, and/or participation
restrictions; A clinical presentation with
stable and/or uncomplicated
characteristics; and Clinical decision
making of low complexity using
standardized patient assessment
instrument and/or measurable
assessment of functional outcome.
Typically, 20 minutes are spent face-toface with the patient and/or family.)
• 97162 (Physical therapy evaluation:
moderate complexity, requiring these
components: A history of present
problem with 1–2 personal factors and/
or comorbidities that impact the plan of
care; An examination of body systems
using standardized tests and measures
in addressing a total of 3 or more
elements from any of the following:
body structures and functions, activity
limitations, and/or participation
restrictions; An evolving clinical
presentation with changing
characteristics; and Clinical decision
making of moderate complexity using
standardized patient assessment
instrument and/or measurable
assessment of functional outcome.
Typically, 30 minutes are spent face-toface with the patient and/or family.)
• 97163 (Physical therapy evaluation:
high complexity, requiring these
components: A history of present
problem with 3 or more personal factors
and/or comorbidities that impact the
plan of care; An examination of body
systems using standardized tests and
measures addressing a total of 4 or more
elements from any of the following:
body structures and functions, activity
limitations, and/or participation
restrictions; A clinical presentation with
unstable and unpredictable
characteristics; and Clinical decision
making of high complexity using
standardized patient assessment
instrument and/or measurable
assessment of functional outcome.
Typically, 45 minutes are spent face-toface with the patient and/or family.)
• 97164 (Re-evaluation of physical
therapy established plan of care,
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19240
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
requiring these components: An
examination including a review of
history and use of standardized tests
and measures is required; and Revised
plan of care using a standardized
patient assessment instrument and/or
measurable assessment of functional
outcome. Typically, 20 minutes are
spent face-to-face with the patient and/
or family.)
• 97165 (Occupational therapy
evaluation, low complexity, requiring
these components: An occupational
profile and medical and therapy history,
which includes a brief history including
review of medical and/or therapy
records relating to the presenting
problem; An assessment(s) that
identifies 1–3 performance deficits (ie,
relating to physical, cognitive, or
psychosocial skills) that result in
activity limitations and/or participation
restrictions; and Clinical decision
making of low complexity, which
includes an analysis of the occupational
profile, analysis of data from problemfocused assessment(s), and
consideration of a limited number of
treatment options. Patient presents with
no comorbidities that affect
occupational performance. Modification
of tasks or assistance (eg, physical or
verbal) with assessment(s) is not
necessary to enable completion of
evaluation component. Typically, 30
minutes are spent face-to-face with the
patient and/or family.)
• 97166 (Occupational therapy
evaluation, moderate complexity,
requiring these components: An
occupational profile and medical and
therapy history, which includes an
expanded review of medical and/or
therapy records and additional review
of physical, cognitive, or psychosocial
history related to current functional
performance; An assessment(s) that
identifies 3–5 performance deficits (ie,
relating to physical, cognitive, or
psychosocial skills) that result in
activity limitations and/or participation
restrictions; and Clinical decision
making of moderate analytic
complexity, which includes an analysis
of the occupational profile, analysis of
data from detailed assessment(s), and
consideration of several treatment
options. Patient may present with
comorbidities that affect occupational
performance. Minimal to moderate
modification of tasks or assistance (eg,
physical or verbal) with assessment(s) is
necessary to enable patient to complete
evaluation component. Typically, 45
minutes are spent face-to-face with the
patient and/or family.)
• 97167 (Occupational therapy
evaluation, high complexity, requiring
these components: An occupational
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
profile and medical and therapy history,
which includes review of medical and/
or therapy records and extensive
additional review of physical, cognitive,
or psychosocial history related to
current functional performance; An
assessment(s) that identifies 5 or more
performance deficits (ie, relating to
physical, cognitive, or psychosocial
skills) that result in activity limitations
and/or participation restrictions; and
Clinical decision making of high
analytic complexity, which includes an
analysis of the patient profile, analysis
of data from comprehensive
assessment(s), and consideration of
multiple treatment options. Patient
presents with comorbidities that affect
occupational performance. Significant
modification of tasks or assistance (eg,
physical or verbal) with assessment(s) is
necessary to enable patient to complete
evaluation component. Typically, 60
minutes are spent face-to-face with the
patient and/or family.)
• 97168 (Re-evaluation of
occupational therapy established plan
of care, requiring these components: An
assessment of changes in patient
functional or medical status with
revised plan of care; An update to the
initial occupational profile to reflect
changes in condition or environment
that affect future interventions and/or
goals; and A revised plan of care. A
formal reevaluation is performed when
there is a documented change in
functional status or a significant change
to the plan of care is required.
Typically, 30 minutes are spent face-toface with the patient and/or family.)
• 97110 (Therapeutic procedure, 1 or
more areas, each 15 minutes;
therapeutic exercises to develop
strength and endurance, range of
motion and flexibility)
• 97112 (Therapeutic procedure, 1 or
more areas, each 15 minutes;
neuromuscular reeducation of
movement, balance, coordination,
kinesthetic sense, posture, and/or
proprioception for sitting and/or
standing activities)
• 97116 (Therapeutic procedure, 1 or
more areas, each 15 minutes; gait
training (includes stair climbing)
• 97535 (Self-care/home management
training (eg, activities of daily living
(ADL) and compensatory training, meal
preparation, safety procedures, and
instructions in use of assistive
technology devices/adaptive equipment)
direct one-on-one contact, each 15
minutes)
• 97750 (Physical performance test or
measurement (eg, musculoskeletal,
functional capacity), with written report,
each 15 minutes)
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
• 97755 (Assistive technology
assessment (e.g., to restore, augment or
compensate for existing function,
optimize functional tasks and/or
maximize environmental accessibility),
direct one-on-one contact, with written
report, each 15 minutes)
• 97760 (Orthotic(s) management and
training (including assessment and
fitting when not otherwise reported),
upper extremity(ies), lower
extremity(ies) and/or trunk, initial
orthotic(s) encounter, each 15 minutes)
• 97761 (Prosthetic(s) training, upper
and/or lower extremity(ies), initial
prosthetic(s) encounter, each 15
minutes)
• 92521 (Evaluation of speech fluency
(eg, stuttering, cluttering)
• 92522 (Evaluation of speech sound
production (eg, articulation,
phonological process, apraxia,
dysarthria)
• 92523 (Evaluation of speech sound
production (eg, articulation,
phonological process, apraxia,
dysarthria); with evaluation of language
comprehension and expression (eg,
receptive and expressive language)
• 92524 (Behavioral and qualitative
analysis of voice and resonance)
• 92507 (Treatment of speech,
language, voice, communication, and/or
auditory processing disorder;
individual)
17. Radiation Treatment Management
Services
The code used to report radiation
treatment management services includes
several components, including
reviewing the radiation dose and
various treatment parameters, as well as
weekly face-to-face visits with the
patient to assess the patient’s response
to treatment and manage any symptoms
the patient may be experiencing. We
believe that in the context of the PHE for
the COVID–19 pandemic, the weekly
face-to-face visit component of this
service could be conducted via
telehealth when the billing practitioner
weighs the exposure risks against the
value of in-person assessment on a caseby-case basis. Therefore, we are adding
CPT code 77427 (Radiation treatment
management, 5 treatments) to the
telehealth list so that the required faceto-face visit can be furnished via
telehealth.
We believe that allowing the services
listed above to be furnished as Medicare
telehealth services will significantly
increase the ability of Medicare
physicians and practitioners to work
without increasing exposure risk to
themselves, their patients, and the
broader community. Given widespread
concerns regarding the health and safety
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
of our beneficiaries and health care
providers during the PHE for the
COVID–19 pandemic, we seek input on
whether there are other services where
the use of telecommunications
technology could mitigate the exposure
risk, and where there is clear clinical
benefit to using such technology in
furnishing the service.
We note that the inclusion of this
code on the telehealth list to ensure that
the included visits can be furnished via
telehealth is similar to the inclusion of
the transitional care management codes
on the telehealth list. In both of these
cases, the non-face-to-face portions of
the service are not considered telehealth
services that are subject to any of the
payment provisions specific to
telehealth services under section
1834(m) of the Act.
• CPT code 77427 (Radiation
treatment management, 5 treatments)
As we noted above, we have
previously considered adding many of
these services to the Medicare telehealth
list in prior rulemaking and declined, in
many cases citing concerns over patient
acuity and the feasibility of fulfilling all
of the required elements of a service via
communication technology. However,
in the context of the PHE for the
COVID–19 pandemic with specific
regard to the exposure risks noted
above, we recognize the clinical benefit
of access to medically reasonable and
necessary services furnished using
telecommunications technology as
opposed to the potential lack of access
that could occur to mitigate the risk of
disease exposure. We are also interested
in learning of any potential negative
consequences of adding these CPT
codes to the list of telehealth services on
an interim basis.
B. Frequency Limitations on Subsequent
Care Services in Inpatient and Nursing
Facility Settings, and Critical Care
Consultations and Required ‘‘HandsOn’’ Visits for ESRD Monthly Capitation
Payments
In adding some services to the
Medicare telehealth list, we have done
so while including certain restrictions
on how frequently a service may be
furnished via Medicare telehealth to
ensure that the services met the category
1 or 2 criteria. For example, in the CY
2011 PFS final rule (75 FR 73317
through 73318), we added the
subsequent hospital care services to the
Medicare telehealth list. We stated that,
because of our concerns regarding the
potential acuity of hospital inpatients,
we would limit the provision of
subsequent hospital care services
through telehealth to once every 3 days.
Similarly, when we added subsequent
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
nursing facility visits to the Medicare
telehealth list, we stated our concerns
regarding the potential acuity and
complexity of nursing facility (NF)
patients, we would limit the provision
of subsequent nursing facility care
services furnished through telehealth to
once every 30 days.
Given our assessment that under the
PHE for the COVID–19 pandemic, there
is a patient population that would
otherwise not have access to clinically
appropriate in-person treatment, we do
not believe these frequency limitations
are appropriate or necessary. In our
prior analysis, for example, we were
concerned that patients might not
receive the necessary in-person services
for nursing facility or hospital inpatient
services. Since in the context of this
PHE, telehealth visits mitigate exposure
risk, fewer in-person visits may reflect
the most appropriate care, depending on
the needs of individual patients.
Consequently, on an interim basis, we
are removing the frequency restrictions
for each of the following listed codes for
subsequent inpatient visits and
subsequent NF visits furnished via
Medicare telehealth for the duration of
the PHE for the COVID–19 pandemic.
Similarly, we note that we previously
limited critical care consultations
through telehealth to only once per day,
given the patient acuity involved in
critical care. However, we also
understand that critical care patients
have significant exposure risks such that
more frequent services furnished via
telehealth may reflect the best available
care in the context and for the duration
of the PHE for the COVID–19 pandemic.
For this reason, we are also removing
the restriction that critical care
consultation codes may only be
furnished to a Medicare beneficiary
once per day. These restrictions were
established through rulemaking and
implemented through systems edits.
1. Subsequent Inpatient Visits: CPT
Codes
• 99231 (Subsequent hospital care,
per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: A problem focused interval
history; A problem focused
examination; Medical decision making
that is straightforward or of low
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the patient is
stable, recovering or improving.
Typically, 15 minutes are spent at the
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
19241
bedside and on the patient’s hospital
floor or unit.)
• 99232 (Subsequent hospital care,
per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: An expanded problem
focused interval history; An expanded
problem focused examination; Medical
decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the patient is
responding inadequately to therapy or
has developed a minor complication.
Typically, 25 minutes are spent at the
bedside and on the patient’s hospital
floor or unit.)
• 99233 (Subsequent hospital care,
per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: A detailed interval history;
A detailed examination; Medical
decision making of high complexity.
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the patient is
unstable or has developed a significant
complication or a significant new
problem. Typically, 35 minutes are
spent at the bedside and on the patient’s
hospital floor or unit.)
2. Subsequent Nursing Facility Visits:
CPT Codes
• 99307 (Subsequent nursing facility
care, per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: A problem focused interval
history; A problem focused
examination; Straightforward medical
decision making. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the patient is
stable, recovering, or improving.
Typically, 10 minutes are spent at the
bedside and on the patient’s facility
floor or unit.)
• 99308 (Subsequent nursing facility
care, per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: An expanded problem
focused interval history; An expanded
problem focused examination; Medical
decision making of low complexity.
E:\FR\FM\06APR2.SGM
06APR2
19242
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
Counseling and/or coordination of care
with other physicians, other qualified
health care professionals, or agencies
are provided consistent with the nature
of the problem(s) and the patient’s and/
or family’s needs. Usually, the patient is
responding inadequately to therapy or
has developed a minor complication.
Typically, 15 minutes are spent at the
bedside and on the patient’s facility
floor or unit.)
• 99309 (Subsequent nursing facility
care, per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: A detailed interval history;
A detailed examination; Medical
decision making of moderate
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. Usually, the patient has
developed a significant complication or
a significant new problem. Typically, 25
minutes are spent at the bedside and on
the patient’s facility floor or unit.)
• 99310 (Subsequent nursing facility
care, per day, for the evaluation and
management of a patient, which
requires at least 2 of these 3 key
components: A comprehensive interval
history; A comprehensive examination;
Medical decision making of high
complexity. Counseling and/or
coordination of care with other
physicians, other qualified health care
professionals, or agencies are provided
consistent with the nature of the
problem(s) and the patient’s and/or
family’s needs. The patient may be
unstable or may have developed a
significant new problem requiring
immediate physician attention.
Typically, 35 minutes are spent at the
bedside and on the patient’s facility
floor or unit.)
jbell on DSKJLSW7X2PROD with RULES2
3. Critical Care Consultation Services:
HCPCS Codes
• G0508 (Telehealth consultation,
critical care, initial, physicians typically
spend 60 minutes communicating with
the patient and providers via
telehealth.)
• G0509 (Telehealth consultation,
critical care, subsequent, physicians
typically spend 50 minutes
communicating with the patient and
providers via telehealth.)
We are seeking information on how
these services are furnished via
telecommunications technology to
ensure that patients are safe and
receiving adequate care.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
4. Required ‘‘Hands-On’’ Visits for ESRD
Monthly Capitation Payments
In the ‘‘Medicare Program; Revisions
to Payment Policies Under the
Physician Fee Schedule for Calendar
Year 2005’’ final rule with comment
period (69 FR 66236, November 15,
2004) (hereinafter referred to the CY
2005 PFS final rule with comment
period), we added ESRD related services
to the Medicare telehealth list; however,
we specified that the required clinical
examination of the vascular access site
must be furnished face-to-face ‘‘hands
on’’ (without the use of an interactive
telecommunications system) by
physician, clinical nurse specialist
(CNS), nurse practitioner (NP), or
physician assistant (PA) (69 FR 66278).
On an interim basis in light of the PHE
for the COVID–19 pandemic, we are
instead permitting the required clinical
examination to be furnished as a
Medicare telehealth service during the
PHE for the COVID–19 pandemic. We
note that sections 1881(b)(3) and
1834(m) of the Act allow an individual
determined to have ESRD receiving
home dialysis to choose to receive
certain monthly ESRD-related clinical
assessments via telehealth on or after
January 1, 2019. The Bipartisan Budget
Act of 2018 (Pub. L. 115–123, enacted
on February 9, 2018) (BBA of 2018)
amended section 1881(b)(3)(B) of the
Act to require that such an individual
must receive a face-to-face visit, without
the use of telehealth, at least monthly in
the case of the initial 3 months of home
dialysis and at least once every 3
consecutive months after the initial 3
months. Due to the conditions presented
by the PHE, we are also exercising
enforcement discretion on an interim
basis to relax enforcement in connection
with the requirements under section
1881(b)(3)(B) of the Act that certain
visits be furnished without the use of
telehealth for services furnished during
the PHE. Specifically, CMS will not
conduct review to consider whether
those visits were conducted face-to-face,
without the use of telehealth. The
following CPT codes, when furnished
via Medicare telehealth, are impacted by
these policies:
• 90951 (End-stage renal disease
(ESRD) related services monthly, for
patients younger than 2 years of age to
include monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 4 or more face-to-face visits by a
physician or other qualified health care
professional per month)
• 90952 (End-stage renal disease
(ESRD) related services monthly, for
patients younger than 2 years of age to
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
include monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 2–3 face-to-face visits by a
physician or other qualified health care
professional per month)
• 90953 (End-stage renal disease
(ESRD) related services monthly, for
patients younger than 2 years of age to
include monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 1 face-to-face visit by a physician
or other qualified health care
professional per month)
• 90954 (End-stage renal disease
(ESRD) related services monthly, for
patients 2–11 years of age to include
monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 4 or more face-to-face visits by a
physician or other qualified health care
professional per month)
• 90955 (End-stage renal disease
(ESRD) related services monthly, for
patients 2–11 years of age to include
monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 2–3 face-to-face visits by a
physician or other qualified health care
professional per month)
• 90957 (End-stage renal disease
(ESRD) related services monthly, for
patients 12–19 years of age to include
monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 4 or more face-to-face visits by a
physician or other qualified health care
professional per month)
• 90958 (End-stage renal disease
(ESRD) related services monthly, for
patients 12–19 years of age to include
monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 2–3 face-to-face visits by a
physician or other qualified health care
professional per month)
• 90959 (End-stage renal disease
(ESRD) related services monthly, for
patients 12–19 years of age to include
monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of parents;
with 1 face-to-face visit by a physician
or other qualified health care
professional per month)
• 90960 (End-stage renal disease
(ESRD) related services monthly, for
patients 20 years of age and older; with
4 or more face-to-face visits by a
physician or other qualified health care
professional per month)
• 90961 (End-stage renal disease
(ESRD) related services monthly, for
patients 20 years of age and older; with
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
2–3 face-to-face visits by a physician or
other qualified health care professional
per month)
• 90962 (End-stage renal disease
(ESRD) related services monthly, for
patients 20 years of age and older; with
1 face-to-face visit by a physician or
other qualified health care professional
per month)
• 90963 (End-stage renal disease
(ESRD) related services for home
dialysis per full month, for patients
younger than 2 years of age to include
monitoring for the adequacy of
nutrition, assessment of growth and
development, and counseling of
parents)
• 90964 (End-stage renal disease
(ESRD) related services for home
dialysis per full month, for patients 2–
11 years of age to include monitoring for
the adequacy of nutrition, assessment of
growth and development, and
counseling of parents)
• 90965 (End-stage renal disease
(ESRD) related services for home
dialysis per full month, for patients 12–
19 years of age to include monitoring for
the adequacy of nutrition, assessment of
growth and development, and
counseling of parents)
• 90966 (End-stage renal disease
(ESRD) related services for home
dialysis per full month, for patients 20
years of age and older)
• 90967 (End-stage renal disease
(ESRD) related services for dialysis less
than a full month of service, per day; for
patients younger than 2 years of age)
• 90968 (End-stage renal disease
(ESRD) related services for dialysis less
than a full month of service, per day; for
patients 2–11 years of age)
• 90969 (End-stage renal disease
(ESRD) related services for dialysis less
than a full month of service, per day; for
patients 12–19 years of age)
• 90970 (End-stage renal disease
(ESRD) related services for dialysis less
than a full month of service, per day; for
patients 20 years of age and older)
C. Telehealth Modalities and CostSharing
jbell on DSKJLSW7X2PROD with RULES2
1. Clarifying Telehealth Technology
Requirements
Our regulation at § 410.78(a)(3) states
that telephones, facsimile machines,
and electronic mail systems do not meet
the definition of an interactive
telecommunications systems for
purposes of Medicare telehealth
services. As we interpret it, this
regulation does not apply to mobile
computing devices that include audio
and video real-time interactive
capabilities, even though such devices
are now referred to colloquially as
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
‘‘phones’’ since they can also be used
for audio-only telecommunications. In
light of the PHE for the COVID–19
pandemic, we believe it is important to
avoid the potential perception that this
language might prohibit use of any
device that could otherwise meet the
interactive requirements for Medicare
telehealth, especially given that
leveraging use of such readily available
technology may be of critical
importance.
Therefore, we are revising
§ 410.78(a)(3) to add an exception to this
language on an interim basis for the
duration of the PHE for the COVID–19
pandemic providing that for the
duration of the public health emergency
as defined in § 400.200, ‘‘interactive
telecommunications system’’ means
multimedia communications equipment
that includes, at a minimum, audio and
video equipment permitting two-way,
real-time interactive communication
between the patient and distant site
physician or practitioner.
In addition, the HHS Office for Civil
Rights (OCR) is exercising enforcement
discretion and waiving penalties for
HIPAA 4 violations against health care
providers that serve patients in good
faith through everyday communications
technologies, such as FaceTime or
Skype, during the PHE for the COVID–
19 pandemic. For more information, see
https://www.hhs.gov/hipaa/forprofessionals/special-topics/emergencypreparedness/. While OCR is
not imposing penalties for
noncompliance with the regulatory
requirements under HIPAA against
covered providers in connection with
the good faith provision of telehealth
during the PHE for the COVID–19
pandemic, HHS, OIG, and DOJ continue
to actively monitor for any healthcare
fraud and abuse, including potential
Medicare coronavirus scams.
2. Beneficiary Cost-Sharing
In response to the unique
circumstances resulting from the
outbreak of COVID–19 and the
Secretary’s January 31, 2020
determination under section 319 of the
Public Health Service Act that a PHE
exists and has existed since January 27,
2020 (COVID–19 Declaration), the Office
of Inspector General (OIG) issued a
Policy Statement 5 to notify physicians
and other practitioners that they will
not be subject to administrative
sanctions for reducing or waiving any
cost-sharing obligations Federal health
4 Health Insurance Portability and Accountability
Act of 1996 (Pub. L. 104–191, enacted August 21,
1996).
5 https://oig.hhs.gov/fraud/docs/
alertsandbulletins/2020/policy-telehealth-2020.pdf.
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
19243
care program beneficiaries may owe for
telehealth services furnished consistent
with the then applicable coverage and
payment rules. OIG’s Policy Statement
is not limited to the services governed
by § 410.78 but applies to a broad
category of non-face-to-face services
furnished through various modalities,
including telehealth visits, virtual
check-in services, e-visits, monthly
remote care management, and monthly
remote patient monitoring. The Policy
Statement applies to a physician or
other practitioner billing for services
provided remotely through information
or communication technology or a
hospital or other eligible individual or
entity billing on behalf of the physician
or practitioner for such services when
the physician or other practitioner has
reassigned his or her right to receive
payments to such individual or entity.
D. Communication Technology-Based
Services (CTBS)
In the ‘‘Medicare Program; Revisions
to Payment Policies Under the
Physician Fee Schedule and Other
Revisions to Part B for CY 2019;
Medicare Shared Savings Program
Requirements; Quality Payment
Program; Medicaid Promoting
Interoperability Program; Quality
Payment Program-Extreme and
Uncontrollable Circumstance Policy for
the 2019 MIPS Payment Year;
Provisions From the Medicare Shared
Savings Program-Accountable Care
Organizations-Pathways to Success; and
Expanding the Use of Telehealth
Services for the Treatment of Opioid
Use Disorder Under the Substance UseDisorder Prevention That Promotes
Opioid Recovery and Treatment
(SUPPORT) for Patients and
Communities Act’’ final rule (83 FR
59452 through 60303) (hereinafter
referred to as the CY 2019 PFS final
rule), we noted that under current PFS
payment rules, Medicare routinely pays
for many kinds of services that are
furnished via telecommunications
technology (83 FR 59482), but are not
considered Medicare telehealth services.
These communication technology-based
services (CTBS) include, for example,
certain kinds of remote patient
monitoring (either as separate services
or as parts of bundled services), and
interpretations of diagnostic tests when
furnished remotely. These services are
different than the kinds of services
specified in section 1834(m) of the Act,
in that they are not the kind of services
that are ordinarily furnished in person
but are routinely furnished using a
telecommunications system.
In the CY 2019 PFS final rule, we
finalized separate payment for a number
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19244
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
of services that could be furnished via
telecommunications technology, but
that are not Medicare telehealth
services. Specifically, we finalized
Healthcare Common Procedure Coding
System (HCPCS) code G2010 (Remote
evaluation of recorded video and/or
images submitted by an established
patient (e.g., store and forward),
including interpretation with follow-up
with the patient within 24 business
hours, not originating from a related E/
M service provided within the previous
7 days nor leading to an E/M service or
procedure within the next 24 hours or
soonest available appointment), and
HCPCS code G2012 (Brief
communication technology-based
service, e.g. virtual check-in, by a
physician or other qualified health care
professional who can report evaluation
and management services, provided to
an established patient, not originating
from a related E/M service provided
within the previous 7 days nor leading
to an E/M service or procedure within
the next 24 hours or soonest available
appointment; 5–10 minutes of medical
discussion). We finalized these codes as
part of the set of codes that is only
reportable by the physicians and
practitioners who can furnish
evaluation and management (E/M)
services. We stated that we believed this
was appropriate since the service
describes a check-in directly with the
billing practitioner to assess whether an
office visit is needed. However, we did
note that similar check-ins provided by
nurses and other clinical staff can be
important aspects of coordinated patient
care (83 FR 59486).
We also finalized that these services
be limited to established patients, and
that beneficiary consent must be
documented in the patient’s medical
record for each service (83 FR 59487).
This latter provision was amended in
the CY PFS 2020 final rule to allow for
a single beneficiary consent to be
obtained annually (84 FR 62699). These
requirements also apply to monthly care
management and remote patient
monitoring services.
In the context of the PHE for the
COVID–19 pandemic, when brief
communications with practitioners and
other non-face-to-face services might
mitigate the need for an in-person visit
that could represent an exposure risk for
vulnerable patients, we believe that
these services should be available to as
large a population of Medicare
beneficiaries as possible. In some cases,
use of telecommunication technology
could mitigate the exposure risk, and in
such cases, the clinical benefit of using
technology to furnish the service is selfapparent. This would be especially true
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
should a significant increase in the
number of people or health care
professionals needing treatment or
isolation occur in a way that would
limit access to brief communications
with established providers. Therefore,
on an interim basis, during the PHE for
the COVID–19 pandemic, we are
finalizing that these services, which
may only be reported if they do not
result in a visit, including a telehealth
visit, can be furnished to both new and
established patients. We are also making
clear that the consent to receive these
services can be documented by auxiliary
staff under general supervision. While
we continue to believe that beneficiary
consent is necessary so that the
beneficiary is notified of any applicable
cost sharing, we do not believe that the
timing or manner in which beneficiary
consent is acquired should interfere
with the provision of one of these
services. Therefore, we are finalizing on
an interim basis during the PHE for the
COVID–19 pandemic that, while
consent to receive these services must
be obtained annually, it may be
obtained at the same time that a service
is furnished. We are also re-emphasizing
that this consent may be obtained by
auxiliary staff under general
supervision, as well as by the billing
practitioner. We are retaining the
requirement that in instances when the
brief communication technology-based
service originates from a related E/M
service (including one furnished as a
telehealth service) provided within the
previous 7 days by the same physician
or other qualified health care
professional, that this service would be
considered bundled into that previous
E/M service and would not be
separately billable.
In the ‘‘Medicare Program; CY 2020
Revisions to Payment Policies Under the
Physician Fee Schedule and Other
Changes to Part B Payment Policies;
Medicare Shared Savings Program
Requirements; Medicaid Promoting
Interoperability Program Requirements
for Eligible Professionals; Establishment
of an Ambulance Data Collection
System; Updates to the Quality Payment
Program; Medicare Enrollment of
Opioid Treatment Programs and
Enhancements to Provider Enrollment
Regulations Concerning Improper
Prescribing and Patient Harm; and
Amendments to Physician Self-Referral
Law Advisory Opinion Regulations
Final Rule’’ (84 FR 62568, November 15,
2019) (hereinafter referred to as the CY
2020 PFS final rule), we finalized
separate payment for CPT codes 99421
(Online digital evaluation and
management service, for an established
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
patient, for up to 7 days, cumulative
time during the 7 days; 5–10 minutes),
99422 (Online digital evaluation and
management service, for an established
patient, for up to 7 days, cumulative
time during the 7 days; 11–20 minutes),
and 99423 (Online digital evaluation
and management service, for an
established patient, for up to 7 days,
cumulative time during the 7 days; 21
or more minutes). We also finalized
separate payment for HCPCS codes
G2061 (Qualified nonphysician
healthcare professional online
assessment and management, for an
established patient, for up to seven
days, cumulative time during the 7
days; 5–10 minutes), G2062 (Qualified
nonphysician healthcare professional
online assessment and management
service, for an established patient, for
up to seven days, cumulative time
during the 7 days; 11–20 minutes), and
G2063 (Qualified nonphysician
qualified healthcare professional
assessment and management service,
for an established patient, for up to
seven days, cumulative time during the
7 days; 21 or more minutes) (84 FR
62796).
In the context of the PHE for the
COVID–19 pandemic, where
communications with practitioners
might mitigate the need for an in-person
visit that could represent an exposure
risk for vulnerable patients, we do not
believe the limitation of these services
to established patients is warranted.
While some of the code descriptors refer
to ‘‘established patient,’’ during the
PHE, we are exercising enforcement
discretion on an interim basis to relax
enforcement of this aspect of the code
descriptors. Specifically, we will not
conduct review to consider whether
those services were furnished to
established patients.
Additionally, in the CY 2020 PFS
final rule (84 FR 62796), we stated that
HCPCS codes G2061–G2063, specific to
practitioners who do not report E/M
codes, may describe services outside the
scope of current Medicare benefit
categories and as such, may not be
eligible for Medicare payment. We have
received a number of questions
regarding which benefit categories
HCPCS codes G2061–G2063 fall under.
In response to these requests, we are
clarifying here that there are several
types of practitioners who could bill for
these service. For example, the services
described by these codes could be
furnished as licensed clinical social
worker services, clinical psychologist
services, physical therapist services,
occupational therapist services, or
speech language pathologist services, so
practitioners that report services in
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
those benefit categories could also
report these online assessment and
management services.
On an interim basis, during the PHE
for the COVID–19 pandemic, we are also
broadening the availability of HCPCS
codes G2010 and G2012 that describe
remote evaluation of patient images/
video and virtual check-ins. We
recognize that in the context of the PHE
for the COVID–19 pandemic,
practitioners such as licensed clinical
social workers, clinical psychologists,
physical therapists, occupational
therapists, and speech-language
pathologists might also utilize virtual
check-ins and remote evaluations
instead of other, in-person services
within the relevant Medicare benefit to
facilitate the best available appropriate
care while mitigating exposure risks. We
note that this is not an exhaustive list
and we are seeking input on other kinds
of practitioners who might be furnishing
these kinds of services as part of the
Medicare services they furnish in the
context of the PHE for the COVID–19
pandemic.
Further, to facilitate billing of the
CTBS services by therapists for the
reasons described above, we are
designating HCPCS codes G2010,
G2012, G2061, G2062, or G2063 as
CTBS ‘‘sometimes therapy’’ services that
would require the private practice
occupational therapist, physical
therapist, and speech-language
pathologist to include the corresponding
GO, GP, or GN therapy modifier on
claims for these services. CTBS therapy
services include those furnished to a
new or established patients that the
occupational therapist, physical
therapist, and speech-language
pathologist practitioner is currently
treating under a plan of care.
E. Direct Supervision by Interactive
Telecommunications Technology
Many services paid under the PFS can
be paid when provided under a level of
physician or nonphysician practitioner
(NPP) supervision rather than personal
performance. In many cases, the
supervision requirements in physician
office settings necessitate the presence
of the physician or NPP in a particular
location, usually in the same location as
the beneficiary when the service is
provided. For example, as described at
§ 410.26, services incident to a
physicians’ service usually require the
direct supervision of a physician. As
currently defined in § 410.32(b)(3)(ii),
direct supervision means that the
physician must be present in the office
suite and immediately available to
furnish assistance and direction
throughout the performance of the
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
procedure. It does not mean that the
physician must be present in the room
when the procedure is performed.
Given the circumstances of the PHE
for the COVID–19 pandemic, we
recognize that in some cases, the
physical proximity of the physician or
practitioner might present additional
exposure risks, especially for high risk
patients isolated for their own
protection or cases where the
practitioner has been exposed to the
virus but could otherwise safely
supervise from another location using
telecommunications technology. In
these cases, we believe that the current
requirement would necessarily limit
access to procedures and tests that
could be appropriately supervised by a
physician isolated for purposes of
limiting exposure to COVID–19. For
example, we consider the possibility
that patients routinely receiving
medically necessary physicianadministered drugs at the office of a
physician may lose access to the
provision of that drug should the
physician who regularly supervises the
provision of that drug be isolated for
purposes of minimizing exposure risks.
Likewise, should that same patient need
to be isolated for purposes of exposure
risk based on presumed or confirmed
COVID–19 infection, administering such
a drug in the patient’s home would
require the billing professional to
accompany the clinical staff to the
patient’s home, presumably with the
necessary personal protective
equipment (PPE) available to both the
physician and the clinical staff.
In some cases, depending upon the
unique circumstances of individual
patients and billing physicians, we
believe that telecommunications
technology could be used in a manner
that would facilitate the physician’s
immediate availability to furnish
assistance and direction without
necessarily requiring the physician’s
physical presence in the location where
the service is being furnished, such as
the office suite or the patient’s home.
For example, we believe that use of realtime, audio and video
telecommunications technology allows
for a billing practitioner to observe the
patient interacting with or responding to
the in-person clinical staff through
virtual means, and thus, their
availability to furnish assistance and
direction could be met without
requiring the physician’s physical
presence in that location. We note that
to be covered under Part B, drugs
furnished ‘‘incident to’’ are typically
injectable drugs that are bought by the
physician, in ordinary circumstances
are administered in the physician’s
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
19245
office, and then billed by the physician
to the Medicare Administrative
Contractor (MAC). By definition,
‘‘incident to a physician’s professional
service’’ requires the item or service to
be billed by the physician. We also note
that the supervision requirements that
apply to both services incident to a
physicians’ service and diagnostic tests
do not necessarily reflect the
appropriate level of supervision for
particular patients, services, and health
care workers. Instead, we view these
levels as the minimum possible
requirement for provision of the service
for purposes of Medicare payment.
Likewise, even in the context of the PHE
for the COVID–19 pandemic and the
inherent exposure risks for Medicare
beneficiaries, physicians and other
health care providers, we believe that in
many cases furnishing services without
the physical presence of the physician
in the same location would not be
appropriate. However, we recognize that
in some cases, technology would allow
appropriate supervision without the
physical presence of a physician. In the
context of the PHE for the COVID–19
pandemic, given the risks of exposure,
the immediate potential risk to needed
medical care, the increased demand for
health care professionals in the context
of the PHE for the COVID–19 pandemic,
and the widespread use of
telecommunications technology, we
believe that individual practitioners are
in the best position to make decisions
based on their clinical judgement in
particular circumstances. Consequently,
we are revising the definition of direct
supervision to allow, for the duration of
the PHE for the COVID–19 pandemic,
direct supervision to be provided using
real-time interactive audio and video
technology. We are seeking information
from commenters as to whether there
should be any guardrails and what kind
of risk might this policy introduce for
beneficiaries while reducing risk of
COVID–19 spread. We note that this
change is limited to only the manner in
which the supervision requirement can
be met, and does not change the
underlying payment or coverage
policies related to the scope of Medicare
benefits, including Part B drugs. We also
note that any and all applicable rules
regarding safe transportation and proper
waste disposal continue to apply.
We note that in specifying that direct
supervision includes virtual presence
through audio/video real-time
communications technology during the
PHE for the COVID–19 pandemic, this
can include instances where the
physician enters into a contractual
arrangement for auxiliary personnel as
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19246
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
defined in § 410.26(a)(1), to leverage
additional staff and technology
necessary to provide care that would
ordinarily be provided incident to a
physicians’ service (including services
that are allowed to be performed via
telehealth). For example, physicians
may enter into contractual arrangements
with a home health agency (defined
under section 1861(o) of the Act), a
qualified infusion therapy supplier
(defined under section 1861(iii)(3)(D) of
the Act), or entities that furnish
ambulance services in order to utilize
their nurses or other clinical staff as
auxiliary personnel under leased
employment (§ 410.26(a)(5)). In such
instances, the provider/supplier would
seek payment for any services they
provided from the billing practitioner
and would not submit claims to
Medicare for such services. For
telehealth services that need to be
personally provided by a physician,
such as an E/M visit, the physician
would need to personally perform the E/
M visit and report that service as a
Medicare telehealth service. However,
we acknowledge that there may be
instances where the physician may want
to use auxiliary personnel to be present
in the home with the patient during the
telehealth service, though this is not
required for telehealth services under
section 1834(m) of the Act. Other
services, including both face-to-face and
non-face-to-face services, could be
provided incident to a physicians’
service by a nurse or other auxiliary
personnel, as long as the billing
practitioner is providing appropriate
supervision through audio/video realtime communications technology (or in
person), when needed. We would not
expect that services furnished at a
patient’s home incident to a physician
service would usually occur during the
same period as a home health episode
of care, and we will be monitoring
claims to ensure that services are not
being inappropriately unbundled from
payments under the home health PPS.
For the reasons discussed above, on
an interim basis for the duration of the
PHE for the COVID–19 pandemic, we
are altering the definition of direct
supervision at § 410.32(b)(3)(ii), to state
that necessary presence of the physician
for direct supervision includes virtual
presence through audio/video real-time
communications technology when use
of such technology is indicated to
reduce exposure risks for the beneficiary
or health care provider. We are revising
§ 410.32(b)(3)(ii) to include, during a
PHE, as defined in § 400.200 of this
chapter, the presence of the physician
includes virtual presence through
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
audio/video real-time communications
technology when use of such technology
is indicated to reduce exposure risks for
the beneficiary or health care provider.
1. Supervision Changes for Certain
Hospital and CAH Diagnostic and
Therapeutic Services
For all of the same reasons described
above, we are adopting similar changes
in the regulations at § 410.28(e)(1) with
respect to the supervision of diagnostic
services furnished directly or under
arrangement in the hospital or in an oncampus or off-campus outpatient
department of the hospital, as defined in
§ 413.65. We note that under current
Medicare rules, most therapeutic
services in the hospital require only
general supervision and the supervision
requirements for diagnostic services
generally conform to the service-level
supervision levels required for payment
under the PFS. Because we have every
reason to believe that potential exposure
risks and limits on the availability of
medical professionals could equally
apply to hospital services, we are
amending the definition of direct
supervision for hospital services for the
duration of the PHE for the COVID–19
pandemic so it continues to conform
with the applicable definitions for
services paid under the PFS. As stated
above, we believe this change is
necessary due to the circumstances of
the PHE for the COVID–19 pandemic.
Specifically, we recognize that in some
cases, the physical proximity of the
physician or practitioner might present
additional exposure risks, especially for
high risk patients isolated for their own
protection or cases where the
practitioner has been exposed to the
virus but could otherwise safely
supervise from another location using
telecommunications technology. In
these cases, we believe that the current
definition would necessarily limit
access to diagnostic procedures and
tests that could be appropriately
supervised by a physician, including
one who is isolated for purposes of
limiting exposure to COVID–19.
In addition, with respect to
pulmonary rehabilitation, cardiac
rehabilitation, and intensive cardiac
rehabilitation services described in the
regulations at §§ 410.47 and 410.49,
respectively, we are adopting a similar
change under § 410.27(a)(1)(iv)(D), for
the duration of the PHE for the COVID–
19 pandemic, for all the reasons
described above, to specify that direct
supervision for these services includes
virtual presence through audio/video
real-time communications technology
when use of such technology is
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
indicated to reduce exposure risks for
the beneficiary or health care provider.
F. Clarification of Homebound Status
Under the Medicare Home Health
Benefit
Sections 1814(a)(2)(C) and
1835(a)(2)(A) of the Act state that
payment for home health services is
made when a physician certifies that
such services are or were required
because the individual is or was
confined to his home and needs or
needed skilled nursing care (other than
solely venipuncture for the purpose of
obtaining a blood sample) on an
intermittent basis or physical or speech
therapy or, in the case of an individual
who has been furnished home health
services based on such a need and who
no longer has such a need for such care
or therapy, continues or continued to
need occupational therapy. In addition,
the physician must certify that a plan
for furnishing such services to such
individual has been established and is
periodically reviewed by the physician
and that such services are or were
furnished while the individual was
under the care of a physician. Also, in
the case of a certification made by a
physician after January 1, 2010, prior to
making such certification the physician
must document that the physician
himself or herself, or an NP or clinical
nurse specialist (CNS) (as those terms
are defined in section 1861(aa)(5) of the
Act) who is working in collaboration
with the physician in accordance with
State law, or a certified nurse-midwife
(as defined in section 1861(gg) of the
Act) as authorized by State law, or a PA
(as defined in section 1861(aa)(5) of the
Act) under the supervision of the
physician, has had a face-to-face
encounter (including through use of
telehealth, subject to the requirements
in section 1834(m) of the Act, and other
than for encounters that are incident to
services involved, as described in
section II.E. of this IFC) with the
individual within a reasonable
timeframe as determined by the
Secretary.
Most recently, we have been asked by
stakeholders to provide more clarity on
whether patients who are instructed to
remain in their homes or are under
‘‘self-quarantine’’ are considered
‘‘confined to the home’’ or
‘‘homebound’’ for purposes of the
Medicare home health benefit in the
context of the PHE for the COVID–19
pandemic. Per sections 1814(a) and
1835(a) of the Act, an individual shall
be considered to be ‘‘confined to his
home’’ if the individual has a condition,
due to an illness or injury, that restricts
the ability of the individual to leave his
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
or her home except with the assistance
of another individual or the aid of a
supportive device (such as crutches, a
cane, a wheelchair, or a walker), or if
the individual has a condition such that
leaving his or her home is medically
contraindicated. While an individual
does not have to be bedridden to be
considered ‘‘confined to his home’’, the
condition of the individual should be
such that there exists a normal inability
to leave home and, that leaving home
requires a considerable and taxing effort
by the individual.
The definition of ‘‘confined to the
home’’ (that is, ‘‘homebound’’) allows
patients to be considered ‘‘homebound’’
if it is medically contraindicated for the
patient to leave the home. As an
example for the PHE for COVID–19
pandemic, this would apply for those
patients: (1) Where a physician has
determined that it is medically
contraindicated for a beneficiary to
leave the home because he or she has a
confirmed or suspected diagnosis of
COVID–19; or (2) where a physician has
determined that it is medically
contraindicated for a beneficiary to
leave the home because the patient has
a condition that may make the patient
more susceptible to contracting COVID–
19. A patient who is exercising ‘‘selfquarantine’’ for one’s own safety would
not be considered ‘‘confined to the
home’’ unless a physician certifies that
it is medically contraindicated for the
patient to leave the home. For the PHE
for the COVID–19 pandemic, the CDC is
currently advising that older adults and
individuals with serious underlying
health conditions stay home (CDC’s
guidance is interim and is expected to
continue to be updated as warranted).6
As such, we expect that many Medicare
beneficiaries could be considered
‘‘confined to the home’’. However,
determinations of whether home health
services are reasonable and necessary,
including whether the patient is
homebound and needs skilled services,
must be based on an assessment of each
beneficiary’s individual condition and
care needs.
In cases where it is medically
contraindicated for the patient to leave
the home, the medical record
documentation for the patient must
include information as to why the
individual condition of the patient is
such that leaving the home is medically
contraindicated. With regards to a
pandemic outbreak of an infectious
disease, this can include reviewing and
applying any guidance on risk
assessment and public health
management issued by the CDC. For
example, the CDC interim guidance
‘‘Preventing the Spread of Coronavirus
Disease 2019 in Homes and Residential
Communities’’ applies for both
confirmed or suspected COVID–19
states that patients who are medically
stable enough to receive care in the
home must isolate at home during their
illness.7 Additionally, these guidelines
state that patients should restrict
activities outside the home, except for
getting medical care. These restrictions
include that the individual not go to
work, school, or public areas, as well as
avoiding use of public transportation,
ride-sharing, or taxis; making it such
that there exists a normal inability for
an individual to leave home and leaving
home would require a considerable and
taxing effort.
In regards to those circumstances in
which the patient does not have
confirmed or suspected diagnosis of an
infectious disease, such as COVID–19,
but the patient’s physician states that it
is medically contraindicated for the
patient to leave the home because the
patient’s condition may make the
patient more susceptible to contracting
a pandemic disease, the patient would
be considered ‘‘confined to the home’’
or ‘‘homebound’’ for purposes of this
eligibility requirement. For example, if
a patient is having an exacerbation of
chronic obstructive pulmonary disease
(COPD) and the physician certifies that
it is medically contraindicated to leave
the home because the patient’s
compromised respiratory system makes
him or her more likely to contract an
infectious disease, such as COVID–19,
the patient would be considered
‘‘confined to the home’’ in alignment
with Medicare home health eligibility
criteria. Another example of this type of
scenario would be a cancer patient
receiving chemotherapy treatment and
where the physician states that it is
medically contraindicated for the
patient to leave the home because the
patient may be more at risk of
contracting an infectious disease
because of the patient’s
immunocompromised state. In both
examples, the medical contraindication
makes it such that there exists a normal
inability for an individual to leave home
and leaving home safely would require
a considerable and taxing effort.
In addition to being considered
‘‘confined to the home’’ or
‘‘homebound’’, the patient must meet
the other Medicare home health
eligibility requirements to receive
Medicare home health services. That is,
6 https://www.cdc.gov/coronavirus/2019-ncov/
specific-groups/high-risk-complications.html.
7 https://www.cdc.gov/coronavirus/2019-ncov/
hcp/guidance-prevent-spread.html.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
19247
the beneficiary must be under the care
of a physician; receiving services under
a plan of care established and
periodically reviewed by a physician; be
in need of skilled nursing care on an
intermittent basis or physical therapy or
speech-language pathology; or have a
continuing need for occupational
therapy. Even if the patient is confined
to the home because of a suspected
diagnosis of an infectious disease as part
of a pandemic event, a home health visit
solely to obtain a nasal or throat culture
would not be considered a skilled
service because it would not require the
skills of a nurse to obtain the culture as
the specimen could be obtained by an
appropriately-trained medical assistant
or laboratory technician. However, a
home health nurse, during an otherwise
covered skilled visit, could obtain the
nasal or throat culture to send to the
laboratory for testing. Please see section
II.M. of this IFC for further discussion
about how a Medicare patient without a
skilled need who is under selfquarantine may be tested at home.
We believe this clarification is not
limited to the PHE for the COVID–19
pandemic, but would also apply for
other outbreaks of an infectious disease
and instances where the condition of a
patient is such that it is medically
contraindicated for the patient to leave
his or her home. We solicit comments
on this clarification.
G. The Use of Technology Under the
Medicare Home Health Benefit During
the PHE for the COVID–19 Pandemic
Section 1895 of the Act outlines the
statutory parameters of the home health
prospective payment system (HH PPS)
that was implemented on October 1,
2000. The HH PPS provides payment for
all services furnished under the
Medicare home health benefit as
outlined in section 1861(m) of the Act
in the form of a ‘‘bundled’’ 30-day unit
of payment that is adjusted for case-mix
and area wage differences in accordance
with section 1895(b) of the Act. Section
1895(e)(1)(A) of the Act states that
nothing under section 1895 of the Act
prevents a home health agency (HHA)
from furnishing services via a
telecommunications system, as long as
such services do not: (1) Substitute for
in-person home health services ordered
as part of a plan of care certified by a
physician; and (2) are not considered a
home health visit for purposes of
eligibility or payment. In the CY 2019
HH PPS proposed rule (83 FR 32425),
we stated that ‘‘remote patient
monitoring’’ is one type of service that
can be furnished via a
telecommunications system to augment
a home health plan of care without
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19248
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
substituting for an in-person visit. In the
CY 2019 HH PPS final rule with
comment (83 FR 56527), for purposes of
the Medicare home health benefit, we
finalized the definition of ‘‘remote
patient monitoring’’ in regulation at 42
CFR 409.46(e) as the collection of
physiologic data (for example, ECG,
blood pressure, glucose monitoring)
digitally stored and/or transmitted by
the patient and/or caregiver to the HHA.
We also included in regulation at
§ 409.46(e) that the costs of remote
patient monitoring are considered
allowable administrative costs
(operating expenses) if remote patient
monitoring is used by the HHA to
augment the care planning process (83
FR 56527).
We received positive feedback from
the policy changes finalized in the CY
2019 HH PPS final rule with comment
period. Commenters encouraged us to
even go further in adopting and
promoting technology use in home
health. Recently, we have been asked by
stakeholders to provide more clarity on
how HHAs can leverage technology to
keep home health clinicians and
patients safe during outbreaks of an
infectious disease, such as the PHE for
the COVID–19 pandemic. While we
remain statutorily-prohibited from
paying for home health services
furnished via a telecommunications
system if such services substitute for inperson home health services ordered as
part of a plan of care and for paying
directly for such services under the
home health benefit, for the duration of
the PHE for the COVID–19 pandemic,
we are amending the regulations at
§ 409.43(a) on an interim basis to
provide HHAs with the flexibility, in
addition to remote patient monitoring,
to use various types of
telecommunications systems (that is,
technology) in conjunction with the
provision of in-person visits.
Specifically, we are amending the
regulations at § 409.43(a) on an interim
basis to state that the use of technology
must be related to the skilled services
being furnished by the nurse/therapist/
therapy assistant to optimize the
services furnished during the home visit
or when there is a home visit. We are
also amending the regulations at
§ 409.43(a) on an interim basis to state
that the use of technology must be
included on the home health plan of
care along with a description of how the
use of such technology will help to
achieve the goals outlined on the plan
of care without substituting for an inperson visit as ordered on the plan of
care. As a reminder, the plan of care
must be signed prior to submitting a
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
final claim to Medicare for payment
(§ 409.43(c)(2)); therefore, HHAs have
flexibility on the timing in which they
obtain physician signatures for changes
to the plan of care when incorporating
the use of technology into the patient’s
plan of care. In addition, HHAs may
also provide services based on verbal
orders in accordance with the
regulations at §§ 484.60(b) and
409.43(d). Finally, on an interim basis
HHAs can report the costs of
telecommunications technology as
allowable administrative and general
(A&G) costs by identifying the costs
using a subscript between line 5.01
through line 5.19.
We reiterate that by law the use of
technology may not substitute for an inperson home visit ordered as part of the
plan of care and services furnished via
a telecommunications system cannot be
considered a home health visit for
purposes of eligibility or payment.
However, we acknowledge that the use
of such technology may result in
changes to the frequency or types of
visits outlined on the plan of care,
especially to combat the PHE for the
COVID–19 pandemic. For example, a
patient recently discharged from the
hospital after coronary bypass surgery
was receiving home health skilled
nursing visits three times a week for
medication management, teaching and
assessment. The patient developed a
fever, cough, sore throat and moderate
shortness of breath and now has a
confirmed COVID–19 diagnosis, which
the doctor has determined can be safely
managed at home with home health
services. The patient has been
prescribed new medications for
symptom management and oxygen
therapy to support the patient’s
respiratory status. The patient’s home
health plan of care was updated to
include an in-person skilled nursing
visit once a week to assess the patient
and to monitor for worsening
symptoms. The plan of care was
updated also to include a video
consultation twice a week between the
skilled nurse and the patient for
medication management, teaching and
assessment, as well as to obtain oxygen
saturation readings that the patient
relays to the nurse during the
consultation.
With regards to payment under the
HH PPS, if the primary reason for home
health care is to provide care to manage
the symptoms resulting from COVID–19,
this 30-day period of care would be
grouped into the Medication,
Management, Teaching and Assessment
(MMTA)—Respiratory clinical group,
and it would be an early 30-day period
of care with an institutional admission
PO 00000
Frm 00020
Fmt 4701
Sfmt 4700
source. Assuming a medium functional
impairment level with ‘‘low’’
comorbidities, the low-utilization
payment adjustment (LUPA) threshold
would be 4 visits. Regardless if the
patient continued to receive the original
3 in-person skilled nursing visits per
week (12 visits total in the 30-day
period) rather than the once per-week
in-person skilled nursing visits (4 visits
total in the 30-day period) the HHA
would still receive the full 30-day
payment amount (rather than paying per
visit if the total number of visits was
below the LUPA threshold). In this
example, the use of technology is not a
substitute for the provision of in-person
visits as ordered on the plan of care, as
the plan of care was updated to reflect
a change in the frequency of the inperson visits and to include ‘‘virtual
visits’’ as part of the management of the
home health patient.
As discussed previously in section
II.E ‘‘Direct Supervision by Interactive
Telecommunications Technology’’ in
this IFC, there may be instances during
the PHE for the COVID–19 pandemic
where physicians can enter into a
contractual arrangement, that meets the
definition of auxiliary personnel at
§ 410.26, with another provider/supplier
type. For example, physicians may enter
into contractual arrangements with a
HHA, a qualified infusion therapy
supplier, or other entity to leverage
auxiliary personnel under leased
employment (§ 410.26(a)(5)), including
nurses or other clinical staff, to provide
virtual visits for patients in their homes.
These virtual visits are considered
provided incident to a physician’s
service, as long as the billing
practitioner is providing appropriate
supervision through audio/video realtime communications technology, when
needed. Payment for such services
would be made to the billing
practitioner who would then make the
appropriate payment to the contracted
entity (for example, the HHA). This
payment would be made in accordance
with the PFS and would not be
considered a home health service under
the Medicare home health benefit. This
particular flexibility can enable more
patients to receive services at home via
telehealth for instances in which there
are no in-person visits that would
trigger payment under the Medicare HH
PPS. As such, we would not expect that
services furnished at a patient’s home
incident to a physician service will
usually occur during the same period as
a home health episode of care, and we
will be monitoring claims that
practitioners are billing under
arrangement to ensure appropriate
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
services are being billed by the
practitioner and not being
inappropriately unbundled from
payments under the HH PPS.
The remainder of this section
includes information on examples of
technology that can be leveraged in
providing care in the home setting, such
as telemedicine, interactive clinician
‘‘consulting’’ and other patient-facing
technologies; and provides a summary
of the regulations text we are amending
in this IFC.
In general, technology has become an
integral part of medicine across the
entire spectrum of healthcare.
Telemedicine, in particular has the
potential to play a large role in
enhancing the delivery of healthcare in
the home for Medicare beneficiaries,
including the provision of information,
education, and services provided via
telecommunications systems. One of the
biggest benefits of telemedicine,
separate from its potential to minimize
risk to clinicians and patients during an
outbreak of an infectious disease, is to
increase access to healthcare to
geographically disadvantaged and
medically underserved populations,
providing an improved quality of care.8
Telemedicine and remote monitoring
can also be used to encourage patient
involvement and autonomy, and to
increase the tools available for the home
health provider.
Recent CMS site visits with HHAs, as
well as meetings with industry
associations detailed the extent to
which HHAs are researching and
integrating technology into their care.
These organizations provided examples
of technology they have tested and/or
are currently using, ranging from patient
facing apps on cell phones to robotics.
Additionally, they provided examples of
patients with specific home health
needs that they believe would benefit
most from leveraging technology in
home health care. They indicated a
wide variety of uses for technology in
home health including medication
management and teaching, behavioral/
crisis or social work counseling, posttransplant monitoring, dietary
counseling, and even functional training
through remote occupational or physical
therapy. In particular, they highlighted
certain diagnoses and conditions for
which they are already utilizing
telecommunications systems. For
diagnoses/conditions such as COPD,
congestive heart failure (CHF), sepsis,
and wounds, technology can offer an
efficient way of monitoring chronic
8 Int
J Environ Res Public Health. 2013 Dec;
10(12): 6472–6484. Published online 2013 Nov 28.
doi: 10.3390/ijerph10126472.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
respiratory and cardiovascular diseases
that represent an increasingly high
burden on healthcare systems.9 We
referenced some of the benefits of
remote patient monitoring of chronic
diseases in the CY 2019 HH PPS
proposed rule (83 FR 32425), including
readmission prevention and improved
patient involvement and accountability.
Certain HHAs and industry groups
have implemented technology that goes
beyond remote patient monitoring for
the treatment of chronic diseases. One
such HHA utilizes two-way, interactive
‘‘consulting’’ between the nurse
furnishing the home visit and a
specialty clinician at the agency. The
nurse furnishing the home visit can use
a tablet to visually connect the patient
with the specialty clinician or advanced
practice nurse at the agency to assess
swelling, breathing, or to review and
reconcile medications. These specialty
clinicians are also beneficial in treating
acute conditions, such as wounds, or
monitoring for the prevention of sepsis.
Wound, Ostomy, and Continence
Nurses (WOCNs) are being utilized for
their specialized skills as consultants for
the nurse in the home. The nurse
furnishing the home visit can use a
tablet to connect visually with the
WOCN at the agency to consult on the
management of the wound. If necessary,
the WOCN can contact the physician or
surgeon to relay progress or request a
change in treatment. Specialized
software can even be utilized to assess
the wound with precision and accuracy,
including measuring surface area and
depth, to improve consistency of care.10
Additionally, incorporating technology
into home health may be beneficial in
attracting these specialty clinicians,
such as cardiac nurses and WOCNs, to
homecare, which promotes the
provision of a more advanced level of
care; a benefit that will become
imperative if the home health patient
population, as a whole, exhibits more
characteristics of an acute care
population. Allowing advanced practice
clinicians to consult virtually with the
RN in the home may minimize
transportation and labor costs and
potentially improve patient access to
specialty care.
Telecommunications systems are also
playing a valuable role in managing
patients at risk for sepsis after a
hospitalization. Sepsis continues to be a
top diagnosis for hospital 30-day
readmission rates amongst Medicare
9 Breathe (Sheff). 2016 Dec; 12(4): 350–356. doi:
10.1183/20734735.014616.
10 https://parablehealth.com/post-acuteinpatient.
PO 00000
Frm 00021
Fmt 4701
Sfmt 4700
19249
patients.11 Utilizing individualized
software platforms to monitor appetite,
mental changes, biometrics, etc., which
alert care providers of any changes that
may indicate a problem, can be helpful
in treating the patient in the home prior
to the patient requiring hospitalization.
These patient-facing devices (tablets or
apps) can be programmed to require the
patient to perform a virtual daily
‘‘check-in’’ to monitor for potential
issues. If the ‘‘check-in’’ goes beyond
specified individualized parameters, an
alert will signal the HHA to follow-up
with the critical care team following the
patient to accelerate treatment. The
software can also be programmed to
deliver specific care instructions and
reminders regarding hygiene or
medications. In addition to diseasespecific monitoring, patient-facing
technologies can also be integral in
promoting patient involvement and
compliance. Certain scheduling and
communication platforms allow HHAs
to interface with patients in more ways
than in-person visits or telephone calls.
Some devices can ‘‘talk’’ to the patient,
even utilizing multiple languages.
Others can provide medication
reminders, daily health tips, and assist
in arranging for community or caregiver
support.
Overall, we have seen how technology
can expand the reach of healthcare into
the home, through consultation with
specialized clinicians and critical care
teams, as well as through the integration
of devices designed to increase patient
involvement and compliance. As
outlined above, incorporating these
various forms of technology, in addition
to remote patient monitoring as defined
under the home health benefit
(§ 409.46(e)), can be appropriate in
furnishing home health services when
used in conjunction with the provision
of in-person visits. In addition,
technology can be used to minimize the
risk of exposure to clinicians, patients,
and the public during an outbreak of an
infectious disease, such as the PHE for
the COVID–19 pandemic. Although
HHAs have the flexibility, in addition to
remote patient monitoring, to use
various types of technology, payment
for home health services remains
contingent on the furnishing of a visit.
Therefore, the use of technology must be
related to the skilled services being
furnished by the nurse or therapist or
therapy assistant to optimize the
services furnished during the home visit
or when there is a home visit. To be
eligible for the home health benefit,
beneficiaries must need intermittent
11 https://www.hcup-us.ahrq.gov/reports/
statbriefs/sb225-Inpatient-US-Stays-Trends.pdf.
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19250
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
skilled nursing or therapy services and
must be considered homebound.
Covered home health services include
skilled nursing, home health aide,
physical therapy, speech-language
pathology, occupational therapy,
medical social services, and medical
supplies, provided on a visiting basis in
a place of residence such as the
individual’s home (section 1861(m) of
the Act). A visit is defined at § 409.48(c)
as an episode of personal contact with
the beneficiary by staff of the HHA or
others under arrangements with the
HHA, for the purpose of providing a
covered service. Generally, one visit
may be covered each time an HHA
employee or someone providing home
health services under arrangement with
the HHA enters the beneficiary’s home
and provides a covered service to a
beneficiary.
To appropriately recognize the role of
technology in furnishing services under
the Medicare home health benefit, the
use of such technology must be
included on the plan of care. The
inclusion of technology on the plan of
care must continue to meet the
requirements at § 484.60, and must be
tied to the patient-specific needs as
identified in the comprehensive
assessment and the measurable
outcomes that the HHA anticipates will
occur as a result of implementing the
plan of care. For example, if a physician
orders an in-person skilled nursing visit
once a week to assess the patient and to
monitor for worsening symptoms and a
video consultation twice a week
between the skilled nurse and the
patient for medication management,
teaching and assessment, as well as to
obtain oxygen saturation readings that
the patient relays to the nurse during
the consult; the plan of care could
specify that the goal of the video
consultation is to increase patient
adherence with medication regimen and
oxygen use with no worsening
respiratory symptoms.
In summary, we are amending the
plan of care requirements at § 409.43(a)
on an interim basis, for the purposes of
Medicare payment, to state that the plan
of care must include any provision of
remote patient monitoring or other
services furnished via a
telecommunications system, and that
these services cannot substitute for a
home visit ordered as part of the plan
of care and cannot be considered a
home visit for the purposes of patient
eligibility or payment. The plan of care
must include a description of how the
use of such technology will help to
achieve the goals outlined on the plan
of care. We believe that this change will
help to increase access to technologies,
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
such as telemedicine and remote patient
monitoring, that enable the necessary
flexibility for Medicare beneficiaries to
be able to receive medically necessary
services without jeopardizing their
health or the health of those who are
providing such services, while
minimizing the overall risk to public
health during the PHE for the COVID–
19 pandemic. As we stated above, HHAs
can report the costs of
telecommunications technology as
allowable A&G costs on an interim basis
by identifying the costs using a
subscript between line 5.01 through line
5.19. We invite feedback on our interim
changes to the plan of care requirements
at § 409.43(a).
H. The Use of Telecommunications
Technology Under the Medicare
Hospice Benefit
As outlined in section II.G. of this
IFC, The Use of Technology Under the
Medicare Home Health Benefit,
technology has become an integral part
of medicine across the entire spectrum
of healthcare. Telemedicine, in
particular has the potential to play a
large role in enhancing the delivery of
healthcare in the home, including the
provision of information, education, and
services provided via
telecommunications systems. One of the
benefits of telemedicine is its potential
to minimize risk to clinicians and
patients during an outbreak of an
infectious disease, such as the PHE for
the COVID–19 pandemic. Recently, we
have been asked by stakeholders to
provide more clarity on how hospices
can leverage technology to keep
clinicians and patients safe during the
PHE for the COVID–19 pandemic.
For the duration of the PHE for the
COVID–19 pandemic, we are amending
the hospice regulations at 42 CFR
418.204 on an interim basis to specify
that when a patient is receiving routine
home care, hospices may provide
services via a telecommunications
system if it is feasible and appropriate
to do so to ensure that Medicare patients
can continue receiving services that are
reasonable and necessary for the
palliation and management of a
patients’ terminal illness and related
conditions without jeopardizing the
patients’ health or the health of those
who are providing such services during
the PHE for the COVID–19 pandemic.
To appropriately recognize the role of
technology in furnishing services under
the hospice benefit, the use of such
technology must be included on the
plan of care. The inclusion of
technology on the plan of care must
continue to meet the requirements at
§ 418.56, and must be tied to the
PO 00000
Frm 00022
Fmt 4701
Sfmt 4700
patient-specific needs as identified in
the comprehensive assessment and the
measurable outcomes that the hospice
anticipates will occur as a result of
implementing the plan of care. The
following is an example of where it
could be appropriate to furnish hospice
services via a telecommunications
system during the PHE for the COVID–
19 pandemic:
A terminally ill 85-year-old male with
heart failure has been receiving hospice
services and recently developed a fever, sore
throat and cough. The patient has been
diagnosed with suspected COVID–19 and his
hospice plan of care now includes
medications for symptom management. He is
mildly short of breath but does not require
supportive oxygen therapy. The patient’s
wife is concerned about potential for
worsening cardiac and respiratory symptoms
as a result of the patient’s risk for increased
complications due to COVID–19. The hospice
plan of care has been updated to include
remote patient monitoring with a
telecommunications system to assess the
patient’s daily weight and oxygen saturation
levels. The plan of care identifies the
measurable goal that the patient will
maintain an oxygen level above 92 percent
and the patient will not gain more than 2
pounds in a 24-hour period. The plan of care
identifies interventions if either of these
goals are not met. The remote patient
monitoring allows for more expedited
modifications to the plan of care in response
to the patient’s changing needs.
We believe that this clarification in
the regulations at § 418.204 will help to
increase access to technologies, such as
telemedicine and remote patient
monitoring, that enable the necessary
flexibility for patients to be able to
receive necessary services without
jeopardizing their health or the health of
those who are providing those services,
while minimizing the overall risk to
public health during the PHE for the
COVID–19 pandemic. Hospices are paid
a per diem payment amount based on
the level of care for each day that a
patient is under a hospice election
(§ 418.302). There is no payment beyond
the per diem amount for the use of
technology in providing services under
the hospice benefit. For the purposes of
the hospice claim submission, only inperson visits (with the exception of
social work telephone calls) should be
reported on the claim. However,
hospices can report the costs of
telecommunications technology used to
furnish services under the routine home
care level of care during the PHE for the
COVID–19 pandemic as ‘‘other patient
care services’’ using Worksheet A, cost
center line 46, or a subscript of line 46
through 46.19, cost center code 4600
through 4619, and identifying this cost
center as ‘‘PHE for COVID–19’’. We
invite feedback on our changes to the
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
special requirements for coverage at
§ 418.204.
I. Telehealth and the Medicare Hospice
Face-to-Face Encounter Requirement
To receive hospice services under the
Medicare hospice benefit, a beneficiary
must be certified as terminally ill with
a medical prognosis of a life expectancy
of 6 months or less if the illness runs its
normal course, in accordance with
section 1814(a)(7) of the Act and as
codified in § 418.22. A written
certification is required at the beginning
of the first 90-day period of hospice
care, a subsequent 90-day period and
each 60-day period thereafter. The
hospice must obtain written
certification of terminal illness for each
benefit period, even if a single election
continues in effect. In accordance with
section 1814(a)(7)(D)(i) of the Act, a
hospice physician or hospice NP must
have a face-to-face encounter with each
Medicare hospice patient whose total
stay across all hospices is anticipated to
reach the 3rd benefit period. The faceto-face encounter must occur prior to,
but no more than 30 calendar days prior
to, the 3rd benefit period recertification,
and every benefit period recertification
thereafter, to gather clinical findings to
determine continued eligibility for
hospice care.
The Medicare hospice face-to-face
encounter is an administrative
requirement related to certifying the
terminal illness as required in section
1814(a)(7)(D)(i) of the Act. By itself, it is
not billable, as it is considered
administrative (see Pub. 100–04,
Medicare Claims Processing Manual,
chapter 11, section 40.1.1). However, if
a hospice physician, or a hospice NP
who is also the patient’s designated
attending physician, provides
reasonable and necessary nonadministrative patient care during the
face-to-face visit, that portion of the visit
would be billable under the Medicare
rules. There are additional requirements
for billing physician services provided
by NPs (see Pub. 100–04, chapter 11,
section 40.1.3.2). Therefore, if a hospice
physician or the hospice NP acting as
the patient’s designated attending
physician provides direct patient care
during the course of the face-to-face
encounter, the physician or NP may bill
for such direct care services for
Medicare beneficiaries under the PFS.
As a reminder, the hospice benefit
defines an ‘‘attending physician’’ as a
doctor of medicine or osteopathy, an
NP, or a PA designated by the
individual at the time he or she elects
to receive hospice care as having the
most significant role in the
determination and delivery of the
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
individual’s medical care (§ 418.3).
However, we note that PAs are not
authorized to perform the required faceto-face encounter under section
1814(a)(7)(D)(i) of the Act. In the event
of a pandemic outbreak of an infectious
disease, such as COVID–19, an example
of direct patient care during the course
of an in-person face-to-face visit for
recertification for Medicare beneficiaries
could be as follows:
An 85-year-old male with a primary
diagnosis of end stage heart failure with
diabetes, peripheral vascular disease, and
hypertension is being seen by the hospice
physician for hospice recertification and has
developed a fever, cough and mild shortness
of breath over the last 24 hours. After
discussion with his caregiver, the hospice
physician discovers that the patient had a
visit from his niece who was found to be
COVID–19 positive. The physician washes
his hands, puts on gloves and then places a
mask on himself, the patient and caregiver.
After examining the patient, the physician
discusses with the patient and caregiver if he
would like to be tested for COVID–19 and if
he would like to continue to be treated at
home. The patient decides that he would like
to be treated at home and that he would like
to be tested. The nasopharyngeal and
oropharyngeal swabs are performed. The
hospice physician discusses with the
patient’s caregiver infection control
techniques, symptomatic treatment, and
provides them with gloves and disposable
masks. During the course of this
recertification visit, the hospice physician
provided direct patient care, and therefore,
can bill for such services.
While we do not believe that direct
patient care for Medicare hospice
patients will typically be furnished via
telehealth, we note that nothing in
statute or regulation precludes a hospice
designated attending physician from
furnishing services via telehealth in
accordance with section 1834(m) of the
Act. In response to the PHE for the
COVID–19 pandemic, The Coronavirus
Preparedness and Response
Supplemental Appropriations Act, 2020
was signed into law on March 6, 2020.
Section 102 of the Coronavirus
Preparedness and Response
Supplemental Appropriations Act, 2020
gives the Secretary the authority to
waive: (1) The telehealth originating site
requirements under section
1834(m)(4)(C) of the Act (both
geographic and site of service) for
telehealth services furnished in an
emergency area; and (2) the restriction
on use of a telephone for furnishing
telehealth services (in § 410.78(a)(3)),
but only if the telephone has audio and
video capabilities that are used for twoway, real-time interactive
communication. The originating site
facility fee would be paid to originating
sites on the current list of permissible
PO 00000
Frm 00023
Fmt 4701
Sfmt 4700
19251
sites (except for the patient’s home) in
any geographic location. The provision
established a definition of ‘‘qualified
providers’’ that specifies the
practitioners eligible for furnishing
distant site services under the waiver.
Specifically, the practitioners currently
permitted to furnish distant site
telehealth services under section
1834(m) of the Act—physicians (as
defined in section 1861(r) of the Act)
and NPPs (as defined in section
1842(b)(18)(C) of the Act)—would be
eligible to furnish telehealth services
under the waiver to patients with an
established relationship with the
practitioner or a practitioner in the same
practice (defined by tax identification
number (TIN)). This would be
determined based on a patient for whom
Medicare payment was made for an item
or service furnished by the practitioner
(or another practitioner within the same
practice) within the previous 3 years.12
The telehealth waiver is in effect and is
limited to the PHE for the COVID–19
pandemic.
The statute is silent as to whether a
face-to-face encounter solely for the
purpose of Medicare hospice
recertification (meaning there is no
direct patient care) could be conducted
via telecommunications technology by
the hospice physician or NP. Given that
a face-to-face visit solely for the purpose
of recertification for Medicare hospice
services is considered an administrative
requirement related to certifying the
terminal illness as required in section
1814(a)(7)(D)(i) of the Act, we believe
that such visit could be performed via
telecommunications technology as a
result of the PHE for the COVID–19
pandemic. We recognize that public
exposure during a pandemic event of an
infectious disease greatly increases the
overall risk to public health and
terminally ill patients are exceptionally
vulnerable to complications associated
with COVID–19. Therefore, we are
amending the regulations at
§ 418.22(a)(4) on an interim basis to
allow the use of telecommunications
technology by the hospice physician or
NP for the face-to-face visit when such
visit is solely for the purpose of
recertifying a patient for hospice
services during the PHE for the COVID–
19 pandemic. By telecommunications
12 We note that HHS will not conduct audits to
ensure that such prior relationship existed for
claims submitted during this PHE. Also, effective
immediately, the HHS Office for Civil Rights (OCR)
will exercise enforcement discretion and waive
penalties for HIPAA violations against health care
providers that serve patients in good faith through
everyday communications technologies, such as
FaceTime or Skype, during the COVID–19
nationwide PHE.
E:\FR\FM\06APR2.SGM
06APR2
19252
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
technology, we mean the use of
multimedia communications equipment
that includes, at a minimum, audio and
video equipment permitting two-way,
real-time interactive communication
between the patient (from home, or any
other site permissible for receiving
services under the hospice benefit) and
distant site hospice physician or
hospice NP.13 Such encounters solely
for the purpose of recertification would
not be a separately billed service, but
rather considered an administrative
expense. We request feedback on the
amendments to the face-to-face visit
requirement for hospice recertification
during the PHE for the COVID–19
pandemic.
J. Modification of the Inpatient
Rehabilitation Facility (IRF) Face-toFace Requirement for the PHE During
the COVID–19 Pandemic
Under 42 CFR 412.622(a)(3)(iv), for an
inpatient rehabilitation facility (IRF)
claim to be considered reasonable and
necessary under section 1862(a)(1) of
the Act, there must be a reasonable
expectation at the time of the patient’s
admission to the IRF that the patient
requires physician supervision by a
rehabilitation physician, defined as a
licensed physician with specialized
training and experience in inpatient
rehabilitation. The requirement for
medical supervision means that the
rehabilitation physician must conduct
face-to-face visits with the patient at
least 3 days per week throughout the
patient’s stay in the IRF to assess the
patient both medically and functionally,
as well as modify the course of
treatment as needed to maximize the
patient’s capacity to benefit from the
rehabilitation process.
The purpose of the physician
supervision requirement is to ensure
that the patient’s medical and functional
statuses are being continuously
monitored as the patient’s overall plan
of care is being carried out.
We continue to believe it is in the
patient’s best interest to be seen in
person by a rehabilitation physician to
assess their medical and functional
statuses while at the IRF, and we
encourage rehabilitation physicians to
continue to visit IRF patients in person
as long as all necessary precautions,
including the use of PPE, are taken to
ensure the health and safety of the
patient and the physician. However,
during the PHE for the COVID–19
pandemic, we believe that it is essential
13 Section 410.78(a)(2) defines a ‘‘distant site’’ as
the site at which the physician or practitioner
delivering the service is located at the time the
service is provided via a telecommunications
system.
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
to temporarily allow the face-to-face
visit requirements at §§ 412.622(a)(3)(iv)
and 412.29(e) to be conducted via
telehealth to safeguard the health and
safety of Medicare beneficiaries and the
rehabilitation physicians treating them.
This allows rehabilitation physicians to
use telehealth services as defined in
section 1834(m)(4)(F) of the Act, to
conduct the required 3 physician visits
per week during the PHE for the
COVID–19 pandemic. By increasing
access to telehealth, this IFC will
provide the necessary flexibility for
Medicare beneficiaries to be able to
receive medically necessary services
without jeopardizing their health or the
health of those who are providing those
services, while minimizing the overall
risk to public health.
To effectuate these changes, on an
interim basis we are finalizing revisions
to the regulations at §§ 412.622(a)(3)(iv)
and 412.29(e) during the PHE for the
COVID–19 pandemic.
In § 412.622(a)(3)(iv), we are revising
this paragraph to state that physician
supervision by a rehabilitation
physician is required, except that during
the PHE, as defined in § 400.200, such
visits may be conducted using
telehealth services (as defined in section
1834(m)(4)(F) of the Act). The
requirement for medical supervision
means that the rehabilitation physician
must conduct face-to-face visits with the
patient at least 3 days per week
throughout the patient’s stay in the IRF
to assess the patient both medically and
functionally, as well as to modify the
course of treatment as needed to
maximize the patient’s capacity to
benefit from the rehabilitation process.
The post-admission physician
evaluation described in paragraph
(a)(4)(ii) may count as one of the faceto-face visits.
In § 412.29(e), we are revising this
paragraph to state that a procedure must
be in effect to ensure that patients
receive close medical supervision, as
evidenced by at least 3 face-to-face visits
per week by a licensed physician with
specialized training and experience in
inpatient rehabilitation to assess the
patient both medically and functionally,
as well as to modify the course of
treatment as needed to maximize the
patient’s capacity to benefit from the
rehabilitation process, except that
during the PHE, as defined in § 400.200,
such visits may be conducted using
telehealth services (as defined in section
1834(m)(4)(F) of the Act).
We welcome feedback on these
revisions to the regulations at
§§ 412.622(a)(3)(iv) and 412.29(e) for the
duration of the PHE.
PO 00000
Frm 00024
Fmt 4701
Sfmt 4700
K. Removal of the IRF Post-Admission
Physician Evaluation Requirement for
the PHE for the COVID–19 Pandemic
and Clarification Regarding the ‘‘3Hour’’ Rule
IRF care is only considered by
Medicare to be reasonable and necessary
under section 1862(a)(1) of the Act if the
patient meets all of the IRF coverage
requirements outlined in
§ 412.622(a)(3), (4), and (5). Failure to
meet the IRF coverage criteria in a
particular case results in denial of the
IRF claim. Under § 412.622(a)(4)(ii), to
document that each patient for whom
the IRF seeks payment is reasonably
expected to meet all of the requirements
in § 412.622(a)(3) at the time of
admission, the patient’s medical record
at the IRF must contain a postadmission physician evaluation that
meets ALL of the following
requirements:
• It is completed by the rehabilitation
physician within 24 hours of the
patient’s admission to the IRF.
• It documents the patient’s status on
admission to the IRF, includes a
comparison with the information noted
in the preadmission screening
documentation, and serves as the basis
for the development of the overall
individualized plan of care.
• It is retained in the patient’s
medical record at the IRF.
In an effort to provide rehabilitation
physicians with as much flexibility as
possible, we are removing the postadmission physician evaluation
requirement at § 412.622(a)(4)(ii) for all
IRFs during the PHE for the COVID–19
pandemic. We believe that removal of
this requirement will greatly reduce the
amount of time rehabilitation
physicians in IRFs spend on completing
paperwork requirements when a patient
is admitted to the IRF, and will free up
their time to focus instead on caring for
patients and helping where they may be
needed with the PHE for the COVID–19
pandemic. Accordingly, we are
amending § 412.622(a)(4)(ii) to note that
the post-admission physician evaluation
is not required during the PHE for the
COVID–19 pandemic. To effectuate this
change, on an interim basis, we are
revising § 412.622(a)(4)(ii) to specify
that the post-admission physician
evaluation is not required during the
PHE for the COVID–19 pandemic.
We note that this does not preclude
an IRF patient from being evaluated by
a rehabilitation physician within the
first 24 hours of admission if the IRF
believes that the patient’s condition
warrants such an evaluation.
We invite feedback on our removal of
the post-admission physician evaluation
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
documentation requirement at
§ 412.622(a)(4)(ii) for all IRFs during the
PHE for the COVID–19 pandemic.
In addition, we are providing clarity
for all IRFs during the PHE for the
COVID–19 pandemic with regard to the
intensive rehabilitation therapy
requirements for IRF coverage at
§ 412.622(a)(3)(ii), commonly known as
the ‘‘3-hour’’ rule. Section
412.622(a)(3)(ii) generally requires that a
beneficiary be reasonably expected to
actively participate in, and benefit from,
an intensive rehabilitation therapy
program on admission to the IRF. Under
current industry standards, this
intensive rehabilitation therapy program
generally consists of at least 3 hours of
therapy (physical therapy, occupational
therapy, speech-language pathology, or
prosthetics/orthotics therapy) per day at
least 5 days per week. In certain welldocumented cases, this intensive
rehabilitation therapy program might
instead consist of at least 15 hours of
intensive rehabilitation therapy within a
7-consecutive day period, beginning
with the date of admission to the IRF.
Benefit from this intensive
rehabilitation therapy program is
demonstrated by measurable
improvement that will be of practical
value to the patient in improving the
patient’s functional capacity or
adaptation to impairments. The required
therapy treatments must begin within 36
hours from midnight of the day of
admission to the IRF.
We recognize that IRFs may have
difficulties in meeting these
requirements because normal staffing
shifts may be disrupted as staff who
would conduct the therapy program
may have COVID–19, be self-isolated, or
be unavailable for other reasons related
to the PHE. As such, while these
requirements remain in place, we are
clarifying that in cases where an IRF’s
intensive rehabilitation therapy program
is impacted by the PHE for the COVID–
19 pandemic (for example, due to
staffing disruptions resulting from selfisolation, infection, or other
circumstances related to the PHE), the
IRF should not feel obligated to meet the
industry standards referenced in
§ 412.622(a)(3)(ii), but should instead
make a note to this effect in the medical
record.
L. Rural Health Clinics (RHCs) and
Federally Qualified Health Centers
(FQHCs)
1. Expansion of Virtual Communication
Services Furnished by RHCs and FQHCs
a. Background
RHC and FQHC visits are face-to-face
(in-person) encounters between a
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
patient and an RHC or FQHC
practitioner during which time one or
more RHC or FQHC qualifying services
are furnished. RHC and FQHC
practitioners are physicians, NPs, PAs,
certified nurse midwives, clinical
psychologists, and clinical social
workers, and under certain conditions,
a registered nurse (RN) or licensed
practical nurse furnishing care to a
homebound RHC or FQHC patient. A
Transitional Care Management service
can also be an RHC or FQHC visit. A
Diabetes Self-Management Training
(DSMT) service or a Medical Nutrition
Therapy (MNT) service furnished by a
certified DSMT or MNT provider may
also be an FQHC visit.
RHCs are paid an all-inclusive rate
(AIR) for medically-necessary, face-toface visits with an RHC practitioner.
The rate is subject to a payment limit,
except for those RHCs that have an
exception to the payment limit for being
‘‘provider-based’’ (see § 413.65). FQHCs
are paid the lesser of their actual
charges or the FQHC PPS rate for
medically-necessary, face-to-face visits
with an FQHC practitioner. Only
medically-necessary medical, mental
health, or qualified preventive health
services that require the skill level of an
RHC or FQHC practitioner can be RHC
or FQHC billable visits.
The RHC and FQHC payment rates
reflect the cost of all services and
supplies that an RHC or FQHC furnishes
to a patient in a single day, and are not
adjusted for the complexity of the
patient health care needs, the length of
the visit, or the number or type of
practitioners involved in the patient’s
care. Services furnished by auxiliary
personnel (such as nurses, medical
assistants, or other clinical personnel
acting under the supervision of the RHC
or FQHC practitioner) are considered to
be incident to the visit and are included
in the per-visit payment. This may
include services furnished prior to or
after the billable visit that occur within
a medically appropriate time period,
which is usually 30 days or less.
RHCs and FQHCs are also paid for
care management services, including
chronic care management services,
general behavioral health integration
services, and psychiatric Collaborative
Care Model services. These are typically
non-face-to-face services that do not
require the skill level of an RHC or
FQHC practitioner and are not included
in the RHC or FQHC payment
methodologies.
In the CY 2019 PFS proposed rule (83
FR 35863), we proposed separate
payments to RHCs and FQHCs for
certain CTBS referred to as ‘‘Brief
Communication Technology-Based
PO 00000
Frm 00025
Fmt 4701
Sfmt 4700
19253
Services’’ for a ‘‘virtual check-in’’ and
separate payment for remote evaluation
of recorded video and/or images.
‘‘Virtual check-ins’’ are brief (5 to 10
minutes), non-face-to-face check ins
with a patient via communication
technology to assess whether the
patient’s condition necessitates an office
visit. This service could be billed only
in situations where the medical
discussion was for a condition not
related to an RHC or FQHC visit
furnished within the previous 7 days,
and does not lead to an RHC or FQHC
visit within the next 24 hours or at the
soonest available appointment. We also
proposed payment for remote evaluation
of patient-transmitted information
conducted via pre-recorded ‘‘store and
forward’’ video or image technology,
including interpretation with verbal
follow-up with the patient within 24
business hours. We had proposed that
payment would be made if the remote
evaluation did not originate from a
related RHC or FQHC visit furnished
within the previous 7 days, or lead to
an RHC or FQHC visit within the next
24 hours or soonest available
appointment.
In the CY 2019 PFS final rule (83 FR
59683), we finalized requirements and
payment for RHCs and FQHCs
furnishing Virtual Communication
Services. Effective January 1, 2019,
RHCs and FQHCs are paid for Virtual
Communication Services HCPCS code
G0071 (Payment for communication
technology-based services for 5 minutes
or more of a virtual (non-face-to-face)
communication between an RHC or
FQHC practitioner and RHC or FQHC
patient, or 5 minutes or more of remote
evaluation of recorded video and/or
images by an RHC or FQHC practitioner,
occurring in lieu of an office visit; RHC
or FQHC only). HCPCS code G0071 is
on an RHC or FQHC claim, either alone
or with other payable services, and at
least 5 minutes of communication
technology-based or remote evaluation
services are furnished by an RHC or
FQHC practitioner to a patient who has
had an RHC or FQHC billable visit
within the previous year, and the
medical discussion or remote evaluation
is for a condition not related to an RHC
or FQHC service provided within the
previous 7 days, and does not lead to an
RHC or FQHC visit within the next 24
hours or at the soonest available
appointment. We added a new
paragraph (e) to 42 CFR 405.2464 to
reflect this payment.
HCPCS code G0071 is set at the
average of the national non-facility PFS
payment rates for HCPCS code G2012
(communication technology-based
services) and HCPCS code G2010
E:\FR\FM\06APR2.SGM
06APR2
19254
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
(remote evaluation services) and is
updated annually based on the PFS
national non-facility payment rate for
these codes. RHC and FQHC face-to-face
requirements are waived when these
services are furnished to an RHC or
FQHC patient. Coinsurance and
deductibles apply to RHC claims for
HCPCS code G0071 and coinsurance
applies to FQHC claims for HCPCS code
G0071.
b. Improving Access to Care
Management and Virtual
Communication Services Furnished by
RHCs and FQHCs
RHCs and FQHCs furnish services in
rural and urban areas that have been
determined to be medically underserved
areas or health professional shortage
areas. They are an integral component of
the Nation’s health care safety net, and
we want to ensure that Medicare
patients who are served by RHCs and
FQHCs are able to communicate with
their RHC or FQHC practitioner in a
manner that enhances access to care,
consistent with evolving medical care.
Particularly in rural areas where
transportation is limited and distances
may be far, we believe the use of CTBS
may help some patients to determine if
they need to schedule a visit at the RHC
or FQHC. If it is determined that a visit
is not necessary, the RHC or FQHC
practitioner would be available for other
patients who need their care.
In the CY 2019 PFS final rule (83 FR
59452), we finalized payment for new
online digital assessment services, also
referred to as ‘‘E-Visits,’’ for
practitioners billing under the PFS.
These are non-face-to face, patientinitiated communications using online
patient portals. An online patient portal
is a secure online website that gives
patients 24-hour access to personal
health information from anywhere with
an internet connection by using a secure
username and password. These digital
assessment services are for established
patients who require a clinical decision
that otherwise typically would have
been provided in the office. To
minimize risks associated with exposure
to COVID–19, and to provide the best
care possible during the PHE for the
COVID–19 pandemic, we believe that
RHCs and FQHC practitioners, like
many other health care providers,
should explore the use of interactive
communications technology in the place
of services that would have otherwise
been furnished in person and reported
and paid under the established
methodologies.
To facilitate the ability of RHCs and
FQHCs to take such measures when
appropriate, on an interim basis, we are
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
expanding the services that can be
included in the payment for HCPCS
code G0071, and update the payment
rate to reflect the addition of these
services. Specifically, we are adding the
following three CPT codes:
• 99421 (Online digital evaluation
and management service, for an
established patient, for up to 7 days,
cumulative time during the 7 days; 5–10
minutes)
• 99422 (Online digital evaluation
and management service, for an
established patient, for up to 7 days,
cumulative time during the 7 days; 11–
20 minutes)
• 99423 (Online digital evaluation
and management service, for an
established patient, for up to 7 days,
cumulative time during the 7 days; 21
or more minutes)
We are revising the payment rate for
HCPCS code G0071 to include the
national non-facility payment rates for
these three new codes. Effective for
services furnished on or after March 1,
2020 and throughout the PHE for the
COVID pandemic, the payment rate for
HCPCS code G0071 will be the average
of the PFS national non-facility payment
rate for HCPCS code G2012
(communication technology-based
services), HCPCS code G2010 (remote
evaluation services), CPT code 99421,
CPT code 99422, and CPT code 99423.
The RHC and FQHC face-to-face
requirements are be waived for these
services. Section 405.2464(e) establishes
payment for communication
technology-based and remote evaluation
services, and no regulatory changes are
required.
The services that are payable using
HCPCS code G0071 require that the
beneficiary has been seen by an RHC or
FQHC practitioner during the previous
12 months. Under the current PHE for
the COVID–19 pandemic, we believe
that it is necessary to make these
services available to beneficiaries who
would otherwise not have access to
clinically appropriate in-person
treatment. Therefore, during the PHE for
the COVID–19 pandemic, we are
finalizing that all virtual
communication services that are billable
using HCPCS code G0071 will also be
available to new patients that have not
been seen in the RHC or FQHC within
the previous 12 months. Also, in
situations where obtaining prior
beneficiary consent would interfere
with the timely provision of these
services, or the timely provision of the
monthly care management services,
during the PHE for the COVID–19
pandemic consent can obtained when
the services are furnished instead of
prior to the service being furnished, but
PO 00000
Frm 00026
Fmt 4701
Sfmt 4700
must be obtained before the services are
billed. We will also allow patient
consent to be acquired by staff under the
general supervision of the RHC or FQHC
practitioner for the virtual
communication and monthly care
management codes during the PHE for
the COVID–19 pandemic. These changes
are consistent with the flexibilities were
are establishing for similar services paid
under the PFS as described in section
II.D. of this IFC.
2. Revision of Home Health Agency
Shortage Area Requirements for
Furnishing Visiting Nursing Services
a. Background
Sections 1861(aa)(1)(A) and (B) of the
Act describes RHC and FQHC services
as services and supplies furnished by a
physician, PA, NP, clinical psychologist
clinical social worker; and items and
services furnished incident to these
services, and specifies requirements for
these practitioners and services.
In the case of an RHC or FQHC that
is located in an area in which there
exists a shortage of HHAs, part-time or
intermittent nursing care and related
medical supplies (other than drugs and
biologicals) are authorized under
section 1861(aa)(1)(C) of the Act. These
services can be furnished by a registered
professional nurse or licensed practical
nurse to a homebound individual under
a written plan of treatment that is
established and periodically reviewed
by an RHC or FQHC physician, or
established by a NP or PA and
periodically reviewed and approved by
the RHC or FQHC physician.
In § 405.2416, we specify that visiting
nurse services are covered if all of the
following are met:
• The RHC or FQHC is located in an
area in which the Secretary has
determined that there is a shortage of
HHAs;
• The services are rendered to a
homebound individual;
• The services are furnished by a
registered professional nurse or licensed
practical nurse that is employed by, or
receives compensation for the services
from the RHC or FQHC;
• The services are furnished under a
written plan of treatment that is
established and reviewed at least every
60 days by a supervising physician of
the RHC or FQHC; or established by an
NP, PA or certified nurse midwife
(CNM); and reviewed at least every 60
days by a supervising physician. The
written plan of treatment must be signed
by the supervising physician, NP, PA or
CNM of the RHC or FQHC.
Nursing care that is covered by this
section includes services that must be
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
performed by a registered professional
nurse or licensed practical nurse if the
safety of the patient is to be assured and
the medically desired results achieved;
and personal care services, to the extent
covered under Medicare as home health
services. These services include helping
the patient to bathe, to get in and out of
bed, to exercise and to take medications.
Household and housekeeping services
or other services that would constitute
custodial care are not covered.
Section 405.2416 also defines
‘‘homebound’’ as an individual who is
permanently or temporarily confined to
his or her place of residence because of
a medical or health condition, or if the
individual leaves the place of residence
infrequently. It does not include a
hospital or long term care facility.
In Pub. 100–02, Medicare Benefit
Policy Manual, Chapter 13, section 190,
we further describe RHC and FQHC
visiting nursing services as skilled
nursing services that require the skills of
a nurse based on the complexity of the
service (for example, intravenous and
intramuscular injections or insertion of
catheters), the condition of the patient
(for example, a non-skilled service that,
because of the patient’s condition, can
only be safely and effectively provided
by a nurse), and accepted standards of
medical and nursing practice. All
services must be reasonable and
necessary to the diagnosis and treatment
of the patient’s illness or injury within
the context of the patient’s unique
medical condition, and a service that
can be safely and effectively selfadministered or performed by a
nonmedical person without the direct
supervision of a nurse, is not considered
a skilled nursing service, even if
provided by a nurse. A service which,
by its nature, requires the skills of a
nurse to be provided safely and
effectively continues to be a skilled
service even if it is taught to the patient,
the patient’s family, or other caregivers.
If a patient needs skilled nursing care
and there is no one trained or able and
willing to provide it, the services of a
nurse would be reasonable and
necessary to the treatment of the illness
or injury. We also specify that the
determination of whether visiting nurse
services are reasonable and necessary is
made by the physician based on the
condition of the patient when the
services were ordered and what is
reasonably expected to be appropriate
treatment for the illness or injury
throughout the certification period.
The requirements for furnishing
visiting nursing services include that
the patient is considered to be
‘‘confined to the home’’ as defined in
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
19255
section 1835(a) of the Act and that the
RHC or FQHC is located in an area that
has a shortage of HHAs. The services
and supplies must be provided under a
written plan of treatment; are furnished
on a part-time or intermittent basis only;
and drugs and biological products are
not provided.
Chapter 13 of the Medicare Benefit
Policy Manual, section 190, specifies
the requirements for HHA shortage areas
for purposes of visiting nursing services
furnished by RHCs and FQHCs. The
RHC or FQHC must be currently located
in a county, parish or similar geographic
area in which the Secretary has
determined that there is no participating
HHA under Medicare; or adequate home
health services are not available to RHC
or FQHC patients even though a
participating HHA is in the area; or,
there are patients whose homes are not
within the area serviced by a
participating HHA; or considering the
area’s climate and terrain, whose homes
are not within a reasonable traveling
distance to a participating HHA. RHCs
and FQHCs that are located in an area
that has not been determined to have a
current HHA shortage and are seeking to
provide visiting nurse services must
make a written request to the
appropriate CMS Regional Office along
with written justification that the area it
serves meets the required conditions.
We believe this flexibility is
important for patient access to nursing
services in the home and the potential
for HHAs to be overwhelmed during
PHE for the COVID–19 pandemic.
However, RHCs and FQHCs should
check the HIPAA Eligibility Transaction
System (HETS) before providing visiting
nurse services to ensure that the patient
is not already under a home health plan
of care. If a patient is under a home
health plan of care, the HHA must
provide optimal care to achieve the
goals and outcomes identified in the
patient’s plan of care, for each patient’s
medical, nursing, and rehabilitative
needs (§ 484.105). Therefore, RHC/
FQHC visiting nurse services would not
be covered by Medicare if such services
are found to overlap with a 30-day
period of home health care. We note
that an RHC/FQHC visiting nurse
service solely to obtain a nasal or throat
culture would not be considered a
nursing service because it would not
require the skills of a nurse to obtain the
culture as the specimen could be
obtained by an appropriately-trained
medical assistant or laboratory
technician. However, during an
otherwise covered RHC/FQHC visiting
nurse service, the nurse could obtain the
nasal or throat culture to send to the
laboratory for testing.
b. Revision of Home Health Agency
Shortage Area Requirements for
Furnishing Visiting Nursing Services
Section 405.2416(a)(2) states that
visiting nursing services are rendered to
a homebound individual, and
§ 405.2416(d) states that homebound
means an individual who is
permanently or temporarily confined to
his or her place of residence because of
a medical or health condition, and that
the individual may be considered
homebound if he or she leaves the place
of residence infrequently. We refer the
reader to the definition of ‘‘homebound’’
as it pertains the PHE for the COVID–
19 pandemic in section II.F. of this IFC,
Clarification of Homebound Status
under the Medicare Home Health
Benefit.
To address the PHE for the COVID–19
pandemic and its impact on
underserved rural and urban
communities, we are implementing, on
an interim basis, changes to the
requirements for visiting nursing
services furnished in the home by RHCs
and FQHCs.
Section 405.2416(a)(1) states that
visiting nurse services are covered if the
RHC or FQHC is located in an area in
which the Secretary has determined that
there is a shortage of HHAs, and
§ 405.2417 provides additional
requirements for an area to be
determined to have a shortage of HHAs.
During the PHE for the COVID–19
pandemic, we believe the need for
visiting nursing services furnished by
RHCs or FQHCs may increase.
Therefore, for the duration of the PHE
for the COVID–19 pandemic, we are
determining that any area typically
served by the RHC, and any area that is
included in the FQHCs service area
plan, is determined to have a shortage
of HHAs, and no request for this
determination is required.
PO 00000
Frm 00027
Fmt 4701
Sfmt 4700
c. Regulatory Changes
To make available additional visiting
nursing services during the PHE for the
COVID–19 pandemic in areas served by
RHCs and FQHCs, we are revising, on
an interim basis, § 405.2416 to add
paragraph (a)(5), to state that during the
PHE for the COVID–19 pandemic, an
area typically served by the RHC, and an
area that is included in the FQHC’s
service area plan, is determined to have
a shortage of HHAs, and no request for
this determination is required.
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19256
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
M. Medicare Clinical Laboratory Fee
Schedule: Payment for Specimen
Collection for Purposes of COVID–19
Testing
In response to the PHE for the
COVID–19 pandemic and in an effort to
be as expansive as possible within the
current authorities to have testing
available to Medicare beneficiaries who
need it, we are changing Medicare
payment policies during the PHE for the
COVID–19 pandemic to provide
payment to independent laboratories for
specimen collection for COVID–19
testing under certain circumstances.
In general, section 1833(h)(3) of the
Act requires the Secretary to provide for
and establish a nominal fee for
specimen collection for laboratory
testing and a fee to cover transportation
and personnel expenses for trained
personnel to collect specimens from
homebound patients and inpatients (not
in a hospital), in addition to the
amounts provided under the Medicare
Clinical Laboratory Fee Schedule
(CLFS). Section 1833(h)(3)(A) of the Act
provides that the Secretary must
establish a nominal fee to cover the
appropriate costs in collecting the
sample on which a clinical diagnostic
laboratory test was performed and for
which payment is made under Medicare
Part B, except that not more than one
such fee may be provided with respect
to samples collected in the same
encounter. The HCPCS codes for the
nominal specimen fees currently listed
on the CLFS (HCPCS codes 36415,
P9612, and P9615) have a payment rate
of $3. Section 216(a) of the Protecting
Access to Medicare Act of 2014 (Pub. L.
113–93, enacted April 1, 2014) added
section 1834A(b)(5) to the Act which
increases by $2 the nominal fee that
would otherwise apply under section
1833(h)(3)(A) of the Act for a sample
collected from an individual in a skilled
nursing facility (SNF) or by a laboratory
on behalf of an HHA. Therefore,
effective April 1, 2014, the nominal fee
that would otherwise apply for a sample
collected from an individual in a SNF
or by a laboratory on behalf of a HHA
is $5 (see § 414.507(f)), and the relevant
HCPCS code is G0471.
In addition, section 1833(h)(3)(B) of
the Act requires the Secretary to provide
for and establish a fee to cover the
transportation and personnel expenses
for trained personnel to travel to the
location of an individual to collect the
sample, except that such a fee may be
provided only with respect to an
individual who is homebound or an
inpatient in an inpatient facility (other
than a hospital). In accordance with this
provision, Medicare established a travel
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
allowance for a laboratory technician to
draw a specimen from homebound
patients and non-hospital inpatients.
Under current guidance, the travel
allowance is intended to cover the
estimated travel costs of collecting a
specimen from a Medicare beneficiary
and to reflect the technician’s salary and
travel costs. It is paid only when the
nominal specimen collection is also
payable and is not available if the
technician is merely performing a
messenger service to pick a specimen
drawn by a physician or nursing home
personnel. The methodology for
determining the travel allowance varies
depending on the round trip mileage to
patients’ homes. For instance, a per mile
travel allowance methodology applies
when the round trip to patients’ homes
is greater than 20 miles and a flat rate
travel allowance methodology applies
when the round trip to patients’ homes
is less than 20 miles. Medicare Part B
MACs calculate the travel allowance for
each claim. We have heard from
stakeholders that in some cases the
MAC requires them to maintain paper
logs of miles traveled to receive the
travel allowance.
CMS’ current policies for payment of
the nominal specimen collection fee and
the fee to cover transportation and
expenses for trained personnel to collect
specimens from homebound patients
and non-hospital inpatients are set forth
in Pub. 100–04, Medicare Claims
Processing Manual, chapter 16, section
60. We also implemented the increased
nominal specimen collection fee under
section 1834A(b)(5) of the Act in our
regulations at § 414.507(f). The manual
instructions regarding payment of these
fees are available on the CMS website at
https://www.cms.gov/Regulations-andGuidance/Guidance/Manuals/
Downloads/clm104c16.pdf. Neither the
annual cash deductible nor the 20
percent coinsurance for Medicare apply
to the specimen collection fees or travel
allowance for laboratory tests.
This IFC is establishing the following
changes to the specimen collection fee
policy for the duration of the PHE for
the COVID–19 pandemic. We will
provide for Medicare payment of a
nominal specimen collection fee and
associated travel allowance to
independent laboratories for collection
of specimens related to COVID–19
clinical diagnostic laboratory testing for
homebound and non-hospital
inpatients. Stakeholders have informed
us that access to COVID–19 testing in
facilities especially is limited due to the
resource costs associated with acquiring
the samples in a manner that prevents
exposure for patients and health care
workers. With patients confined to their
PO 00000
Frm 00028
Fmt 4701
Sfmt 4700
homes for their own safety or the safety
of others, there is an additional need to
have patients tested in their homes and
minimize exposure to others. We
believe that providing a specimen
collection fee for COVID–19 testing
during the PHE will provide
independent laboratories with
additional resources to provide this
testing and at the same time help with
efforts to limit patients’ exposure to the
general population and alleviate
patients’ unease with leaving the home.
Under this policy, the nominal
specimen collection fee for COVID–19
testing for homebound and non-hospital
inpatients generally will be $23.46 and
for individuals in a SNF or individuals
whose samples will be collected by
laboratory on behalf of an HHA will be
$25.46. Medicare-enrolled independent
laboratories can bill Medicare for the
specimen collection fee using one of
two new HCPCS codes for specimen
collection for COVID–19 testing and bill
for the travel allowance with the current
HCPCS codes set forth in section 60.2 of
the Medicare Claims Processing Manual
(P9603 and P9604). Our policy will also
incorporate the clarification in the
definition of homebound as discussed
in section II.F. of this IFC, relating to the
clarification of homebound status under
the Medicare home health benefit.
In establishing a nominal fee for
COVID–19 specimen collection, we
considered the type of trained
laboratory personnel required to collect
the specimen and the resources this
type of collection could require. As
noted previously, the current specimen
collection fee HCPCS codes on the CLFS
for homebound and non-hospital
inpatients are $3 and $5, but we
recognize that these fees are not
intended to address additional resources
needed during the PHE for the COVID–
19 pandemic. Absent concrete
information regarding the costs
associated with independent
laboratories collecting such specimens
for COVID–19 tests in the context of the
PHE, we looked to similar services in
other settings of care as a potential
benchmark. In looking at other Medicare
payment systems, we believe the PFS is
the best source for a potential payment
amount since physicians and other
practitioners often bill for services that
involve specimen collection by trained,
non-institutional staff.
Under the PFS, a Level 1 office visit
(CPT code 99211) typically does not
require the presence of a physician or
other qualified health care professional
and the usual presenting problem(s) are
minimal. This code is what is typically
reported by physician practices when
the patient only sees clinical office staff
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
for services like acquiring a routine
specimen sample. CPT code 99211,
describes an:
Office visit for E/M of an established
patient that may be performed by
clinical staff under supervision (may not
require a physician’s presence). Usually
the presenting problem(s) are minimal
and typically 5 minutes are spent
supervising or performing the service.
The CY 2020 national PFS payment
amount for Level 1 established patient
office visits is $23.46 on the PFS. We
also considered establishing a higher
payment amount that considered the
Level 1 E/M visit plus the payment
amount for CPT code 89220, Sputum
obtaining specimen aerosol induced
technique, for a specimen collection fee
of $40.06, but we believe there is likely
overlapping costs in staff time for these
two services and the Level 1 office visit
payment rate is adequate.
For initial diagnostic testing for
COVID–19, the CDC issued interim
guidelines that recommend collecting
and testing for the virus using an upper
respiratory nasopharyngeal swab (NP).
The CDC guidance also states that
collection of oropharyngeal swabs (OP)
is a lower priority and if collected
should be combined in the same tube as
the NP. The CDC guidance advises that
collection of sputum should only be
done for those patients with productive
coughs. See https://www.cdc.gov/
coronavirus/2019-ncov/lab/guidelinesclinical-specimens.html. Similar
collection method types, that is, NP or
OP swabs are also used in other
laboratory developed tests for COVID–
19.
Section 1833(h)(3) of the Act does not
specifically describe the types of
specimen collection methods that are
eligible for the nominal fee and
transportation and personnel expenses.
However, section 1833(h)(3)(B) of the
Act does refer to ‘‘trained personnel’’
that would collect the sample from
homebound individuals and inpatients
in non-hospital inpatient facilities. This
suggests that to be medically necessary
and for payment to be made for sample
collection, the method of sample
collection must require some training or
skill on the part of the laboratory
technician and cannot be conducted by
the beneficiary, the beneficiary’s
caregiver, or facility staff if the facility
does not have a laboratory, and
therefore, is using an outside laboratory
to perform its testing of patients. The
Medicare Claims Processing Manual
provides additional guidance on the
medical necessity requirements for
specimen collection. Specifically, the
manual states that ‘‘Medicare allows
payment for a specimen collection fee
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
when it is medically necessary for a
laboratory technician to draw a
specimen from either a nursing home
patient or homebound patient’’ and that
‘‘the technician must personally draw
the specimen.’’ It also states that ‘‘[t]his
fee will not be paid to anyone who has
not extracted the specimen’’ and lists
‘‘venipuncture or urine sample by
catheterization’’ as examples of a
technician personally drawing the
specimen. The manual further clarifies
what it means for a specimen collection
to be medically necessary stating that
‘‘. . .where the specimen is a type that
would require only the services of a
messenger and would not require the
skills of a laboratory technician, for
example, urine or sputum, a specimen
pickup service would not be considered
medically necessary.’’
We note that venipuncture and urine
sample by catheterization are currently
provided in the Medicare Claims
Processing Manual as examples of a
technician personally drawing a
specimen, however, they are not an
exhaustive list of all possible scenarios
that require trained personnel to collect
a specimen. In the case of collecting a
specimen for COVID–19 testing, we
believe that in the context of and for the
duration of the PHE for the COVID–19
pandemic, collecting specimens using
NP or OP swabs or collection of sputum
will require a trained laboratory
professional, as well as additional
precautions that must be taken to
minimize exposure risks in handling
specimens that are suspected or
confirmed for COVID–19. Thus, we
believe that collecting a specimen for
COVID–19 testing will incur higher
costs than similar specimen collection
services which require a trained
laboratory professional but not
additional precautions, to minimize
exposure risks. The CDC advises that
specimen collection must be performed
correctly the first time the specimen is
collected. A focus of the response to the
PHE for the COVID–19 pandemic is to
quickly identify individuals who are
infected so that appropriate treatment
for the patients being tested is provided
in a timely manner. At the same time,
another goal is to appropriately isolate
those patients and quarantine those
exposed to the patients to prevent
further spread of the virus. We believe
laboratory personnel will need to be
trained on how to handle the specimen
to maximize accurate test results for
COVID–19. Laboratory personnel also
will need to be trained on how to
minimize risks for spreading the virus to
themselves and/or others in the chain of
handling the specimen before it arrives
PO 00000
Frm 00029
Fmt 4701
Sfmt 4700
19257
at the laboratory for analysis. The CDC
guidance states that specimens should
be collected as soon as possible once a
person under investigation (PUI) is
identified, regardless of the time of
symptom onset, and that proper
infection control must be maintained
when collecting specimens. We believe
that specimens for COVID–19 testing
using NP, OP, or sputum must be
collected by trained laboratory
personnel, and the specimens are a type
that would not require only the services
of a messenger or specimen pick up
service. The manual currently lists
collection of sputum as a type that
would require only the services of a
messenger, and therefore, is not
considered medically necessary.
However, for the PHE for the COVID–19
pandemic only, we believe a specimen
collection fee for sputum collection
would be warranted and medically
necessary due to the reasons discussed
previously. If in the future other types
of COVID–19 tests are available, such as
serological tests or point of care tests,
we note that the specimen collection fee
would apply if the specimen collection
method must be performed by trained
laboratory personnel. However, COVID–
19 tests that allow patients to collect the
specimen themselves would not be
eligible for the specimen collection fee.
To identify specimen collection for
COVID–19 testing, we are establishing
two new level II HCPCS codes.
Independent laboratories must use one
of these HCPCS codes when billing
Medicare for the nominal specimen
collection fee for COVID–19 testing for
the duration of the PHE for the COVID–
19 pandemic. These new HCPCS codes
are:
• G2023, specimen collection for
severe acute respiratory syndrome
coronavirus 2 (SARS-CoV–2)
(Coronavirus disease [COVID–19]), any
specimen source.
• G2024, specimen collection for
severe acute respiratory syndrome
coronavirus 2 (SARS-CoV–2)
(Coronavirus disease [COVID–19]), from
an individual in a SNF or by a
laboratory on behalf of a HHA, any
specimen source.
We created the second Level II HCPCS
code, G2024, because section
1834A(b)(5) of the Act and our
regulations at § 414.507(f) require a
higher fee for collecting a specimen
from an individual in a SNF or by a
laboratory on behalf of an HHA, as
described previously in this section of
the IFC. We will issue guidance when
the PHE for the COVID–19 pandemic is
over and when these codes are no longer
valid and terminated in the HCPCS file
and/or the CLFS as appropriate.
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19258
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
In addition, Medicare payment for
transportation and expenses for trained
personnel to collect specimens from
homebound patients (as discussed in
section II.F. of this IFC, relating to the
clarification of homebound status under
the Medicare home health benefit) and
inpatients (not in a hospital) for
purposes of COVID–19 testing will be
made in accordance with existing
instructions found in the Medicare
Claims Processing Manual. Independent
laboratories must use the existing level
II HCPCS codes when billing for the
travel allowance, that is, the per mile
travel allowance as described by HCPCS
code P9603 and the flat rate travel
allowance as described by HCPCS code
P9604. Additionally, we are clarifying
that paper documentation of miles
traveled is not required and laboratories
can maintain electronic logs with that
information. However, laboratories will
need to be able to produce these
electronic logs in a form and manner
that can be shared with MACs. As stated
previously, we have heard from
stakeholders that maintaining paper logs
of miles is burdensome, especially with
the development of GPS systems and
various applications for cellular phones
in recent years that can track miles
traveled. Thus, we are clarifying that
there is no requirement that laboratories
maintain logs on paper to document
travel, and that laboratories may use
digital documentation of this
information if preferred. The MACs may
provide more information on acceptable
formats.
In defining an individual who is
homebound for purposes of the
specimen collection fee and the travel
allowance under section 1833(h)(3) of
the Act, the manual refers to Chapters
7 and 15 of Pub. 100–02, the Medicare
Benefit Policy Manual. The definition of
‘‘homebound’’ in Chapters 7 and 15 of
Pub. 100–02 originate from the statutory
definition of ‘‘confined to the home’’
(that is, ‘‘homebound’’) under sections
1814(a) and 1835(a) of the Act. As
discussed in section II.F. of this IFC,
relating to the clarification of
homebound status under the Medicare
home health benefit patients are
considered ‘‘confined to the home’’ (that
is, ‘‘homebound’’) if it is medically
contraindicated for the patient to leave
the home. When it is medically
contraindicated for a patient to leave the
home, there exists a normal inability for
an individual to leave home and leaving
home safely would require a
considerable and taxing effort.
As an example for the PHE for
COVID–19 pandemic, this would apply
for those patients: (1) Where a physician
has determined that it is medically
VerDate Sep<11>2014
19:15 Apr 03, 2020
Jkt 250001
contraindicated for a beneficiary to
leave the home because he or she has a
confirmed or suspected diagnosis of
COVID–19; or (2) where a physician has
determined that it is medically
contraindicated for a beneficiary to
leave the home because the patient has
a condition that may make the patient
more susceptible to contracting COVID–
19. A patient who is exercising ‘‘selfquarantine’’ for his or her own safety,
would not be considered ‘‘homebound’’
unless it is also medically
contraindicated for the patient to leave
the home. Determinations of whether
the patient is homebound must be based
on an assessment of each beneficiary’s
individual condition. For the PHE for
the COVID–19 pandemic, the CDC is
currently advising that older adults and
individuals with serious underlying
health conditions stay home (CDC’s
guidance is interim and is expected to
continue to be updated as warranted).14
As such, during the PHE for the COVID–
19 pandemic, we expect that many
Medicare beneficiaries could be
considered ‘‘homebound’’. In light of
this clarification regarding the
definition of homebound, we are noting
this clarification pertains to the
specimen collection fee and travel
allowance in the PHE for COVID–19
pandemic testing for homebound
patients; that is, a patient is considered
homebound for purposes of the fees
under sections 1833(h)(3) and
1834A(b)(5) of the Act if it is medically
contraindicated for the patient to leave
home.
In summary, to address the PHE for
the COVID–19 pandemic, we are using
this IFC as a vehicle to provide
additional payment during the PHE in
the form of a specimen collection fee of
$23.46 generally, and $25.46 for an
individual in a SNF or by a laboratory
on behalf of a HHA, for COVID–19
testing and to provide a travel allowance
for a laboratory technician to collect a
specimen for COVID–19 testing from a
non-hospital inpatients or homebound
patients under section 1833(h)(3) of the
Act.
N. Requirements for Opioid Treatment
Programs (OTP)
In the CY 2020 PFS final rule (84 FR
62645 and 62646), we finalized allowing
the use of interactive two-way audio/
video communication technology to
furnish the counseling and therapy
portions of the weekly bundle of
services furnished by OTPs. In light of
the PHE for the COVID–19 pandemic,
during which the public has been
14 https://www.cdc.gov/coronavirus/2019-ncov/
specific-groups/high-risk-complications.html.
PO 00000
Frm 00030
Fmt 4701
Sfmt 4700
instructed to practice self-isolation or
social distancing, and because
interactive audio-video communication
technology may not be available to all
beneficiaries, we are revising
§ 410.67(b)(3) and (4) to allow the
therapy and counseling portions of the
weekly bundles, as well as the add-on
code for additional counseling or
therapy, to be furnished using audioonly telephone calls rather than via twoway interactive audio-video
communication technology during the
PHE for the COVID–19 pandemic if
beneficiaries do not have access to twoway audio/video communications
technology, provided all other
applicable requirements are met. We
believe this change is necessary to
ensure that beneficiaries with opioid
use disorders are able to continue to
receive these important services during
the current PHE.
O. Application of Teaching Physician
and Moonlighting Regulations During
the PHE for the COVID–19 Pandemic
a. Background
In context of the PHE for the COVID–
19 pandemic, we have been asked by
stakeholders to relax supervision
requirements related to the provision of
teaching physician services under the
PFS. For teaching physicians, section
1842(b) of the Act specifies that in the
case of physicians’ services furnished to
a patient in a hospital with a teaching
program, the Secretary shall not provide
payment for such services unless the
physician renders sufficient personal
and identifiable physicians’ services to
the patient to exercise full, personal
control over the management of the
portion of the case for which payment
is sought. We have also been asked to
allow residents to independently
furnish services in their capacity as
fully licensed physicians outside of the
scope of their approved GME residency
in the inpatient setting of the hospital at
which they provide services.
b. Revisions to Teaching Physician
Regulations During a PHE for the
COVID–19 Pandemic
Regulations regarding PFS payment
for teaching physician services and
moonlighting are codified in 42 CFR
part 415. Under § 415.172, if a resident
participates in a service furnished in a
teaching setting, PFS payment is made
only if the teaching physician is present
during the key portion of any service or
procedure for which payment is sought.
The provisions in § 415.174 exempt
certain office/outpatient E/M services
provided in the outpatient department
of a hospital or another ambulatory care
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
entity (that is, primary care centers)
from the physical presence requirement
for the key portion of the service,
pending all provisions of the regulation
are met. The regulations in § 415.180
state that for the interpretation of
diagnostic radiology and other
diagnostic tests, PFS payment is made if
the interpretation is performed or
reviewed by a physician other than a
resident. For § 415.184, the requirement
for the presence of the teaching
physician during psychiatric services in
which a resident is involved may be met
by observation of the service by use of
a one-way mirror, video equipment, or
similar device.
In context of the PHE for the COVID–
19 pandemic, teaching hospitals have
expressed a need to increase their
capacity to respond to the PHE for the
COVID–19 pandemic because there has
been increased demand for physicians
to respond to patient needs. For
example, we have been asked by
stakeholders to allow Medicare to make
payment under the PFS for services
billed by teaching physicians when
residents have furnished the entirety of
a service in the inpatient setting in the
area of their approved GME program
and have a teaching physician review
and sign off on the service, rather than
requiring the teaching physician be
physically present for the key portion of
the service.
Given the circumstances of the PHE
for the COVID–19 pandemic, we believe
that the requirements for the physical
presence of the teaching physician
during the key portion of the service
would necessarily limit access to
services paid under the PFS. We
recognize that in some cases, the
physical proximity of the physician
might present additional exposure risks,
especially for high risk patients isolated
for their own protection or in cases
where the teaching physician and/or the
resident has been exposed to the virus
and must be under quarantine, or who
may be at home caring for family
members or providing childcare. If the
teaching physician and/or the resident
is under quarantine or at home, it could
unintentionally limit the number of
licensed practitioners available to
furnish services to Medicare patients
and could have the unintended
consequence of limiting access to
services paid under the PFS.
To increase the capacity of teaching
settings to respond to the PHE for the
COVID–19 pandemic as more
practitioners are increasingly being
asked to assist with the COVID–19
response, on an interim basis, for the
duration of the PHE for the COVID–19
pandemic, we are amending the
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
teaching physician regulations to allow
that as a general rule under § 415.172,
the requirement for the presence of a
teaching physician can be met, at a
minimum, through direct supervision
by interactive telecommunications
technology, as described in section II.E.
of this IFC. In other words, the teaching
physician must provide supervision
either with physical presence or be
present through interactive
telecommunications technology during
the key portion of the service.
Specifically, we believe that when use
of such real-time, audio and video
telecommunications technology allows
for the teaching physician to interact
with the resident through virtual means,
their ability to furnish assistance and
direction could be met without
requiring the teaching physician’s
physical presence for the key portion of
the service.
Currently, under the primary care
exception in § 415.174, certain lower
and mid-level office/outpatient E/M
services provided in primary care
centers are exempt from the physical
presence requirement for the key
portion of the service. The teaching
physician must direct the care from
such proximity as to constitute
immediate availability (that is, provide
direct supervision). In context of the
PHE for the COVID–19 pandemic, the
teaching physician may be under
quarantine or otherwise at home, or the
physical proximity of the teaching
physician might present additional
exposure risks. Additionally, during the
PHE for the COVID–19 pandemic, more
patients may present with more
complex needs, such as an underlying
condition that places them at high risk
for COVID–19 and that necessitate a
high level office/outpatient E/M service
(that is, level 4 or 5 visit). Consequently,
on an interim basis, for the duration of
the PHE for the COVID–19 pandemic,
we are amending § 415.174 to allow that
all levels of an office/outpatient E/M
service provided in primary care centers
may be provided under direct
supervision of the teaching physician by
interactive telecommunications
technology. We believe use of real-time,
audio and video telecommunications
technology allows for the teaching
physician to interact with the resident
through virtual means, and thus would
meet the requirement for teaching
physician presence for office/outpatient
E/M services furnished in primary care
centers. For § 415.180, for the duration
of the PHE for the COVID–19 pandemic,
we will allow PFS payment to be made
for the interpretation of diagnostic
radiology and other diagnostic tests
PO 00000
Frm 00031
Fmt 4701
Sfmt 4700
19259
when the interpretation is performed by
a resident under direct supervision of
the teaching physician by interactive
telecommunications technology. The
teaching physician must still review the
resident’s interpretation. For § 415.184,
for the duration of the PHE for the
COVID–19 pandemic, the requirement
for the presence of the teaching
physician during the psychiatric service
in which a resident is involved may be
met by the teaching physician’s direct
supervision by interactive
telecommunications technology. For
both §§ 415.180 and 415.184, allowing
residents to furnish these services under
direct supervision of the teaching
physician by interactive
telecommunications technology would
allow for the presence requirement to be
met. These diagnostic radiology,
diagnostic tests, and psychiatry services
could continue to be provided to
patients that need them in the event the
teaching physician is in quarantine or
otherwise at home, or where the
physical proximity of the teaching
physical might present additional
exposure risk.
The regulations describing PFS
payment for teaching physician services
do have additional exceptions for
specific policies. For example, as
described in § 415.172, in the case of
surgical, high-risk, or other complex
procedures, the teaching physician must
be present during all critical portions of
the procedure and immediately
available to furnish services during the
entire service or procedure. In the case
of procedures performed through an
endoscope, the teaching physician must
be present during the entire viewing. As
described in § 415.178 for anesthesia
services, the teaching anesthesiologist
must be present during all critical or key
portions of the anesthesia service or
procedure involved and the teaching
anesthesiologist must be immediately
available to furnish anesthesia services
during the entire procedure. Given the
complex nature of these procedures and
the potential danger to the patient, even
in the context of the PHE for the
COVID–19 pandemic and the inherent
exposure risks for patients and
physicians, we believe that the
requirements for physical presence for
either the entire procedure or the key
portions of the service, whichever are
applicable, are necessary for patient
safety. Thus, the PHE for the COVID–19
pandemic exceptions previously
described will not apply in the case of
surgical, high risk, interventional, or
other complex procedures, services
performed through an endoscope, and
anesthesia services. We seek comment
E:\FR\FM\06APR2.SGM
06APR2
19260
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
on whether other procedures should
also be exempt from this policy given
the complex nature or potential danger
to the patient.
Collectively, the flexibilities
described for §§ 415.172, 415.174,
415.180, and 415.184 are intended to
ensure there are as many qualified
practitioners as possible. They are also
intended to minimize the number of
people coming into contact with one
another by removing the need for inperson direct supervision. We view
direct supervision by interactive
telecommunications technology as the
minimum requirement for provision of
the service for purposes of Medicare
payment. However, teaching physicians
may continue to exercise their clinical
judgment to decide whether it is
appropriate to utilize these flexibilities
in furnishing their services involving
residents. We also seek comment on our
belief that direct supervision by
interactive telecommunications
technology is appropriate in the context
of this PHE, as well as whether any
guardrails should be included, and how
it balances risks that might be
introduced for beneficiaries with
reducing exposure risk and the
increased spread of the disease, in the
context of this PHE.
c. Application of the Expansion of
Telehealth Services to Teaching
Physician Services
On March 17, 2020, we announced
the expansion of telehealth services on
a temporary and emergency basis
pursuant to waiver authority added
under section 1135(b)(8) by the
Coronavirus Preparedness and Response
Supplemental Appropriations Act.15
Starting on March 1, 2020, Medicare can
pay for telehealth services, including
office, hospital, and other visits
furnished by physicians and other
practitioners to patients located
anywhere across the country including
in a patient’s place of residence. We
have been asked by stakeholders to
clarify whether this expansion applies
to teaching physician services,
including those furnished under the
primary care exception. We believe that
allowing Medicare payment for services
billed by the teaching physician when
the resident is furnishing services,
including office/outpatient E/M services
provided in primary care centers, via
telehealth under direct supervision by
interactive telecommunications
technology would allow residents to
furnish services remotely to patients
15 https://www.cms.gov/newsroom/press-releases/
president-trump-expands-telehealth-benefitsmedicare-beneficiaries-during-covid-19-outbreak.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
who may need to be isolated for
purposes of exposure risk based on
presumed or confirmed COVID–19
infection, and as a result, would
increase access to services for patients.
To increase the capacity of teaching
settings to respond to the PHE for the
COVID–19 pandemic as more
practitioners are increasingly being
asked to assist with the COVID–19
response, we believe that, for telehealth
services involving residents, the
requirement that a teaching physician
be present for key portions of the service
can be met through virtual means. We
also believe same is true for telehealth
services furnished by the resident in
primary care centers. The use of realtime, audio and video
telecommunications technology allows
for the teaching physician to interact
with the resident through virtual means
while the resident is furnishing services
via telecommunications technology, and
thus, in the circumstances of the PHE,
would meet the requirement for
teaching physician presence for office/
outpatient E/M services furnished in
primary care centers. Consequently, on
an interim basis for the duration of the
PHE for the COVID–19 pandemic, we
are revising our regulations to specify
that Medicare may make payment under
the PFS for teaching physician services
when a resident furnishes telehealth
services to beneficiaries under direct
supervision of the teaching physician
which is provided by interactive
telecommunications technology.
Additionally, on an interim basis, for
the duration of the PHE for the COVID–
19 pandemic, Medicare may make
payment under the PFS for services
billed under the primary care exception
by the teaching physician when a
resident furnishes telehealth services to
beneficiaries under the direct
supervision of the teaching physician by
interactive telecommunications
technology. We also seek comment on
our belief that direct supervision by
interactive telecommunications
technology is appropriate in the context
of this PHE, as well as whether and how
it balances risks that might be
introduced for beneficiaries with
reducing exposure risk and the
increased spread of the disease, in the
context of this PHE.
d. Payment Under the PFS for Teaching
Physician Services When Resident
Under Quarantine
There also may be circumstances in
which the resident may need to furnish
services while under quarantine (for
example, while at home). We have been
asked by stakeholders if residents who
have been exposed to COVID–19 and are
PO 00000
Frm 00032
Fmt 4701
Sfmt 4700
under quarantine, and otherwise well
and able to work, are able to furnish
services that do not require face-to-face
patient care, such as reading the results
of tests and other imaging studies.
Because current regulations require the
physical presence of the teaching
physician during the key portion of the
service, residents would not be able to
furnish services from quarantine, which
could limit the number of licensed
practitioners available to furnish
services to Medicare patients and could
have the unintended consequence of
limiting access to services paid under
the PFS. Because we are amending the
teaching physician regulations to allow
that as a general rule under § 415.172,
the requirement for the presence of a
teaching physician can be met through
direct supervision by interactive
telecommunications technology, on an
interim basis, for the duration of the
PHE for the COVID–19 pandemic,
Medicare may also make payment under
the PFS for teaching physician services
when the resident is furnishing these
services while in quarantine under
direct supervision of the teaching
physician by interactive
telecommunications technology. We
believe this policy will limit exposure to
COVID–19 and to allow for the
continued access to physicians’ services
of residents while in quarantine.
e. Revisions to Moonlighting
Regulations During a PHE for the
COVID–19 Pandemic
A licensed resident physician is
considered to be ‘‘moonlighting’’ when
they furnish physicians’ services to
outpatients outside the scope of an
approved graduate medical education
(GME) program. Under current
regulations, the services of residents in
hospitals in which the residents have
their approved GME program are not
considered separately billable as
physicians’ services and instead are
payable under §§ 413.75 through 413.83
regarding direct GME payments,
whether or not the services are related
to the approved GME training program.
When a resident furnishes services that
are not related to their approved GME
programs in an outpatient department or
emergency department of a hospital in
which they have their training program,
those services can be billed separately
as physicians’ services and payable
under the PFS if they meet the criteria
described in our regulation at
§ 415.208(b)(2).
In light of the PHE for the COVID–19
pandemic, teaching hospitals need to
secure as much physician coverage as
possible because there has been
increased demand for physicians to
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
respond to patient needs, such as
furnishing services to patients in
inpatient settings who have either a
presumed or confirmed COVID–19
infection. Stakeholders have requested
that residents be able to furnish
physicians’ services to patients in the
inpatient setting outside of the scope of
their approved GME programs in the
hospital where they have their training.
We believe that our regulation at
§ 415.208(b), which limits the scope of
services that can be separately billable
by moonlighting residents when
furnished outside their approved GME
programs to patients in an outpatient
department or emergency department of
a hospital in which they have their
training program, does not adequately
meet the needs of teaching hospitals to
ensure there are as many qualified
practitioners available as possible given
the circumstances of the PHE for the
COVID–19 pandemic. Under current
policy, for example, a resident in a
hospital’s approved GME program for
anesthesia who typically furnishes only
anesthesia-related services in an
operating room would not be able to
provide separately billable physicians’
services when treating inpatients in the
intensive care unit for COVID–19
infection, even if these services were not
part of the resident’s approved GME
program. As a result, this regulation
could unintentionally limit the number
of licensed practitioners available to
furnish services to Medicare patients
and could have the unintended
consequence of limiting access to
critically needed care. Consequently, on
an interim basis, for the duration of the
PHE for the COVID–19 pandemic, we
are amending our regulation in
§ 415.208 to state that the services of
residents that are not related to their
approved GME programs and are
performed in the inpatient setting of a
hospital in which they have their
training program are separately billable
physicians’ services for which payment
can be made under the PFS provided
that the services are identifiable
physicians’ services and meet the
conditions of payment for physicians’
services to beneficiaries in providers in
§ 415.102(a), the resident is fully
licensed to practice medicine,
osteopathy, dentistry, or podiatry by the
State in which the services are
performed, and the services are not
performed as part of the approved GME
program.
P. Special Requirements for Psychiatric
Hospitals (§ 482.61(d))
In the June 16, 2016 Federal Register,
we published the ‘‘Medicare and
Medicaid Programs; Hospital and
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
Critical Access Hospital (CAH) Changes
To Promote Innovation, Flexibility, and
Improvement in Patient Care’’ proposed
rule (81 FR 39447), which outlined a
number of proposed hospital and CAH
Condition of Participation (CoP)
requirements, including those focused
on infection control, antibiotic use, and
scope of practice for NPPs (that is,
advanced practice providers (APPs)
such as PAs, NPs, psychologists, and
CNSs, as well as other qualified,
licensed practitioners to whom this
revision might also be applicable).
Subsequently, in the September 30,
2019 Federal Register, we published the
‘‘Medicare and Medicaid Programs;
Hospital and Critical Access Hospital
(CAH) Changes To Promote Innovation,
Flexibility, and Improvement in Patient
Care’’ final rule (84 FR 51775) that
finalized several of these proposed
changes to modernize the hospital and
CAH requirements, improve quality of
care, and support HHS and CMS
priorities. In that final rule, we deleted
the modifying term ‘‘independent’’ from
the Patient’s Rights CoP at 42 CFR
482.13(e)(5) and (e)(8)(ii) regarding
which practitioners may order the use of
restraints and seclusion. These revisions
to the regulatory text were intended to
finally make the language of the hospital
CoPs consistent with the language of the
Children’s Health Act of 2000 (CHA)
(Pub. L. 106–310, enacted October 17,
2000) regarding restraint and seclusion
orders and licensed practitioners, and
upon which the CoP language was
originally intended to be based.
Additionally, and to remain consistent
throughout this CoP, we revised
§ 482.13(e)(10) and (11), (e)(12)(i)(A),
(e)(14), and (g)(4)(ii) that contained the
term ‘‘licensed independent
practitioner’’ by changing the term from
‘‘licensed independent practitioner’’ to
simply ‘‘licensed practitioner.’’
In the final rule, we stated that the
revision reflected our goal to have
health professionals operate within the
scope of practice allowed by state law,
and that it also recognized the need to
fully utilize the healthcare workforce.
We also stated that we believe that this
change will reduce unnecessary burden
for hospitals and remove obstacles APPs
face when ordering seclusion and
restraints. However, we stated that we
disagreed with the commenters who
stated that the removal of the term
‘‘independent’’ will cause confusion
over the applicability of this
requirement. Our removal of the term
‘‘independent’’ is consistent with the
language used in the CHA, which
utilizes the term ‘‘other licensed
practitioner,’’ without the independent
modifying term. In addition, the order of
PO 00000
Frm 00033
Fmt 4701
Sfmt 4700
19261
restraint or seclusion must be ordered
by a licensed practitioner who is
authorized by hospital policy in
accordance with State law to do so.
In the September 30, 2019 final rule,
we made additional revisions to address
other areas of the hospital CoPs that we
viewed as being either conflicting with,
or more stringent than, existing state
scope-of-practice laws and licensing
requirements, and which, if
appropriately revised, would give APPs
greater flexibility to practice more
broadly in the current healthcare system
while still being in accordance with
respective state scope-of-practice laws.
Therefore, in our review of the
Hospital CoPs for the proposed rule, we
discovered that there were several
provisions that incorrectly reference
§ 482.12(c)(1), which lists the types of
physicians and applies only to patients
who are Medicare beneficiaries. Section
482.12(c) states that the governing body
of the hospital must ensure that every
Medicare patient is under the care of
one of the following practitioners:
• A doctor of medicine or osteopathy;
• A doctor of dental surgery or dental
medicine who is legally authorized to
practice dentistry by the State and who
is acting within the scope of his or her
license;
• A doctor of podiatric medicine, but
only with respect to functions which he
or she is legally authorized by the State
to perform;
• A doctor of optometry who is
legally authorized to practice optometry
by the State in which he or she
practices;
• A chiropractor who is licensed by
the State or legally authorized to
perform the services of a chiropractor,
but only with respect to treatment by
means of manual manipulation of the
spine to correct a subluxation
demonstrated by X-ray to exist; and
• A clinical psychologist as defined
in § 410.71, but only for a clinical
psychologist services as defined in
§ 410.71 and only to the extent
permitted by State law.
The reference of this ‘‘Medicare
beneficiary-only’’ requirement in certain
other provisions of the hospital CoPs
(which we have listed below)
inappropriately links it to all patients
and not Medicare beneficiaries
exclusively. In fact, per section
1861(e)(4) of the Act, every patient with
respect to whom payment may be made
under this title must be under the care
of a physician except that a patient
receiving qualified psychologist services
(as defined in subsection (ii)) may be
under the care of a clinical psychologist
with respect to such services to the
extent permitted under State law. In
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19262
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
accordance with that provision, we have
chosen to apply § 482.12(c) to Medicare
patients. With the exception of a few
provisions in the CoPs such as those
directly related to § 482.12(c) described
here, the remainder of the CoPs apply to
all patients, regardless of payment
source, and not just Medicare
beneficiaries. For example, the Nursing
Services CoP, at § 482.23(c)(1), requires
that all drugs and biologicals must be
prepared and administered in
accordance with Federal and State laws,
the orders of the practitioner or
practitioners responsible for the
patient’s care as specified under
§ 482.12(c), and accepted standards of
practice. Since the CoPs clearly allow
hospitals to determine which categories
of practitioners would be responsible for
the care of other patients, outside the
narrow Medicare beneficiary restrictions
of § 482.12(c), this reference is
inappropriate and unnecessarily
restrictive of hospitals and their medical
staffs to make these determinations
based on State law and practitioner
scope of practice.
To clarify that these provisions apply
to all patients and not only Medicare
beneficiaries, we deleted any
inappropriate references to § 482.12(c)
in the final rule. Therefore, we deleted
references to § 482.12(c) found in the
following provisions: § 482.13(e)(5),
(e)(8)(ii), (e)(14), and (g)(4)(ii) in the
Patients’ Rights CoP; and § 482.23(c)(1)
and (3) in the Nursing Services CoP. We
note here that we did not receive any
comments on these changes as they
proposed in the June 2016 proposed
rule, and therefore, we finalized them
without change.
In performing our most recent review
of the hospital CoPs, including the
Requirements for Specialty Hospitals at
subpart E of 42 CFR part 482, we
discovered that we inadvertently failed
to propose to delete another
inappropriate reference to § 482.12(c),
which is contained in the current
provision at § 482.61(d) in the Special
Medical Record Requirements for
Psychiatric Hospitals CoP (pertaining to
which hospital personnel may complete
progress notes for patients). The current
provision also contains the term
‘‘licensed independent practitioner.’’
Therefore, in the interests of consistency
with the other recent revisions we have
noted here, we are now deleting the
reference to § 482.12(c) along with the
modifier ‘‘independent’’ in this IFC.
We believe that as currently written
and implemented, this requirement
requires some clarification for the
reasons that we have discussed. As we
have already stated and made clear
through our recent revisions to the
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
hospital CoPs, we believe that APPs,
including PAs, NPs, psychologists, and
CNSs (as well as other qualified,
licensed practitioners to whom this
revision might also be applicable), when
acting in accordance with State law,
their scope of practice, and hospital
policy, should have the authority to
practice more broadly and to the highest
level of their education, training, and
qualifications as allowed under their
respective state requirements and laws
in this area.
We believe that NPPs practicing in the
psychiatric hospital setting should be
able to record progress notes of
psychiatric patients for whom they are
responsible. Therefore, we will allow
the use of NPPs, or APPs, to document
progress notes of patients receiving
services in psychiatric hospitals, in
addition to MDs/DOs as is currently
allowed.
Given the changes made to the
requirements under § 482.13 regarding
the removal of the word ‘‘independent’’
from the phrase ‘‘licensed independent
practitioner’’ when referencing NPPs
that we have previously discussed, we
are making the same change for this
provision. We believe that the
regulatory language should be as
consistent as possible throughout the
hospital CoPs and, in addition, as was
the case with the requirement under
§ 482.13, using the term ‘‘licensed
independent practitioner’’ may
inadvertently exacerbate workforce
shortage concerns, might unnecessarily
impose regulatory burden on hospitals
by restricting a hospital’s ability to
allow APPs and other NPPs to operate
within the scope of practice allowed by
state law, and does not recognize the
benefits to patient care that might be
derived from fully utilizing APPs and
their clinical skills to the highest levels
of their training, education, and
experience as allowed by hospital
policy in accordance with state law. We
believe that this change permits a
greater scope of practice for these
professionals in the psychiatric hospital
context.
Q. Innovation Center Models
1. Medicare Diabetes Prevention
Program (MDPP) Expanded Model
Emergency Policy
Through this IFC, we are amending
the Medicare Diabetes Prevention
Program (MDPP) expanded model to
modify certain MDPP policies during
the PHE. Specifically, this IFC will
permit certain beneficiaries to obtain the
set of MDPP services more than once
per lifetime, increase the number of
virtual make-up sessions, and allow
PO 00000
Frm 00034
Fmt 4701
Sfmt 4700
certain MDPP suppliers to deliver
virtual MDPP sessions on a temporary
basis. These changes are in response to
COVID–19, which resulted in an
interruption to expanded model services
delivered by MDPP suppliers and/or
prevented MDPP beneficiaries from
attending sessions. Throughout the
rulemaking for the MDPP expanded
model, we sought to ensure that the
MDPP set of services would be
delivered in-person, in a classroom
based setting, within an established
timeline. At the time, the priority was
placed on establishing a structured
service that, when delivered within the
confines of the rule, would create the
least risk of fraud and abuse, increase
the likelihood of success, and maintain
the integrity of the data collected for
evaluation purposes. However, the
COVID–19 pandemic has led to
suspension of in-person class sessions
and guidance from CDC that Medicareage beneficiaries stay home. In response,
we will implement provisions that
allow for temporary flexibilities that
prioritize availability and continuity of
services for MDPP suppliers and MDPP
beneficiaries impacted by extreme and
uncontrollable circumstances during the
COVID–19 PHE. The changes in this IFC
are applicable to MDPP suppliers, as
defined in § 410.79(b), that are enrolled
in MDPP as March 1, 2020, and MDPP
beneficiaries as defined in § 410.79(b)
who were receiving MDPP set of
services as of March 1, 2020. Under
these temporary flexibilities, the
requirement for in-person attendance at
the first core-session will remain in
effect. As a result, if beneficiaries are
prohibited from attending the first core
session in person, suppliers will be
unable to start any new cohorts with
MDPP beneficiaries. All flexibilities
described in this IFC will cease to be
available at the conclusion of the PHE.
The CDC issued guidance to all National
Diabetes Prevention Program suppliers
on or about March 12, 2020, providing
alternative delivery options during the
COVID–19 national emergency,
including encouraging organizations to
use virtual make-up sessions as
necessary, regardless of usual delivery
mode; if virtual make-up sessions are
not possible, organizations may pause
offering classes. When classes resume,
the CDC is allowing suppliers to pick up
where they left off, or to restart the
expanded model program from week
one. It is our intent to conform with the
CDC guidance where feasible, with the
overall intent to minimize disruption of
services for MDPP suppliers and MDPP
beneficiaries; by allowing MDPP
beneficiaries to maintain their
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
eligibility. We are amending the MDPP
regulations to provide for certain
changes, including allowing MDPP
suppliers to either deliver MDPP
services virtually or suspend in-person
services and resume services at a later
date. The limit to the number of virtual
make-up sessions is waived for MDPP
suppliers with existing capabilities to
provide services virtually, so long as the
virtual services are furnished in a
manner that is consistent with the CDC
Diabetes Prevention Recognition
Program (DPRP) standards for virtual
sessions, follow the CDC-approved DPP
curriculum requirements, and are
provided upon the individual MDPP
beneficiary’s request. In addition, the
MDPP supplier may only furnish to the
MDPP beneficiary a maximum of one
session on the same day as a regularly
scheduled session and a maximum of
one virtual make-up session per week.
Virtual make-up sessions may only be
furnished to achieve attendance goals
and may not be furnished to achieve
weight-loss goals. An MDPP supplier
may offer to an MDPP beneficiary no
more than: 15 virtual make-up sessions
offered weekly during the core session
period; 6 virtual make-up sessions
offered monthly during the core
maintenance session interval periods;
and 12 virtual make-up sessions offered
monthly during the ongoing
maintenance session interval periods.
In addition, these changes permit
certain MDPP beneficiaries to obtain the
set of MDPP services more than once
per lifetime, for the limited purposes of
allowing a pause in service and to
provide the flexibilities that will allow
MDPP beneficiaries to maintain
eligibility for MDPP services despite a
break in service, attendance, or weight
loss achievement.
We are amending our provisions at
§ 410.79 by adding paragraph (e).
2. Changes to the Comprehensive Care
for Joint Replacement (CJR) Model To
Extend the Length of Performance Year
5 by Three Additional Months and To
Change the Extreme and Uncontrollable
Circumstances Policy To Account for
the COVID–19 Pandemic
Through this IFC, we are
implementing two changes to the
Comprehensive Care for Joint
Replacement (CJR) model to support the
continuity of model operations and to
ensure that CJR participants do not
unfairly suffer financial consequences
from the impact of COVID–19 due to
their participation in CJR. Specifically,
we are implementing a 3-month
extension to CJR performance year (PY)
5 such that the model will now end on
March 31, 2021, rather than ending on
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
December 31, 2020. On February 24,
2020, we published a proposed rule
titled ‘‘Medicare Program:
Comprehensive Care for Joint
Replacement Model Three-Year
Extension and Changes to Episode
Definition and Pricing’’ (85 FR 10516;
CMS–5529–P). We wish to ensure
continuity of CJR model operations in
participant hospitals during this PHE for
the COVID–19 pandemic so that we do
not create any additional disruptions to
the standard care procedures hospitals
have in place during this challenging
time. Therefore, we are implementing a
3-month extension of CJR PY 5 and
amending the provisions at 42 CFR
510.2 and 510.200(a) to reflect that
extension.
Further, recognizing that the current
CJR model policy for extreme and
uncontrollable circumstances policy is
not applicable to the PHE for the
COVID–19 pandemic, we also are
implementing a change to that policy in
this IFC such that it will be applicable
to episodes impacted by the COVID–19
pandemic. Currently, the CJR extreme
and uncontrollable circumstances
policy, which is codified at § 510.305(k),
applies only during major disaster
declarations where a participant
hospital and its beneficiaries are
affected by natural disasters, such as,
hurricanes, earthquakes, wildfires.16
Although the COVID–19 outbreak in the
United States was declared as a national
emergency on March 13, 2020,17 the
current CJR extreme and uncontrollable
circumstances policy does not apply to
this national emergency. Although we
do not expect many new CJR episodes
to initiate as we have recently issued
guidance 18 stressing the need to avoid
elective surgeries in light of the COVID–
19 virus, we recognize that a number of
beneficiaries are in active CJR episodes
that initiated prior to March 2020.
Further, we acknowledge that CJR hip
fracture episodes, which generally result
from emergent accidents and are not
necessarily avoidable, will continue to
occur. Given the challenges to the
health care delivery system in
responding to COVID–19 cases and the
expenses associated with treating this
highly contagious virus, we want to
avoid inadvertently creating incentives
to place cost considerations above
patient safety within the CJR model
during this COVID–19 pandemic.
16 82
FR 57066.
https://www.whitehouse.gov/presidentialactions/proclamation-declaring-nationalemergency-concerning-novel-coronavirus-diseasecovid-19-outbreak/.
18 See: https://www.cms.gov/files/document/
31820-cms-adult-elective-surgery-and-proceduresrecommendations.pdf.
17 See:
PO 00000
Frm 00035
Fmt 4701
Sfmt 4700
19263
Therefore, to enable the CJR model to
adjust for the effect of COVID–19, we
are broadening the extreme and
uncontrollable circumstances policy by
applying certain financial safeguards to
participant hospitals that have a CCN
primary address that is located in an
emergency area for episodes that
overlap with the emergency period, as
those terms are defined in section
1135(g) of the Act, for which the
Secretary issued a waiver or
modification of requirements under
section 1135 of the Act on March 13,
2020, which applies nationwide.19
Accordingly, all participant hospitals
are located in the emergency area and
qualify for applicable financial
safeguards during the emergency period.
Amending the extreme and
uncontrollable circumstances policy to
account for all participant hospitals
affected by the COVID–19 pandemic
allows participant hospitals to
concentrate on patient care and ensures
that participant hospitals are not held
financially liable for episode costs that
escalate due to effects from the COVID–
19 pandemic. While this amendment
greatly broadens the extreme and
uncontrollable circumstances policy,
the significant impact the health care
delivery system faces in responding to
COVID–19 cases and the expenses
associated with treating this highlycontagious virus justifies modifying the
extreme and uncontrollable
circumstances policy and increasing the
financial safeguards. Specifically, we
are stating that for a fracture or nonfracture episode with a date of
admission to the anchor hospitalization
that is on or within 30 days before the
date that the emergency period (as
defined in section 1135(g) of the Act)
begins or that occurs through the
termination of the emergency period (as
described in section 1135(e) of the Act),
actual episode payments are capped at
the target price determined for that
episode under § 510.300. Though
different financial safeguards apply for
fracture and non-fracture episodes when
a major disaster declaration is declared,
we believe applying equal financial
safeguards for both episodes during the
COVID–19 pandemic is more
appropriate due to its nationwide
impact on hospitals and post-acute care
facilities ability to provide care for
beneficiaries during this PHE.
We are codifying these provisions at
§ 510.305 (k)(3) and (4).
19 See https://www.phe.gov/emergency/news/
healthactions/section1135/Pages/covid1913March20.aspx.
E:\FR\FM\06APR2.SGM
06APR2
19264
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
3. Alternative Payment Model
Treatment Under the Quality Payment
Program
As has been described previously in
this IFC, we are seeking to give entities
and individuals that provide services to
Medicare beneficiaries needed
flexibilities to respond effectively to the
serious public health threats posed by
the spread of the COVID–19, and to
address the needs of health care
providers specific to this declared
national emergency. We further
recognize that flexibilities may be
necessary and appropriate in the context
of Alternative Payment Models (APMs),
including applicable model tests
conducted under section 1115A of the
Act by the CMS Center for Medicare and
Medicaid Innovation (Innovation
Center), as well as the Medicare Shared
Savings Program. We note that aspects
of APM policies under the Quality
Payment Program are designed to follow
on from the specific designs, policies,
and operations of individual APMs. We
recognize that our current regulations
may be insufficient for purposes of
adequately responding to the stillemerging COVID–19 national emergency
and that additional action may be
necessary and appropriate to prevent
APM participants from facing undue
burden in or negative consequences
through the Quality Payment Program.
We acknowledge that possible
changes might be needed to address
issues that may arise for APM
participants in light of the current
emergency. We will consider
undertaking additional rulemaking,
including possibly another interim final
rule, to amend or suspend APM QPP
policies as necessary to ensure accurate
and appropriate application of Quality
Payment Program policies in light of the
PHE due to COVID–19.
jbell on DSKJLSW7X2PROD with RULES2
R. Remote Physiologic Monitoring
In recent years, we have finalized
payment for seven CPT codes in the
Remote Physiologic Monitoring (RPM)
code family. We finalized payment in
the CY 2018 PFS final rule for CPT code
99091 (Collection and interpretation of
physiologic data digitally stored and/or
transmitted by the patient and/or
caregiver to the physician or other
qualified health care professional,
qualified by education, training,
licensure/regulation requiring a
minimum of 30 minutes of time). The
following year, we finalized payment for
CPT codes 99453 (Remote monitoring of
physiologic parameter(s)(e.g., weight,
blood pressure, pulse oximetry,
respiratory flow rate), initial; set-up and
patient education on use of equipment),
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
99454 (Remote monitoring of
physiologic parameter(s)(e.g., weight,
blood pressure, pulse oximetry,
respiratory flow rate), initial; device(s)
supply with daily recording(s) or
programmed alert(s) transmission, each
30 days), and 99457 (Remote
physiologic monitoring treatment
management services, clinical staff/
physician/other qualified health care
professional time in a calendar month
requiring interactive communication
with the patient/caregiver during the
month; first 20 minutes)). Most recently,
for the CY 2020 PFS final rule (84 FR
62645 and 62646), we finalized a
treatment management add-on code CPT
code 99458 (Remote physiologic
monitoring treatment management
services, clinical staff/physician/other
qualified health care professional time
in a calendar month requiring
interactive communication with the
patient/caregiver during the month;
each additional 20 minutes) and two
self-measured blood pressure
monitoring codes, CPT code 99473
(Self-measured blood pressure using a
device validated for clinical accuracy;
patient education/training and device
calibration) and CPT code 99474
(Separate self-measurements of two
readings one minute apart, twice daily
over a 30-day period (minimum of 12
readings), collection of data reported by
the patient and/or caregiver to the
physician or other qualified health care
professional, with report of average
systolic and diastolic pressures and
subsequent communication of a
treatment plan to the patient).
We are concerned that under the PHE
for the COVID–19 pandemic, physicians
and other health care professionals are
faced with challenges regarding
potential exposure risks for themselves
and their patients. In response, the CDC
has urged health care professionals to
make every effort to interview patients
by telephone, text monitoring, or video
conferencing instead of in-person. We
believe that RPM services support the
CDC’s goal of reducing human exposure
to the novel coronavirus while also
increasing access to care and improving
patient outcomes.
RPM services are considered to be
CTBS and, as such, would be billable
only for established patients. Our goal
during the PHE for the COVID–19
pandemic is to reduce exposure risks to
the novel coronavirus for practitioners
and patients and to increase access to
services by eliminating as many
obstacles as possible to delivering
necessary services. Allowing RPM
services to be furnished only to
established patients could be an
obstacle to delivery of reasonable and
PO 00000
Frm 00036
Fmt 4701
Sfmt 4700
necessary care particularly during
current conditions. Thus, in response to
the PHE for the COVID–19 pandemic,
we are finalizing on an interim basis,
that RPM services can be furnished to
new patients, as well as to established
patients.
In addition to current policy that
there be an established patientpractitioner relationship, we require for
CTBS at least verbal consent from a
Medicare beneficiary to receive the
services. We finalized this requirement
to avoid scenarios where beneficiaries
are unexpectedly responsible for copays
for services that do not involve the
typical in-person, face-to-face service
that a patient receives during an office
visit. We continue to believe that patient
consent is important. However, we also
believe that acquiring patient consent
should not interfere with the provision
of RPM services during the PHE for the
COVID–19 pandemic. Therefore, we are
finalizing on an interim basis that
consent to receive RPM services can be
obtained once annually, including at the
time services are furnished, during the
duration of the PHE for the COVID–19
pandemic. However, to enhance
beneficiary protection, for both new and
established patients, we suggest that the
physician or other health care
practitioner review consent information
with a beneficiary, obtain the
beneficiary’s verbal consent, and
document in the medical record that
consent was obtained.
Finally, we are clarifying that RPM
codes can be used for physiologic
monitoring of patients with acute and/
or chronic conditions. The typical
patient needing RPM services may have
a chronic condition (for example, high
blood pressure, diabetes, COPD).
However, RPM can be used for other
conditions. For example, RPM services
allow a patient with an acute respiratory
virus to monitor pulse and oxygen
saturation levels using pulse oximetry.
Nurses, working with physicians, can
check-in with the patient and then using
patient data, determine whether home
treatment is safe, all the while reducing
exposure risk and eliminating
potentially unnecessary emergency
department and hospital visits.
S. Telephone Evaluation and
Management (E/M) Services
For CY 2008, the CPT Editorial Panel
created CPT codes to describe E/M
services furnished by a physician or
qualified healthcare professional via
telephone or online, including CPT
codes 98966 (Telephone assessment and
management service provided by a
qualified nonphysician health care
professional to an established patient,
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
parent, or guardian not originating from
a related assessment and management
service provided within the previous 7
days nor leading to an assessment and
management service or procedure
within the next 24 hours or soonest
available appointment; 5–10 minutes of
medical discussion), 98967 (Telephone
assessment and management service
provided by a qualified nonphysician
health care professional to an
established patient, parent, or guardian
not originating from a related
assessment and management service
provided within the previous 7 days nor
leading to an assessment and
management service or procedure
within the next 24 hours or soonest
available appointment; 11–20 minutes
of medical discussion), 98968
(Telephone assessment and
management service provided by a
qualified nonphysician health care
professional to an established patient,
parent, or guardian not originating from
a related assessment and management
service provided within the previous 7
days nor leading to an assessment and
management service or procedure
within the next 24 hours or soonest
available appointment; 21–30 minutes
of medical discussion), 99441
(Telephone evaluation and management
service by a physician or other qualified
health care professional who may report
evaluation and management services
provided to an established patient,
parent, or guardian not originating from
a related E/M service provided within
the previous 7 days nor leading to an
E/M service or procedure within the
next 24 hours or soonest available
appointment; 5–10 minutes of medical
discussion), 99442 (Telephone
evaluation and management service by
a physician or other qualified health
care professional who may report
evaluation and management services
provided to an established patient,
parent, or guardian not originating from
a related E/M service provided within
the previous 7 days nor leading to an
E/M service or procedure within the
next 24 hours or soonest available
appointment; 11–20 minutes of medical
discussion), and 99443 (Telephone
evaluation and management service by
a physician or other qualified health
care professional who may report
evaluation and management services
provided to an established patient,
parent, or guardian not originating from
a related E/M service provided within
the previous 7 days nor leading to an
E/M service or procedure within the
next 24 hours or soonest available
appointment; 21–30 minutes of medical
discussion). We assigned a status
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
indicator of ‘‘N’’ (Noncovered) to these
services because: (1) These services are
non-face-to-face; and (2) the code
descriptors include language that
recognizes the provision of services to
parties other than the beneficiary for
whom Medicare does not provide
coverage (for example, a guardian).
We do not believe that we should
continue to consider these to be
categorically non-covered services. In
PFS rulemaking subsequent to CY 2008,
we established separate payment for
numerous non-face-to-face services,
including care management services and
prolonged non-face-to-face E/M
services. We have also noted, for
example in CY 2017, that we recognize
that in current medical practice,
practitioner interaction with caregivers
is an integral part of treatment for some
patients. Accordingly, the descriptions
for several payable codes under the PFS
include direct interactions between
practitioners and caregivers (81 FR
80331).
When we established separate
payment for services like virtual checkins and e-visits, we recognized that nonface-to-face services had become an
important part of overall physician care
of Medicare beneficiaries, especially
relative to care for chronic conditions.
The current Medicare policy regarding
the CPT codes that describe telephone
E/M services predated our ongoing
recognition of the need to pay separately
for these kinds of services. Despite the
fact that these are classified as E/M
services in the coding, we do not believe
that these codes describe full E/M
services, but rather are closely
analogous to the virtual check-in
services. Although we assigned a
‘‘Noncovered’’ status indicator for the
telephone E/M codes, we still
established the American Medical
Association’s RUC-recommended RVUs
for them. To establish the payment rate
for the virtual check-in service, we used
the RUC-recommended valuation for the
lowest level telephone E/M code.
However, the telephone E/M codes
provide additional stratification by time
for circumstances when a practitioner
spends more than a brief amount of time
in direct communication with the
patient. We believe that under ordinary
circumstances outside of the PHE, if the
needs of the patient are significant
enough to require the amount of time
and attention from the practitioner
specified in the codes for higher level
telephone evaluations or assessments,
either an in-person visit or a telehealth
visit would be required. Alternatively, if
the needs of the patient are less acute
and lengthy, a virtual check-in would
suffice. However, in the context of the
PO 00000
Frm 00037
Fmt 4701
Sfmt 4700
19265
goal of reducing exposure risks
associated with the PHE for the COVID–
19 pandemic, especially in the case that
two-way, audio and video technology
required to furnish a Medicare
telehealth service might not be
available, we believe there are many
circumstances where prolonged, audioonly communication between the
practitioner and the patient could be
clinically appropriate yet not fully
replace a face-to-face visit. We believe
that the existing telephone E/M codes,
in both description and valuation, are
the best way to recognize the relative
resource costs of these kinds of services.
Therefore, we are finalizing, on an
interim basis for the duration of the PHE
for the COVID–19 pandemic, separate
payment for CPT codes 98966–98968
and CPT codes 99441–99443. For these
codes, we are finalizing on an interim
basis for the duration of the PHE for the
COVID–19 pandemic, work RVUs as
recommended by the AMA Health Care
Professionals Advisory Committee
(HCPAC) for CY PFS 2008 rulemaking
as discussed in the CY 2008 PFS final
rule (72 CFR 66371) of 0.25 for CPT
code 98966, 0.50 work RVUs for CPT
code 98967, and 0.75 for CPT code
98968, and work RVUs as recommended
by the AMA Relative Value Scale
Update Committee (RUC) of 0.25 for
CPT code 99441, 0.50 for CPT code
99442, and 0.75 for CPT code 99443. We
are finalizing the HCPAC and RUCrecommended direct PE inputs which
consist of 3 minutes of post-service RN/
LPN/MTA clinical labor time for each
code.
Similar to the CTBS described in
section II.D. of this IFC, we believe it is
important during the PHE to extend
these services to both new and
established patients. While some of the
code descriptors refer to ‘‘established
patient,’’ during the PHE we are
exercising enforcement discretion on an
interim basis to relax enforcement of
this aspect of the code descriptors.
Specifically, we will not conduct review
to consider whether those services were
furnished to established patients. CPT
codes 98966–98968 described
assessment and management services
performed by practitioners who cannot
separately bill for E/Ms. We are noting
that these services may be furnished by,
among others, LCSWs, clinical
psychologists, and physical therapists,
occupational therapists, and speech
language pathologists when the visit
pertains to a service that falls within the
benefit category of those practitioners.
To facilitate billing of these services
by therapists, we are designating CPT
codes 98966–98968 as CTBS
‘‘sometimes therapy’’ services that
E:\FR\FM\06APR2.SGM
06APR2
19266
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
would require the private practice
occupational therapist, physical
therapist, and speech-language
pathologist to include the corresponding
GO, GP, or GN therapy modifier on
claims for these services.
T. Physician Supervision Flexibility for
Outpatient Hospitals—Outpatient
Hospital Therapeutic Services Assigned
to the Non-Surgical Extended Duration
Therapeutic Services (NSEDTS) Level of
Supervision
Non-surgical extended duration
therapeutic services (NSEDTS) describe
services that have a significant
monitoring component that can extend
for a sizable period of time, that are not
surgical, and that typically have a low
risk of complications after the
assessment at the beginning of the
service. The minimum default
supervision level of NSEDTS was
established in the CY 2011 OPPS/ASC
final rule with comment period (75 FR
72003 through 72013) as being direct
supervision during the initiation of the
service, which may be followed by
general supervision at the discretion of
the supervising physician or the
appropriate NPP (§ 410.27(a)(1)(iv)(E)).
In this case, initiation means the
beginning portion of the NSEDTS which
ends when the patient is stable and the
supervising physician or the appropriate
NPP determines that the remainder of
the service can be delivered safely
under general supervision. We
established general supervision as the
appropriate level of supervision after
the initiation of the service because it is
challenging for hospitals to ensure
direct supervision for services with an
extended duration and a significant
monitoring component, particularly for
CAHs and small rural hospitals.
In the CY 2020 OPPS/ASC final rule
with comment period (84 FR 61359
through 61363), we changed the
generally applicable minimum required
level of supervision for most hospital
outpatient therapeutic services from
direct supervision to general
supervision for hospitals and CAHs.
Given the circumstances of the PHE for
the COVID–19 pandemic, we believe it
is critical that hospitals have the most
flexibility as possible to provide the
services Medicare beneficiaries need
during this challenging time. Changing
the minimum default level of
supervision to general supervision for
NSEDTS during the initiation of the
service will give providers additional
flexibility they will need to handle the
burdens created by the PHE for the
COVID–19 pandemic.
Therefore, we are assigning, on an
interim basis, all outpatient hospital
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
therapeutic services that fall under
§ 410.27(a)(1)(iv)(E), a minimum level of
general supervision to be consistent
with the minimum default level of
general supervision that applies for
most outpatient hospital therapeutic
services, and we are revising
§ 410.27(a)(1)(iv)(E) to reflect this
change in the minimum level of
supervision. General supervision, as
defined in our regulation at
§ 410.32(b)(3)(i) means that the
procedure is furnished under the
physician’s overall direction and
control, but that the physician’s
presence is not required during the
performance of the procedure.
U. Application of Certain National
Coverage Determination and Local
Coverage Determination Requirements
During the PHE for the COVID–19
Pandemic
National Coverage Determinations
(NCDs) are determinations by the
Secretary with respect to whether or not
a particular item or service is covered
nationally under Title XVIII. Local
Coverage Determinations (LCDs) are
determinations by a Medicare
Administrative Contractor (MAC) with
respect to whether or not a particular
item or service is covered under section
1862(a)(1)(A) of the Act in the particular
MAC’s geographical areas. Articles are
often published alongside LCDs and
contain coding or other guidelines that
complement an LCD. NCDs and LCDs
contain clinical conditions a patient
must meet to qualify for coverage of the
item or service. Some NCDs and LCDs
may also contain requirements for faceto-face, timely evaluations or reevaluations for a patient to initially
qualify for coverage or to qualify for
continuing coverage of the item or
service. These requirements are more
often present in NCDs and LCDs for
durable medical equipment than for
other items and services.
1. Face-to-Face and In-Person
Requirements
For the duration of this PHE for the
COVID–19 pandemic, it is in the best
interest of patients, health care
professionals and suppliers to limit
face-to-face encounters and avoid
exposure of vulnerable Medicare
beneficiaries to COVID–19. Therefore,
on an interim basis, we are finalizing
that to the extent an NCD or LCD
(including articles) would otherwise
require a face-to-face or in-person
encounter for evaluations, assessments,
certifications or other implied face-toface services, those requirements would
not apply during the PHE for the
COVID–19 pandemic.
PO 00000
Frm 00038
Fmt 4701
Sfmt 4700
We note that some face-to-face
encounter requirements for DMEPOS
Power Mobility Devices (PMDs) are
mandated by statute for program
integrity purposes. This IFC does not
apply to those statutory requirements.
For example, PMD face-to-face
encounter requirements are found in
section 1834(a)(1)(E)(iv) of the Act, as
codified in § 410.38, and our regulation
already permits the use of telehealth in
accordance with Medicare guidelines.
We have extended flexibilities to permit
a broader use of telehealth services
during the PHE for the COVID–19
pandemic. It should be noted that this
does not confer changes to the clinical
indications of coverage for any LCD or
NCD unless specifically indicated
below.
2. Clinical Indications for Certain
Respiratory, Home Anticoagulation
Management and Infusion Pump
Policies
During the PHE for the COVID–19
pandemic, it is possible that patients
receiving services for respiratory related
indications will be required to receive
care in unexpected settings, including
the home. This may be necessary as
COVID–19 and other patients are shifted
across healthcare settings to
accommodate an increase in patient
volume.
Therefore, we are finalizing on an
interim basis that we will not enforce
the clinical indications for coverage
across respiratory, home anticoagulation
management and infusion pump NCDs
and LCDs (including articles) allowing
for maximum flexibility for practitioners
to care for their patients. This
enforcement discretion will only apply
during the PHE for the COVID–19
pandemic. These policies include, but
are not limited to:
• NCD 240.2 Home Oxygen.
• NCD 240.4 Continuous Positive
Airway Pressure for Obstructive Sleep
Apnea.
• LCD L33800 Respiratory Assist
Devices (ventilators for home use).
• NCD 240.5 Intrapulmonary
Percussive Ventilator.
• LCD L33797 Oxygen and Oxygen
Equipment (for home use).
• NCD 190.11 Home Prothrombin
Time/International Normalized Ratio
(PT/INR) Monitoring for
Anticoagulation Management.
• NCD 280.14 Infusion Pumps.
• LCD L33794 External Infusion
Pumps.
At the conclusion of the PHE for the
COVID–19 pandemic, we will return to
enforcement of these clinical
indications for coverage.
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
3. Requirements for Consultations or
Services Furnished by or With the
Supervision of a Particular Medical
Practitioner or Specialist
Staffing is being adjusted in both
facility and non-facility settings to
accommodate for the needs of patients
during the PHE for the COVID–19
pandemic. These staffing decisions may
impact the availability of physicians
and physician specialists to furnish
evaluations, consultations and
procedures or to supervise others. To
the extent NCDs and LCDs require a
specific practitioner type or physician
specialty to furnish a service, procedure
or any portion thereof, we are finalizing
on an interim basis the chief medical
officer or equivalent of the facility can
authorize another physician specialty or
other practitioner type to meet those
requirements during the PHE for the
COVID–19 pandemic. Additionally, to
the extent NCDs and LCDs require a
physician or physician specialty to
supervise other practitioners,
professionals or qualified personnel, the
chief medical officer of the facility can
authorize that such supervision
requirements do not apply during the
PHE for the COVID–19 pandemic.
V. Change to Medicare Shared Savings
Program Extreme and Uncontrollable
Circumstances Policy
In December 2017, we issued an
interim final rule with comment period,
titled ‘‘Medicare Shared Savings
Program: Extreme and Uncontrollable
Circumstances Policies for Performance
Year 2017’’ (hereinafter referred to as
the ‘‘December 2017 interim final rule
with comment period’’), which
appeared in the Federal Register on
December 26, 2017 (82 FR 60912
through 60919). The December 2017
interim final rule with comment period
established a policy for determining
quality performance scores for
accountable care organizations (ACOs)
participating in the Medicare Shared
Savings Program (Shared Savings
Program), when the ACO, its
participating ACO providers and
suppliers, and assigned beneficiaries
were located in geographic areas that
were impacted by extreme and
uncontrollable circumstances, such as
hurricanes, wildfires, or other triggering
events, during performance year (PY)
2017, including the applicable quality
data reporting period for the
performance year if the quality reporting
period was not extended. In the CY
2019 PFS final rule we extended the
extreme and uncontrollable
circumstances policy finalized for PY
2017 to PY 2018 and subsequent
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
performance years. Under the policy
adopted in that final rule, for a given
performance year, including the
applicable quality data reporting period
for the performance year if the quality
reporting period is not extended, we
will use an alternative approach to
calculating the quality score for ACOs
affected by extreme and uncontrollable
circumstances (42 CFR 425.502(f)).
Under this current policy at
§ 425.502(f), the Shared Savings
Program extreme and uncontrollable
circumstances policy does not apply for
a performance year if an extreme and
uncontrollable circumstance occurs
during the quality reporting period for
that performance year and the quality
reporting period is extended. For all
performance years starting in 2019, the
original quality reporting period was
January 2, 2020, through March 31,
2020. In response to the PHE for the
COVID–19 pandemic, we have
determined that the 2019 MIPS data
submission deadline will be extended
by 30 days until April 30, 2020, to give
eligible clinicians more time to report
quality and other data for purposes of
MIPS. This extended timeline also
applies to Shared Savings Program
ACOs because they are required to
report quality data via the CMS Web
Interface and we align the Shared
Savings Program data submission
timeline with the timeline for MIPS data
submission. While the extended
timeframe for data submission is
intended to give eligible clinicians
sufficient time to complete all the
elements of MIPS reporting during the
PHE for the COVID–19 pandemic, we
realize that this extension alone may not
be sufficient to ease the burden of
reporting given the increased burden of
providing care to all patients during this
time. For this reason, under the Quality
Payment Program, we have determined
that the MIPS automatic extreme and
uncontrollable circumstances policy
will apply to MIPS eligible clinicians,
who do not submit their MIPS data by
the extended timeline. Under this
automatic extreme and uncontrollable
circumstances policy, MIPS eligible
clinicians, who are not participants in
APMs, who do not submit any MIPS
data will have all performance
categories reweighted to zero percent,
resulting in a score equal to the
performance threshold, and a neutral
MIPS payment adjustment. However,
under the policy, if a MIPS eligible
clinician submits data on two or more
MIPS performance categories, they will
be scored and receive a 2021 MIPS
payment adjustment based on their final
score.
PO 00000
Frm 00039
Fmt 4701
Sfmt 4700
19267
The automatic extreme and
uncontrollable circumstances policy
described above does not apply to MIPS
eligible clinicians who are subject to the
APM scoring standard (82 FR 53899),
such as MIPS eligible clinicians
participating in Shared Savings Program
ACOs. Instead, these MIPS eligible
clinicians will continue to be scored
under the existing APM scoring
standard. Generally, if no MIPS eligible
clinicians in an APM Entity submit data
by the extended deadline for the Quality
and Promoting Interoperability
performance categories due to extreme
and uncontrollable circumstances, the
APM scoring standard would apply as
follows. The Cost performance category
will be weighted at zero percent, as
usual. The Improvement Activities
performance category will be scored as
usual. The Quality performance
category will be reweighted to zero
percent where the APM has waived
quality reporting for purposes of the
APM as in these circumstances CMS
determines that there are not sufficient
measures or activities applicable and
available to MIPS eligible clinicians,
consistent with § 414.1370(h). Finally, if
all MIPS eligible clinicians in an APM
Entity have been excepted from
reporting the Promoting Interoperability
performance category, then the
Promoting Interoperability performance
category weight will be reweighted to
zero for the APM Entity for that MIPS
performance period
(§ 414.1370(g)(4)(iii)(A)). As a result, in
these circumstances, the Quality, Cost,
and Promoting Interoperability
categories would all be weighted at zero
percent. And as only one performance
category will be scored, the
Improvement Activities performance
category, such MIPS eligible clinicians
would receive a neutral MIPS payment
adjustment.
For MIPS eligible clinicians
participating in Shared Savings Program
ACOs that do not report quality and
obtain a neutral payment adjustment
under MIPS, according to the existing
APM scoring standard described above,
the Shared Savings Program must
determine that the ACOs are impacted
by an extreme and uncontrollable
circumstance and waive the quality
reporting requirement under the Shared
Savings Program. As currently written,
the Shared Savings Program extreme
and uncontrollable circumstances
policy does not allow for the
determination that an ACO has been
impacted by an extreme and
uncontrollable circumstance that occurs
during the quality reporting period if
quality reporting period is extended, as
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19268
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
it has been for performance years
starting in 2019.
In addition, under the Shared Savings
Program, if an ACO fails to report
quality data by the submission deadline,
the ACO will not have met the quality
performance standard and will receive a
quality score of zero, unless the extreme
and uncontrollable circumstances
policy under § 425.502(f) applies. In the
event an ACO receives a quality
performance score of zero, the ACO
would be ineligible to share in savings,
if earned and would owe maximum
losses if participating under Track 2 or
the ENHANCED track. The current
Medicare Shared Savings Program
extreme and uncontrollable
circumstances policy for purposes of
determining an ACO’s quality score for
use in determining shared savings or
losses applies if twenty percent or more
of an ACO’s assigned beneficiaries or its
legal business entity are located in an
area identified under the Quality
Payment Program as being affected by
an extreme and uncontrollable
circumstance for the performance year,
including the quality reporting period if
the quality reporting period is not
extended.
The effect of the MIPS quality
reporting period extension is that the
current Shared Savings Program
extreme and uncontrollable
circumstance policy does not apply,
because the current extreme and
uncontrollable circumstances policy is
only available for extreme and
uncontrollable circumstances that occur
during the quality reporting period,
such as the current PHE for the COVID–
19 pandemic, if the quality reporting
period is not extended. The inability to
apply the extreme and uncontrollable
circumstances policy to waive the
quality reporting requirements under
the Shared Savings Program during the
PHE may adversely impact ACOs and
their participating ACO providers and
suppliers, because the extended
timeline to submit data alone may not
be sufficient to support ACOs and their
participating ACO providers and
suppliers, who are focused on care
delivery during the national emergency.
The intent of the Shared Savings
Program extreme and uncontrollable
circumstance policy is to mitigate any
impact on quality performance and the
resultant effect on financial
reconciliation due to emergency
circumstances outside of the ACO’s
control. Accordingly, we believe it is
necessary to revise the policies
governing the availability of the Shared
Savings Program extreme and
uncontrollable circumstances policies to
extend the protection to ACOs that may
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
not be able to completely and accurately
report their quality data for 2019,
despite the extension of the quality
reporting period. To provide relief to all
ACOs participating in the Shared
Savings Program during 2019, we need
to modify the extreme and
uncontrollable circumstances policy as
it applies to disasters that occur during
the reporting period to eliminate the
restriction that the extreme and
uncontrollable circumstances policy
applies only if the reporting period is
not extended.
As explained above, the PHE for the
COVID–19 pandemic was declared
during the quality reporting period for
performance years starting in 2019. The
PHE for the COVID–19 pandemic
applies to all counties in the United
States, and we believe it is appropriate
to offer relief under the Shared Savings
Program extreme and uncontrollable
circumstances policy to all Shared
Savings Program ACOs that are unable
to completely and accurately report
quality for 2019 by the extended
deadline due to the PHE for the COVID–
19 pandemic. Due to the PHE for the
COVID–19 pandemic and our desire to
provide relief for Shared Savings ACOs
who need to focus resources on patient
care at this time, we believe that this
policy must be effective starting with
the quality reporting period for
performance years starting in 2019.
Further, as illustrated by the current
PHE for the COVID–19 pandemic, there
may be unanticipated situations in the
future, during which extension of a
quality reporting window alone would
not provide sufficient relief from
reporting burden at a time when ACOs
and their ACO providers and suppliers
need to focus on patient care.
Accordingly, in this IFC, we are revising
the regulation at § 425.502(f) to remove
the restriction which prevents the
application of the Shared Savings
Program extreme and uncontrollable
circumstances policy for disasters that
occur during the quality reporting
period if the reporting period is
extended, to offer relief under the
Shared Savings Program to all ACOs
that may be unable to completely and
accurately report quality data for 2019
due to the PHE for the COVID–19
pandemic. Specifically, we are
amending the regulation at § 425.502(f)
to remove the phrase ‘‘if the quality
reporting period is not extended,’’
effective with quality reporting for PY
2019.
We are considering whether the
current policy, which assigns an ACO
the higher of the mean quality score
across all ACOs and the ACO’s own
quality score, in the event the ACO is
PO 00000
Frm 00040
Fmt 4701
Sfmt 4700
determined to be impacted by an
extreme and uncontrollable
circumstances, will continue to be
appropriate for PY 2020 and beyond.
Any change to that current policy would
be made through future notice and
comment rulemaking.
Regarding Shared Savings Program
financial reconciliations for
performance years starting in 2019, we
note that because the PHE for the
COVID–19 pandemic was declared
during the reporting period for those
performance years, the provisions that
allow for an adjustment to the amount
of shared losses for ACOs found to be
affected by an extreme and
uncontrollable circumstance during a
performance year would not apply for
performance years starting in 2019.
However, for PY 2020 financial
reconciliation, we will reduce the
amount of an ACO’s shared losses by an
amount determined by multiplying the
shared losses by the percentage of the
total months in the performance year
affected by an extreme and
uncontrollable circumstance, and the
percentage of the ACO’s assigned
beneficiaries who reside in an area
affected by an extreme and
uncontrollable circumstance. At this
time, the PHE for the COVID–19
pandemic applies to all counties in the
country; therefore, 100 percent of
assigned beneficiaries for all Shared
Savings Program ACOs reside in an
affected area and the total months
affected by an extreme and
uncontrollable circumstance will begin
with March and continue through the
end of the current PHE, as defined in
§ 400.200.
Additionally, the Medicare Shared
Savings Program financial methodology
includes updating each ACO’s
benchmark at the end of each
performance year based on the
performance year expenditure trend.
The factors used to update ACOs’
benchmarks will reflect the national and
regional trends related to spending and
utilization changes during 2020,
including any changes arising from the
PHE for the COVID–19 pandemic.
W. Level Selection for Office/Outpatient
E/M Visits When Furnished Via
Medicare Telehealth
In the CY 2020 PFS final rule (84 FR
62847 and 62848), we finalized a
number of changes to the framework of
the office/outpatient E/M requirements
for CY 2021. Beginning January 1, 2021
for office/outpatient E/M visits, the code
level will be selected based on either the
level of MDM or the total time
personally spent by the reporting
practitioner on the day of the visit
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
(including face-to-face and non-face-toface time). We noted that there was
broad support for these changes from
the AMA and other specialty societies.
Currently, telehealth office/outpatient
E/Ms can be furnished to beneficiaries
in their homes only when they are for
individuals with a substance use
disorder (SUD) diagnosis for purposes of
treatment of such disorder or cooccurring mental health disorder. For
these services, the primary factor in
selecting the appropriate level of E/M
service to bill would be time spent
counseling the patient. Under the
waiver issued by the Secretary pursuant
to section 1135(b)(8) of the Act,
telehealth office/outpatient E/Ms can be
furnished to any patient in their home
regardless of their diagnosis or medical
condition. However, the current E/M
coding guidelines would preclude the
billing practitioner from selecting the
office/outpatient E/M code level based
on time in circumstances where the
practitioner is not engaged in
counseling and/or care coordination.
On an interim basis, we are revising
our policy to specify that the office/
outpatient E/M level selection for these
services when furnished via telehealth
can be based on MDM or time, with
time defined as all of the time
associated with the E/M on the day of
the encounter; and to remove any
requirements regarding documentation
of history and/or physical exam in the
medical record. This policy is similar to
the policy that will apply to all office/
outpatient E/Ms beginning in 2021
under policies finalized in the CY 2020
PFS final rule. It remains our
expectation that practitioners will
document E/M visits as necessary to
ensure quality and continuity of care.
To reduce the potential for confusion,
we are maintaining the current
definition of MDM. We note that
currently there are typical times
associated with the office/outpatient E/
Ms, and we are finalizing those times as
what should be met for purposes of
level selection. The typical times
associated with the office/outpatient E/
Ms are available as a public use file at
https://www.cms.gov/Medicare/
Medicare-Fee-for-Service-Payment/
PhysicianFeeSched/PFS-FederalRegulation-Notices-Items/CMS-1715-F.
This policy only applies to office/
outpatient visits furnished via Medicare
telehealth, and only during the PHE for
the COVID–19 pandemic.
X. Counting of Resident Time During
the PHE for the COVID–19 Pandemic
In section II.O. of this IFC,
‘‘Application of the Teaching Physician
Regulations During the PHE for the
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
COVID–19 pandemic,’’ we state that the
teaching supervision requirement can be
met in certain circumstances through
direct supervision using interactive
telecommunications technology,
including when a medical resident is
quarantined at home. Regarding
claiming of the residents for indirect
medical education (IME) and Direct
graduate medical education (DGME)
purposes, under current regulations, if a
resident is training in a hospital, that
hospital claims the resident for IME and
DGME (per § 413.78(a)), and if a resident
is training in a nonprovider site such as
a doctor’s office or clinic, the hospital
or hospitals that pays the resident’s
salaries and fringe benefits claims the
resident for IME and DGME (per
§ 413.78(g)). Currently, there is no
provision in the regulations for a
hospital to claim a resident for IME or
DGME if the resident is performing
patient care activities within the scope
of his or her approved program in his
or her own home, or in a patient’s home.
For the duration of this emergency
situation, we are permitting the hospital
that is paying the resident’s salary and
fringe benefits for the time that the
resident is at home or in the home of a
patient that is already a patient of the
physician or hospital, but performing
patient care duties within the scope of
the approved residency program (and
meets appropriate physician
supervision requirements as stated in
section II.O. of this IFC) to claim that
resident for IME and DGME purposes.
Y. Addressing the Impact of COVID–19
on Part C and Part D Quality Rating
Systems
1. Background
a. Legislative Authority for Star Ratings
Based on its authority to disseminate
comparative information, including
about quality, to beneficiaries under
sections 1851(d) and 1860D–1(c) of the
Act and authority to collect various
types of quality data under section
1852(e) of the Act, CMS develops and
publicly posts a 5-star ratings system for
MA and Part D plans. That system is
also the basis for determining quality
bonus payment (QBP) status for MA
plans under section 1853(o) of the Act.
Section 1876 cost plans are also
included in the MA and Part D Star
Rating system as codified at 42 CFR
417.472(k) and are also required by
§ 417.472(j) to make CAHPS survey data
available to CMS. In a final rule,
‘‘Medicare Program; Contract Year 2019
Policy and Technical Changes to the
Medicare Advantage, Medicare Cost
Plans, Medicare Fee-for-Service, the
Medicare Prescription Drug Benefit
PO 00000
Frm 00041
Fmt 4701
Sfmt 4700
19269
Programs, and the PACE Program,’’
published on April 16, 2018 (83 FR
16519 through 16589), we adopted
regulations to govern this quality rating
system for cost MA and Part D plans,
which are generally rated at the contract
level. In a final rule, ‘‘Medicare and
Medicaid Program; Policy and
Technical Changes to the Medicare
Advantage, Medicare Prescription Drug
Benefit, Programs of All-Inclusive Care
for the Elderly (PACE), Medicaid Feefor-Service, and Medicaid Managed Care
Programs for Years 2020 and 2021,’’
published April 16, 2019 (84 FR 15830
and 15831), we amended the regulations
governing the quality rating program for
MA and Part D plans. Those final rules
contain a more detailed discussion of
CMS’ authority in this area and we
encourage readers to refer to those final
rules.
In the CY 2020 Final Call Letter and
the CY 2020 final rule, published in the
Federal Register on April 16, 2019 (84
FR 15830 and 15831), we finalized a set
of rules for adjusting the calculation of
Star Ratings for the cost and Parts C and
D organizations that are impacted by
extreme and uncontrollable
circumstances. We provided in the 2021
Advance Notice that the same policy as
used for adjustments to 2020 Star
Ratings based on extreme and
uncontrollable circumstances would be
continued for CY 2021 Star Ratings. We
did not envision the unprecedented
circumstances surrounding the PHE for
the COVID–19 pandemic when we
developed the adjustments for extreme
and uncontrollable circumstances for
the Part C and D Star Ratings program;
as they exist currently, they are not
sufficient in the case of the PHE for the
COVID–19 pandemic.
b. Overview of Star Ratings
The Star Ratings are generally based
on measures of performance during a
period that is 2 calendar years before the
year for which the Star Ratings are
issued; 2021 Star Ratings will generally
be based on performance during 2019
and the 2022 Star Ratings will similarly
be based on performance in 2020. We
use multiple data sources to measure
quality and performance of contracts.
Various regulations require plans to
report on quality improvement and
quality assurance and to provide data
which we can use to help beneficiaries
compare plans (for example,
§§ 417.472(j) and (k), 422.152(b),
423.153(c), and 423.156). In addition,
we may require plans to report statistics
and other information in specific
categories (§§ 422.516 and 423.514).
Data from these sources and other
sources are used to calculate measures
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19270
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
of plan sponsor performance each year,
as provided in §§ 422.162 and 423.182.
The Star Ratings serve an important
purpose in providing comparative
information to enrollees and are also
used to identify whether an MA plan is
eligible for a QBP under section 1853(o)
of the Act. The Patient Protection and
Affordable Care Act (Pub. L. 111–148),
as amended by the Healthcare and
Education Reconciliation Act (Pub. L.
111–152), provides for quality ratings,
based on a 5-star rating system and the
information collected under section
1852(e) of the Act, to be used in
calculating payment to MA
organizations beginning in 2012.
Specifically, sections 1853(o) and
1854(b)(1)(c) of the Act were added and
amended to provide, respectively, for an
increase in the benchmark against
which MA organizations bid and in the
portion of the savings between the bid
and the benchmark available to the MA
organization to use as a rebate. We
assign both low and high performing
icons that are displayed on
www.Medicare.gov to help Medicare
beneficiaries make plan decisions based
on either consistently low performance
for 3 or more years or receiving 5 stars
for the highest rating, respectively.
Additionally, plans that demonstrate
exceptional performance due to
achieving a 5 Star Rating for their
highest rating can market year round
and beneficiaries receive a special
election period that allows the eligible
beneficiary to enroll in a 5-star plan
during the contract year. We also have
the authority to terminate plans that
have below a 3-star rating for 3 or more
years. The Star Ratings therefore serve a
number of important purposes for cost,
MA and Part D plans; we believe that
plans engage in behavior during the
performance measurement period to
improve their Star Ratings and to
achieve higher Star Ratings.
Healthcare Effectiveness Data and
Information Set (HEDIS) and Consumer
Assessment of Healthcare Providers and
Systems (CAHPS) data are the basis for
the calculation of the majority of
measures for both the Part C and Part D
Star Ratings. HEDIS measures include
clinical measures assessing the
effectiveness of care, access/availability
measures, and service use measures and
are calculated by CMS through a
contract with the National Committee
for Quality Assurance (NCQA). Many of
the HEDIS measures require plans to
perform reviews of patients’ medical
records or to obtain information directly
from physician offices, which is a timeintensive activity.
CAHPS refers to a comprehensive
family of surveys that ask consumers
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
and patients to evaluate experiences of
care. Cost plans, Part C plans, and Part
D plans are all required by regulation
(§§ 417.472, 422.152, and 423.156,
respectively) to contract with approved
Medicare CAHPS survey vendors to
conduct the Medicare CAHPS
satisfaction survey of Medicare plan
enrollees in accordance with CMS
specifications and submit the survey
data to CMS. The Star Ratings system
uses measures from HEDIS and CAHPS
extensively, and there are negative
consequences for a plan’s Star Ratings
(overall and on specific measures) if the
necessary data for the HEDIS and
CAHPS measures are not reported or
validated. Although the 2021 Star
Ratings reflect performance in 2019 for
most of the measures, data collection for
HEDIS and CAHPS is conducted in the
first half of CY 2020 to feed into the
2021 Star Ratings that are finalized by
October 2020. Similarly, the Health
Outcomes Survey will occur in 2020 to
collect data used for the 2022 Star
Ratings and the same concerns about
survey activities apply to that survey.
2. Impact of COVID–19 on Star Ratings
Data Collection
The World Health Organization
(WHO) has characterized COVID–19 as
a pandemic, and there are alarming
levels of spread and severity of COVID–
19 across the United States. The CDC
and medical professionals recommend
that the best way to prevent the spread
of the virus is to avoid contact with
infected individuals. Social distancing
is a method that public health officials
use to curb the transmission and spread
of infectious illnesses like COVID–19.
Prior research has shown that these
measures help mitigate the spread of
contagious viruses in the absence of
vaccines (https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3372334/), as is the
case with COVID–19.
To help curb the spread of COVID–19,
governors around the country are
putting in place actions to protect
public health and safety and help
mitigate the spread of the virus,
including school closures, limiting the
size of gatherings and events, and
restaurant closures. Employers are
moving to mandatory telework when
feasible. The intent of these actions is to
save lives, keep people safe, and slow
the rate of infection. As of March 28,
2020, all 50 states were under a State of
Emergency. Additionally, areas of the
country are being put under shelter-inplace orders to further curtail the spread
of the virus. CDC has provided guidance
to health care facilities (for example,
https://www.cdc.gov/coronavirus/2019ncov/healthcare-facilities/guidance-
PO 00000
Frm 00042
Fmt 4701
Sfmt 4700
hcf.html) that range from rescheduling
non-urgent outpatient visits and elective
surgeries, promoting telehealth visits,
and managing mildly ill COVID–19
patients at home. Also, on March 16,
2020, CDC issued interim guidance
(https://www.cdc.gov/coronavirus/2019ncov/community/large-events/
index.html) advising the public against
holding gatherings of more than 10
individuals. On March 18, 2020, we
released recommendations related to
delaying adult elective surgeries, nonessential medical, surgical, and dental
procedures during the COVID–19
outbreak to be able to focus health care
professionals on those most in need of
healthcare (https://www.cms.gov/
newsroom/press-releases/cms-releasesrecommendations-adult-electivesurgeries-non-essential-medicalsurgical-and-dental).
On March 13, 2020, President Trump
declared a national emergency as a
result of the COVID–19 pandemic. The
declaration of the PHE for the COVID–
19 pandemic allows certain Medicare
requirements and conditions of
participation to be waived under section
1135 of the Act providing more
flexibility to providers in furnishing
medically necessary health care to
beneficiaries.
Currently, data collection for HEDIS
measures is ongoing for services and
performance during the 2019
measurement period. MA contracts are
required to submit their HEDIS
summary-level data to the NCQA by
June 15, 2020, as well as to submit their
HEDIS patient-level data to CMS the
same day. Currently, data collection
activities are underway to meet the June
deadlines. Some of the HEDIS measures
require medical record review or
obtaining information directly from
physician offices. We recognize that
obtaining medical records from
physician offices and the necessary
documentation from physician offices
needed for the plan to meet HEDIS
requirements, and requiring plans to
participate in HEDIS audits will put a
strain on the limited resources available
to these health care providers. Some of
these activities are generally done in
person so compliance with social
distancing efforts, travel bans and
quarantines raise additional challenges,
as well as risks to staff. CMS’ top
priority is to ensure public health and
safety, including that of beneficiaries,
health and drug plan staff, and
providers, and to allow health and drug
plans, providers, and physician offices
to focus on what is most important at
this time: The provision of care.
Under §§ 417.472(i) and (j),
422.152(b)(5), and 423.156, all
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
coordinated care MA plans, section
1876 contracts, and Part D sponsors,
respectively, are required to contract
with a CMS-approved CAHPS survey
vendor to conduct the Medicare CAHPS
satisfaction survey in accordance CMS
specifications and to submit the data to
CMS. The administration of the surveys
and data collection are currently
ongoing until the end of May 2020 for
the CAHPS survey data that would be
used for the 2021 Star Ratings. We are
concerned that the COVID–19 pandemic
will pose significant challenges and
safety concerns in successfully
completing the current CAHPS data
collection. Most of the survey
administration protocols cannot be
completed remotely, requiring staff to
work in mail facilities and call centers
where telephone interviewers assemble
in close quarters to perform the
telephone administration of the survey.
We are concerned that cost plans, MA
organizations, and Part D plan sponsors
will not be able to complete this year’s
data collection without jeopardizing the
health and safety of survey vendor staff.
We have similar concerns about the
Health Outcomes Survey (HOS) data
collection scheduled for later in 2020.
This IFC amends, as necessary, the
calculations for the 2021 and 2022 Part
C and D Star Ratings to incorporate
changes to address the expected impact
of the PHE for the COVID–19 pandemic
on data collection and performance.
Plans urgently need to know these
changes so as not to further exacerbate
the PHE for the COVID–19 pandemic by
continuing efforts to complete the
HEDIS and CAHPS data collection
activities. The HEDIS data collection
diverts physicians’ offices and health
plans from handling the day-to-day
emergencies as a result of the PHE for
the COVID–19 pandemic. Additionally,
we are concerned it is not possible to
safely continue the HEDIS and CAHPS
data collection activities while
complying with the CDC
recommendation for social distancing.
Under normal circumstances, if Part C
and section 1876 plans do not fully
complete their HEDIS data collection
activities and successfully meet NCQA’s
HEDIS audit requirements, we assign
each of the HEDIS Star Ratings measures
1 star. Similarly, if the CAHPS data
cannot be completed and submitted on
time by Part C, section 1876 cost, and
Part D plans, we historically have
assigned each of the CAHPS Star
Ratings measures 1 star. Furthermore,
unreliable CAHPS measure scores are
excluded from the Part C and D Star
Ratings calculations. Without knowing
the changes made by this IFC to the
methodology for calculating the 2021
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
and 2022 Star Rating, plans could have
conflicting incentives, needing
physician offices and plan staff to focus
on caring for those impacted by COVID–
19 and keeping Medicare beneficiaries
and those involved in data collection
activities safe, while at the same time
wanting to ensure that future Star
Ratings and QBP ratings are not
impacted by the PHE for the COVID–19
pandemic which could negatively
impact future benefits offered by MA
organizations. The changes to the
calculations for 2021 and 2022 Star
Ratings are designed to avoid
inadvertently creating incentives for
plans to place cost and Star Rating
considerations above efforts to address
the COVID–19 pandemic.
3. Provisions of IFC
This IFC is modifying the calculation
of the 2021 and 2022 Part C and D Star
Ratings to address the expected
disruption to data collection posed by
the PHE for the COVID–19 pandemic.
Specifically, this IFC: (1) Replaces the
2021 Star Ratings measures calculated
based on HEDIS and Medicare CAHPS
data collections with earlier values from
the 2020 Star Ratings (which are not
affected by the public health threats
posed by COVID–19); (2) establishes
how we will calculate or assign Star
Ratings for 2021 in the event that CMS’
functions become focused on only
continued performance of essential
Agency functions and the Agency and/
or its contractors do not have the ability
to calculate the 2021 Star Ratings; (3)
modifies the current rules for the 2021
Star Ratings to replace any measure that
has a data quality issue for all plans due
to the COVID–19 outbreak with the
measure-level Star Ratings and scores
from the 2020 Star Ratings; (4) in the
event that we are unable to complete
HOS data collection in 2020 (for the
2022 Star Ratings), replaces the
measures calculated based on HOS data
collections with earlier values that are
not affected by the public health threats
posed by COVID–19 for the 2022 Star
Ratings; (5) removes guardrails for the
2022 Star Ratings; and (6) expands the
existing hold harmless provision for the
Part C and D Improvement measures to
include all contracts for the 2022 Star
Ratings.
a. HEDIS, CAHPS, and HOS Data
Collection and Submission for 2021 Star
Ratings and 2022 Star Ratings
We issued a Health Plan Management
System (HPMS) memo, entitled
‘‘Reporting Requirements for 2020
HEDIS®, HOS, and CAHPS® Measures,’’
on September 9, 2019 to establish the
due date for the 2019 measurement year
PO 00000
Frm 00043
Fmt 4701
Sfmt 4700
19271
for HEDIS. In light of the public safety
issues in continuing to require the
submission of HEDIS data for the 2019
measurement year, we are eliminating
the HEDIS 2020 submission requirement
that covers the 2019 measurement year
and we are requesting that Medicare
health plans, including MA and section
1876 organizations, curtail HEDIS data
collection work immediately. This will
allow health plans, providers, and
physician offices to focus on caring for
Medicare beneficiaries during this PHE
for the COVID–19 pandemic and will
minimize risk of the spread of infection
by eliminating travel and in-person
work for the collection of HEDIS data.
Our goal is to ensure that offices of
health care providers remain focused on
patients needing care. Medicare health
plans can use any HEDIS data that they
have collected for their internal quality
improvement efforts.
We are also amending the regulations
requiring the submission of the CAHPS
survey data to CMS for Medicare health
and drug plans to relieve them of the
requirement as it applies to the 2020
survey data collection to ensure the
safety of survey vendor staff and align
with the CDC’s social distancing
guidance. Both Part C and D plans can
use any CAHPS survey data already
collected for their internal quality
improvement efforts. Accordingly, we
are modifying regulations in parts 417,
422, and 423 to eliminate requirements
for the collection of HEDIS and CAHPS
data that would otherwise occur in
2020. Specifically, we are revising the
Part C regulation at § 422.152 by adding
a new paragraph (b)(6), which provides
that MA organizations are not required
to submit HEDIS and CAHPS data that
would otherwise be required for the
calculation of the 2021 Star Ratings. In
addition, we are revising the cost plan
regulation at § 417.472(i) and (j) in two
ways: In paragraph (i), to add a
requirement for cost plans to comply
with § 422.152(b)(6) and in paragraph
(j), to make the obligation for cost plans
to conduct CAHPS surveys subject to
paragraph (i). Finally, we are revising
the Part D regulations at §§ 423.156 and
423.182. We are revising § 423.156 to
not require Part D sponsors to submit
CAHPS data that would otherwise be
required for the calculation of the 2021
Star Ratings. We are also adding
§ 423.182(c)(3) so that for 2021 Star
Ratings only, Part D sponsors are not
required to submit CAHPS data that
would otherwise be required for the
calculation of the 2021 Star Ratings.
While our revisions do not outright
prohibit cost plans, MA plans, and Part
D plans from continuing efforts to
E:\FR\FM\06APR2.SGM
06APR2
19272
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
collect HEDIS data or conduct CAHPS
surveys during 2020, such as to use that
data about plan performance in 2019 for
the plan’s own internal quality
initiatives, we do not expect plans to do
so. An additional component of the
HEDIS data collection is the HOS that
NCQA administers in partnership with
CMS. This year’s HOS survey
administration was scheduled to be
from April through July 2020. Given the
significant safety concerns, similar to
the ones related to the administration of
the CAHPS survey, we are moving the
HOS survey administration to late
summer and will provide MA plans
more information in the upcoming
months. We will continue to monitor
the situation to see if any further
adjustments are needed. To prepare for
the possibility that the PHE for the
COVID–19 pandemic continues and the
HOS survey data cannot be collected
starting in late summer for the 2022 Star
Ratings, we are amending the
regulations for the Part C 2022 Star
Ratings (by adding new § 422.166(j)(2))
to allow us to use the Star Ratings and
measure scores for the 2021 Star Ratings
for any measures that come from the
HOS survey; this will address any gaps
in the necessary HOS data if the HOS
survey cannot be administered in 2020.
The measures from the HOS survey
include the following: Improving or
Maintaining Physical Health; Improving
or Maintaining Mental Health; Reducing
the Risk of Falling; Improving Bladder
Control; and Monitoring Physical
Activity.
b. Adjustments to the 2021 Star Ratings
Methodology Due To Lack of HEDIS and
CAHPS Data
In response to the PHE for the
COVID–19 pandemic and its impact on
health care delivery and data collection,
we are making a series of adjustments to
the Star Ratings methodology to protect
the health and safety of individuals who
would collect the HEDIS and CAHPS
data; to allow health and drug plans and
their providers to focus on caring for
Medicare beneficiaries during the PHE
for the COVID–19 pandemic; and to
address the unusual, unexpected, and
uncontrollable changes that this
pandemic is likely to have on the Part
C and D Star Ratings. Because of the
short time frame during which
information is collected, analyzed, and
used in the calculation of the Star
Ratings published in October each year,
immediate action is necessary to amend
the methodology as a result of the
extraordinary circumstances created by
the PHE for the COVID–19 pandemic.
Data collection is currently underway
for both the HEDIS and CAHPS data,
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
and the data are due to CMS in June
2020. A series of adjustments to the
2021 Star Ratings are being made to
account for eliminating the need to
collect and submit HEDIS and CAHPS
data for the 2021 Star Ratings.
The April 2018 final rule (83 FR
16538 through 16546) included the
measures finalized for the 2021 Star
Ratings. Included in those measures are
many that use HEDIS or CAHPS as the
data source. In the 2020 Star Ratings, 14
measures had HEDIS as their data
source, and nine measures had CAHPS
as their data source. The measurement
period for most of the Star Ratings
measures is 2019; for many of those
measures, we (or the plans) already have
the data necessary to calculate a
measure score and assign a 2021
measure-level rating but validation and
analysis of those data remain to be done.
For the HEDIS data source, the
measurement period finalized in the
April 2018 final rule is the calendar year
2 years prior to the Star Ratings year so
for the 2021 Star Ratings, the HEDIS
measurement period is the 2019
measurement year. However, those data
are collected in 2020.
Similarly, for the CAHPS data source,
the measurement period finalized for
the 2021 Star Ratings is the most recent
data submitted for the survey of
enrollees. In general, the most recent
data would be the survey conducted
from March through the end of May
each year, which for the 2021 Star
Ratings would have corresponded to
March through May 2020 data
collection. However, these data will not
be available for HEDIS and CAHPS
measures. CMS considered if we could
remove all of the HEDIS and CAHPS
measures from the 2021 Star Ratings. If
we removed these measures from the
Star Ratings, we would not have enough
measures to rate plans and to have a
complete picture of performance given
approximately half of the Star Ratings
measures come from HEDIS and
CAHPS. Removing all of these measures
would severely compromise the
integrity of the Part C and D Star Ratings
and would have significant impact on
payment for MA organizations. Given
measure scores and stars do not
fluctuate significantly year to year, we
believe using the 2020 measure-level
stars and scores for the missing HEDIS
and CAHPS data provides the best
approximation of performance in 2019.
This substitution addresses the lack of
HEDIS and CAHPS data that would
otherwise be used for 2021 Star Ratings
while permitting us to calculate and use
reliable Star Ratings for 2021 enrollment
and 2022 QBP status determinations.
Given the issues related to PHE for the
PO 00000
Frm 00044
Fmt 4701
Sfmt 4700
COVID–19 pandemic associated with
completing the HEDIS data collection
for the 2019 measurement year, we will
use the HEDIS measure scores and Star
Ratings based on the 2018 measurement
year (that is, the data used for the 2020
Star Ratings) for the 2021 Star Ratings.
For the 2021 Star Ratings, given the
safety concerns related to completing
the CAHPS surveys and data collection
and the inability of survey vendors to
fully complete data collection for 2020,
we will use the CAHPS data submitted
to CMS in June 2019. To accomplish
this, we are revising §§ 422.166 and
423.186 to add new regulation text that
the measures calculated based on HEDIS
data are calculated based on data for the
2018 performance period and the
measures calculated based on CAHPS
data are calculated based on survey data
collected from March through May
2019. Specifically, we are adding a new
paragraph (j) to each of these regulations
and are codifying these specific rules
about HEDIS and CAHPS data at
§§ 422.166(j)(1)(i) and (ii) and
423.186(j)(1)(i).
The measurement period for all other
measures will not change from what
was finalized in the April 2018 final
rule. For both HEDIS and CAHPS
measures, we will use 2020 measurelevel Star Ratings (and associated
measure-level scores) in all the Star
Ratings calculations codified at
§§ 422.160, 422.162, 422.164, 422.166,
423.180, 423.182, 423.184, and 423.186
in calculating the 2021 Star Ratings. For
the 2021 Star Ratings, there will be no
changes from the prior year in the
measure-level cut points for any of the
HEDIS and CAHPS measures. We had
previously announced in the April 2019
final rule that the Plan All-Cause
Readmissions measure would be moved
to display for the 2021 Star Ratings due
to the substantive specification change.
We will continue to exclude this
measure for the 2021 Star Ratings as
provided in that final rule, so the data
associated with it for the 2018
performance period (collected in spring
2019) will be posted on the display page
for 2021 ratings.
Since we will be using the 2020 Star
Ratings data for the HEDIS and CAHPS
measures, we will carry forward the
measure-level improvement change
score as described at §§ 422.164(f)(4)(i)
and 423.184(f)(4)(i) from the 2020 Star
Ratings for all HEDIS or CAHPS
measures for the 2021 Star Ratings Part
C and D improvement measure
calculations. We are codifying this at
§§ 422.166(j)(1)(iii) and 423.186(j)(1)(ii).
Under §§ 422.164(g)(1) and (2) and
423.184(g)(2), we reduce HEDIS and
CAHPS measures to 1 star when either
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
HEDIS measures used to populate the
Star Ratings are not reported or for
failure to adhere to CAHPS reporting
requirements. For the 2021 Star Ratings,
we will not reduce these measures to 1
star for failure to report the 2020 HEDIS
or CAHPS data and is codifying that
approach at §§ 422.166(j)(1)(iv) and
423.186(j)(1)(iii). We are amending
§§ 422.166 and 423.186 by adding
paragraph (j) to codify these various
special rules for the 2021 Star Ratings.
c. Use of 2020 Star Ratings To Substitute
for 2021 Star Ratings in the Event of
Extraordinarily Compromised CMS
Capabilities or Systemic Data Issues
There is great uncertainty about how
the COVID–19 pandemic will evolve
over the next 6 to 9 months, and the
impact on the American population and
institutions resulting from the
pandemic. We have considered the
normal activities required to prepare,
calculate, and publish the Star Ratings,
as well as finalize the ratings to be used
as the basis for MA QBPs in the event
that CMS’ functions to calculate the
2021 Star Ratings are significantly
impacted. The operational timelines for
calculating the Star Ratings each year
are extremely tight. For example, when
we receive all of the measure-level data
in early August, we have approximately
1 month to: Review the Star Ratings
measure data for accuracy; prepare data
and supportive material to provide
plans with a preview period so they can
review their numeric measure scores
and raise issues to CMS; work with
contractors to calculate the Star Ratings;
prepare for a second preview period for
plans to see their preliminary measure
level and overall star ratings. This work
must be completed in the months of
August and September so that the Star
Ratings are ready for public display on
Medicare Plan Finder in early October
for the Annual Enrollment Period. If the
COVID–19 pandemic or actions
necessary in connection with the PHE
impact the ability of CMS and its
contractors to complete these steps to
calculate the 2021 Star Ratings, it would
be impracticable and contrary to the
public interest to begin rulemaking in
August to adopt a policy for how to
address such an unprecedented
situation. The normal notice and
comment rulemaking process would
also prevent CMS from providing
quality ratings to Medicare beneficiaries
choosing a 2021 plan during the Annual
Enrollment Period beginning in October
and conflict with CMS providing MA
organizations the opportunity to appeal
their QBP ratings for 2022 payment in
time for 2022 bid submissions. There
would be insufficient time to engage in
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
notice and comment rulemaking to
make changes to the 2021 Star Ratings
methodology in time to issue the Star
Ratings on Medicare Plan Finder.
Star Ratings are used to identify
which MA plans are eligible for a QBP
and for a greater percentage of the
amount by which the benchmark for the
plan’s service area exceeds the plan’s
bid for covering Part A and Part B
benefits; the quality bonus results in an
increase to the benchmark for an MA
plan’s service area and the percentage
that determines the amount of the
beneficiary rebate. See §§ 422.258(d)(7)
and 422.260. Together, these financial
consequences for a high Star Rating, can
result in higher beneficiary rebates,
which are used to pay for supplemental
benefits and reductions in the Part B or
Part D premium for enrollees in the
plan. Given the impact the Star Ratings
have on payment and the benefits
offered to Medicare beneficiaries, it is
critical that MA organizations have
certainty in terms of how the ratings
would be calculated if this situation
should occur.
Adopting a provision to address such
extraordinary circumstances before they
come to pass in connection with the
COVID–19 pandemic will ensure that
Medicare health and drug plans and
Medicare beneficiaries are aware of the
steps CMS will take before those actions
become necessary. This advance notice
will alleviate uncertainty and provide
stability for cost plans, MA
organizations, and Part D sponsors so
they can focus on continuing to ensure
Medicare beneficiaries have access to
needed medical care. In case the PHE
for the COVID–19 pandemic gets to a
point that CMS’ functions become
focused on only continued performance
of essential agency functions or the
agency and its contractors do not have
the ability to calculate the 2021 Star
Ratings, as part of this IFC, we are
establishing rules for this circumstance.
These rules would only be implemented
for the 2021 Star Ratings if the impact
of the PHE for the COVID–19 pandemic
reaches a point where CMS and its
contractors are compromised to the
point the 2021 Star Ratings cannot be
calculated using the methodology set
forth in the April 2018 final rule and
this IFC. Calculating the Star Ratings
requires a full team of staff and
contractors with specialized skill sets. If
the PHE for the COVID–19 pandemic
escalates, we will need to devote more
resources to activities to address
essential Agency functions so that
adding staff or resources to calculate the
Star Ratings would not be appropriate.
If CMS’ resources become
extraordinarily compromised, we will
PO 00000
Frm 00045
Fmt 4701
Sfmt 4700
19273
use the 2020 Star Ratings as the 2021
Star Ratings. This authority is codified
at §§ 422.166(j)(1)(v) and
423.186(j)(1)(iv) and limited specifically
to the COVID–19 pandemic.
We are also concerned, given the
uncertainties ahead, whether CMS and
plans will be able to safeguard against
data quality issues for non-CAHPS and
non-HEDIS measures for which CMS
does not already have data for the 2021
Star Ratings. As an example, sponsors
report Special Needs Plan (SNP) Care
Management and Medication Therapy
Management (MTM) data to CMS by
March 2020, and these data undergo
independent data validation beginning
in April. While validation activities can
be conducted remotely between the
plans’ staff and data validation
reviewers, there may be other
difficulties in completing the work this
year on time and consistent with CMS
requirements due to the significant
impact of the PHE for the COVID–19
pandemic. Normally, as codified at
§§ 422.164(b) and 423.184(b), we review
the quality of the data before making a
final determination about inclusion of
the measures in each year’s Star Ratings.
Given the potential for multiple
measures to have data quality issues
across many plans as a result of COVID–
19, we are addressing this possibility by
adopting a rule to permit replacing the
2021 Star Ratings measure scores and
stars with the 2020 Star Ratings
measures scores and stars for the
impacted measures for all plans rather
than excluding multiple measures from
the 2021 Star Ratings calculations.
Removing multiple measures from the
Star Ratings can cause unanticipated
changes in the ratings which would
create more instability for Medicare
health and drug plan sponsors and
could have significant impacts on MA
QBPs at a time where MA organizations
need stability in the ratings when they
need to focus on caring for those
impacted by COVID–19.
To be prepared if we have data quality
issues for any non-HEDIS or nonCAHPS 2021 Star Ratings measures, we
are adopting a specific rule limited to
the PHE for the COVID–19 pandemic. At
§§ 422.164(i) and 423.184(i), we are
adopting authority for CMS to substitute
the score and star for the measure used
in the 2020 Star Ratings in the
calculation of the 2021 Star Ratings
when there is a systemic data quality
issue for all plans as a result of the PHE
for the COVID–19 pandemic. Therefore,
in the above example, we would use
sponsors’ SNP Care Management and
MTM Program Completion Rate for
Comprehensive Medication Review
measures’ scores and stars from the
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19274
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
2020 Star Ratings as the sponsors’ 2021
Star Ratings on those measures.
We are making these adjustments to
the Star Ratings methodology since our
inability to make calculations at a late
stage in the annual Star Ratings
publication process would severely
jeopardize our ability to calculate 2022
MA payments accurately and consistent
with the statutory QBP provision
particularly since our ability to change
other deadlines based on availability of
the Star Ratings (for example, the bid
deadline, Annual Election Period, and
the start of the new plan benefit year) is
limited but the Star Ratings are an
integral part of those other activities. In
extreme situations like the ones
described above, the solicitation and
consideration of public comments to
establish how CMS should proceed
would be impracticable since the
process could not be completed in time
to issue new Star Ratings that could be
used to inform beneficiary choice
during the Annual Election Period. The
MA statute, at section 1851(d) of the
Act, requires that information about
plan quality and performance indicators
be provided to Medicare beneficiaries to
help them make informed plan choices.
In addition, MA plans need to know
their eligibility for QBPs in advance of
the bid deadline to develop their bids;
the bid deadline is also set by the
statute, as the first Monday in the June
prior to the coverage year. The 2021 Star
Ratings will be the basis for 2022 QBPs
so definitive Star Ratings need to be
available to plans in advance of June
2021, to accommodate bid planning and
to ensure that plans have the ability to
appeal their QBP status if necessary. We
understand that MA organizations begin
developing and pricing their plan
benefit packages well before the June
bid deadline and depend on the release
of Star Ratings in the preceding October
as a critical milestone in their planning
for an upcoming plan year. Adopting
the new rule at §§ 422.164(i) and
423.184(i) to address measure-level
substitutions of 2020 scores for data
quality issues that impact the
availability, accuracy, reliability and
validity of the measure-level data that
would otherwise be used for 2021
ratings will provide stability and
certainty for the program. This approach
will allow CMS and MA organizations
to move seamlessly to a new basis for
calculating QBPs in the event that the
original one (that is, using the data
about 2019 performance) is unavailable.
It will also allow MA organizations to
incorporate into their planning the
possibility that they will be required to
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
use the 2020 Star Ratings for some or all
measures in developing their 2022 bids.
To codify these provisions, we are
amending §§ 422.164 and 423.184 by
adding a new paragraph (i) to each
section, as well as by amending
§ 422.166 by adding a new paragraph
(j)(1)(v) and amending § 423.186 by
adding a new paragraph (j)(1)(iv).
d. 2022 Star Ratings
For the 2022 Star Ratings, we expect
plans to submit HEDIS data in June
2021 and to administer the CAHPS
survey in 2021 as usual. The majority of
measures for the 2022 Star Ratings are
based on the 2020 measurement year,
which is ongoing during the PHE for the
COVID–19 pandemic. We are using the
IFC to make immediate changes to the
methodology for the 2022 Star Ratings
so as not to inappropriately incentivize
actions by plans and healthcare
providers that are not directly related to
the PHE for the COVID–19 pandemic.
By adopting these changes immediately,
Medicare health and drug plans will be
assured as quickly as possible about
how performance changes driven or
caused by the COVID–19 pandemic will
be addressed in the Star Ratings that use
this performance period. Except as
addressed in this IFC, we anticipate that
the 2022 Star Ratings will be
implemented as codified at §§ 422.160,
422.162, 422.164, 422.166, 423.180,
423.182, 423.184, and 423.186.
i. Guardrails
We recognize that health and drug
plans and their providers are needing to
adapt their current care practices in
light of the PHE for the COVID–19
pandemic and the need to care for the
most vulnerable patients, such as the
elderly and those with chronic health
conditions; these changes in how plans
and providers care for Medicare
beneficiaries as a result of COVID–19
will impact performance for the 2020
measurement period which feeds into
the 2022 Star Ratings. On March 18,
2020, we issued guidance (available on
the CMS website at https://
www.cms.gov/files/document/31820cms-adult-elective-surgery-andprocedures-recommendations.pdf) to
delay all non-essential planned
surgeries and procedures, including
dental, until further notice. Healthcare
providers are being asked to encourage
patients to remain at home, except for
emergencies, to help curb the spread of
COVID–19 and to help limit the
exposure to the virus. Plans and their
providers are focused primarily on
providing urgent care to Medicare
beneficiaries who may be infected by
COVID–19. We realize that this will
PO 00000
Frm 00046
Fmt 4701
Sfmt 4700
impact the data collected during the
2020 measurement year which will
impact the 2022 Part C and D Star
Ratings. Thus, as part of this IFC, we are
making some adjustments to account for
the potential decreases in measure-level
scores so health plans can have some
degree of certainty knowing that the Star
Ratings will be adjusted and can focus
right now on patients who are most in
need.
To increase the predictability of the
cut points used for measure-level
ratings, we previously finalized that,
starting with the 2022 Star Ratings,
guardrails would be implemented for
measures that have been in the program
for more than 3 years. As specified at
§§ 422.166(a)(2)(i) and 423.186(a)(2)(i),
the guardrails ensure that the measurethreshold-specific cut points for nonCAHPS measures do not increase or
decrease more than 5 percentage points
from one year to the next. As noted in
the April 2019 final rule, the trade-off
for the predictability provided by the bidirectional cap is the inability to fully
keep pace with changes in performance
across the industry. While cut points
that change less than the cap would be
unbiased and keep pace with changes in
the measure score trends, changes in the
overall performance that are greater than
the cap would not be reflected in the
new cut points. The performance that
will be used for the 2022 Star Ratings is
performance in 2020, that is, during the
PHE for the COVID–19 pandemic. We
anticipate that most, if not all, plans
could have performance changes on
certain measures as they deal with the
demands the PHE for the COVID–19
pandemic will place on the health care
system in the United States. Guardrails
that prevent the cut points for measures
from lowering, even when performance
scores are lower across the board, will
result in plans having similar low
measure-level ratings even if their
performance is relatively
distinguishable.
Since the Star Ratings are used to
calculate the payment to MA
organizations by providing an increase
in the benchmark against which MA
organizations bid and in the portion of
the savings between the bid and
benchmark available to MA
organizations to use as rebates,
unanticipated significant declines in the
Star Ratings would create significant
uncertainty in the program and
potential beneficiary access issues if
ratings significantly decline across the
cost plan, MA and Part D programs.
Given the enormity of this situation we
believe it is important for plans to be
able to focus on patients that are in the
most need during the outbreak, and our
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
guardrails, as currently constructed,
could have unintended incentives to the
contrary. In addition, adopting this
policy as soon as possible will minimize
incentives for plans and providers to
focus on non-urgent care or
administrative efforts, even if those
issues are tied to existing Star Ratings
measures, and focus their attention on
urgent care issues. As such, in response
to the PHE for the COVID–19 pandemic,
we are delaying implementation of the
guardrails so that cut points can change
by more than 5 percentage points if
national performance declines as a
result of the PHE for the COVID–19
pandemic. We are modifying
§§ 422.166(a)(2)(i) and 423.186(a)(2)(i)
to delay the application of the guardrails
beginning with the 2023 Star Ratings
produced in October 2022. No other
aspect of the guardrails policies
finalized in the April 2019 final rule is
changing with this modification.
jbell on DSKJLSW7X2PROD with RULES2
ii. Improvement Measure
The existing Star Ratings system and
regulations include a well-developed
improvement measure and methodology
for calculating and using it. However,
because we anticipate that performance
during the 2020 measurement period
may decline for plans across the nation,
we believe that it is appropriate to adopt
a provision to minimize the negative
effect of the improvement measure and
improvement scores. As with the
guardrails policy, this amendment to the
existing regulations is designed to
minimize or eliminate incentives in the
Star Ratings that might be inconsistent
with the steps necessary to address the
COVID–19 pandemic. We are revising
the methodology for the Part C and D
improvement measure for the 2022 Star
Ratings to expand the hold harmless
rule to include all contracts at the
overall and summary rating levels
recognizing that the PHE for the
COVID–19 pandemic may result in a
decline in industry performance.
Currently, for MA–PD contracts with an
overall rating of 4 or more stars, if the
inclusion of the improvement
measure(s) reduces a contract’s overall
Star Rating, the Part C and D
improvement measures are excluded
from the overall Star Ratings
calculations for that contract. Similarly,
for MA-only contracts with 4 or more
stars, if the inclusion of the Part C
improvement measure reduces the Part
C summary Star Rating, it is excluded
from the calculations for that contract.
Our revision will expand the current
hold harmless rule and how it works to
all contracts regardless of their ratings
and also apply it to the Part C and D
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
19275
summary ratings for the 2022 Star
Ratings only.
We are codifying a new paragraph
(g)(3) at §§ 422.166 and 423.186 and
adding text at the end of the existing
text in §§ 422.166(f)(1)(i) and
423.186(f)(1)(i) to implement this new
hold harmless provision for the 2022
Star Ratings only.
have due to the elimination of HEDIS
and CAHPS data.
iii. Categorical Adjustment Index
Title XIX of the Act requires that, to
receive Federal Medicaid matching
funds, a State must offer certain basic
services to the categorically needy
populations specified in the Act. Home
health services for Medicaid-eligible
individuals who are entitled to nursing
facility services is one of these
mandatory services. Individuals
‘‘entitled to’’ nursing facility services
include the basic categorically needy
populations that receive the standard
Medicaid benefit package, and can
include medically needy populations if
nursing facility services are offered to
the medically needy within a State.
Home health services include part-time
or intermittent nursing, home health
aide services, medical supplies,
equipment, and appliances, and may
include therapeutic services. Current
Medicaid regulations require an
individual’s physician to order home
health services as part of a written plan
of care. The plan of care must be
reviewed every 60 days, except for
medical supplies, equipment and
appliances which must be reviewed by
a physician annually.
We recognize that increased demand
on the direct care services provided by
physicians during the PHE for the
COVID–19 pandemic could cause a
delay in the availability of physicians to
order home health services in the
normal timeframe. In recognition of the
critical need to expand workforce
capacity, we are amending 42 CFR
440.70 to allow licensed practitioners
practicing within their scope of practice,
such as, but not limited to, NPs and
PAs, to order Medicaid home health
services during the existence of the PHE
for the COVID–19 pandemic.
This change to § 440.70 will expand
the workforce and is also a continuation
of CMS’ efforts to align with Medicare
on who can order medical supplies,
equipment, and appliances, and
allowing smoother access to services for
Medicaid beneficiaries, including those
who are dually eligible. This alignment
will also eliminate administrative
burden to states and providers when
dealing with inconsistencies in the
practitioners who may order these items
between the Medicare and Medicaid
programs.
Beginning with the 2017 Star Ratings,
we implemented the Categorical
Adjustment Index (CAI) that adjusts for
the average within-contract disparity in
performance associated with the
percentages of enrollees who receive a
low-income subsidy and/or are dual
eligible (LIS/DE) and/or have disability
status. For the 2022 Star Ratings, we
will calculate the CAI as codified at
§§ 422.166(f)(2) and 423.186(f)(2). The
CAI values will be calculated based on
the 2021 Star Ratings data which will
use the older HEDIS and CAHPS data
from the 2020 Star Ratings. For each
measure, adjusted measure scores which
are used to construct the CAI values will
be calculated using the enrollment year
associated with the year of data being
used for that measure (that is, 2018
enrollment year data for HEDIS and
CAHPS measures, 2019 enrollment year
data for all other measures). Given we
are following the rules codified in
regulation, there are no changes to the
regulatory text. We are providing this
explanation to avoid uncertainty on this
point for Medicare health and drugs
plans.
iv. QBP Calculations for New Contracts
Under § 422.252, a new MA plan
means an MA contract offered by a
parent organization that has not had
another MA contract in the previous 3
years. For just the 2022 QBP ratings that
are based on 2021 Star Ratings, we are
modifying this definition to treat an MA
plan as a new MA plan if it is offered
by a parent organization that has not
had another MA contract for the
previous 4 years. This change would
account for how new plans that started
in 2019 would have reported HEDIS and
CAHPS data to CMS for the first time in
2020 for the 2021 Star Ratings; because
of our elimination of the HEDIS and
CAHPS data submissions to CMS, these
plans will not have enough measures to
calculate the 2021 Star Ratings and,
consequently, the 2022 QBP rating. A
new contract with an effective date of
January 1, 2019 would normally be
treated as new for purposes of QBPs for
2019, 2020, and 2021. The 2022 QBP
rating would be based on the 2021 Star
Ratings which these contracts will not
PO 00000
Frm 00047
Fmt 4701
Sfmt 4700
Z. Changes To Expand Workforce
Capacity for Ordering Medicaid Home
Health Nursing and Aide Services,
Medical Equipment, Supplies and
Appliances and Physical Therapy,
Occupational Therapy or Speech
Pathology and Audiology Services
E:\FR\FM\06APR2.SGM
06APR2
19276
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
This change applies to who can order
Medicaid home health nursing and aide
services, medical supplies, equipment
and appliances and physical therapy,
occupational therapy or speech
pathology and audiology services
covered under § 440.70(b)(1), (2), (3),
and (4).
This change does not expand the
benefit categories where these items can
be covered. States must continue to
cover and claim home health nursing
and aide services, medical supplies,
equipment and appliances, and physical
therapy, occupational therapy or speech
pathology and audiology services (that
are covered under the home health
benefit) under the home health benefit,
unless otherwise allowed by federal
regulations.
AA. Origin and Destination
Requirements Under the Ambulance Fee
Schedule
Section 1861(s)(7) of the Act
establishes an ambulance service as a
Medicare Part B service where the use
of other methods of transportation is
contraindicated by the individual’s
condition, but only to the extent
provided in regulations. We have
established regulations at § 410.40 that
govern Medicare coverage of ambulance
services. Under § 410.40(e)(1), Medicare
Part B covers ground (land and water)
and air ambulance transport services
only if they are furnished to a Medicare
beneficiary whose medical condition is
such that other means of transportation
are contraindicated. The beneficiary’s
condition must require both the
ambulance transportation itself and the
level of service provided for the billed
services to be considered medically
necessary.
Under § 410.40(e)(1), nonemergency
transportation by ambulance is
appropriate if either the beneficiary is
bed-confined, and it is documented that
the beneficiary’s condition is such that
other methods of transportation are
contraindicated; or, if his or her medical
condition, regardless of bed
confinement, is such that transportation
by ambulance is medically required.
That section further provides that bed
confinement is not the sole criterion in
determining the medical necessity of
ambulance transportation but is one
factor that is considered in medical
necessity determinations. For a
beneficiary to be considered bedconfined, § 410.40 (e)(1) states that all of
the following criteria must be met: (1)
The beneficiary is unable to get up from
bed without assistance, (2) the
beneficiary is unable to ambulate, and
(3) the beneficiary is unable to sit in a
chair or wheelchair.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
The origin and destination
requirements for coverage of ambulance
services are addressed in our regulations
at § 410.40(f). As provided in that
section, Medicare covers the following
ambulance transportation:
• From any point of origin to the
nearest hospital, critical access hospital
(CAH), or skilled nursing facility (SNF)
that is capable of furnishing the
required level and type of care for the
beneficiary’s illness or injury. The
hospital or CAH must have available the
type of physician or physician specialist
needed to treat the beneficiary’s
condition;
• From a hospital, CAH, or SNF to the
beneficiary’s home;
• From a SNF to the nearest supplier
of medically necessary services not
available at the SNF where the
beneficiary is a resident, including the
return trip; and
• For a beneficiary who is receiving
renal dialysis for treatment of ESRD,
from the beneficiary’s home to the
nearest facility that furnishes renal
dialysis, including the return trip.
We continue to believe that our
current regulatory requirements
governing coverage of ambulance
services are appropriate under normal
circumstances. However, in the context
of the PHE for the COVID–19 pandemic,
we recognize that providers and
suppliers furnishing ground ambulance
services and other health care
professionals are faced with new
challenges regarding potential exposure
risks, for Medicare beneficiaries and for
members of the community at large.
Therefore, on an interim basis, we
will expand the list of destinations at
§ 410.40(f) for which Medicare covers
ambulance transportation to include all
destinations, from any point of origin,
that are equipped to treat the condition
of the patient consistent with
Emergency Medical Services (EMS)
protocols established by state and/or
local laws where the services will be
furnished. The EMS protocols are
recognized operating procedures that all
emergency service professionals such as
emergency medical technicians (EMTs)
and paramedics must follow for patient
assessment, treatment, transportation
and delivery to definitive care. These
protocols are designed by national, state
and/or local medical authorities and
institutions. Based on these protocols, a
patient suspected of having COVID–19
that requires a medically necessary
transport may be transported to a testing
facility to get tested for COVID–19
instead of a hospital in an effort to
prevent possible exposure to other
patients and medical staff.
PO 00000
Frm 00048
Fmt 4701
Sfmt 4700
These destinations may include, but
are not limited to: Any location that is
an alternative site determined to be part
of a hospital, CAH or SNF, community
mental health centers, FQHCs, RHCs,
physicians’ offices, urgent care facilities,
ambulatory surgery centers (ASCs), any
location furnishing dialysis services
outside of an ESRD facility when an
ESRD facility is not available, and the
beneficiary’s home. This expanded list
of destinations will apply to medically
necessary emergency and nonemergency ground ambulance transports
of beneficiaries during the PHE for the
COVID–19 pandemic. Consistent with
section 1861(s)(7) of the Act, there must
be a medically necessary ground
ambulance transport of a patient in
order for an ambulance service to be
covered.
We are revising, on an interim basis,
§ 410.40 to add a new paragraph (f)(5),
to state that during the PHE for the
COVID–19 pandemic only, a covered
destination includes a ground
ambulance transport from any point of
origin to a destination that is equipped
to treat the condition of the patient
consistent with state and local EMS
protocols where the services will be
furnished. These destinations include,
but are not limited to, any location that
is an alternative site determined to be
part of a hospital, CAH or SNF,
community mental health centers,
FQHCs, RHCs, physician offices, urgent
care facilities, ASCs, any location
furnishing dialysis services outside of
an ESRD facility when an ESRD facility
is not available, and the beneficiary’s
home. Home may be an appropriate
destination for a COVID–19 patient who
is discharged from the hospital to home
to be under quarantine (as noted above,
there must be a medically necessary
ground ambulance transport of a patient
in order for an ambulance service to be
covered).
BB. Merit-Based Incentive Payment
System (MIPS) Updates
1. MIPS Improvement Activities
Inventory Update
The CY 2018 Quality Payment
Program final rule (82 FR 53660)
finalized that we would add new
improvement activities or make
modifications to existing improvement
activities in the Improvement Activities
Inventory through notice-and-comment
rulemaking. An improvement activity
means an activity that relevant MIPS
eligible clinician, organizations and
other relevant stakeholders identify as
improving clinical practice or care
delivery and that the Secretary
determines, when effectively executed,
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
is likely to result in improved outcomes.
We refer readers to Table H in the
Appendix of the CY 2017 Quality
Payment Program final rule (81 FR
77177 through 77199), Tables F and G
in the Appendix of the CY 2018 Quality
Payment Program final rule (82 FR
54175 through 54229), Tables A and B
in the Appendix 2 of the CY 2019 PFS
final rule (83 FR 60286 through 60303),
and Tables A, B, and C in the Appendix
2 of the CY 2020 PFS final rule (84 FR
63514 through 63538) for our previously
finalized Improvement Activities
Inventory. We also refer readers to the
Quality Payment Program website at
https://qpp.cms.gov/ for a complete list
of the most current list of improvement
activities.
The COVID–19 pandemic has been
deemed a PHE by the Secretary of the
Department of Health and Human
Services. Information regarding the PHE
for the COVID–19 pandemic may be
found at https://www.phe.gov/
emergency/news/healthactions/phe/
Pages/default.aspx. In this IFC, we are
adding one new improvement activity to
the Improvement Activities Inventory
for the CY 2020 performance period in
response to this PHE. We refer readers
to Table 1 for a full description which
includes the type of action that would
qualify for this improvement activity.
This improvement activity promotes
clinician participation in a COVID–19
clinical trial utilizing a drug or
biological product to treat a patient with
a COVID–19 infection.20 To receive
credit for this clinical improvement,
clinicians must report their findings
through an open source clinical data
repository or clinical data registry.
When utilizing the term ‘‘open source’’
we mean making available to the public
the results of research, including
publications and scientific data, which
enables reuse, increases transparency,
and facilitates reproductibility of
research results.21
We believe that participation in this
activity is likely to result in improved
outcomes by improving the collection of
data clinicians use for the care of their
patients as they monitor and manage
COVID–19 and drive care
improvements. We believe that
encouraging clinicians to utilize an
open source clinical data repository or
clinical data registry for data reporting
will bring the results of their research to
the forefront of healthcare far quicker
than if it goes through the cycle of peer
review and publishing. In addition, we
believe that this could improve clinical
practice and care delivery, a relevant
stakeholder donated a database for the
pandemic so that health officials/
clinicians/the public could track
patients and drugs that work to better
improve outcomes of COVID–19
patients.
In the CY 2019 PFS (83 FR 59778
through 59782), we provided details
regarding the Annual Call for Activities
and how stakeholders submit potential
improvement activities. In general, to
nominate a new activity or request a
19277
modification to an existing
improvement activity, a stakeholder
must submit a nomination form
available at www.qpp.cms.gov during
the Annual Call for Activities. For this
new improvement activity, we are
making a one-time exception from our
established Annual Call for Activities
timeframe and processes due to this
PHE.
New improvement activities should
meet one or more criteria to be included
in the Improvement Activities Inventory
(82 FR 53660). We believe that this
activity meets the improvement
activities submission criteria of a
‘‘public health emergency as determined
by the Secretary,’’ which was finalized
in the 2019 PFS final rule (83 FR
59779). As noted in the CY 2017 Quality
Payment Program final rule, we use the
criteria for nominating new
improvement activities in selecting
improvement activities for inclusion in
the program (82 FR 53659). We also
clarified that those criteria are but one
factor in determining which
improvement activities we ultimately
proposed (83 FR 59780). For MIPS
eligible clinicians who wish to submit
this new improvement activity, we refer
readers to the CY 2019 PFS final rule
(83 FR 59778 through 59782) for our
previously finalized improvement
activities submission requirements.
Table 1 displays the new improvement
activity.
TABLE 1—NEW IMPROVEMENT ACTIVITY FOR THE MIPS CY 2020 PERFORMANCE PERIOD
Improvement activity
Activity ID: .......................................
Subcategory: ...................................
Activity Title: ....................................
Activity Description: .........................
jbell on DSKJLSW7X2PROD with RULES2
Weighting: .......................................
IA_ERP_XX.
Emergency Response And Preparedness.
COVID–19 Clinical Trials.
To receive credit for this activity, a MIPS-eligible clinician must participate in a COVID–19 clinical trial utilizing a drug or biological product to treat a patient with a COVID–19 infection and report their findings
through a clinical data repository or clinical data registry for the duration of their study. For more information on the COVID–19 clinical trials we refer readers to the U.S. National Library of Medicine website
at https://clinicaltrials.gov/ct2/results?cond=COVID-19.
High.
2. MIPS Applications for Reweighting
Based on Extreme and Uncontrollable
Circumstances
As a result of the PHE for the COVID–
19 pandemic, we are applying the MIPS
automatic extreme and uncontrollable
circumstances policy at
§ 414.1380(c)(2)(i)(A)(8) and
(c)(2)(i)(C)(3) to MIPS eligible clinicians
for the 2019 MIPS performance period/
2021 MIPS payment year. We believe
that this application of the policy is
appropriate given the impact COVID–19
will likely have on the ability of many
MIPS eligible clinicians to complete
data submission for the MIPS program
for the 2019 MIPS performance period
because most of those submissions will
occur during CY 2020.
Due to the timing of the PHE, we
realize that there may be scenarios
where MIPS-eligible clinicians are not
covered by the automatic extreme and
uncontrollable circumstances policy.
For example, as we stated in the CY
2019 PFS final rule, the automatic
extreme and uncontrollable
circumstances policy does not apply to
groups or virtual groups (83 FR 59874
20 For more information on the COVID–19 clinical
trials we refer readers to the U.S. National Library
of Medicine website at https://clinicaltrials.gov/ct2/
results?cond=COVID-19.
21 More information on open source is available
at https://www.nlm.nih.gov/NIHbmic/nih_data_
sharing_repositories.html; https://www.phe.gov/
emergency/news/healthactions/phe/Pages/
default.aspx.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
PO 00000
Frm 00049
Fmt 4701
Sfmt 4700
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
19278
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
and 59875); however, under
§ 414.1380(c)(2)(i), individual
clinicians, groups and virtual groups
could submit an application for
reweighting the performance categories
based on extreme and uncontrollable
circumstances. To provide additional
relief to individual clinicians, groups,
and virtual groups for whom sufficient
MIPS measures and activities may not
be available for the 2019 MIPS
performance period due to the PHE for
the COVID–19 pandemic, we are
extending the deadline to submit an
application for reweighting the quality,
cost, and improvement activities
performance categories based on
extreme and uncontrollable
circumstances (§ 414.1380(c)(2)(i)(A)(6))
and the Promoting Interoperability
performance category based on extreme
and uncontrollable circumstances
(§ 414.1380(c)(2)(i)(C)(2)) from
December 31, 2019 to April 30, 2020, or
a later date that we may specify. This
extended deadline of April 30, 2020
mirrors the MIPS data submission
deadline extension. The extended
deadline is available only for
applications that demonstrate the
clinician has been adversely affected by
the PHE for the COVID–19 pandemic.
We are also modifying our existing
policy for the 2019 performance period/
2021 MIPS payment year so that if a
MIPS eligible clinician, group, or virtual
group submits an application for
reweighting based on the PHE for the
COVID–19 pandemic by the extended
deadline, any MIPS data they have
submitted or will submit would not
effectively void their application. Under
§ 414.1380(c)(2)(i)(A)(6) and (c)(2)(i)(C),
if an application for reweighting the
performance categories based on
extreme and uncontrollable
circumstances is submitted, but data on
measures or activities for a performance
category are also submitted, a MIPS
eligible clinician will be scored on the
submitted data, and the performance
categories for which data are submitted
will not be reweighted. However, for the
2019 performance period we believe it
is appropriate to modify this policy,
because we believe it is possible that a
MIPS eligible clinician, group, or virtual
group could have submitted some MIPS
data prior to the PHE for the COVID–19
pandemic, but due to circumstances
related to the PHE for the COVID–19
pandemic, are not able to complete their
submission such that the data they
submitted may not reflect their actual
performance on the measures and
activities. As a result, we are modifying
the policy at § 414.1380(c)(2)(i)(A)(6) to
create an exception for the 2019
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
performance period/2021 MIPS
payment year only, such that if a MIPS
eligible clinician demonstrates through
an application submitted to CMS that
they have been adversely affected by the
PHE for the COVID–19 pandemic, but
also submits data for the quality, cost,
or improvement activities performance
categories, the performance categories
for which data are submitted would still
be reweighted (subject to CMS’ approval
of the application), and the data
submission would not effectively void
the application for reweighting. We are
also modifying the policy at
§ 414.1380(c)(2)(i)(C) to create a similar
exception for the Promoting
Interoperability performance category
for the 2019 performance period/2021
MIPS payment year only.
CC. Inpatient Hospital Services
Furnished Under Arrangements Outside
the Hospital During the Public Health
Emergency (PHE) for the COVID–19
Pandemic
1. Overview for Inpatient Hospital
Services
For purposes of Medicare payment,
section 1861(b) of the Act defines
inpatient hospital services in part as the
following items and services furnished
to an inpatient of a hospital and (except
as provided in paragraph (3)) by the
hospital: (1) Bed and board; (2) such
nursing services and other related
services, such use of hospital facilities,
and such medical social services as are
ordinarily furnished by the hospital for
the care and treatment of inpatients, and
(3) such other diagnostic or therapeutic
items or services, furnished by the
hospital or by others under
arrangements with them made by the
hospital, as are ordinarily furnished to
inpatients either by such hospital or by
others under such arrangements.
Routine services in the hospital
setting are those described in sections
1861(b)(1) and (b)(2) of the Act. Under
our current policy for hospital services
furnished under arrangements that we
adopted in the FY 2012 IPPS/LTCH PPS
rulemaking (76 FR 51714), routine
services cannot be provided under
arrangement outside the hospital. Only
the therapeutic and diagnostic services
described in section 1886(b)(3) of the
Act can be provided under arrangement
outside the hospital.
We continue to believe that our
current policy prohibiting routine
services from being provided under
arrangement outside the hospital is
consistent with the statute and
appropriate for the reasons discussed in
the FY 2012 IPPS/LTCH PPS
rulemaking. However, we wish to give
PO 00000
Frm 00050
Fmt 4701
Sfmt 4700
hospitals that provide services to
Medicare beneficiaries flexibility to
respond effectively to the serious public
health threats posed by COVID–19.
Recognizing the urgency of this
situation, and understanding that our
current policy may inhibit use of
capacity in settings that might otherwise
be effective in the efforts to mitigate the
impact of the pandemic on Medicare
beneficiaries and the American public,
we are changing our under
arrangements policy during the PHE for
the COVID–19 pandemic so that
hospitals are allowed broader
flexibilities to furnish inpatient services,
including routine services outside the
hospital.
2. Prior Rulemaking
In the FY 2012 IPPS/LTCH PPS
rulemaking (76 FR 51711), we noted
that the statute specifies that ‘‘routine
services,’’ for example, bed, board,
nursing and other related services,
except those specified at paragraph (3)
of section 1861(b) of the Act are to be
provided by ‘‘the hospital,’’ and not just
‘‘a hospital.’’ Similarly, we noted that
our implementing regulations at
§ 409.12 indicate that Medicare pays for
nursing and related services, use of
hospital facilities, and medical social
services as inpatient hospital services or
inpatient CAH services only if those
services are ordinarily furnished by the
hospital or CAH. We pointed out that,
consistent with section 1861(b)(3) of the
Act, only with regard to other diagnostic
or therapeutic services do the
regulations at § 409.16 state that
Medicare will also pay for these services
if furnished ‘‘by others under
arrangements made by the hospital or
CAH.’’
Under our current policy adopted in
the FY 2012 IPPS/LTCH PPS
rulemaking, if routine services, that is,
services described in sections 1861(b)(1)
and (b)(2) of the Act, are provided in the
hospital, they are considered as being
provided ‘‘by the hospital.’’ We stated
that we believe this policy is consistent
with the statute because the statutory
language specifying that the routine
services described in sections 1861(b)(1)
and (b)(2) of the Act be provided ‘‘by the
hospital’’ suggests that the hospital is
required to exercise professional
responsibility over the services,
including quality controls. In situations
in which certain routine services are
provided through arrangement ‘‘in the
hospital,’’ for example, contracted
nursing services, we stated that we
believe the arrangement generally
results in the hospital exercising the
same level of control over those services
as the hospital does in situations in
E:\FR\FM\06APR2.SGM
06APR2
jbell on DSKJLSW7X2PROD with RULES2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
which the services are provided by the
hospital’s salaried employees.
Therefore, if routine services are
provided in the hospital to its
inpatients, we consider the service as
being provided by the hospital.
However, if these services are provided
to its patients outside the hospital, the
services are considered as being
provided under arrangement, and not by
the hospital. Therefore, consistent with
the statute, we stated that only
therapeutic and diagnostic services can
be provided under arrangement outside
the hospital.
Some commenters during the FY 2012
IPPS/LTCH PPS rulemaking stated that
our policy to limit the services a
hospital may provide under
arrangements is not required by the
statute or regulations. Some commenters
also believed that CMS’ proposed
reading of the statutory definition of
inpatient hospital services is only one
possible interpretation of the statute.
In our response to these comments,
we noted that we focused on section
1861(b) of the Act because it provides
the statutory basis for our policy to limit
the services that may be furnished
under arrangement. As we noted in that
rulemaking, the reference to diagnostic
or therapeutic items or services in
section 1861(b)(3) of the Act is to
services furnished by the hospital or by
others under arrangements. Therefore,
we stated that we believe it is consistent
with the statutory language to limit the
services that may be furnished outside
of a hospital under arrangement to only
diagnostic and therapeutic services.
We noted that our policy does not
alter the definition of inpatient hospital
services, but instead limits the services
a hospital may provide under
arrangements outside the hospital. If a
patient of Hospital A is in Hospital B
receiving routine services, the patient
will still be an ‘‘inpatient,’’ but the
services will not be considered
‘‘inpatient hospital services’’ furnished
by the hospital for purposes of payment
for services defined under section
1861(b) of the Act. If the patient is
admitted to Hospital B, then the patient
would be an ‘‘inpatient’’ of Hospital B
and the routine services furnished to
that individual would meet the
definition of ‘‘inpatient routine
services’’ under section 1861(b) of the
Act.
We also discussed in the FY 2012
IPPS/LTCH PPS rulemaking the policy
considerations supporting this change.
We stated that we became aware that
some hospitals were furnishing certain
routine services, including ICU services,
under arrangement. For example, under
certain arrangements, if an inpatient of
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
an IPPS-excluded hospital (‘‘hospital
A’’) required ICU services, and the IPPSexcluded hospital could not provide
these services, the patient was moved to
an IPPS hospital (‘‘hospital B’’) that
could furnish the ICU services. In these
situations, the patient was not
transferred to hospital B but was moved
from an inpatient bed of hospital A to
an inpatient bed of hospital B. However,
the IPPS-excluded hospital treated these
services as being provided under
arrangement and included the cost of
those services on its cost report. We
found it problematic that the patient
was, at all times, considered an
inpatient of hospital A even though the
patient occupied an inpatient bed at
hospital B.
Because the two hospitals in the
example above are under two different
payment systems, we stated that we
believe this arrangement can result in
inappropriate and potentially excessive
Medicare payments. The IPPS-excluded
hospital, hospital A, is paid on a
reasonable cost basis, subject to a
ceiling. In most cases, this payment is
greater than if the hospital were paid
under the IPPS for the same patient.
Furthermore, although there is a ceiling
on the amount of Medicare payment for
hospital A, there are also provisions that
allow hospital A to receive adjustments
to its ceiling in certain circumstances,
which in the absence of our policy
could allow payment to hospital A
above those allowed by its ceiling.
Therefore, in the absence of our policy
these arrangements could allow hospital
A to request an adjustment to its ceiling
because its ICU costs had increased
beyond what is allowed. In that case,
hospital A would receive additional
payments beyond its ceiling. We stated
that we believe that by limiting the
furnishing of routine services under
arrangements to situations in which the
services are furnished in hospital A, we
reduce the opportunity for gaming. In
these more limited situations, hospital
A exercises sufficient control over the
use of hospital resources when
furnishing these services such that the
services are appropriately included in
hospital A’s cost report.
Under our current policy adopted in
that rulemaking, if hospital A did not
have the resources to treat a patient, it
would transfer the patient to hospital B
for ICU services, and hospital B would
bill Medicare consistent with the IPPS
provisions. Hospital A would be paid
for an inpatient discharge.
PO 00000
Frm 00051
Fmt 4701
Sfmt 4700
19279
3. Inpatient Hospital Services Furnished
Under Arrangements Outside the
Hospital During the PHE for the COVID–
19 Pandemic
As noted earlier in this section, we
continue to believe that our current
policy is consistent with the statute and
appropriate for the reasons discussed in
the FY 2012 IPPS/LTCH PPS
rulemaking. However, we wish to give
hospitals that provide services to
Medicare beneficiaries additional
flexibilities to respond effectively to the
serious public health threats posed by
the spread of COVID–19. Recognizing
the urgency of this situation, and
understanding that some pre-existing
Medicare payment rules may inhibit use
of capacity that might otherwise be
effective in the efforts to mitigate the
impact of the pandemic on Medicare
beneficiaries and the American public,
we are changing our under
arrangements policy during the PHE for
the COVID–19 pandemic beginning
March 1, 2020, so that hospitals are
allowed broader flexibilities to furnish
inpatient services, including routine
services outside the hospital.
We believe that our concerns
articulated in the FY 2012 rulemaking
regarding gaming of routine services
provided outside the hospital for
payment reasons are significantly
mitigated by the existence of the PHE.
Hospitals would be treating patients in
locations outside the hospital for a
variety of reasons, including limited
beds and/or limited specialized
equipment such as ventilators, and for
a limited time period. We do not expect
that during the PHE for the COVID–19
pandemic hospitals would be treating
patients outside the hospital for gaming
reasons.
As noted, we continue to believe that
our current policy of limiting the
services that may be provided under
arrangements outside of the hospital to
therapeutic and diagnostic items and
services is consistent with the statute
and supported by the policy
considerations discussed in the FY 2012
IPPS/LTCH PPS final rule. However, we
do not believe that the statute would
preclude this change in policy to allow
routine services to also be provided
under arrangements outside the
hospital, in light of the compelling
circumstances and the need for
additional, short-term flexibility during
the current PHE for the COVID–19
pandemic. Consistent with this, and as
previously summarized in section
II.BB.2 of this IFC, we note that we
received comments during the FY 2012
rulemaking that our policy to limit the
services a hospital may provide under
E:\FR\FM\06APR2.SGM
06APR2
19280
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
arrangements is not required by the
statute and that CMS’ reading of the
statutory definition of inpatient hospital
services is only one possible
interpretation of the statute.
While we are changing our under
arrangements policy during the PHE for
the COVID–19 pandemic to allow
hospitals broader flexibilities in
furnishing inpatient services, we
emphasize that we are not changing our
policy that a hospital needs to exercise
sufficient control and responsibility
over the use of hospital resources in
treating patients, as discussed in the FY
2012 IPPS/LTCH PPS final rule and
Section 10.3 of Chapter 5 of the
Medicare General Information,
Eligibility, and Entitlement Manual
(Pub. 100–01). Nothing in the current
PHE for the COVID–19 pandemic has
changed our policy or thinking with
respect to this issue and we are making
no modifications to this aspect of the
policy. Hospitals need to continue to
exercise sufficient control and
responsibility over the use of hospital
resources in treating patients regardless
of whether that treatment occurs in the
hospital or outside the hospital under
arrangements. If a hospital cannot
exercise sufficient control and
responsibility over the use of hospital
resources in treating patients outside the
hospital under arrangements, the
hospital should not provide those
services outside the hospital under
arrangements.
For the reasons set forth above,
effective for services provided for
discharges for patients admitted to the
hospital during the PHE for COVID–19
beginning March 1, 2020, if routine
services are provided under
arrangements outside the hospital to its
inpatients, these services are considered
as being provided by the hospital.
DD. Advance Payments to Suppliers
Furnishing Items and Services Under
Part B
In an effort to be able to be more
responsive to situations in which Part B
suppliers could request advance
payments from CMS, we are making
modifications to existing advance
payments rules found in 42 CFR
421.214. Currently, § 421.214 limits
CMS’ ability to make advance payments
in situations where a CMS contractor is
unable to process claims within
established time limits. In light of the
PHE Declaration related to COVID–19
and the inability to project the impact
it may have in the future on CMS’
abilities to ensure timely payment and
the potential challenges for suppliers to
prepare and submit claims to CMS
contractors, we are revising the
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
definition of advance payment in
§ 421.214(b). Currently, paragraph (b)
defines advance payment as a
conditional partial payment made by
the carrier in response to a claim that it
is unable to process within established
time limits. We are revising this
definition to state that the conditional
partial payment will be made by the
‘‘contractor’’ (not the carrier) except as
provided in paragraph (j). We are also
adding language to permit payments
under an exception at § 421.214(c). In
addition, we are also adding paragraph
(j) to specifically address emergency
situations in which it will be able to
make advance payments. Additionally,
existing rules limit CMS to no more
than 80 percent of the anticipated
payment for that claim based upon the
historical assigned claims payment data
for claims paid to the supplier. Under
exceptional circumstances as outlined
in paragraph (j), we are increasing this
limit to 100 percent of the anticipated
payment for that claim based upon the
historical assigned claims payment data
for claims paid to the supplier in
paragraph (f)(1)(i). We are also adding a
criterion to § 421.214 that suppliers in
bankruptcy would not be eligible to
receive advance payments to ensure
that, with such expanded authority,
CMS is able to appropriately pay and
recover advance payments made to Part
B suppliers.
III. Waiver of Proposed Rulemaking
We ordinarily publish a notice of
proposed rulemaking in the Federal
Register and invite public comment on
the proposed rule before the provisions
of the rule take effect, in accordance
with 5 U.S.C. 553(b) of the
Administrative Procedure Act (APA)
and section 1871 of the Act.
Specifically, section 553(b) of the APA
requires the agency to publish a notice
of the proposed rule in the Federal
Register that includes a reference to the
legal authority under which the rule is
proposed, and the terms and substance
of the proposed rule or a description of
the subjects and issues involved.
Section 553(c) of the APA further
requires the agency to give interested
parties the opportunity to participate in
the rulemaking through public comment
before the provisions of the rule take
effect. Similarly, section 1871(b)(1) of
the Act requires the Secretary to provide
for notice of the proposed rule in the
Federal Register and a period of not less
than 60 days for public comment.
Section 553(b)(3)(B) of the APA and
section 1871(b)(2)(C) of the Act
authorize the agency to waive these
procedures, however, if the agency finds
good cause that notice and comment
PO 00000
Frm 00052
Fmt 4701
Sfmt 4700
procedures are impracticable,
unnecessary, or contrary to the public
interest and incorporates a statement of
the finding and its reasons in the rule
issued.
Section 553(d) of the APA ordinarily
requires a 30-day delay in the effective
date of a final rule from the date of its
publication in the Federal Register.
This 30-day delay in effective date can
be waived, however, if an agency finds
good cause to support an earlier
effective date. Section 1871(e)(1)(B)(i) of
the Act also prohibits a substantive rule
from taking effect before the end of the
30-day period beginning on the date the
rule is issued or published. Section
1871(e)(1)(B)(ii) of the Act permits a
substantive rule to take effect before 30
days if the Secretary finds that a waiver
of the 30-day period is necessary to
comply with statutory requirements or
that the 30-day delay would be contrary
to the public interest. Furthermore,
section 1871(e)(1)(A)(ii) of the Act
permits a substantive change in
regulations, manual instructions,
interpretive rules, statements of policy,
or guidelines of general applicability
under Title XVIII of the Act to be
applied retroactively to items and
services furnished before the effective
date of the change if the failure to apply
the change retroactively would be
contrary to the public interest.
The nation is experiencing an
emergency of unprecedented
magnitude. Ensuring the health and
safety of Medicare beneficiaries,
Medicaid recipients, and healthcare
workers is of primary importance. As
this IFC directly supports that goal by
offering healthcare professionals
flexibilities in furnishing services while
combatting the COVID–19 pandemic
and ensuring that sufficient health care
items and services are available to meet
the needs of individuals enrolled in the
Medicare and Medicaid programs, it is
critically important that we implement
this IFC as quickly as possible. As we
are in the midst of a PHE, we find good
cause to waive notice and comment
rulemaking as we believe it would be
contrary to the public interest for us to
undertake normal notice and comment
rulemaking procedures. For the same
reasons, because we cannot afford any
delay in effectuating this IFC, we find
good cause to waive the 30-day delay in
the effective date and, moreover, to
make this IFC effective as of March 1,
2020—the date the President of the
United States declared to be the
beginning of the national emergency
concerning the COVID–19 outbreak.
On January 30, 2020, the International
Health Regulations Emergency
Committee of the World Health
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
Organization (WHO) declared the
outbreak of the 2019 Novel Coronavirus
(COVID–19) to be a Public Health
Emergency of International Concern.22
On January 31, 2020, Health and Human
Services Secretary Alex M. Azar II
declared a Public Health Emergency
(PHE) 23 under section 319 of the Public
Health Service Act (42 U.S.C. 247d), in
response to COVID–19. On March 11,
2020, the WHO publicly declared
COVID–19 to be a pandemic.24 On
March 13, 2020, the President declared
that the COVD–19 outbreak in the
United States constitutes a national
emergency,25 beginning March 1, 2020.
This declaration, along with the
Secretary’s January 30, 2020 declaration
of a PHE, conferred on the Secretary
certain waiver authorities under section
1135 of the Act. On March 13, 2020, the
Secretary authorized waivers under
section 1135 of the Act, effective March
1, 2020.26
In support of the imperative to
contain and combat the virus in the
United States, this IFC will give health
care workers and hospitals additional
flexibility to respond to the virus and
continue caring for patients while
minimizing exposure. CDC guidelines
are clear that public exposure greatly
increases the overall risk to public
health and they stress the importance of
containment and mitigation strategies to
minimize public exposure and the
spread of COVID–19. As of March 29th,
the CDC reports 122,653 cases of
COVID–19 in the United Sates and
2,112 deaths.27 Individuals such as
healthcare workers who come in close
contact with those infected with
COVID–19 are at an elevated risk of
contracting the disease. To minimize
these risks, the CDC has urged
healthcare professionals to make every
effort to distance themselves from those
who are potentially sick with COVID–19
by using modalities such as telephonic
interviews, text monitoring systems, or
22 https://www.who.int/news-room/detail/30-012020-statement-on-the-second-meeting-of-theinternational-health-regulations-(2005)-emergencycommittee-regarding-the-outbreak-of-novelcoronavirus-(2019-ncov).
23 https://www.phe.gov/emergency/news/
healthactions/phe/Pages/2019-nCoV.aspx.
24 https://www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-mediabriefing-on-covid-19---11-march-2020.
25 https://www.whitehouse.gov/presidentialactions/proclamation-declaring-nationalemergency-concerning-novel-coronavirus-diseasecovid-19-outbreak/.
26 https://www.phe.gov/emergency/news/
healthactions/section1135/Pages/covid1913March20.aspx.
27 https://www.cdc.gov/coronavirus/2019-ncov/
cases-updates/cases-in-us.html.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
video conference.28 As the healthcare
community works to establish and
implement infection prevention and
control practices, CMS is also working
to revise and implement regulations that
function in concert with those
healthcare community infection
prevention and treatment practices.
This IFC offers flexibilities in certain
Medicare and Medicaid regulations that
support measures to combat the COVID–
19 pandemic and safeguard all interests
by protecting healthcare providers and
vulnerable beneficiaries. The provisions
of this IFC better enable and facilitate
physicians and other clinicians, to focus
on caring for these beneficiaries during
this PHE for the COVID–19 pandemic
and minimize their own risks to
COVID–19 exposure. For example, by
increasing access to telehealth and
testing in a patient’s home, and
improving infection control, this IFC
will provide flexibilities for Medicare
beneficiaries to be able to receive
medically necessary services without
jeopardizing their health or the health of
those who are providing those services,
in turn minimizing public exposure and
the overall risk to public health.
Moreover, changes to Medicare payment
rules will confer on practitioners and
other healthcare providers the broadest
flexibility to use remote
communications technology to avoid
exposure risks to themselves, their
patients, and communities. These
changes include greater flexibilities to
use communications technology to
interact with patients directly and to
supervise care directly provided by
other clinicians. This IFC alters the
applicable payment rules to provide
specimen collection fees for
independent laboratories collecting
specimens from beneficiaries who are
homebound or inpatients (not in a
hospital) for COVID–19 testing.
Additionally, certain new modelspecific requirements for Innovation
Center Models and program-specific
requirements for the Quality Payment
Program will reduce or prevent
practices that might inappropriately
incentivize cost considerations over
patient safety. Changes to the
calculation of the 2021 and 2022 Part C
and D Star Ratings will address the
expected disruption to data collection
and measure scores posed by the
COVID–19 pandemic, and amendments
to the Medicaid home health regulations
will enable other licensed practitioners
to order services, equipment, and
therapy they otherwise could not.
28 https://www.cdc.gov/coronavirus/2019-ncov/
php/guidance-evaluating-pui.html.
PO 00000
Frm 00053
Fmt 4701
Sfmt 4700
19281
We believe it would be contrary to the
public interest for us to undertake
normal notice and comment procedures
and to delay the effective date of this
IFC. We find good cause to waive notice
of proposed rulemaking under section
553(b)(3)(B) of the APA and section
1871(b)(2)(C) of the Act, and, for the
reasons stated, we find that it would be
contrary to the public interest to delay
the effective date of this IFC, under
section 553(d) of the APA and section
1871(e)(1)(B)(i) of the Act.
Furthermore, the President declared
that the COVID–19 outbreak in the
United States constituted a national
emergency beginning March 1, 2020. To
ensure the consistent availability
throughout the national emergency
period of measures we are taking to
address the COVID–19 pandemic, we
believe it is vital that the effective date
of this IFC align with the first day of the
national emergency. It is also important
to ensure the health care providers that
acted expeditiously to implement
appropriate physical and operational
changes to their practices to adapt to
emergency conditions, even in the
absence of changes in our policies to
address them, are not disadvantaged
relative to other health care providers,
and will not be discouraged from taking
similar appropriate actions in the future.
March 1, 2020 precedes the date of
publication of this IFC in the Federal
Register, which means this rule has a
retroactive effect. However, section
1872(e)(1)(A)(ii) of the Act permits the
Secretary to issue a rule with retroactive
effect if the failure to do so would be
contrary to the public interest. As we
have explained above, we believe it
would be contrary to the public interest
not to implement this IFC as soon as we
are authorized to do so under the
authority of section 1871(e)(1)(A)(ii) of
the Act, that is, retroactively to March
1, 2020. We are providing a 60-day
public comment period for this IFC as
specified in the DATES section of this
document.
IV. Collection of Information
Requirements
For IFC changes to the MA and Part
D Star Ratings program, the elimination
of the requirement to collect and submit
data for OMB control numbers 0938–
1028 (HEDIS) and 0938–0732 (CAHPS)
will reduce some burden. Those
collections are approved for 164,200
hours and 123,375 hours annually,
respectively. Due to the ongoing nature
of these information collections, it is
difficult to determine the extent of the
burden. However, the burden estimates
for the HEDIS and CAHPS information
collection requests are approved
E:\FR\FM\06APR2.SGM
06APR2
19282
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
through November 30, 2020 and April
30, 2021, respectively. Upon
resubmission for OMB approval, we will
revise both information collections to
more accurately account for the burden
decreases.
V. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
VI. Regulatory Impact Analysis
Executive Order 12866 and other laws
and Executive orders require economic
analysis of the effects of proposed and
final (including interim final) rules.29
The Office of Management and Budget
has designated this rulemaking as
‘‘economically significant’’ under E.O.
12866 and also major under the
Congressional Review Act. This IFC’s
designation under Executive Order
13771, titled ‘‘Reducing Regulation and
Controlling Regulatory Costs’’ (82 FR
9339), which was issued on January 30,
2017, will be informed by public
comments received.
jbell on DSKJLSW7X2PROD with RULES2
A. Statement of Need
Throughout this IFC, we discuss
several changes to payment and
coverage policies intended to allow
health care providers maximum
flexibility to minimize the spread of
COVID–19 among Medicare and
Medicaid beneficiaries, health care
personnel, and the community at large
and increase capacity to address the
needs of their patients. The flexibilities
and changes contained within this IFC
are responsive to this developing
pandemic emergency. Given the
potentially catastrophic impact to
public health, it is difficult to estimate
the economic impact of the spread of
COVID–19 under current payment rules
compared to the rules issued in this IFC.
We believe that the needs of Medicare
patients will likely test the capacity of
the health care system over the coming
months. Our policies during the PHE for
29 Section 202 of the Unfunded Mandates Reform
Act of 1995 (UMRA) (Pub. L. 104–04, enacted on
March 22, 1995) also requires that agencies assess
anticipated costs and benefits before issuing any
rule whose mandates require spending in any 1 year
of $100 million in 1995 dollars, updated annually
for inflation. In 2020, that amount is approximately
$156 million. This IFC does not mandate, on an
unfunded basis, any requirements for State, local,
or tribal governments, or for the private sector.
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
the COVID–19 Pandemic will allow
home health agencies and hospices
more flexibility to furnish services via
telecommunications technologies to
minimize exposure risks to patients,
clinicians and the general public; and
there would be no change in Medicare
payment rates or change in the types of
patients treated under these policies
compared to the absence of these policy
changes.
Our additions to the list of Medicare
telehealth services will allow more
physicians’ services to be furnished in
a manner that reduces the exposure risk
to patients and physicians. To the extent
that physicians utilize these new
flexibilities for patients that would have
been treated in more traditional offices
or hospital settings without this policy
change, given the competing demand for
physicians’ services during the
pandemic this additional flexibility
would not result in any significant
change in aggregate Medicare payments
for physicians’ services.
Still, it is possible that the flexibilities
and changes contained within this IFC
would increase aggregate Medicare
payments. For example, if its
protections against exposure risk are
effective, providers may maintain their
own health and thus be available to
provide more medical treatment overall.
Improvements in both provider and/or
patient health are intended benefits of
this IFC.
We anticipate that the change in the
site of service payment amount for
telehealth services under the PHE along
with the changes that allow for broader
flexibilities in supervision will allow
physicians and other practitioners to
better maintain overall level of needed
care to Medicare beneficiaries in the
face of exposure risks and competing
demands for health care providers.
Finally, the changes to Medicaid’s
regulations to expand the scope of
certain providers are anticipated to
eliminate some burdens on providers
and beneficiaries.
The modifications to the calculations
for the 2021 and 2022 Part C and D Star
Ratings to address the expected
disruption to data collection and
measure scores posed by the PHE for the
COVID–19 pandemic should not have a
significant impact on the distribution of
ratings across Part C and D sponsors.
Consequently, there should be
negligible impacts on payments for MA
organizations from these modifications.
B. Special Requirements for Psychiatric
Hospitals
In section II.P. of this final rule, we
note that existing requirements for
psychiatric hospitals specify that
PO 00000
Frm 00054
Fmt 4701
Sfmt 4700
progress notes must be recorded by the
physician(s), psychologists, or other
licensed independent practitioner(s)
responsible for the care of the patient.
We believe that this provision requires
clarification and revision since the
regulatory language is inconsistent with
other recent changes finalized
throughout the hospital CoPs as this
provision applies to APPs, including
PAs, NPs, psychologists, and CNSs.
Continued use of this outdated term
may inadvertently exacerbate workforce
shortage concerns, might unnecessarily
impose regulatory burden on hospitals,
especially psychiatric hospitals, by
restricting a hospital’s ability to allow
APPs to operate within the scope of
practice allowed by state law. We
believe that the existing regulation fails
to recognize the benefits to patient care
that might be derived from fully
utilizing APPs and their clinical skills to
the highest levels of their training,
education, and experience as allowed by
hospital policy in accordance with state
law.
Therefore, we are removing the term
‘‘licensed independent practitioner(s)’’
from the regulations. We believe that
this revision is non-controversial, and
that the public interest will be served by
permitting a greater scope of practice for
professionals in the psychiatric hospital
context and further believe that these
trained and qualified practitioners,
when acting in accordance with State
law, their scope of practice, and hospital
policy, should have the authority to
record progress notes of psychiatric
patients for whose care they are
responsible.
At § 482.61(d), we are allowing NPPs,
or APPs, to document progress notes in
accordance with State laws and scopeof-practice requirements. We believe
that clarification of the intent of the
regulation is necessary and will result in
NPPs (specifically PAs, NPs, and CNSs)
documenting in the progress notes for
patients receiving services in
psychiatric hospitals.
We estimate that MDs/DOs currently
spend approximately 30 minutes
documenting progress notes in
psychiatric hospitals, and that 33
percent of this time would be covered
by NPPs. Of the 4,823 Medicare
participating hospitals, approximately
620 (or 13 percent) are psychiatric
hospitals. According to AHA, there were
36,510,207 inpatient hospital stays in
2017, and therefore, an estimated 13
percent of these stays were at
psychiatric hospitals. The change will
result in a savings of $153.5 million
(4,746,327 psychiatric hospital stays × 2
progress notes per stay × 0.5 hours of
physician/psychiatrist time × $98 per
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
hourly wage difference between
physicians/psychiatrists ($198) and
NPPs ($100, the average wage between
NPs and PAs) × 33 percent of physician
time spent writing progress notes
covered by NPPs, or APPs).
C. Anticipated Effects of Changes to the
MDPP Expanded Model
1. Effects on Beneficiaries
In section II.Q. of this IFC, we are
amending the MDPP expanded model to
modify certain requirements of the
model in an emergency area during an
emergency period, as those terms are
defined in section 1135(g) of the Act, for
which the Secretary has issued a waiver
under section 1135 of the Act.
Specifically, as the Secretary has issued
a waiver under section 1135 of the Act,
certain MDPP beneficiaries will be
permitted to obtain the set of MDPP
services more than once per lifetime, the
number of virtual make-up sessions is
increased, and certain MDPP suppliers
will be permitted to deliver time limited
virtual MDPP sessions. These changes
apply only to MDPP beneficiaries (as
defined in § 410.79(b)) who were
receiving the MDPP set of services
during the emergency period, as defined
under section 1135(g) of the Act.
We believe that during this COVID–19
pandemic, Medicare beneficiaries will
not be able to attend in-person classes.
Because we do not want to disrupt their
progress and we want to promote both
MDPP beneficiary and MDPP supplier
retention, we have modified how the set
of services can be delivered to make the
program accessible to currently enrolled
MDPP beneficiaries during this national
emergency. Our policies during the PHE
for the COVID–19 Pandemic will allow
enrolled MDPP suppliers with active
MDPP cohorts more flexibility to
furnish virtual sessions, as described by
the CDC’s DPRP Standards.
With the exception of the requirement
for in-person attendance and the inperson body weight measurement at the
first core-session, the in-person
attendance requirements are waived.
MDPP suppliers shall not start any new
cohorts with MDPP beneficiaries
throughout the COVID–19 PHE period
in the geographic area, as defined under
section 1135(g) of the Act, given that
most beneficiaries cannot receive inperson services right now.
During the emergency period, the
number of virtual make-up sessions is
waived for MDPP suppliers, with an
MDPP supplier offering MDPP
beneficiaries no more than 15 weekly
virtual make-up sessions during the core
session period, no more than 6 monthly
virtual make-up sessions during the core
maintenance session interval period, no
more than 12 monthly virtual make-up
sessions during the ongoing
maintenance session interval periods.
All flexibilities described in this IFC
will cease to be available as of the
effective end date of the PHE. When inperson classes resume, the CDC is
allowing suppliers to pick up where
they left off, or to restart the program
from week one. It is our intent to
conform with the CDC guidance where
feasible, with the overall intent to
minimize disruption of services for
MDPP suppliers and MDPP
beneficiaries; by allowing MDPP
beneficiaries to maintain their
eligibility. In this IFC, we are amending
the MDPP regulations to provide for
19283
changes as described in section II.Q.1 of
this IFC, including allowing MDPP
suppliers to either deliver MDPP
services virtually or suspend delivery
and resume services at a later date, in
an emergency area and during this
COVID–19 PHE period, as those terms
are defined in section 1135(g) of the Act,
for which the Secretary has authorized
a waiver under section 1135 of the Act
and the Secretary has declared a PHE.
In addition, these changes permit
certain MDPP beneficiaries to obtain the
set of MDPP services more than once
per lifetime, for the limited purposes of
allowing a pause in service and allow
MDPP beneficiaries to maintain
eligibility for MDPP services despite a
break in service, attendance, or weight
loss achievement. These changes will
have a positive impact on affected
MDPP beneficiaries, as it will allow
them to maintain eligibility for the
expanded model, and request virtual
make-up sessions if needed for
successful completion of attendance and
weight loss milestones.
2. Effects on the Market
Currently, more than 196
organizations nationally are enrolled as
MDPP suppliers. There are
approximately 798 locations. We
anticipate that of the 1,818 beneficiaries
identified through our monitoring data
and the CDC’s Diabetes Prevention
Recognition Program (DPRP) data, 1,358
beneficiaries may be impacted by
allowing both the once-per-lifetime
benefit and the minimum weight loss
requirement to be waived for those
beneficiaries in the first 12 months of
MDPP.
TABLE 2
Recommended waivers
Cost impact
Adjust the limit to the # Virtual Make-up sessions ..............................................................................................................................
Waive the once per lifetime requirement ............................................................................................................................................
Waive the minimum weight loss requirement for OM .........................................................................................................................
Waive the MDPP services time periods and intervals ........................................................................................................................
Average Y1 MDPP Payments (Y1) with no COVID action .................................................................................................................
$—
279,748.00
53,301.50
—
177,898.00
Total cost of COVID–19 response ...............................................................................................................................................
333,049.50
jbell on DSKJLSW7X2PROD with RULES2
Assumptions:
—Average MDPP payments in Year 1: $412, assuming that beneficiaries attended 9 sessions, and reached the 5 percent weight loss during
interval 1 of the core maintenance session
—Average MDPP payments in Year 1 with no COVID–19 action: $131, assuming beneficiaries attended 2 ongoing maintenance sessions
D. Modification to the Extreme and
Uncontrollable Circumstances Policy
Under the Shared Savings Program
In section II.V. of this IFC, we discuss
a modification to the extreme and
uncontrollable circumstances policy
under the Shared Savings Program. The
current Medicare Shared Savings
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
Program extreme and uncontrollable
circumstances policy for purposes of
determining an ACO’s quality score for
use in determining shared savings or
shared losses applies if twenty percent
or more of an ACO’s assigned
beneficiaries or its legal business entity
are located in an area identified under
PO 00000
Frm 00055
Fmt 4701
Sfmt 4700
the Quality Payment Program as being
affected by an extreme and
uncontrollable circumstance, during the
performance year, including the
applicable quality data reporting period
for the performance year if, the quality
reporting period is not extended. In
response to the National Emergency for
E:\FR\FM\06APR2.SGM
06APR2
19284
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
the COVID–19 pandemic declared on
March 13, 2020, we have determined
that the 2019 MIPS data submission
deadline will be extended by 30 days
until April 30, 2020, to give eligible
clinicians more time to report quality
and other data for purposes of MIPS.
This extended timeline also applies to
Shared Savings Program ACOs because
they are required to report quality data
via the CMS Web Interface and we align
the Shared Savings Program data
submission timeline with the timeline
for MIPS data submission. As currently
written, our extreme and uncontrollable
circumstances policy cannot be applied
to waive the quality reporting
requirements under the Shared Savings
Program because the quality data
submission period has been extended.
The PHE for the COVID–19 pandemic
applies to all counties in the United
States, and we think it is appropriate to
offer relief under the Shared Savings
Program extreme and uncontrollable
circumstances policy to all Shared
Savings Program ACOs that are unable
to completely and accurately report
quality for 2019 by the extended
deadline. Accordingly, in this IFC, we
are revising the regulation at
§ 425.502(f) to remove the restriction
which prevents the application of the
Shared Savings Program extreme and
uncontrollable circumstances policy for
disasters that occur during the quality
period if the reporting period is
extended, to offer relief under the
Shared Savings Program to all ACOs
that may be unable to completely and
accurately report quality for 2019 due to
the PHE for the COVID–19. As currently
written, our extreme and uncontrollable
circumstances policy cannot be applied
to waive the quality reporting
requirements under the Shared Savings
Program because the quality data
submission period has been extended.
The PHE for the COVID–19 pandemic
applies to all counties in the United
States, and we think it is appropriate to
offer relief under the Shared Savings
Program extreme and uncontrollable
circumstances policy to all Shared
Savings Program ACOs that are unable
to completely and accurately report
quality for 2019 by the extended
deadline, Accordingly, in this interim
final rule, we are revising the regulation
at § 425.502(f) to remove the restriction
which prevents the application of the
Shared Savings Program extreme and
uncontrollable circumstances policy for
disasters that occur during the quality
period if the reporting period is
extended, in order to offer relief under
the Shared Savings Program to all ACOs
that may be unable to completely and
accurately report quality for 2019 due to
the PHE for the COVID–19 pandemic.
We estimate based on patterns evident
in the financial reconciliation for
performance year 2018 that this change
would allow roughly 100 ACOs that
achieve savings either to qualify to
receive shared savings or to receive a
higher effective sharing rate. We
estimate the average resulting benefit to
such ACOs ranging from $150,000 to
$200,000 per ACO. The total impact of
extending the extreme and
uncontrollable circumstances policy
despite the extension of the quality
reporting period for 2019 is therefore
estimated to be $20 million with a range
of uncertainty in such estimate
spanning $15 million to $25 million.
E. Anticipated Effects of Changes to the
Quality Payment Program
Since it is not possible to
comprehensively predict the impact of
the evolving PHE for the COVID–19
pandemic at this time, the Office of the
Actuary was unable to calculate a
discrete impact estimate for the effect of
extending CJR PY 5 an additional 3
months. However, given the previous
estimate for PY 5 in the
‘‘Comprehensive Care for Joint
Replacement Model Three-Year
Extension and Changes to Episode
Definition and Pricing’’ proposed rule
(CMS–5529–P), we anticipate the
impact of the additional 3 months could
range between $0 and $1.2 million. We
will continue to refine this analysis and
will provide a more detailed estimate in
the final rule if available. Table 3
summarizes the financial impact of
extending PY 5 an additional 3 months.
Table 3 includes the full amount of FFS
episode payments and also includes any
reconciliation payments related to the
model. Table 3 also shows costs/savings
(costs are represented as positive
amounts and savings as negative
amounts) imposed on non-federal
entities (that is, participating medical
facilities), as well as net transfers of
federal funds (that is, increases in
Medicare program expenditures are
indicated as positive amounts and
decreases in Medicare program
expenditures are indicated as negative
amounts).
TABLE 3—FINANCIAL IMPACT OF EXTENDING PY 5 AN ADDITIONAL 3 MONTHS
Scenario
Costs/benefits
Transfers
(millions)
Net financial impact of extending CJR model PY 5 by 3 additional months ..........................................................
........................
1.2
jbell on DSKJLSW7X2PROD with RULES2
F. Overall Impact
The RFA requires agencies to analyze
options for regulatory relief of small
entities, if a rule has a significant impact
on a substantial number of small
entities. The great majority of hospitals
and most other health care providers
and suppliers are small entities, either
by being nonprofit organizations or by
meeting the SBA definition of a small
business (having revenues of less than
$8.0 million to $41.5 million in any one
year). Individuals and states are not
included in the definition of a small
entity. As its measure of significant
economic impact on a substantial
number of small entities, HHS uses an
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
adverse change in revenue of more than
3 to 5 percent. We do not believe that
this threshold will be reached by the
provisions in this IFC.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 604 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
as a hospital that is located outside of
a metropolitan statistical area and has
fewer than 100 beds. This IFC will not
have a significant impact on the
PO 00000
Frm 00056
Fmt 4701
Sfmt 4700
operations of a substantial number of
small rural hospitals.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it issues a proposed
rule that imposes substantial direct
requirement costs on state and local
governments, preempts state law, or
otherwise has federalism implications.
This IFC does not have a substantial
direct cost impact on state or local
governments, preempt state law, or
otherwise have federalism implications.
Under the Congressional Review Act
(5 U.S.C. 801 et seq.), the Office of
Information and Regulatory Affairs
designated this rule as a major rule, as
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
defined by 5 U.S.C. 804(2). As such, this
rule has been transmitted to the
Congress and the Comptroller General
for review.
maintenance organizations (HMO),
Medicare, Penalties, Privacy, Reporting
and recordkeeping requirements.
■
42 CFR Part 423
List of Subjects
§ 405.2416
Administrative practice and
procedure, Emergency medical services,
Health facilities, Health maintenance
organizations (HMO), Health
professionals, Medicare, Penalties,
Privacy, Reporting and recordkeeping
requirements.
(a) * * *
(5) During a PHE, as defined in
§ 400.200 of this chapter, an area
typically served by the RHC, and an area
that is included in the FQHC’s service
area plan, is determined to have a
shortage of home health agencies, and
no request for this determination is
required.
*
*
*
*
*
42 CFR Part 400
Grant programs—health, Health
facilities, Health maintenance
organizations (HMO), Medicaid,
Medicare, Reporting and recordkeeping
requirements.
42 CFR Part 405
Administrative practice and
procedure, Diseases, Health facilities,
Health insurance, Health professions,
Medical devices, Medicare, Reporting
and recordkeeping requirements, Rural
areas, X-rays.
42 CFR Part 409
Health facilities, Medicare.
42 CFR Part 425
Administrative practice and
procedure, Health facilities, Health
professions, Medicare, Reporting and
recordkeeping requirements.
42 CFR Part 440
Grant programs—health, Medicaid.
42 CFR Part 482
Grant programs—health, Hospitals,
Medicaid, Medicare, Reporting and
recordkeeping requirements.
42 CFR Part 410
Diseases, Health facilities, Health
professions, Laboratories, Medicare,
Reporting and recordkeeping
requirements, Rural areas, X-rays.
42 CFR Part 510
42 CFR Part 412
Administrative practice and
procedure, Health facilities, Medicare,
Puerto Rico, Reporting and
recordkeeping requirements.
42 CFR Part 414
Administrative practice and
procedure, Biologics, Diseases, Drugs,
Health facilities, Health professions,
Medicare, Reporting and recordkeeping
requirements.
Administrative practice and
procedure, Health facilities.
For the reasons set forth in the
preamble, the Centers for Medicare &
Medicaid Services amends 42 CFR
chapter IV as set forth below:
PART 400—INTRODUCTION;
DEFINITIONS
1. The authority citation part 400 is
revised to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh, and
44 U.S.C. Chapter 35.
2. Section 400.200 is amended by
adding the definition of ‘‘Public Health
Emergency’’ in alphabetical order to
read as follows:
42 CFR Part 415
Health facilities, Health professions,
Medicare, Reporting and recordkeeping
requirements.
■
42 CFR Part 417
Administrative practice and
procedure, Grant programs—health,
Health care, Health insurance, Health
maintenance organizations (HMO), Loan
programs—health, Medicare, Reporting
and recordkeeping requirements.
§ 400.200
42 CFR Part 418
Health facilities, Hospice care,
Medicare, Reporting and recordkeeping
requirements.
jbell on DSKJLSW7X2PROD with RULES2
19285
42 CFR Part 421
Administrative practice and
procedure, Health facilities, Health
professions, Medicare, Reporting and
recordkeeping requirements.
42 CFR Part 422
Administrative practice and
procedure, Health facilities, Health
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
General definitions.
*
*
*
*
*
Public Health Emergency (PHE)
means the Public Health Emergency
determined to exist nationwide as of
January 27, 2020, by the Secretary
pursuant to section 319 of the Public
Health Security Act on January 31,
2020, as a result of confirmed cases of
COVID–19, including any subsequent
renewals.
*
*
*
*
*
PART 405—FEDERAL HEALTH
INSURANCE FOR THE AGED AND
DISABLED
3. The authority citation part 405
continues to read as follows:
■
Authority: 42 U.S.C. 263a, 405(a), 1302,
1320b–12, 1395x, 1395y(a), 1395ff, 1395hh,
1395kk, 1395rr, and 1395ww(k).
PO 00000
Frm 00057
Fmt 4701
Sfmt 4700
4. Section 405.2416 is amended by
adding paragraph (a)(5) to read as
follows:
Visiting nurse services.
PART 409—HOSPITAL INSURANCE
BENEFITS
5. The authority citation for part 409
continues to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh.
6. Section 409.43 is amended by
revising paragraph (a)(3) to read as
follows:
■
§ 409.43
Plan of care requirements.
(a) * * *
(3) The plan of care must include the
identification of the responsible
discipline(s) and the frequency and
duration of all visits, as well as those
items listed in § 484.60(a) of this chapter
that establish the need for such services.
All care provided must be in accordance
with the plan of care. During a PHE, as
defined in § 400.200 of this chapter, the
plan of care must include any provision
of remote patient monitoring or other
services furnished via a
telecommunications system and such
services must be tied to the patientspecific needs as identified in the
comprehensive assessment, cannot
substitute for a home visit ordered as
part of the plan of care, and cannot be
considered a home visit for the purposes
of patient eligibility or payment. The
plan of care must include a description
of how the use of such technology will
help to achieve the goals outlined on the
plan of care.
*
*
*
*
*
PART 410—SUPPLEMENTARY
MEDICAL INSURANCE (SMI)
BENEFITS
7. The authority citation for part 410
continues to read as follows:
■
Authority: 42 U.S.C. 1302, 1395m, 1395hh,
1395rr, and 1395ddd.
8. Section 410.27 is amended by
revising paragraphs (a)(1)(iv)(D) and (E)
to read as follows:
■
E:\FR\FM\06APR2.SGM
06APR2
19286
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
jbell on DSKJLSW7X2PROD with RULES2
§ 410.27 Therapeutic outpatient hospital or
CAH services and supplies incident to a
physician’s or nonphysician practitioner’s
service: Conditions.
(a) * * *
(1) * * *
(iv) * * *
(D) For pulmonary rehabilitation,
cardiac rehabilitation, and intensive
cardiac rehabilitation services, direct
supervision must be furnished by a
doctor of medicine or a doctor of
osteopathy, as specified in §§ 410.47
and 410.49, respectively. For purposes
of this section, direct supervision means
that the physician or nonphysician
practitioner must be immediately
available to furnish assistance and
direction throughout the performance of
the procedure. It does not mean that the
physician or nonphysician practitioner
must be present in the room when the
procedure is performed. During a Public
Health Emergency, as defined in
§ 400.200 of this chapter, the presence
of the physician includes virtual
presence through audio/video real-time
communications technology when use
of such technology is indicated to
reduce exposure risks for the beneficiary
or health care provider; and
(E) For nonsurgical extended duration
therapeutic services (extended duration
services), which are hospital or CAH
outpatient therapeutic services that can
last a significant period of time, have a
substantial monitoring component that
is typically performed by auxiliary
personnel, have a low risk of requiring
the physician’s or appropriate
nonphysician practitioner’s immediate
availability after the initiation of the
service, and are not primarily surgical in
nature, Medicare requires a minimum of
direct supervision during the initiation
of the service which may be followed by
general supervision at the discretion of
the supervising physician or the
appropriate nonphysician practitioner.
Initiation means the beginning portion
of the nonsurgical extended duration
therapeutic service which ends when
the patient is stable and the supervising
physician or the appropriate
nonphysician practitioner determines
that the remainder of the service can be
delivered safely under general
supervision. During a Public Health
Emergency, as defined in § 400.200 of
this chapter, Medicare requires a
minimum level of general supervision
for the entire service; and
*
*
*
*
*
9. Section 410.28 is amended by
revising paragraph (e)(1) to read as
follows:
■
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
§ 410.28 Hospital or CAH diagnostic
services furnished to outpatients:
Conditions.
*
*
*
*
*
(e) * * *
(1) For services furnished directly or
under arrangement in the hospital or in
an on-campus or off-campus outpatient
department of the hospital, as defined in
§ 413.65 of this chapter, ‘‘direct
supervision’’ means that the physician
must be immediately available to
furnish assistance and direction
throughout the performance of the
procedure. It does not mean that the
physician must be present in the room
where the procedure is performed.
During a Public Health Emergency, as
defined in § 400.200 of this chapter, the
presence of the physician includes
virtual presence through audio/video
real-time communications technology
when use of such technology is
indicated to reduce exposure risks for
the beneficiary or health care provider.
*
*
*
*
*
■ 10. Section 410.32 is amended by
revising paragraph (b)(3)(ii) to read as
follows:
§ 410.32 Diagnostic x-ray tests, diagnostic
laboratory tests, and other diagnostic tests:
Conditions.
*
*
*
*
*
(b) * * *
(3) * * *
(ii) Direct supervision in the office
setting means the physician must be
present in the office suite and
immediately available to furnish
assistance and direction throughout the
performance of the procedure. It does
not mean that the physician must be
present in the room when the procedure
is performed. During a PHE, as defined
in § 400.200 of this chapter, the
presence of the physician includes
virtual presence through audio/video
real-time communications technology
when use of such technology is
indicated to reduce exposure risks for
the beneficiary or health care provider.
*
*
*
*
*
■ 11. Section 410.40 is amended by
adding paragraph (f)(5) to read as
follows:
§ 410.40
Coverage of ambulance services.
*
*
*
*
*
(f) * * *
(5) During a Public Health Emergency,
as defined in § 400.200 of this chapter,
a ground ambulance transport from any
point of origin to a destination that is
equipped to treat the condition of the
patient consistent with any applicable
state or local Emergency Medical
Services protocol that governs the
destination location. Such destinations
PO 00000
Frm 00058
Fmt 4701
Sfmt 4700
include, but are not limited to,
alternative sites determined to be part of
a hospital, critical access hospital or
skilled nursing facility, community
mental health centers, federally
qualified health centers, rural health
clinics, physician offices, urgent care
facilities, ambulatory surgical centers,
any location furnishing dialysis services
outside of an ESRD facility when an
ESRD facility is not available, and the
beneficiary’s home.
*
*
*
*
*
■ 12. Section 410.67(b) is amended in
paragraphs (3) and (4) of the definition
of ‘‘Opioid use disorder treatment
service’’ by adding a sentence at the end
of each paragraph to read as follows:
§ 410.67 Medicare coverage and payment
of Opioid use disorder treatment services
furnished by Opioid treatment programs.
*
*
*
*
*
(b) * * *
Opioid use disorder treatment service
* * *
(3) * * * During a Public Health
Emergency, as defined in § 400.200 of
this chapter, where audio/video
communication technology is not
available to the beneficiary, the
counseling services may be furnished
using audio-only telephone calls if all
other applicable requirements are met.
(4) * * * During a Public Health
Emergency, as defined in § 400.200 of
this chapter, where audio/video
communication technology is not
available to the beneficiary, the therapy
services may be furnished using audioonly telephone calls if all other
applicable requirements are met.
*
*
*
*
*
■ 13. Section 410.78 is amended by—
■ a. Adding paragraph (a)(3)(i) and
reserved paragraph (a)(3)(ii); and
■ b. Revising paragraph (b) introductory
text.
The additions and revision read as
follows:
§ 410.78
Telehealth services.
(a) * * *
(3) * * *
(i) Exception. For the duration of the
Public Health Emergency as defined in
§ 400.200 of this chapter, Interactive
telecommunications system means
multimedia communications equipment
that includes, at a minimum, audio and
video equipment permitting two-way,
real-time interactive communication
between the patient and distant site
physician or practitioner.
(ii) [Reserved]
*
*
*
*
*
(b) General rule. Medicare Part B pays
for covered telehealth services included
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
on the telehealth list when furnished by
an interactive telecommunications
system if the following conditions are
met, except that for the duration of the
Public Health Emergency as defined in
§ 400.200 of this chapter, Medicare Part
B pays for office and other outpatient
visits, professional consultation,
psychiatric diagnostic interview
examination, individual psychotherapy,
pharmacologic management and end
stage renal disease related services
included in the monthly capitation
payment furnished by an interactive
telecommunications system if the
following conditions are met:
*
*
*
*
*
■ 14. Section 410.79 is amended by
adding paragraph (e) to read as follows:
§ 410.79 Medicare Diabetes Prevention
Program expanded model: Conditions of
coverage.
jbell on DSKJLSW7X2PROD with RULES2
*
*
*
*
*
(e) MDPP expanded model emergency
policy. (1) Notwithstanding paragraphs
(a) through (d) of this section, the
policies described in this paragraph (e)
apply during the Public Health
Emergency (PHE), as defined in
§ 400.200 of this chapter.
(2) MDPP requirement changes
described in paragraph (e)(1) of this
section are applicable to:
(i) Organizations that are enrolled as
an MDPP supplier as defined in
paragraph (b) of this section, as of
March 1, 2020; and
(ii) MDPP beneficiaries as defined in
paragraph (b) of this section, who are
receiving the MDPP set of services as of
March 1, 2020.
(3) The following changes apply
under this paragraph (e):
(i) The in-person attendance
requirements of paragraphs (c)(1)(ii)(A),
(c)(1)(iii)(A), and (c)(3)(ii) of this section
are waived. MDPP suppliers shall not
start new cohorts with MDPP
beneficiaries who are unable to attend
the first core session in-person;
(ii) The limit described in paragraphs
(d)(2) and (d)(3)(i) and (ii) of this section
to the number of virtual make-up
sessions is waived for MDPP suppliers
with capabilities to provide services
virtually so long as the provision of
virtual services complies with the
following:
(A) The curriculum furnished during
the virtual make-up session must
address the same CDC-approved DPP
curriculum topic as the regularly
scheduled session;
(B) The MDPP supplier furnishes to
the MDPP beneficiary a maximum of
one session on the same day as a
regularly scheduled session;
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
(C) The MDPP supplier furnishes to
the MDPP beneficiary a maximum of
one virtual make-up session per week;
(D) Virtual make-up sessions must be
furnished in a manner consistent with
the DPRP standards for virtual sessions;
(E) Virtual make-up sessions can only
be furnished to achieve attendance goals
and cannot be furnished to achieve
weight-loss goals;
(F) An MDPP supplier can only offer
virtual make-up sessions upon an
individual MDPP beneficiary’s request;
and
(G) An MDPP supplier can offer to an
MDPP beneficiary:
(1) No more than 15 virtual make-up
sessions offered weekly during the core
session period, months 1 through 6 of
the MDPP services period;
(2) No more than 6 virtual make-up
sessions offered monthly during the
core maintenance session interval
periods, months 7 through 12 of the
MDPP services period; and
(3) No more than 12 virtual make-up
sessions offered monthly during the
ongoing maintenance session interval
periods, months 13 through 24;
(iii) The once per lifetime requirement
as described in paragraph (c)(1)(i)(B) of
this section is waived to permit MDPP
beneficiaries whose sessions were
paused or cancelled due to the PHE to
obtain the set of MDPP services more
than once per lifetime by electing to
restart the MDPP set of services or
resume with the most recent attendance
session of record;
(iv) The minimum weight loss
requirements for beneficiary eligibility
in the ongoing maintenance session
intervals described in paragraphs
(c)(1)(ii)(B) and (c)(1)(iii)(B) of this
section are waived; and
(v) MDPP suppliers may pause or
delay the delivery of the MDPP set of
services and subsequently resume
services on a delayed schedule. The
time periods and intervals must be
consistent with the MDPP requirements
as described in paragraphs (c)(1)(i)(B),
(c)(1)(ii)(A), (c)(1)(iii)(A), (c)(2)(i)(A) and
(B), and (c)(3)(i) and (ii) of this section.
PART 412—PROSPECTIVE PAYMENT
SYSTEMS FOR INPATIENT HOSPITAL
SERVICES
15. The authority citation for part 412
continues to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh.
16. Section 412.29 is amended by
revising paragraph (e) to read as follows:
■
§ 412.29 Classification criteria for payment
under the inpatient rehabilitation facility
prospective payment system.
*
PO 00000
*
*
Frm 00059
*
Fmt 4701
*
Sfmt 4700
19287
(e) Have in effect a procedure to
ensure that patients receive close
medical supervision, as evidenced by at
least 3 face-to-face visits per week by a
licensed physician with specialized
training and experience in inpatient
rehabilitation to assess the patient both
medically and functionally, as well as to
modify the course of treatment as
needed to maximize the patient’s
capacity to benefit from the
rehabilitation process, except that
during a Public Health Emergency, as
defined in § 400.200 of this chapter,
such visits may be conducted using
telehealth services (as defined in section
1834(m)(4)(F) of the Act).
*
*
*
*
*
■ 17. Section 412.622 is amended by
revising paragraphs (a)(3)(iv) and
(a)(4)(ii) introductory text to read as
follows:
§ 412.622
Basis of payment.
(a) * * *
(3) * * *
(iv) Requires physician supervision by
a rehabilitation physician. The
requirement for medical supervision
means that the rehabilitation physician
must conduct face-to-face visits with the
patient at least 3 days per week
throughout the patient’s stay in the IRF
to assess the patient both medically and
functionally, as well as to modify the
course of treatment as needed to
maximize the patient’s capacity to
benefit from the rehabilitation process,
except that during a Public Health
Emergency, as defined in § 400.200 of
this chapter, such visits may be
conducted using telehealth services (as
defined in section 1834(m)(4)(F) of the
Act). The post-admission physician
evaluation described in paragraph
(a)(4)(ii) of this section may count as
one of the face-to-face visits.
(4) * * *
(ii) A post-admission physician
evaluation that meets all of the
following requirements, except for the
duration of the Public Health
Emergency, as defined in § 400.200 of
this chapter—
*
*
*
*
*
PART 414—PAYMENT FOR PART B
MEDICAL AND OTHER HEALTH
SERVICES
18. The authority citation for part 414
continues to read as follows:
■
Authority: 42 U.S.C. 1302, 1395hh, and
1395rr(b)(l).
19. Section 414.1380 is amended by—
a. Revising paragraphs (c)(2)(i)(A)(6)
and (c)(2)(i)(C) introductory text; and
■ b. Adding paragraph (c)(2)(i)(C)(11).
■
■
E:\FR\FM\06APR2.SGM
06APR2
19288
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
The revisions and addition read as
follows:
§ 414.1380
Scoring.
jbell on DSKJLSW7X2PROD with RULES2
*
*
*
*
*
(c) * * *
(2) * * *
(i) * * *
(A) * * *
(6) Beginning with the 2020 MIPS
payment year, for the quality, cost, and
improvement activities performance
categories, the MIPS eligible clinician
demonstrates through an application
submitted to CMS that they were subject
to extreme and uncontrollable
circumstances that prevented the
clinician from collecting information
that the clinician would submit for a
performance category or submitting
information that would be used to score
a performance category for an extended
period of time. Beginning with the 2021
MIPS payment year, in the event that a
MIPS eligible clinician submits data for
the quality, cost, or improvement
activities performance categories, the
scoring weight specified in paragraph
(c)(1) of this section will be applied and
its weight will not be redistributed,
unless an exception applies. Exception:
for the 2021 MIPS payment year only,
if a MIPS eligible clinician demonstrates
through an application submitted to
CMS that they have been adversely
affected by the Public Health Emergency
for the COVID–19 pandemic and also
submits data for the quality, cost, or
improvement activities performance
categories, the preceding sentence will
not apply.
*
*
*
*
*
(C) Under section 1848(o)(2)(D) of the
Act, a significant hardship exception or
other type of exception is granted to a
MIPS eligible clinician based on the
following circumstances for the
Promoting Interoperability performance
category. Except as provided in
paragraphs (c)(2)(i)(C)(10) and (11) of
this section, in the event that a MIPS
eligible clinician submits data for the
Promoting Interoperability performance
category, the scoring weight specified in
paragraph (c)(1) of this section will be
applied and its weight will not be
redistributed.
*
*
*
*
*
(11) For the 2021 MIPS payment year
only, the MIPS eligible clinician
demonstrates through an application
submitted to CMS that they have been
adversely affected by the Public Health
Emergency for the COVID–19 pandemic.
*
*
*
*
*
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
PART 415—SERVICES FURNISHED BY
PHYSICIANS IN PROVIDERS,
SUPERVISING PHYSICIANS IN
TEACHING SETTINGS, AND
RESIDENTS IN CERTAIN SETTINGS
20. The authority citation for part 415
continues to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh.
21. Section 415.172 is amended by
revising paragraphs (a) introductory
text, (a)(2), and (b) to read as follows:
■
§ 415.172 Physician fee schedule payment
for services of teaching physicians.
(a) General rule. If a resident
participates in a service furnished in a
teaching setting, physician fee schedule
payment is made only if a teaching
physician is present during the key
portion of any service or procedure for
which payment is sought. During the
Public Health Emergency, as defined in
§ 400.200 of this chapter, if a resident
participates in a service furnished in a
teaching setting, physician fee schedule
payment is made if a teaching physician
is present during the key portion of the
service using interactive
telecommunications technology for any
service or procedure for which payment
is sought.
*
*
*
*
*
(2) In the case of evaluation and
management services, the teaching
physician must be present during the
portion of the service that determines
the level of service billed. (However, in
the case of evaluation and management
services furnished in hospital outpatient
departments and certain other
ambulatory settings, the requirements of
§ 415.174 apply.) During a Public Health
Emergency, as defined in § 400.200 of
this chapter, the teaching physician may
be present during the portion of the
service that determines the level of
service billed using interactive
telecommunications technology.
(However, in the case of evaluation and
management services furnished in
hospital outpatient departments and
certain other ambulatory settings, the
requirements of § 415.174 apply.)
(b) Documentation. Except for
services furnished as set forth in
§§ 415.174 (concerning an exception for
services furnished in hospital outpatient
and certain other ambulatory settings),
415.176 (concerning renal dialysis
services), and 415.184 (concerning
psychiatric services), the medical
records must document the teaching
physician was present at the time the
service is furnished. The presence of the
teaching physician during procedures
and evaluation and management
services may be demonstrated by the
PO 00000
Frm 00060
Fmt 4701
Sfmt 4700
notes in the medical records made by
the physician or as provided in
§ 410.20(e) of this chapter. During a
Public Health Emergency, as defined in
§ 400.200 of this chapter, except for
services furnished as set forth in
§§ 415.174 (concerning an exception for
services furnished in hospital outpatient
and certain other ambulatory settings),
415.176 (concerning renal dialysis
services), and 415.184 (concerning
psychiatric services), the medical
records must document if the teaching
physician was physically present or if
the teaching physician was present
through interactive telecommunications
technology at the time the service is
furnished. The presence of the teaching
physician during procedures and
evaluation and management services
may be demonstrated by the notes in the
medical records made by the physician
or as provided in § 410.20(e) of this
chapter.
*
*
*
*
*
■ 22. Section 415.174 is amended by
adding paragraph (b) to read as follows:
§ 415.174 Exception: Evaluation and
management services furnished in certain
centers.
*
*
*
*
*
(b) During a Public Health Emergency,
as defined in § 400.200 of this chapter,
carriers may make physician fee
schedule payment for a service
furnished by a resident if the teaching
physician is present through interactive
telecommunications technology.
■ 23. Section 415.180 is revised to read
as follows:
§ 415.180 Teaching setting requirements
for the interpretation of diagnostic
radiology and other diagnostic tests.
(a) General rule. Physician fee
schedule payment is made for the
interpretation of diagnostic radiology
and other diagnostic tests if the
interpretation is performed or reviewed
by a physician other than a resident.
During a Public Health Emergency, as
defined in § 400.200 of this chapter,
physician fee schedule payment may
also be made for the interpretation of
diagnostic radiology and other
diagnostic tests if the interpretation is
performed by a resident when the
teaching physician is present through
interactive telecommunications
technology.
(b) [Reserved]
■ 24. Section 415.184 is revised to read
as follows:
§ 415.184
Psychiatric services.
To qualify for physician fee schedule
payment for psychiatric services
furnished under an approved GME
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
program, the physician must meet the
requirements of §§ 415.170 and 415.172,
including documentation, except that
the requirement for the presence of the
teaching physician during the service in
which a resident is involved may be met
by observation of the service by use of
a one-way mirror, video equipment, or
similar device. During a Public Health
Emergency, as defined in § 400.200 of
this chapter, the requirement for the
presence of the teaching physician
during the service in which a resident
is involved may be met by direct
supervision by interactive
telecommunications technology.
■ 25. Section 415.208 is amended by
revising paragraph (b)(2) introductory
text to read as follows:
§ 415.208 Services of moonlighting
residents.
*
*
*
*
*
(b) * * *
(2) Services of residents that are not
related to their approved GME programs
and are performed in an outpatient
department or emergency department of
a hospital in which they have their
training program are covered as
physician services and payable under
the physician fee schedule if criteria in
paragraphs (b)(2)(i) through (iii) of this
section are met. During a Public Health
Emergency, as defined in § 400.200 of
this chapter, the services of residents
that are not related to their approved
GME programs and are furnished to
inpatients of a hospital in which they
have their training program are covered
as physician services and payable under
the physician fee schedule if criteria in
paragraphs (b)(2)(i) through (iii) of this
section are met.
*
*
*
*
*
PART 417—HEALTH MAINTENANCE
ORGANIZATIONS, COMPETITIVE
MEDICAL PLANS, AND HEALTH CARE
PREPAYMENT PLANS
26. The authority citation for part 417
is revised to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh,
and 300e, 300e–5, and 300e–9, and 31 U.S.C.
9701.
27. Section 417.472 is amended by
revising paragraphs (i) and (j) to read as
follows:
■
§ 417.472
Basic contract requirements.
jbell on DSKJLSW7X2PROD with RULES2
*
*
*
*
*
(i) HMOs and CMPs. The HMO or
CMP must comply with the
requirements at § 422.152(b)(5) and (6)
of this chapter.
(j) Coordinated care and cost
contracts. Subject to paragraph (i) of this
section, all coordinated care contracts
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
(including local and regional PPOs,
contracts with exclusively SNP benefit
packages, private fee-for-service
contracts, and MSA contracts), and all
cost contracts under section 1876 of the
Act, with 600 or more enrollees in July
of the prior year, must contract with
approved Medicare Consumer
Assessment of Healthcare Providers and
Systems (CAHPS) survey vendors to
conduct the Medicare CAHPS
satisfaction survey of Medicare plan
enrollees in accordance with CMS
specifications and submit the survey
data to CMS.
*
*
*
*
*
palliation and management of a
patients’ terminal illness and related
conditions. The use of such technology
in furnishing services must be included
on the plan of care, meet the
requirements at § 418.56, and must be
tied to the patient-specific needs as
identified in the comprehensive
assessment and the plan of care must
include a description of how the use of
such technology will help to achieve the
goals outlined on the plan of care.
PART 421—MEDICARE CONTRACTING
31. The authority citation for part 421
is revised to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh.
PART 418—HOSPICE CARE
28. The authority citation for part 418
continues to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh.
29. Section 418.22 is amended by—
a. Redesignating the text of paragraph
(a)(4) as paragraph (a)(4)(i); and
■ b. Adding paragraph (a)(4)(ii).
The addition reads as follows:
■
■
§ 418.22
Certification of terminal illness.
(a) * * *
(4) * * *
(ii) During a Public Health
Emergency, as defined in § 400.200 of
this chapter, if the face-to-face
encounter conducted by a hospice
physician or hospice nurse practitioner
is for the sole purpose of hospice
recertification, such encounter may
occur via a telecommunications
technology and is considered an
administrative expense.
Telecommunications technology means
the use of interactive multimedia
communications equipment that
includes, at a minimum, the use of
audio and video equipment permitting
two-way, real-time interactive
communication between the patient and
the distant site hospice physician or
hospice nurse practitioner.
*
*
*
*
*
■ 30. Section 418.204 is amended by
adding paragraph (d) to read as follows:
§ 418.204
Special coverage requirements.
*
*
*
*
*
(d) Use of technology in furnishing
services during a Public Health
Emergency. When a patient is receiving
routine home care, during a Public
Health Emergency as defined in
§ 400.200 of this chapter, hospices may
provide services via a
telecommunications system if it is
feasible and appropriate to do so to
ensure that Medicare patients can
continue receiving services that are
reasonable and necessary for the
PO 00000
Frm 00061
Fmt 4701
Sfmt 4700
19289
32. Section 421.214 is amended by—
a. Revising paragraphs (b) and (c)
introductory text;
■ b. Adding paragraph (d)(5);
■ c. Revising paragraph (f)(1)(i); and
■ d. Adding paragraph (j).
The revisions and additions read as
follows:
■
■
§ 421.214 Advance payments to suppliers
furnishing items and services under Part B.
*
*
*
*
*
(b) Definition. As used in this section,
advance payment means a conditional
partial payment made by the contractor
in response to a claim that it is unable
to process within established time limits
except as provided in paragraph (j) of
this section.
(c) When advance payments may be
made. Unless otherwise qualified under
paragraph (j) of this section, an advance
payment may be made if all of the
following conditions are met:
*
*
*
*
*
(d) * * *
(5) Is in bankruptcy.
*
*
*
*
*
(f) * * *
(1) * * *
(i) Unless otherwise qualified under
paragraph (j) of this section, a contractor
must calculate an advance payment for
a particular claim at no more than 80
percent of the anticipated payment for
that claim based upon the historical
assigned claims payment data as
defined in paragraph (f)(1)(ii) of this
section for claims paid to the supplier.
For suppliers qualifying and approved
for advance payments under paragraph
(j) of this section, a contractor may
calculate an advance payment for a
particular claim at up to 100 percent of
the anticipated payment for that claim
based upon the historical assigned
claims payment data as defined in
paragraph (f)(1)(ii) of this section for
claims paid to the supplier.
*
*
*
*
*
E:\FR\FM\06APR2.SGM
06APR2
19290
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
(j) Advanced payments in exceptional
circumstances. CMS may approve, in
writing to the contractor, the making of
advance payments during the period of
a Public Health Emergency, as defined
in § 400.200 of this chapter, or during
the period under a Presidential Disaster
Declaration, under the following
exceptional conditions:
(1) The contractor is unable to process
the claim timely, or is at risk of being
untimely in processing the claim; or
(2) When the supplier has
experienced a temporary delay in
preparing and submitting bills to the
contractor beyond its normal billing
cycle.
PART 422—MEDICARE ADVANTAGE
PROGRAM
33. The authority citation for part 422
continues to read as follows:
■
Authority: 42 U.S.C. 1302 and 1395hh.
34. Section 422.152 is amended by
adding paragraph (b)(6) to read as
follows:
■
§ 422.152
Quality improvement program.
*
*
*
*
*
(b) * * *
(6) For 2021 Star Ratings only, MA
organizations are not required to submit
HEDIS and CAHPS data that would
otherwise be required for the calculation
of the 2021 Star Ratings.
*
*
*
*
*
■ 35. Section 422.164 is amended by
adding paragraph (i) to read as follows:
§ 422.164 Adding, updating, and removing
measures.
*
*
*
*
(i) Special rule for 2021 Star Ratings
only. In the event that the threat to
health and safety posed by the COVID–
19 pandemic compromises the quality
of the data, or ability to validate such
data for all plans used to calculate a
particular measure, CMS will substitute
and use the 2021 Star Ratings measure
score and Star Rating with the 2020 Star
Ratings measure score and Star Rating.
■ 36. Section 422.166 is amended—
■ a. By revising paragraph (a)(2)(i);
■ b. In paragraph (f)(1)(i), by adding a
sentence to the end of the paragraph;
and
■ c. By adding paragraphs (g)(3) and (j).
The revision and additions read as
follows:
jbell on DSKJLSW7X2PROD with RULES2
*
§ 422.166
Calculation of Star Ratings.
(a) * * *
(2) * * *
(i) The method maximizes differences
across the star categories and minimizes
the differences within star categories
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
using mean resampling with the
hierarchal clustering of the current
year’s data. Effective for the Star Ratings
issued in October 2022 and subsequent
years, CMS will add a guardrail so that
the measure-threshold-specific cut
points for non-CAHPS measures do not
increase or decrease more than the value
of the cap from one year to the next. The
cap is equal to 5 percentage points for
measures having a 0 to 100 scale
(absolute percentage cap) or 5 percent of
the restricted range for measures not
having a 0 to 100 scale (restricted range
cap). New measures that have been in
the Part C and Part D Star Rating
program for 3 years or less use the
hierarchal clustering methodology with
mean resampling with no guardrail for
the first 3 years in the program.
*
*
*
*
*
(f) * * *
(1) * * *
(i) * * * For the 2022 Star Ratings
only, since all contracts may have the
improvement measure(s) excluded in
the determination of their highest rating
and summary rating(s), each contract’s
weighted variance and weighted mean
are calculated both with and without
the improvement measures.
*
*
*
*
*
(g) * * *
(3) For 2022 Star Ratings only, CMS
runs the calculations twice for the
highest rating for each contract-type
(overall rating for MA–PD contracts and
Part C summary rating for MA-only
contracts) and Part C summary rating for
MA–PDs with all applicable
adjustments (CAI and the reward factor),
once including the improvement
measure(s) and once without including
the improvement measure(s). In
deciding whether to include the
improvement measures in a contract’s
highest and summary rating(s), CMS
applies the following rules:
(i) For MA–PDs and MA-only
contracts, a comparison of the highest
rating with and without the
improvement measure is done. The
higher rating is used for the highest
rating.
(ii) For MA–PDs, a comparison of the
Part C summary rating with and without
the improvement measure is done. The
higher rating is used for the summary
rating.
*
*
*
*
*
(j) Special rules for 2021 and 2022
Star Ratings only. (1) For the 2021 Star
Ratings:
(i) The measures calculated based on
HEDIS data are calculated based on data
from the 2018 performance period.
(ii) The measures calculated based on
CAHPS data are calculated based on
PO 00000
Frm 00062
Fmt 4701
Sfmt 4700
survey data collected from March
through May 2019.
(iii) The measure-level change score
calculation described at
§ 422.164(f)(4)(i) is not applied for
HEDIS and CAHPS measures and the
measure-level change score used for the
2020 Star Ratings is applied in its place
for all HEDIS and CAHPS-based
measures.
(iv) The provisions of § 422.164(g)(1)
and (2) are not applied for the failure to
submit HEDIS and CAHPS-based
measures.
(v) In the event that there are
extraordinary circumstances resulting
from the COVID–19 pandemic that
compromise CMS resources to the
extent that CMS cannot calculate or
issue 2021 Star Ratings by October 2020,
CMS will adopt the 2020 Star Ratings as
the 2021 Star Ratings.
(2) For the 2022 Star Ratings:
(i) In the event that the threat to
health and safety posed by the COVID–
19 pandemic compromises the ability to
collect the Health Outcomes Survey in
2020, CMS will adopt the 2021 Star
Ratings and measure scores for the
measures that come from the Health
Outcomes Survey as the 2022 Star
Ratings and measures scores for the
measures that come from the Health
Outcomes Survey.
(ii) [Reserved]
■ 37. Section 422.252 is amended by
revising the definition of ‘‘New MA
plan’’ to read as follows:
§ 422.252
Terminology.
*
*
*
*
*
New MA plan means a MA contract
offered by a parent organization that has
not had another MA contract in the
previous 3 years. For purposes of 2022
quality bonus payments based on 2021
Star Ratings only, new MA plan means
an MA contract offered by a parent
organization that has not had another
MA contract in the previous 4 years.
*
*
*
*
*
PART 423—VOLUNTARY MEDICARE
PRESCRIPTION DRUG BENEFIT
38. The authority for part 423
continues to read as follows:
■
Authority: 42 U.S.C. 1302, 1395w–101
through 1395w–152, and 1395hh.
39. Section 423.156 is amended by
adding a sentence at the end of the
paragraph to read as follows:
■
§ 423.156
Consumer satisfaction surveys.
* * * Part D sponsors are not
required to submit CAHPS data that
would otherwise be required for the
calculation of the 2021 Star Ratings.
E:\FR\FM\06APR2.SGM
06APR2
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
40. Section 423.182 is amended by
adding paragraph (c)(3) to read as
follows:
■
§ 423.182 Part D Prescription Drug Plan
Quality Rating System.
*
*
*
*
*
(c) * * *
(3) For 2021 Star Ratings only, Part D
sponsors are not required to submit
CAHPS data that would otherwise be
required for the calculation of the 2021
Star Ratings.
■ 41. Section 423.184 is amended by
adding paragraph (i) to read as follows:
§ 423.184 Adding, updating, and removing
measures.
*
*
*
*
*
(i) Special rule for 2021 Star Ratings
only. In the event that the threat to
health and safety posed by the COVID–
19 pandemic compromises the quality
of the data, or ability to validate such
data, for all plans, used to calculate a
particular measure, CMS will substitute
and use the 2021 Star Ratings measure
score and Star Ratings with the 2020
Star Ratings measure score and Star
Rating.
■ 42. Section 423.186 is amended—
■ a. By revising paragraph (a)(2)(i);
■ b. In paragraph (f)(1)(i), by adding a
sentence to the end of the paragraph;
and
■ c. By adding paragraphs (g)(3) and (j).
The revision and additions read as
follows:
jbell on DSKJLSW7X2PROD with RULES2
§ 423.186
Calculation of Star Ratings.
(a) * * *
(2) * * *
(i) The method maximizes differences
across the star categories and minimizes
the differences within star categories
using mean resampling with the
hierarchal clustering of the current
year’s data. Effective for the Star Ratings
issued in October 2022 and subsequent
years, CMS will add a guardrail so that
the measure-threshold-specific cut
points for non-CAHPS measures do not
increase or decrease more than the value
of the cap from one year to the next. The
cap is equal to 5 percentage points for
measures having a 0 to 100 scale
(absolute percentage cap) or 5 percent of
the restricted range for measures not
having a 0 to 100 scale (restricted range
cap). New measures that have been in
the Part C and D Star Rating program for
3 years or less use the hierarchal
clustering methodology with mean
resampling with no guardrail for the
first 3 years of the program.
*
*
*
*
*
(f) * * *
(1) * * *
(i) * * * For the 2022 Star Ratings
only, since all contracts may have the
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
improvement measure(s) excluded in
the determination of their highest rating
and summary rating(s), each contract’s
weighted variance and weighted mean
are calculated both with and without
the improvement measures.
*
*
*
*
*
(g) * * *
(3) For 2022 Star Ratings only, CMS
runs the calculations twice for the
highest rating for each contract-type
(overall rating for MA–PD contracts and
Part D summary rating for PDPs) and
Part D summary rating for MA–PDs with
all applicable adjustments (CAI and the
reward factor), once including the
improvement measure(s) and once
without including the improvement
measure(s). In deciding whether to
include the improvement measures in a
contract’s highest and summary
rating(s), CMS applies the following
rules:
(i) For MA–PDs and PDPs, a
comparison of the highest rating with
and without the improvement measure
is done. The higher rating is used for the
highest rating.
(ii) For MA–PDs, a comparison of the
Part D summary rating with and without
the improvement measure is done. The
higher rating is used for the summary
rating.
*
*
*
*
*
(j) Special rules for 2021 Star Ratings
only. (1) For the 2021 Star Ratings:
(i) The measures calculated based on
CAHPS data are calculated based on
survey data collected from March
through May 2019.
(ii) The measure-level change score
calculation described at
§ 423.184(f)(4)(i) is not applied for
CAHPS measures and the measure-level
change score used for the 2020 Star
Ratings is applied in its place for all
CAHPS-based measures.
(iii) The provisions of § 423.184(g)(2)
are not applied for failure to submit
CAHPS-based measures.
(iv) In the event that there are
extraordinary circumstances resulting
from the COVID–19 pandemic that
compromise CMS resources to the
extent that CMS cannot calculate or
issue 2021 Star Ratings by October 2020,
CMS will adopt the 2020 Star Ratings as
the 2021 Star Ratings.
(2) [Reserved]
PART 425—MEDICARE SHARED
SAVINGS PROGRAM
43. The authority citation for part 425
continues to read as follows:
■
Authority: 42 U.S.C. 1302, 1306, 1395hh,
and 1395jjj.
PO 00000
Frm 00063
Fmt 4701
Sfmt 4700
§ 425.502
19291
[Amended]
44. Section 425.502 is amended in
paragraph (f) introductory text by
removing the phrase ‘‘if the quality
reporting period is not extended’’.
■
PART 440—SERVICES: GENERAL
PROVISIONS
45. The authority citation for part 440
is revised to read as follows:
■
Authority: 42 U.S.C. 1302.
46. Section 440.70 is amended by
revising paragraphs (a)(2), (b)(1)(ii), and
(b)(3)(iii) and (iv) to read as follows:
■
§ 440.70
Home health services.
(a) * * *
(2) On his or her physician’s orders as
part of a written plan of care that the
physician reviews every 60 days for
services described in paragraphs (b)(1),
(2), and (4) of this section, or, for the
period of the Public Health Emergency,
as defined in § 400.200 of this chapter,
orders written by an other licensed
practitioner of the healing arts acting
within the scope of practice authorized
under State law, as part of a written
plan of care that the ordering
practitioner reviews every 60 days for
services described in paragraphs (b)(1),
(2), and (4) of this section.
(b) * * *
(1) * * *
(ii) Receives written orders from the
patient’s physician or, for the period of
the Public Health Emergency, as defined
in § 400.200 of this chapter, other
licensed practitioner of the healing arts
acting within the scope of practice
authorized under State law;
*
*
*
*
*
(3) * * *
(iii) A beneficiary’s need for medical
supplies, equipment, and appliances
must be reviewed by a physician or, for
the period of the Public Health
Emergency, as defined in § 400.200 of
this chapter, an other licensed
practitioner of the healing arts acting
within the scope of practice authorized
under State law, annually.
(iv) Frequency of further physician or,
for the period of the Public Health
Emergency, as defined in § 400.200 of
this chapter, an other licensed
practitioner review of a beneficiary’s
continuing need for the items is
determined on a case-by-case basis
based on the nature of the item
prescribed.
*
*
*
*
*
PART 482—CONDITIONS OF
PARTICIPATION FOR HOSPITALS
47. The authority citation for part 482
continues to read as follows:
■
E:\FR\FM\06APR2.SGM
06APR2
19292
Federal Register / Vol. 85, No. 66 / Monday, April 6, 2020 / Rules and Regulations
Authority: 42 U.S.C. 1302, 1395hh, 1395rr,
and 1395lll unless otherwise noted.
PART 510—COMPREHENSIVE CARE
FOR JOINT REPLACEMENT MODEL
48. Section 482.61 is amended by
revising paragraph (d) to read as
follows:
■
■
49. The authority citation of part 510
is revised to read as follows:
Authority: 42 U.S.C. 1302, 1315a, and
1395hh.
§ 482.61 Condition of participation:
Special medical record requirements for
psychiatric hospitals.
*
*
*
*
(d) Standard: Recording progress.
Progress notes for the patient must be
documented, in accordance with
applicable State scope-of-practice laws
and hospital policies, by the following
qualified practitioners: Doctor(s) of
medicine or osteopathy, or other
licensed practitioner(s), who is
responsible for the care of the patient;
nurse(s) and social worker(s) (or social
service staff) involved in the care of the
patient; and, when appropriate, others
significantly involved in the patient’s
active treatment modalities.
The frequency of progress notes is
determined by the condition of the
patient but must be recorded at least
weekly for the first 2 months and at
least once a month thereafter and must
contain recommendations for revisions
in the treatment plan as indicated, as
well as precise assessment of the
patient’s progress in accordance with
the original or revised treatment plan.
*
*
*
*
*
jbell on DSKJLSW7X2PROD with RULES2
*
VerDate Sep<11>2014
17:59 Apr 03, 2020
Jkt 250001
50. Section 510.2 is amended by
revising the definition of ‘‘Performance
year’’ to read as follows:
■
§ 510.2
Definitions.
*
*
*
*
*
Performance year means one of the
years in which the CJR model is being
tested. Performance years for the model
correlate to calendar years with the
exceptions of performance year 1, which
is April 1, 2016 through December 31,
2016 and performance year 5, which is
January 1, 2020 through March 31, 2021.
*
*
*
*
*
§ 510.200
[Amended]
51. Section 510.200 is amended in
paragraph (a) by removing the phrase
‘‘before December 31, 2020’’ and adding
in its place the phrase ‘‘before March 31,
2021’’.
■ 52. Section 510.305 is amended by
adding paragraphs (k)(3) and (4) to read
as follows:
■
§ 510.305 Determination of the NPRA and
reconciliation process.
*
*
*
*
*
(k) * * *
(3) The following is an extreme and
uncontrollable circumstances
PO 00000
Frm 00064
Fmt 4701
Sfmt 9990
adjustment for 2019 Novel Coronavirus
(previously referred to as 2019–nCoV,
now as COVID–19):
(i) The episode spending adjustments
specified in paragraph (k)(4) of this
section apply for a participant hospital
that has a CCN primary address that is
located in an emergency area during an
emergency period, as those terms are
defined in section 1135(g) of the Act, for
which the Secretary issued a waiver or
modification of requirements under
section 1135 of the Act on March 13,
2020.
(ii) [Reserved]
(4) For a fracture or non-fracture
episode with a date of admission to the
anchor hospitalization that is on or
within 30 days before the date that the
emergency period (as defined in section
1135(g) of the Act) begins or that occurs
through the termination of the
emergency period (as described in
section 1135(e) of the Act), actual
episode payments are capped at the
target price determined for that episode
under § 510.300.
Dated: March 24, 2020.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
Dated: March 26, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2020–06990 Filed 3–31–20; 4:15 pm]
BILLING CODE 4120–01–P
E:\FR\FM\06APR2.SGM
06APR2
]]>Agencies
[Federal Register Volume 85, Number 66 (Monday, April 6, 2020)]
[Rules and Regulations]
[Pages 19230-19292]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06990]
[[Page 19229]]
Vol. 85
Monday,
No. 66
April 6, 2020
Part II
Department of Health and Human Services
-----------------------------------------------------------------------
Centers for Medicare and Medicaid
-----------------------------------------------------------------------
42 CFR Parts 400, 405, 409, et al.
Medicare and Medicaid Programs; Policy and Regulatory Revisions in
Response to the COVID-19 Public Health Emergency; Interim Final Rule
Federal Register / Vol. 85 , No. 66 / Monday, April 6, 2020 / Rules
and Regulations
[[Page 19230]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Parts 400, 405, 409, 410, 412, 414, 415, 417, 418, 421, 422,
423, 425, 440, 482, and 510
[CMS-1744-IFC]
RIN 0938-AU31
Medicare and Medicaid Programs; Policy and Regulatory Revisions
in Response to the COVID-19 Public Health Emergency
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Interim final rule with comment period.
-----------------------------------------------------------------------
SUMMARY: This interim final rule with comment period (IFC) gives
individuals and entities that provide services to Medicare
beneficiaries needed flexibilities to respond effectively to the
serious public health threats posed by the spread of the 2019 Novel
Coronavirus (COVID-19). Recognizing the urgency of this situation, and
understanding that some pre-existing Medicare payment rules may inhibit
innovative uses of technology and capacity that might otherwise be
effective in the efforts to mitigate the impact of the pandemic on
Medicare beneficiaries and the American public, we are changing
Medicare payment rules during the Public Health Emergency (PHE) for the
COVID-19 pandemic so that physicians and other practitioners, home
health and hospice providers, inpatient rehabilitation facilities,
rural health clinics (RHCs), and federally qualified health centers
(FQHCs) are allowed broad flexibilities to furnish services using
remote communications technology to avoid exposure risks to health care
providers, patients, and the community. We are also altering the
applicable payment policies to provide specimen collection fees for
independent laboratories collecting specimens from beneficiaries who
are homebound or inpatients (not in a hospital) for COVID-19 testing.
We are also expanding, on an interim basis, the list of destinations
for which Medicare covers ambulance transports under Medicare Part B.
In addition, we are making programmatic changes to the Medicare
Diabetes Prevention Program (MDPP) and the Comprehensive Care for Joint
Replacement (CJR) Model in light of the PHE, and program-specific
requirements for the Quality Payment Program to avoid inadvertently
creating incentives to place cost considerations above patient safety.
This IFC will modify the calculation of the 2021 and 2022 Part C and D
Star Ratings to address the expected disruption to data collection and
measure scores posed by the COVID-19 pandemic and also to avoid
inadvertently creating incentives to place cost considerations above
patient safety. This rule also amends the Medicaid home health
regulations to allow other licensed practitioners to order home health
services, for the period of this PHE for the COVID-19 pandemic in
accordance with state scope of practice laws. We are also modifying our
under arrangements policy during the PHE for the COVID-19 pandemic so
that hospitals are allowed broader flexibilities to furnish inpatient
services, including routine services outside the hospital.
DATES:
Effective date: These regulations are effective on March 31, 2020.
Applicability date: These regulations are applicable beginning on
March 1, 2020.
Comment date: To be assured consideration, comments must be
received at one of the addresses provided below, no later than 5 p.m.
on June 1, 2020.
ADDRESSES: In commenting, please refer to file code CMS-1744-IFC.
Comments, including mass comment submissions, must be submitted in one
of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-1744-IFC, P.O. Box 8016,
Baltimore, MD 21244-8016.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-1744-IFC, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Jamie Hermansen, (410) 786-2064, for
general information, contact one of the following:
[email protected], for issues related to telehealth
services, and communication technology-based services; frequency limits
on subsequent care services in inpatient and non-facility settings,
critical care consultations, required ``hands-on'' visits for ESRD
monthly capitation payments; removal of restrictions on technology, and
supervision of interactive telecommunications technology; clinical
laboratory fee schedule; services furnished by opioid treatment
programs; payment under Medicare Part B for teaching physician services
and resident moonlighting; remote physiologic monitoring; physician
supervision flexibility for outpatient hospital services; payment for
office/outpatient evaluation and management visits; counting of
resident time at alternate locations; Ambulance Fee Schedule; rural
health clinic services; federally qualified health center services; and
inpatient hospital services furnished under arrangements outside of the
hospital. (Note this email address has an underscore ``_'' between
``HAPG'' and ``COVID-19''.)
[email protected], for issues related to the Medicare
inpatient rehabilitation facility benefits.
[email protected], for issues related to
national coverage determination and local coverage determination
requirements.
[email protected], for issues related to Medicare
Parts C and D quality rating system.
[email protected], for issues related to Medicaid
home health provider flexibility.
Hillary Loeffler, (410) 786-0456, [email protected], or
[email protected], for issues related to the Medicare home
health and hospice benefits.
Megan Hyde, (410) 786-3247, and Rebecca Cole, (410) 786-1589, for
issues related to Innovation Center Models, and alternative payment
model treatment under the Quality Payment Program.
Kim Spalding Bush, (410) 786-3232, and Fiona Larbi, (410) 786-7224,
for issues related to the Medicare Shared Savings Program.
Molly MacHarris, (410) 786-4461, for issues related to the Merit-
based Incentive Payment System (MIPS).
Heather Holsey, (410) 786-0028, for Comprehensive Care for Joint
Replacement model.
Amanda Rhee, (410) 786-3888, and Elizabeth Matthews, (410) 786-
5433, for Medicare Diabetes Prevention Program expanded model.
[[Page 19231]]
Brittany LaCouture, (410) 786-0481, for Alternative Payment Model
provisions of the Quality Payment Program.
CAPT Scott Cooper, USPHS, (410) 786-9496, for issues related to
special requirements for psychiatric hospitals.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following
website as soon as possible after they have been received: https://regulations.gov. Follow the search instructions on that website to view
public comments.
Table of Contents
I. Background
II. Provisions of the Interim Final Rule
A. Payment for Medicare Telehealth Services Under Section
1834(m) of the Act
B. Frequency Limitations on Subsequent Care Services in
Inpatient and Nursing Facility Settings, and Critical Care
Consultations and Required ``Hands-on'' Visits for ESRD Monthly
Capitation Payments
C. Telehealth Modalities and Cost-sharing
D. Communication Technology-Based Services (CTBS)
E. Direct Supervision by Interactive Telecommunications
Technology
F. Clarification of Homebound Status Under the Medicare Home
Health Benefit
G. The Use of Telecommunications Technology Under the Medicare
Home Health Benefit During the PHE for the COVID-19 Pandemic
H. The Use of Technology Under the Medicare Hospice Benefit
I. Telehealth and the Medicare Hospice Face-to-Face Encounter
Requirement
J. Modification of the Inpatient Rehabilitation Facility (IRF)
Face-to-Face Requirement for the PHE During the COVID-19 Pandemic
K. Removal of the IRF Post-Admission Physician Evaluation
Requirement for the PHE for the COVID-19 Pandemic and Clarification
Regarding the ``3-Hour'' Rule
L. Rural Health Clinics (RHCs) and Federally Qualified Health
Centers (FQHCs)
M. Medicare Clinical Laboratory Fee Schedule: Payment for
Specimen Collection for Purposes of COVID-19 Testing
N. Requirements for Opioid Treatment Programs (OTP)
O. Application of Teaching Physician and Moonlighting
Regulations During the PHE for the COVID-19 pandemic During the PHE
for COVID-19
P. Special Requirements for Psychiatric Hospitals (Sec.
482.61(d))
Q. Innovation Center Models
R. Remote Physiologic Monitoring
S. Telephone Evaluation and Management (E/M) Services
T. Physician Supervision Flexibility for Outpatient Hospitals--
Outpatient Hospital Therapeutic Services Assigned to the Non-
Surgical Extended Duration Therapeutic Services (NSEDTS) Level of
Supervision
U. Application of Certain National Coverage Determination and
Local Coverage Determination Requirements During the PHE for the
COVID-19 Pandemic
V. Change to Medicare Shared Savings Program Extreme and
Uncontrollable Circumstances Policy
W. Level Selection for Office/Outpatient E/M Visits When
Furnished Via Medicare Telehealth
X. Counting of Resident Time During the PHE for the COVID-19
Pandemic
Y. Addressing the Impact of COVID-19 on Part C and Part D
Quality Rating Systems
Z. Changes to Expand Workforce Capacity for Ordering Medicaid
Home Health Services, Medical Equipment, Supplies and Appliances and
Physical Therapy, Occupational Therapy or Speech Pathology and
Audiology Services
AA. Origin and Destination Requirements Under the Ambulance Fee
Schedule
BB. Merit-Based Incentive Payment System Updates
CC. Inpatient Hospital Services Furnished Under Arrangements
Outside the Hospital During the Public Health Emergency (PHE) for
the COVID-19 Pandemic
DD. Advance Payments to Suppliers Furnishing Items and Services
Under Part B
III. Waiver of Proposed Rulemaking
IV. Collection of Information Requirements
V. Response to Comments
VI. Regulatory Impact Analysis
Regulations Text
Addenda Available Only Through the Internet on the CMS Website
The Addenda along with other supporting documents and tables
referenced in this interim final rule with comment period (IFC) are
available through the internet on the CMS website at https://www.cms.gov/. For this IFC, refer to item CMS-1744-IFC. Readers who
experience any problems accessing any of the Addenda or other documents
referenced in this IFC and posted on the CMS website identified above
should contact [email protected].
CPT (Current Procedural Terminology) Copyright Notice
Throughout this IFC, we use CPT codes and descriptions to refer to
a variety of services. We note that CPT codes and descriptions are
copyright 2019 American Medical Association. All Rights Reserved. CPT
is a registered trademark of the American Medical Association (AMA).
Applicable Federal Acquisition Regulations (FAR) and Defense Federal
Acquisition Regulations (DFAR) apply.
I. Background
The United States is responding to an outbreak of respiratory
disease caused by a novel (new) coronavirus that was first detected in
China and which has now been detected in more than 190 locations
internationally, including in all 50 States and the District of
Columbia. The virus has been named ``SARS-CoV-2'' and the disease it
causes has been named ``coronavirus disease 2019'' (abbreviated
``COVID-19'').
On January 30, 2020, the International Health Regulations Emergency
Committee of the World Health Organization (WHO) declared the outbreak
a ``Public Health Emergency of international concern'' (PHEIC). On
January 31, 2020, Health and Human Services Secretary, Alex M. Azar II,
declared a PHE for the United States to aid the nation's healthcare
community in responding to COVID-19 (hereafter referred to as the PHE
for the COVID-19 pandemic). On March 11, 2020, the WHO publicly
characterized COVID-19 as a pandemic. On March 13, 2020 the President
of the United States declared the COVID-19 outbreak a national
emergency.
Coronaviruses are a large family of viruses that are common in
people and many different species of animals, including camels, cattle,
cats, and bats. Rarely, animal coronaviruses can infect people and then
spread between people such as with MERS-CoV, SARS-CoV, and now with
this new virus (COVID-19).
The complete clinical picture with regard to COVID-19 is not fully
known. Reported illnesses have ranged from very mild (including some
with no reported symptoms) to severe, including illness resulting in
death. While information so far suggests that most COVID-19 illness is
mild, a report out of China suggests serious illness occurs in 16
percent of cases. Older people and people of all ages with severe
chronic medical conditions--like heart disease, lung disease and
diabetes, for example--seem to be at higher risk of developing serious
COVID-19 illness.\1\
---------------------------------------------------------------------------
\1\ https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/summary.html.
---------------------------------------------------------------------------
A pandemic is a global outbreak of disease. Pandemics happen when a
new virus emerges to infect people and can spread between people
sustainably. Because there is little to no pre-existing
[[Page 19232]]
immunity against the new virus, it spreads worldwide. The virus that
causes COVID-19 is infecting people and spreading easily from person-
to-person. This is the first pandemic known to be caused by the
emergence of a new coronavirus.\2\
---------------------------------------------------------------------------
\2\ https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/summary.html.
---------------------------------------------------------------------------
People in places where ongoing community spread of the virus that
causes COVID-19 has been reported are at elevated risk of exposure,
with the level of risk dependent on the location. Healthcare workers
caring for patients with COVID-19 are at elevated risk of exposure.
Close contacts of persons with COVID-19 also are at elevated risk of
exposure.
Early information out of China, where COVID-19 first started, shows
that some people are at higher risk of getting very sick from this
illness. This includes:
Older adults, with risk increasing by age.
People who have serious chronic medical conditions like:
++ Heart disease.
++ Diabetes.
++ Lung disease.
The Centers for Disease Control and Prevention (CDC) has developed
guidance to help in the risk assessment and management of people with
potential exposures to COVID-19, including recommending that health
care professionals make every effort to interview a person under
investigation for infection by telephone, text monitoring system, or
video conference.\3\
---------------------------------------------------------------------------
\3\ https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/summary.html.
---------------------------------------------------------------------------
As the healthcare community works to implement and establish
recommended infection prevention and control practices, regulatory
agencies under appropriate waiver authority granted by the PHE for the
COVID-19 pandemic declaration are also working to revise and implement
regulations that work in concert with healthcare community infection
prevention and treatment practices. Based on the current and projected
increase in rate of incidence of the COVID-19 disease in the US
population, and observed fatalities in the elderly population, who are
particularly vulnerable due to age and co-morbidities, and
additionally, impact on health workers that are at increased risk due
to treating the population, we believe that certain Medicare and
Medicaid regulations that may offer providers flexibilities in
furnishing services to combat the COVID-19 pandemic should be reviewed
and revised as appropriate. We are addressing some of these regulations
in this interim final rule with comment period (IFC) to ensure that
sufficient health care items and services are available to meet the
needs of individuals enrolled in the programs under Title XVIII
(Medicare) and Title XIX (Medicaid) of the Social Security Act (the
Act).
In this extraordinary circumstance, we recognize that public
exposure greatly increases the overall risk to public health. We
believe that this increased risk produces an immediate change, not only
in the circumstances under which services can safely occur, but also
results in an immediate change to the business relationships between
providers, suppliers, and practitioners. By increasing access to
services delivered using telecommunications technology, increasing
access to testing in a patient's home, and improving infection control,
this IFC will provide the necessary flexibility for Medicare
beneficiaries to be able to receive medically necessary services
without jeopardizing their health or the health of those who are
providing those services, while minimizing the overall risk to public
health.
II. Provisions of the Interim Final Rule
In this IFC, we are defining the term, ``Public Health Emergency,''
in the regulation at 42 CFR 400.200, which contains definitions that
apply under the entirety of chapter 400 of title 42 of the CFR. The
definition identifies the PHE determined to exist nationwide by the
Secretary of Health and Human services under section 319 of the Public
Health Service Act on January 31, 2020, as a result of confirmed cases
of COVID-19, including any subsequent renewals.
A. Payment for Medicare Telehealth Services Under Section 1834(m) of
the Act
Section 1834(m) of the Act specifies the payment amounts and
circumstances under which Medicare makes payment for a discrete set of
services, all of which must ordinarily be furnished in-person, when
they are instead furnished using interactive, real-time
telecommunication technology. When furnished under the telehealth
rules, many of these specified Medicare telehealth services are still
reported using codes that describe ``face-to-face'' services but are
furnished using audio/video, real-time communication technology instead
of in-person. The list of these eligible telehealth services is
published on the CMS website at https://www.cms.gov/Medicare/Medicare-General-Information/Telehealth/.
In contrast, Medicare pays separately for other professional
services that are commonly furnished remotely using telecommunications
technology, but that do not usually require the patient to be present
in-person with the practitioner when they are furnished. These
services, including remote physician interpretation of diagnostic
tests, care management services and virtual check-ins among many
others, are considered physicians' services in the same way as services
that are furnished in-person without the use of telecommunications
technology. They are covered and paid in the same way as services
delivered without the use of telecommunications technology, but are not
considered Medicare telehealth services and are not subject to the
conditions of payment under section 1834(m) of the Act.
On March 17, 2020, we announced the expansion of telehealth
services on a temporary and emergency basis pursuant to waiver
authority added under section 1135(b)(8) of the Act by the Coronavirus
Preparedness and Response Supplemental Appropriations Act, 2020 (Pub.
L. 116-123, March 6, 2020). Starting on March 6, 2020, Medicare can pay
for telehealth services, including office, hospital, and other visits
furnished by physicians and other practitioners to patients located
anywhere in the country, including in a patient's place of residence.
In the context of the PHE for the COVID-19 pandemic, we recognize that
physicians and other health care professionals are faced with new
challenges regarding potential exposure risks, for people with
Medicare, for health care providers, and for members of the community
at large. For example, the CDC has urged health care professionals to
make every effort to interview persons under investigation for
infection by telephone, text messaging system, or video conference
instead of in-person. To facilitate the use of telecommunications
technology as a safe substitute for in-person services, we are, on an
interim basis, adding many services to the list of eligible Medicare
telehealth services, eliminating frequency limitations and other
requirements associated with particular services furnished via
telehealth, and clarifying several payment rules that apply to other
services that are furnished using telecommunications technologies that
can reduce exposure risks.
As discussed in this IFC and in prior rulemaking, several
conditions must be met for Medicare to make payment for telehealth
services under the Physician Fee Schedule (PFS). For further details,
see the full discussion of the scope of
[[Page 19233]]
Medicare telehealth services in the ``Medicare Program; Revisions to
Payment Policies Under the Physician Fee Schedule and Other Revisions
to Part B for CY 2018; Medicare Shared Savings Program Requirements;
and Medicare Diabetes Prevention Program'' final rule (82 FR 53006,
November 17, 2017) (hereinafter referred to as the CY 2018 PFS final
rule) and in our regulations at 42 CFR 410.78 and 414.65.
1. Site of Service Differential for Medicare Telehealth Services
Under the PFS, there are two payment rates for many physicians'
services: The facility rate; and the non-facility, or office, rate. The
PFS non-facility rate is the single amount paid to a physician or other
practitioner for services furnished in their office. The PFS facility
rate is the amount generally paid to a professional when a service is
furnished in a setting of care, like a hospital, where Medicare is
making a separate payment to an entity in addition to the payment to
the billing physician or practitioner. This separate payment, often
referred to as a ``facility fee'' reflects the facility's costs
associated with the service (clinical staff, supplies and equipment)
and is paid in addition to what is paid to the professional through the
PFS.
We note that, in accordance with section 1834(m)(2)(B) of the Act,
a facility fee is, in most cases, paid to the ``originating site''
where the beneficiary is located at the time a telehealth service is
furnished. The payment amount for the telehealth originating site
facility fee is a nationally applicable flat fee, paid without
geographic or site of service adjustments that generally apply to
payments for different kinds of services furnished by Medicare
providers and suppliers.
For Medicare telehealth services, we currently make payment to the
billing physician or practitioner at the PFS facility rate since the
facility costs (clinical staff, supplies, and equipment) associated
with furnishing the service would generally be incurred by the
originating site, where the patient is located, and not by the
practitioner at the distant site; and because the statute requires
Medicare to pay an originating site facility fee to the site that hosts
the patient.
When a physician or practitioner submits a claim for their
services, including claims for telehealth services, they include a
place of service (POS) code that is used to determine whether a service
is paid using the facility or non-facility rate. Currently, CMS
requires that claims for Medicare telehealth services include the POS
code 02, which is specific to telehealth services.
Under the waiver authority exercised by the Secretary in response
to the PHE for the COVID-19 pandemic, Medicare telehealth services can
be furnished to patients wherever they are located, including in the
patient's home. As provided by the amendments to section 1135(b)(8) of
the Act, when telehealth services are furnished under the waiver to
beneficiaries located in places that are not identified as permissible
originating sites in section 1834(m)(4)(C)(ii)(I) through (IX) of the
Act, no originating site facility fee is paid. We also recognize that
as physician practices suddenly transition a potentially significant
portion of their services from in-person to telehealth visits in the
context of the PHE for the COVID-19 pandemic, the relative resource
costs of furnishing these services via telehealth may not significantly
differ from the resource costs involved when these services are
furnished in person. For example, we expect that physician offices will
continue to employ nursing staff to engage with patients during
telehealth visits or to coordinate pre- or post-visit care, regardless
of whether or not the visit takes place in person, as it would have
outside of the PHE for the COVID-19 pandemic, or through telehealth in
the context of the PHE for the COVID-19 pandemic. Consequently, the
assumptions that have supported payment of telehealth services at the
PFS facility rate would not apply in many circumstances for services
furnished during the PHE for the COVID-19 pandemic. Instead, we believe
that, as more telehealth services are furnished to patients wherever
they are located rather than in statutory originating sites, it would
be appropriate to assume that the relative resource costs of services
furnished through telehealth should be reflected in the payment to the
furnishing physician or practitioner as if they furnished the services
in person, and to assign the payment rate that ordinarily would have
been paid under the PFS were the services furnished in-person. For
example, a physician practicing in an office setting who, under the PHE
for the COVID-19 pandemic, sees patients via telehealth instead of in
person would be paid at the non-facility, or office, rate for these
services. Similarly, a physician who typically sees patients in an
outpatient provider-based clinic of a hospital would be paid the
facility rate for services newly furnished via telehealth.
To implement this change on an interim basis, we are instructing
physicians and practitioners who bill for Medicare telehealth services
to report the POS code that would have been reported had the service
been furnished in person. This will allow our systems to make
appropriate payment for services furnished via Medicare telehealth
which, if not for the PHE for the COVID-19 pandemic, would have been
furnished in person, at the same rate they would have been paid if the
services were furnished in person. Given the potential importance of
using telehealth services as means of minimizing exposure risks for
patients, practitioners, and the community at large, we believe this
interim change will maintain overall relativity under the PFS for
similar services and eliminate potential financial deterrents to the
clinically appropriate use of telehealth. Because we currently use the
POS code on the claim to identify Medicare telehealth services, we are
finalizing on an interim basis the use of the CPT telehealth modifier,
modifier 95, which should be applied to claim lines that describe
services furnished via telehealth. We note that we are maintaining the
facility payment rate for services billed using the general telehealth
POS code 02, should practitioners choose, for whatever reason, to
maintain their current billing practices for Medicare telehealth during
the PHE for the COVID-19 pandemic.
2. Adding Services to the List of Medicare Telehealth Services
In the ``Medicare Program; Revisions to Payment Policies Under the
Physician Fee Schedule for Calendar Year 2003 and Inclusion of
Registered Nurses in the Personnel Provision of the Critical Access
Hospital Emergency Services Requirement for Frontier Areas and Remote
Locations'' final rule with comment period (67 FR 79988, December 31,
2002) (hereinafter referred to the CY 2003 PFS final rule with comment
period), we established a process for adding services to or deleting
services from the list of Medicare telehealth services in accordance
with section 1834(m)(4)(F)(ii) of the Act. This process provides the
public with an ongoing opportunity to submit requests for adding
services, which we then review. We have also routinely reviewed
potential services for addition to the list of telehealth services and
sought comment on any such proposed additions. Under this process, we
assign any potential addition to the list of telehealth services to one
of the following two categories:
[[Page 19234]]
Category 1: Services that are similar to professional
consultations, office visits, and office psychiatry services that are
currently on the list of telehealth services. In reviewing these
requests, we look for similarities between the requested and existing
telehealth services for the roles of, and interactions among, the
beneficiary, the physician (or other practitioner) at the distant site
and, if necessary, the telepresenter, a practitioner who is present
with the beneficiary in the originating site. We also look for
similarities in the telecommunications system used to deliver the
service; for example, the use of interactive audio and video equipment.
Category 2: Services that are not similar to those on the
current list of telehealth services. Our review of these requests
includes an assessment of whether the service is accurately described
by the corresponding code when furnished via telehealth and whether the
use of a telecommunications system to furnish the service produces
demonstrated clinical benefit to the patient. Submitted evidence should
include both a description of relevant clinical studies that
demonstrate the service furnished by telehealth to a Medicare
beneficiary improves the diagnosis or treatment of an illness or injury
or improves the functioning of a malformed body part, including dates
and findings, and a list and copies of published peer reviewed articles
relevant to the service when furnished via telehealth. Our evidentiary
standard of clinical benefit does not include minor or incidental
benefits.
Some examples of clinical benefit include the following:
Ability to diagnose a medical condition in a patient
population without access to clinically appropriate in-person
diagnostic services.
Treatment option for a patient population without access
to clinically appropriate in-person treatment options.
Reduced rate of complications.
Decreased rate of subsequent diagnostic or therapeutic
interventions (for example, due to reduced rate of recurrence of the
disease process).
Decreased number of future hospitalizations or physician
visits.
More rapid beneficial resolution of the disease process
treatment.
Decreased pain, bleeding, or other quantifiable symptom.
Reduced recovery time.
The list of telehealth services, including the additions described
later in this section, can be located on the CMS website at https://www.cms.gov/Medicare/Medicare-General-Information/Telehealth/.
On an interim basis, we are adding the following services to the
Medicare telehealth list on a Category 2 basis for the duration of this
PHE for the COVID-19 pandemic, for telehealth services with dates of
service beginning March 1, 2020 through the end of the declared PHE
including any subsequent renewals. When we previously considered adding
these services to the list of telehealth services, either through a
public request or through our own internal review, we considered
whether or not these services met the category 1 or category 2
criteria. In many cases we reviewed requests to add these services on a
category 1 basis but did not receive or identify information that
allowed us to review the services on a category 2 basis. While we do
not believe the context of this PHE for the COVID-19 pandemic changes
the assessment of these services as category 1, we have reassessed all
of these services on a category 2 basis in the context of the
widespread presence of COVID-19 in the community. Given the exposure
risks for beneficiaries, the health care work force, and the community
at large, in-person interaction between professionals and patients
poses an immediate potential risk that would not have been present when
we previously reviewed these services. This new risk creates a unique
circumstance where health care professionals need to weigh the risks
associated with disease exposure so they can bill Medicare for the
service. For example, certain persons, especially older adults who are
particularly vulnerable to this specific virus, those considered at
risk because of underlying health conditions, and those known to be
recently exposed or diagnosed, and therefore, likely to spread the
virus to others, are often being directed by local public health
officials to self-isolate as much as possible. At the same time, we
note that the risks to medical professionals treating patients is high
and we consider it likely that medical professionals will try to treat
patients as effectively as possible without exposing themselves or
their patients unnecessarily. In some cases, use of telecommunication
technology could mitigate the exposure risk, and in such cases, there
is a clear clinical benefit of using such technology in furnishing the
service. In other words, patients who should not be seen by a
professional in-person due to the exposure risk are highly likely to be
without access to clinically appropriate treatment or diagnostic
options unless they have access to services furnished through
interactive communication technology. Therefore, in the context of the
PHE for the COVID-19 pandemic, we believe all of the following services
meet the category 2 criteria to be added to the list of telehealth
services on the basis that there is a patient population that would
otherwise not have access to clinically appropriate treatment. We note
that, as with other services on the Medicare telehealth list, it may
not be clinically appropriate or possible to use telecommunications
technology to furnish these particular services to every person or in
every circumstance. However, in the context of the PHE for the COVID-19
pandemic with specific regard to the exposure risks noted above, we
recognize the clinical benefit of access to medically reasonable and
necessary services furnished using telecommunications technology as
opposed to the potential lack of access that could occur to mitigate
the risk of disease exposure. In light of the PHE for the COVID-19
pandemic, the demand for physicians in areas heavily impacted by COVID-
19 or under served by clinicians may intensify, resulting in a need for
critical care services for patients with suspected or diagnosed COVID-
19 and those who are in acute care settings due to other conditions.
These practitioners may be working with nurses, consulting with other
healthcare professionals, writing orders, looking at images,
communicating with family members for patients with a number of acute
conditions. The CPT codes describing E/M services reflect an assumption
that the nature of the work involved in evaluation and management
visits varies, in part, based on the setting of care and the patient's
status. Consequently, there are separate sets of E/M codes for
different settings of care, such as office/outpatient codes, nursing
facility codes, or emergency department codes. We expect physicians and
other practitioners to use the E/M code that best describes the nature
of the care they are providing, regardless of the physical location or
status of the patient. Under ordinary circumstances, we would expect
the kind of E/M code reported to generally align with the physical
location or status of the patient. In the context of the PHE, we
recognize that the relationship among the setting of care, patient
status, and kind of E/M code reported may depend on the needs of local
communities and the capacity of local health care institutions.
Consequently, we are reiterating that practitioners should report the
E/M code that best describes the nature of the care they are providing.
[[Page 19235]]
We are adding the following codes to the existing list of
telehealth services on a Category 2 basis for the PHE for the COVID-19
pandemic:
3. Emergency Department Visits: CPT Codes
99281 (Emergency department visit for the evaluation and
management of a patient, which requires these 3 key components: A
problem focused history; A problem focused examination; and
Straightforward medical decision making. Counseling and/or coordination
of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
presenting problem(s) are self limited or minor.)
99282 (Emergency department visit for the evaluation and
management of a patient, which requires these 3 key components: An
expanded problem focused history; An expanded problem focused
examination; and Medical decision making of low complexity. Counseling
and/or coordination of care with other physicians, other qualified
health care professionals, or agencies are provided consistent with the
nature of the problem(s) and the patient's and/or family's needs.
Usually, the presenting problem(s) are of low to moderate severity.)
99283 (Emergency department visit for the evaluation and
management of a patient, which requires these 3 key components: An
expanded problem focused history; An expanded problem focused
examination; and Medical decision making of moderate complexity.
Counseling and/or coordination of care with other physicians, other
qualified health care professionals, or agencies are provided
consistent with the nature of the problem(s) and the patient's and/or
family's needs. Usually, the presenting problem(s) are of moderate
severity.)
99284 (Emergency department visit for the evaluation and
management of a patient, which requires these 3 key components: A
detailed history; A detailed examination; and Medical decision making
of moderate complexity. Counseling and/or coordination of care with
other physicians, other qualified health care professionals, or
agencies are provided consistent with the nature of the problem(s) and
the patient's and/or family's needs. Usually, the presenting problem(s)
are of high severity, and require urgent evaluation by the physician,
or other qualified health care professionals but do not pose an
immediate significant threat to life or physiologic function.)
99285 (Emergency department visit for the evaluation and
management of a patient, which requires these 3 key components within
the constraints imposed by the urgency of the patient's clinical
condition and/or mental status: A comprehensive history; A
comprehensive examination; and Medical decision making of high
complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the presenting problem(s) are of high
severity and pose an immediate significant threat to life or
physiologic function.)
4. Initial and Subsequent Observation, and Observation Discharge Day
Management: CPT Codes
99217 (Observation care discharge day management (This
code is to be utilized to report all services provided to a patient on
discharge from outpatient hospital ``observation status'' if the
discharge is on other than the initial date of ``observation status.''
To report services to a patient designated as ``observation status'' or
``inpatient status'' and discharged on the same date, use the codes for
Observation or Inpatient Care Services [including Admission and
Discharge Services, 99234-99236 as appropriate.])
99218 (Initial observation care, per day, for the
evaluation and management of a patient which requires these 3 key
components: A detailed or comprehensive history; A detailed or
comprehensive examination; and Medical decision making that is
straightforward or of low complexity. Counseling and/or coordination of
care with other physicians, other qualified health care professionals,
or agencies are provided consistent with the nature of the problem(s)
and the patient's and/or family's needs. Usually, the problem(s)
requiring admission to outpatient hospital ``observation status'' are
of low severity. Typically, 30 minutes are spent at the bedside and on
the patient's hospital floor or unit.)
99219 (Initial observation care, per day, for the
evaluation and management of a patient, which requires these 3 key
components: A comprehensive history; A comprehensive examination; and
Medical decision making of moderate complexity. Counseling and/or
coordination of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
problem(s) requiring admission to outpatient hospital ``observation
status'' are of moderate severity. Typically, 50 minutes are spent at
the bedside and on the patient's hospital floor or unit.)
99220 (Initial observation care, per day, for the
evaluation and management of a patient, which requires these 3 key
components: A comprehensive history; A comprehensive examination; and
Medical decision making of high complexity. Counseling and/or
coordination of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
problem(s) requiring admission to outpatient hospital ``observation
status'' are of high severity. Typically, 70 minutes are spent at the
bedside and on the patient's hospital floor or unit.)
99224 (Subsequent observation care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: Problem focused interval history; Problem
focused examination; Medical decision making that is straightforward or
of low complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the patient is stable, recovering, or
improving. Typically, 15 minutes are spent at the bedside and on the
patient's hospital floor or unit.)
99225 (Subsequent observation care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: An expanded problem focused interval history;
An expanded problem focused examination; Medical decision making of
moderate complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the patient is responding inadequately
to therapy or has developed a minor complication. Typically, 25 minutes
are spent at the bedside and on the patient's hospital floor or unit.)
99226 (Subsequent observation care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: A detailed interval history; A detailed
examination; Medical
[[Page 19236]]
decision making of high complexity. Counseling and/or coordination of
care with other physicians, other qualified health care professionals,
or agencies are provided consistent with the nature of the problem(s)
and the patient's and/or family's needs. Usually, the patient is
unstable or has developed a significant complication or a significant
new problem. Typically, 35 minutes are spent at the bedside and on the
patient's hospital floor or unit.)
99234 (Observation or inpatient hospital care, for the
evaluation and management of a patient including admission and
discharge on the same date, which requires these 3 key components: A
detailed or comprehensive history; A detailed or comprehensive
examination; and Medical decision making that is straightforward or of
low complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually the presenting problem(s) requiring
admission are of low severity. Typically, 40 minutes are spent at the
bedside and on the patient's hospital floor or unit.)
99235 (Observation or inpatient hospital care, for the
evaluation and management of a patient including admission and
discharge on the same date, which requires these 3 key components: A
comprehensive history; A comprehensive examination; and Medical
decision making of moderate complexity. Counseling and/or coordination
of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually the
presenting problem(s) requiring admission are of moderate severity.
Typically, 50 minutes are spent at the bedside and on the patient's
hospital floor or unit.)
99236 (Observation or inpatient hospital care, for the
evaluation and management of a patient including admission and
discharge on the same date, which requires these 3 key components: A
comprehensive history; A comprehensive examination; and Medical
decision making of high complexity. Counseling and/or coordination of
care with other physicians, other qualified health care professionals,
or agencies are provided consistent with the nature of the problem(s)
and the patient's and/or family's needs. Usually the presenting
problem(s) requiring admission are of high severity. Typically, 55
minutes are spent at the bedside and on the patient's hospital floor or
unit.)
5. Initial Hospital Care and Hospital Discharge Day Management: CPT
Codes
99221 (Initial hospital care, per day, for the evaluation
and management of a patient, which requires these 3 key components: A
detailed or comprehensive history; A detailed or comprehensive
examination; and Medical decision making that is straightforward or of
low complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the problem(s) requiring admission are
of low severity. Typically, 30 minutes are spent at the bedside and on
the patient's hospital floor or unit.)
99222 (Initial hospital care, per day, for the evaluation
and management of a patient, which requires these 3 key components: A
comprehensive history; A comprehensive examination; and Medical
decision making of moderate complexity. Counseling and/or coordination
of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
problem(s) requiring admission are of moderate severity. Typically, 50
minutes are spent at the bedside and on the patient's hospital floor or
unit.)
99223 (Initial hospital care, per day, for the evaluation
and management of a patient, which requires these 3 key components: A
comprehensive history; A comprehensive examination; and Medical
decision making of high complexity. Counseling and/or coordination of
care with other physicians, other qualified health care professionals,
or agencies are provided consistent with the nature of the problem(s)
and the patient's and/or family's needs. Usually, the problem(s)
requiring admission are of high severity. Typically, 70 minutes are
spent at the bedside and on the patient's hospital floor or unit.)
99238 (Hospital discharge day management; 30 minutes or
less)
99239 (Hospital discharge day management; more than 30
minutes)
6. Initial Nursing Facility Visits and Nursing Facility Discharge Day
Management: CPT Codes
99304 (Initial nursing facility care, per day, for the
evaluation and management of a patient, which requires these 3 key
components: A detailed or comprehensive history; A detailed or
comprehensive examination; and Medical decision making that is
straightforward or of low complexity. Counseling and/or coordination of
care with other physicians, other qualified health care professionals,
or agencies are provided consistent with the nature of the problem(s)
and the patient's and/or family's needs. Usually, the problem(s)
requiring admission are of low severity. Typically, 25 minutes are
spent at the bedside and on the patient's facility floor or unit.)
99305 (Initial nursing facility care, per day, for the
evaluation and management of a patient, which requires these 3 key
components: A comprehensive history; A comprehensive examination; and
Medical decision making of moderate complexity. Counseling and/or
coordination of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
problem(s) requiring admission are of moderate severity. Typically, 35
minutes are spent at the bedside and on the patient's facility floor or
unit.)
99306 (Initial nursing facility care, per day, for the
evaluation and management of a patient, which requires these 3 key
components: A comprehensive history; A comprehensive examination; and
Medical decision making of high complexity. Counseling and/or
coordination of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
problem(s) requiring admission are of high severity. Typically, 45
minutes are spent at the bedside and on the patient's facility floor or
unit.)
99315 (Nursing facility discharge day management; 30
minutes or less)
99316 (Nursing facility discharge day management; more
than 30 minutes)
7. Critical Care Services: CPT Codes
99291 (Critical care, evaluation and management of the
critically ill or critically injured patient; first 30-74 minutes)
99292 (Critical care, evaluation and management of the
critically ill or critically injured patient; each additional 30
minutes (List separately in addition to code for primary service))
[[Page 19237]]
8. Domiciliary, Rest Home, or Custodial Care Services: CPT Codes
99327 (Domiciliary or rest home visit for the evaluation
and management of a new patient, which requires these 3 key components:
A comprehensive history; A comprehensive examination; and Medical
decision making of moderate complexity. Counseling and/or coordination
of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
presenting problem(s) are of high severity. Typically, 60 minutes are
spent with the patient and/or family or caregiver.)
99328 (Domiciliary or rest home visit for the evaluation
and management of a new patient, which requires these 3 key components:
A comprehensive history; A comprehensive examination; and Medical
decision making of high complexity. Counseling and/or coordination of
care with other physicians, other qualified health care professionals,
or agencies are provided consistent with the nature of the problem(s)
and the patient's and/or family's needs. Usually, the patient is
unstable or has developed a significant new problem requiring immediate
physician attention. Typically, 75 minutes are spent with the patient
and/or family or caregiver.)
99334 (Domiciliary or rest home visit for the evaluation
and management of an established patient, which requires at least 2 of
these 3 key components: A problem focused interval history; A problem
focused examination; Straightforward medical decision making.
Counseling and/or coordination of care with other physicians, other
qualified health care professionals, or agencies are provided
consistent with the nature of the problem(s) and the patient's and/or
family's needs. Usually, the presenting problem(s) are self-limited or
minor. Typically, 15 minutes are spent with the patient and/or family
or caregiver.)
99335 (Domiciliary or rest home visit for the evaluation
and management of an established patient, which requires at least 2 of
these 3 key components: An expanded problem focused interval history;
An expanded problem focused examination; Medical decision making of low
complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the presenting problem(s) are of low to
moderate severity. Typically, 25 minutes are spent with the patient
and/or family or caregiver.)
99336 (Domiciliary or rest home visit for the evaluation
and management of an established patient, which requires at least 2 of
these 3 key components: A detailed interval history; A detailed
examination; Medical decision making of moderate complexity. Counseling
and/or coordination of care with other physicians, other qualified
health care professionals, or agencies are provided consistent with the
nature of the problem(s) and the patient's and/or family's needs.
Usually, the presenting problem(s) are of moderate to high severity.
Typically, 40 minutes are spent with the patient and/or family or
caregiver.)
99337 (Domiciliary or rest home visit for the evaluation
and management of an established patient, which requires at least 2 of
these 3 key components: A comprehensive interval history; A
comprehensive examination; Medical decision making of moderate to high
complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the presenting problem(s) are of
moderate to high severity. The patient may be unstable or may have
developed a significant new problem requiring immediate physician
attention. Typically, 60 minutes are spent with the patient and/or
family or caregiver.)
9. Home Visits: CPT Codes
99341 (Home visit for the evaluation and management of a
new patient, which requires these 3 key components: A problem focused
history; A problem focused examination; and Straightforward medical
decision making. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the presenting problem(s) are of low
severity. Typically, 20 minutes are spent face-to-face with the patient
and/or family.)
99342 (Home visit for the evaluation and management of a
new patient, which requires these 3 key components: An expanded problem
focused history; An expanded problem focused examination; and Medical
decision making of low complexity. Counseling and/or coordination of
care with other physicians, other qualified health care professionals,
or agencies are provided consistent with the nature of the problem(s)
and the patient's and/or family's needs. Usually, the presenting
problem(s) are of moderate severity. Typically, 30 minutes are spent
face-to-face with the patient and/or family.)
99343 (Home visit for the evaluation and management of a
new patient, which requires these 3 key components: A detailed history;
A detailed examination; and Medical decision making of moderate
complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the presenting problem(s) are of
moderate to high severity. Typically, 45 minutes are spent face-to-face
with the patient and/or family.)
99344 (Home visit for the evaluation and management of a
new patient, which requires these 3 key components: A comprehensive
history; A comprehensive examination; and Medical decision making of
moderate complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the presenting problem(s) are of high
severity. Typically, 60 minutes are spent face-to-face with the patient
and/or family.)
99345 (Home visit for the evaluation and management of a
new patient, which requires these 3 key components: A comprehensive
history; A comprehensive examination; and Medical decision making of
high complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the patient is unstable or has
developed a significant new problem requiring immediate physician
attention. Typically, 75 minutes are spent face-to-face with the
patient and/or family.)
99347 (Home visit for the evaluation and management of an
established patient, which requires at least 2 of these 3 key
components: A problem focused interval history; A problem focused
examination; Straightforward medical decision making. Counseling and/or
coordination of care with other physicians, other qualified health care
professionals, or agencies are provided
[[Page 19238]]
consistent with the nature of the problem(s) and the patient's and/or
family's needs. Usually, the presenting problem(s) are self limited or
minor. Typically, 15 minutes are spent face-to-face with the patient
and/or family.)
99348 (Home visit for the evaluation and management of an
established patient, which requires at least 2 of these 3 key
components: An expanded problem focused interval history; An expanded
problem focused examination; Medical decision making of low complexity.
Counseling and/or coordination of care with other physicians, other
qualified health care professionals, or agencies are provided
consistent with the nature of the problem(s) and the patient's and/or
family's needs. Usually, the presenting problem(s) are of low to
moderate severity. Typically, 25 minutes are spent face-to-face with
the patient and/or family.)
99349 (Home visit for the evaluation and management of an
established patient, which requires at least 2 of these 3 key
components: A detailed interval history; A detailed examination;
Medical decision making of moderate complexity. Counseling and/or
coordination of care with other physicians, other qualified health care
professionals, or agencies are provided consistent with the nature of
the problem(s) and the patient's and/or family's needs. Usually, the
presenting problem(s) are moderate to high severity. Typically, 40
minutes are spent face-to-face with the patient and/or family.)
99350 (Home visit for the evaluation and management of an
established patient, which requires at least 2 of these 3 key
components: A comprehensive interval history; A comprehensive
examination; Medical decision making of moderate to high complexity.
Counseling and/or coordination of care with other physicians, other
qualified health care professionals, or agencies are provided
consistent with the nature of the problem(s) and the patient's and/or
family's needs. Usually, the presenting problem(s) are of moderate to
high severity. The patient may be unstable or may have developed a
significant new problem requiring immediate physician attention.
Typically, 60 minutes are spent face-to-face with the patient and/or
family.)
10. Inpatient Neonatal and Pediatric Critical Care: CPT Codes
99468 (Initial inpatient neonatal critical care, per day,
for the evaluation and management of a critically ill neonate, 28 days
of age or younger)
99469 (Subsequent inpatient neonatal critical care, per
day, for the evaluation and management of a critically ill neonate, 28
days of age or younger)
99471 (Initial inpatient pediatric critical care, per day,
for the evaluation and management of a critically ill infant or young
child, 29 days through 24 months of age)
99472 (Subsequent inpatient pediatric critical care, per
day, for the evaluation and management of a critically ill infant or
young child, 29 days through 24 months of age)
99473 (Self-measured blood pressure using a device
validated for clinical accuracy; patient education/training and device
calibration)
99475 (Initial inpatient pediatric critical care, per day,
for the evaluation and management of a critically ill infant or young
child, 2 through 5 years of age)
99476 (Subsequent inpatient pediatric critical care, per
day, for the evaluation and management of a critically ill infant or
young child, 2 through 5 years of age)
11. Initial and Continuing Intensive Care Services: CPT Codes
99477 (Initial hospital care, per day, for the evaluation
and management of the neonate, 28 days of age or younger, who requires
intensive observation, frequent interventions, and other intensive care
services)
99478 (Subsequent intensive care, per day, for the
evaluation and management of the recovering very low birth weight
infant (present body weight less than 1500 grams))
99479 (Subsequent intensive care, per day, for the
evaluation and management of the recovering low birth weight infant
(present body weight of 1500-2500 grams))
99480 (Subsequent intensive care, per day, for the
evaluation and management of the recovering infant (present body weight
of 2501-5000 grams))
12. Care Planning for Patients With Cognitive Impairment: CPT Code
99483 (Assessment of and care planning for a patient with
cognitive impairment, requiring an independent historian, in the office
or other outpatient, home or domiciliary or rest home, with all of the
following required elements: Cognition-focused evaluation including a
pertinent history and examination; Medical decision making of moderate
or high complexity; Functional assessment (eg, basic and instrumental
activities of daily living), including decision-making capacity; Use of
standardized instruments for staging of dementia (eg, functional
assessment staging test [FAST], clinical dementia rating [CDR]);
Medication reconciliation and review for high-risk medications;
Evaluation for neuropsychiatric and behavioral symptoms, including
depression, including use of standardized screening instrument(s);
Evaluation of safety (eg, home), including motor vehicle operation;
Identification of caregiver(s), caregiver knowledge, caregiver needs,
social supports, and the willingness of caregiver to take on caregiving
tasks; Development, updating or revision, or review of an Advance Care
Plan; Creation of a written care plan, including initial plans to
address any neuropsychiatric symptoms, neuro-cognitive symptoms,
functional limitations, and referral to community resources as needed
(eg, rehabilitation services, adult day programs, support groups)
shared with the patient and/or caregiver with initial education and
support. Typically, 50 minutes are spent face-to-face with the patient
and/or family or caregiver.)
13. Group Psychotherapy: CPT Code
90853 (Group psychotherapy (other than of a multiple-
family group))
14. End-Stage Renal Disease (ESRD) Services: CPT Codes
90952 (End-stage renal disease (ESRD) related services
monthly, for patients younger than 2 years of age to include monitoring
for the adequacy of nutrition, assessment of growth and development,
and counseling of parents; with 2-3 face-to-face visits by a physician
or other qualified health care professional per month)
90953 (End-stage renal disease (ESRD) related services
monthly, for patients younger than 2 years of age to include monitoring
for the adequacy of nutrition, assessment of growth and development,
and counseling of parents; with 1 face-to-face visit by a physician or
other qualified health care professional per month)
90959 (End-stage renal disease (ESRD) related services
monthly, for patients 12-19 years of age to include monitoring for the
adequacy of nutrition, assessment of growth and development, and
counseling of parents; with 1 face-to-face visit by a physician or
other qualified health care professional per month)
90962 (End-stage renal disease (ESRD) related services
monthly, for patients 20 years of age and older; with 1 face-to-face
visit by a physician or other qualified health care professional per
month)
[[Page 19239]]
15. Psychological and Neuropsychological Testing: CPT Codes
96130 (Psychological testing evaluation services by
physician or other qualified health care professional, including
integration of patient data, interpretation of standardized test
results and clinical data, clinical decision making, treatment planning
and report, and interactive feedback to the patient, family member(s)
or caregiver(s), when performed; first hour)
96131 (Psychological testing evaluation services by
physician or other qualified health care professional, including
integration of patient data, interpretation of standardized test
results and clinical data, clinical decision making, treatment planning
and report, and interactive feedback to the patient, family member(s)
or caregiver(s), when performed; each additional hour (List separately
in addition to code for primary procedure))
96132 (Neuropsychological testing evaluation services by
physician or other qualified health care professional, including
integration of patient data, interpretation of standardized test
results and clinical data, clinical decision making, treatment planning
and report, and interactive feedback to the patient, family member(s)
or caregiver(s), when performed; first hour)
96133 (Neuropsychological testing evaluation services by
physician or other qualified health care professional, including
integration of patient data, interpretation of standardized test
results and clinical data, clinical decision making, treatment planning
and report, and interactive feedback to the patient, family member(s)
or caregiver(s), when performed; each additional hour (List separately
in addition to code for primary procedure))
96136 (Psychological or neuropsychological test
administration and scoring by physician or other qualified health care
professional, two or more tests, any method; first 30 minutes)
96137 (Psychological or neuropsychological test
administration and scoring by physician or other qualified health care
professional, two or more tests, any method; each additional 30 minutes
(List separately in addition to code for primary procedure))
96138 (Psychological or neuropsychological test
administration and scoring by technician, two or more tests, any
method; first 30 minutes)
96139 (Psychological or neuropsychological test
administration and scoring by technician, two or more tests, any
method; each additional 30 minutes (List separately in addition to code
for primary procedure))
16. Therapy Services
We have received a number of requests, most recently for CY 2018
PFS rulemaking, that we add therapy services to the Medicare telehealth
list. In the CY 2018 PFS final rule, we noted that section
1834(m)(4)(E) of the Act specifies the types of practitioners who may
furnish and bill for Medicare telehealth services as those
practitioners under section 1842(b)(18)(C) of the Act. Physical
therapists, occupational therapists and speech-language pathologists
are not among the practitioners identified in section 1842(b)(18)(C) of
the Act. We stated in the Medicare Program; Revisions to Payment
Policies under the Physician Fee Schedule and Other Revisions to Part B
for CY 2017; Medicare Advantage Bid Pricing Data Release; Medicare
Advantage and Part D Medical Loss Ratio Data Release; Medicare
Advantage Provider Network Requirements; Expansion of Medicare Diabetes
Prevention Program Model; Medicare Shared Savings Program
Requirements'' final rule (81 FR 80198, November 15, 2016) (hereinafter
referred to as the CY 2017 PFS final rule) that because these services
are predominantly furnished by physical therapists, occupational
therapists and speech-language pathologists, we did not believe it
would be appropriate to add them to the list of telehealth services at
this time. In a subsequent request to consider adding these services
for 2018, the original requester suggested that we might propose these
services to be added to the list so that they can be furnished via
telehealth when furnished by eligible distant site practitioners. Since
the majority of the codes are furnished over 90 percent of the time by
therapy professionals, who are not included on the statutory list of
eligible distant site practitioners, we stated that we believed that
adding therapy services to the telehealth list could result in
confusion about who is authorized to furnish and bill for these
services when furnished via telehealth.
In light of the PHE for the COVID-19 pandemic, we believe that the
risks associated with confusion are outweighed by the potential
benefits for circumstances when these services might be furnished via
telehealth by eligible distant site practitioners. We believe this is
sufficient clinical evidence to support the addition of therapy
services to the Medicare telehealth list on a category 2 basis.
However, we note that the statutory definition of distant site
practitioners under section 1834(m) of the Act does not include
physical therapists, occupational therapists, or speech-language
pathologists, meaning that it does not provide for payment for these
services as Medicare telehealth services when furnished by physical
therapists, occupational therapists, or speech-language pathologists.
CPT codes:
97161 (Physical therapy evaluation: low complexity,
requiring these components: A history with no personal factors and/or
comorbidities that impact the plan of care; An examination of body
system(s) using standardized tests and measures addressing 1-2 elements
from any of the following: body structures and functions, activity
limitations, and/or participation restrictions; A clinical presentation
with stable and/or uncomplicated characteristics; and Clinical decision
making of low complexity using standardized patient assessment
instrument and/or measurable assessment of functional outcome.
Typically, 20 minutes are spent face-to-face with the patient and/or
family.)
97162 (Physical therapy evaluation: moderate complexity,
requiring these components: A history of present problem with 1-2
personal factors and/or comorbidities that impact the plan of care; An
examination of body systems using standardized tests and measures in
addressing a total of 3 or more elements from any of the following:
body structures and functions, activity limitations, and/or
participation restrictions; An evolving clinical presentation with
changing characteristics; and Clinical decision making of moderate
complexity using standardized patient assessment instrument and/or
measurable assessment of functional outcome. Typically, 30 minutes are
spent face-to-face with the patient and/or family.)
97163 (Physical therapy evaluation: high complexity,
requiring these components: A history of present problem with 3 or more
personal factors and/or comorbidities that impact the plan of care; An
examination of body systems using standardized tests and measures
addressing a total of 4 or more elements from any of the following:
body structures and functions, activity limitations, and/or
participation restrictions; A clinical presentation with unstable and
unpredictable characteristics; and Clinical decision making of high
complexity using standardized patient assessment instrument and/or
measurable assessment of functional outcome. Typically, 45 minutes are
spent face-to-face with the patient and/or family.)
97164 (Re-evaluation of physical therapy established plan
of care,
[[Page 19240]]
requiring these components: An examination including a review of
history and use of standardized tests and measures is required; and
Revised plan of care using a standardized patient assessment instrument
and/or measurable assessment of functional outcome. Typically, 20
minutes are spent face-to-face with the patient and/or family.)
97165 (Occupational therapy evaluation, low complexity,
requiring these components: An occupational profile and medical and
therapy history, which includes a brief history including review of
medical and/or therapy records relating to the presenting problem; An
assessment(s) that identifies 1-3 performance deficits (ie, relating to
physical, cognitive, or psychosocial skills) that result in activity
limitations and/or participation restrictions; and Clinical decision
making of low complexity, which includes an analysis of the
occupational profile, analysis of data from problem-focused
assessment(s), and consideration of a limited number of treatment
options. Patient presents with no comorbidities that affect
occupational performance. Modification of tasks or assistance (eg,
physical or verbal) with assessment(s) is not necessary to enable
completion of evaluation component. Typically, 30 minutes are spent
face-to-face with the patient and/or family.)
97166 (Occupational therapy evaluation, moderate
complexity, requiring these components: An occupational profile and
medical and therapy history, which includes an expanded review of
medical and/or therapy records and additional review of physical,
cognitive, or psychosocial history related to current functional
performance; An assessment(s) that identifies 3-5 performance deficits
(ie, relating to physical, cognitive, or psychosocial skills) that
result in activity limitations and/or participation restrictions; and
Clinical decision making of moderate analytic complexity, which
includes an analysis of the occupational profile, analysis of data from
detailed assessment(s), and consideration of several treatment options.
Patient may present with comorbidities that affect occupational
performance. Minimal to moderate modification of tasks or assistance
(eg, physical or verbal) with assessment(s) is necessary to enable
patient to complete evaluation component. Typically, 45 minutes are
spent face-to-face with the patient and/or family.)
97167 (Occupational therapy evaluation, high complexity,
requiring these components: An occupational profile and medical and
therapy history, which includes review of medical and/or therapy
records and extensive additional review of physical, cognitive, or
psychosocial history related to current functional performance; An
assessment(s) that identifies 5 or more performance deficits (ie,
relating to physical, cognitive, or psychosocial skills) that result in
activity limitations and/or participation restrictions; and Clinical
decision making of high analytic complexity, which includes an analysis
of the patient profile, analysis of data from comprehensive
assessment(s), and consideration of multiple treatment options. Patient
presents with comorbidities that affect occupational performance.
Significant modification of tasks or assistance (eg, physical or
verbal) with assessment(s) is necessary to enable patient to complete
evaluation component. Typically, 60 minutes are spent face-to-face with
the patient and/or family.)
97168 (Re-evaluation of occupational therapy established
plan of care, requiring these components: An assessment of changes in
patient functional or medical status with revised plan of care; An
update to the initial occupational profile to reflect changes in
condition or environment that affect future interventions and/or goals;
and A revised plan of care. A formal reevaluation is performed when
there is a documented change in functional status or a significant
change to the plan of care is required. Typically, 30 minutes are spent
face-to-face with the patient and/or family.)
97110 (Therapeutic procedure, 1 or more areas, each 15
minutes; therapeutic exercises to develop strength and endurance, range
of motion and flexibility)
97112 (Therapeutic procedure, 1 or more areas, each 15
minutes; neuromuscular reeducation of movement, balance, coordination,
kinesthetic sense, posture, and/or proprioception for sitting and/or
standing activities)
97116 (Therapeutic procedure, 1 or more areas, each 15
minutes; gait training (includes stair climbing)
97535 (Self-care/home management training (eg, activities
of daily living (ADL) and compensatory training, meal preparation,
safety procedures, and instructions in use of assistive technology
devices/adaptive equipment) direct one-on-one contact, each 15 minutes)
97750 (Physical performance test or measurement (eg,
musculoskeletal, functional capacity), with written report, each 15
minutes)
97755 (Assistive technology assessment (e.g., to restore,
augment or compensate for existing function, optimize functional tasks
and/or maximize environmental accessibility), direct one-on-one
contact, with written report, each 15 minutes)
97760 (Orthotic(s) management and training (including
assessment and fitting when not otherwise reported), upper
extremity(ies), lower extremity(ies) and/or trunk, initial orthotic(s)
encounter, each 15 minutes)
97761 (Prosthetic(s) training, upper and/or lower
extremity(ies), initial prosthetic(s) encounter, each 15 minutes)
92521 (Evaluation of speech fluency (eg, stuttering,
cluttering)
92522 (Evaluation of speech sound production (eg,
articulation, phonological process, apraxia, dysarthria)
92523 (Evaluation of speech sound production (eg,
articulation, phonological process, apraxia, dysarthria); with
evaluation of language comprehension and expression (eg, receptive and
expressive language)
92524 (Behavioral and qualitative analysis of voice and
resonance)
92507 (Treatment of speech, language, voice,
communication, and/or auditory processing disorder; individual)
17. Radiation Treatment Management Services
The code used to report radiation treatment management services
includes several components, including reviewing the radiation dose and
various treatment parameters, as well as weekly face-to-face visits
with the patient to assess the patient's response to treatment and
manage any symptoms the patient may be experiencing. We believe that in
the context of the PHE for the COVID-19 pandemic, the weekly face-to-
face visit component of this service could be conducted via telehealth
when the billing practitioner weighs the exposure risks against the
value of in-person assessment on a case-by-case basis. Therefore, we
are adding CPT code 77427 (Radiation treatment management, 5
treatments) to the telehealth list so that the required face-to-face
visit can be furnished via telehealth.
We believe that allowing the services listed above to be furnished
as Medicare telehealth services will significantly increase the ability
of Medicare physicians and practitioners to work without increasing
exposure risk to themselves, their patients, and the broader community.
Given widespread concerns regarding the health and safety
[[Page 19241]]
of our beneficiaries and health care providers during the PHE for the
COVID-19 pandemic, we seek input on whether there are other services
where the use of telecommunications technology could mitigate the
exposure risk, and where there is clear clinical benefit to using such
technology in furnishing the service.
We note that the inclusion of this code on the telehealth list to
ensure that the included visits can be furnished via telehealth is
similar to the inclusion of the transitional care management codes on
the telehealth list. In both of these cases, the non-face-to-face
portions of the service are not considered telehealth services that are
subject to any of the payment provisions specific to telehealth
services under section 1834(m) of the Act.
CPT code 77427 (Radiation treatment management, 5
treatments)
As we noted above, we have previously considered adding many of
these services to the Medicare telehealth list in prior rulemaking and
declined, in many cases citing concerns over patient acuity and the
feasibility of fulfilling all of the required elements of a service via
communication technology. However, in the context of the PHE for the
COVID-19 pandemic with specific regard to the exposure risks noted
above, we recognize the clinical benefit of access to medically
reasonable and necessary services furnished using telecommunications
technology as opposed to the potential lack of access that could occur
to mitigate the risk of disease exposure. We are also interested in
learning of any potential negative consequences of adding these CPT
codes to the list of telehealth services on an interim basis.
B. Frequency Limitations on Subsequent Care Services in Inpatient and
Nursing Facility Settings, and Critical Care Consultations and Required
``Hands-On'' Visits for ESRD Monthly Capitation Payments
In adding some services to the Medicare telehealth list, we have
done so while including certain restrictions on how frequently a
service may be furnished via Medicare telehealth to ensure that the
services met the category 1 or 2 criteria. For example, in the CY 2011
PFS final rule (75 FR 73317 through 73318), we added the subsequent
hospital care services to the Medicare telehealth list. We stated that,
because of our concerns regarding the potential acuity of hospital
inpatients, we would limit the provision of subsequent hospital care
services through telehealth to once every 3 days. Similarly, when we
added subsequent nursing facility visits to the Medicare telehealth
list, we stated our concerns regarding the potential acuity and
complexity of nursing facility (NF) patients, we would limit the
provision of subsequent nursing facility care services furnished
through telehealth to once every 30 days.
Given our assessment that under the PHE for the COVID-19 pandemic,
there is a patient population that would otherwise not have access to
clinically appropriate in-person treatment, we do not believe these
frequency limitations are appropriate or necessary. In our prior
analysis, for example, we were concerned that patients might not
receive the necessary in-person services for nursing facility or
hospital inpatient services. Since in the context of this PHE,
telehealth visits mitigate exposure risk, fewer in-person visits may
reflect the most appropriate care, depending on the needs of individual
patients. Consequently, on an interim basis, we are removing the
frequency restrictions for each of the following listed codes for
subsequent inpatient visits and subsequent NF visits furnished via
Medicare telehealth for the duration of the PHE for the COVID-19
pandemic. Similarly, we note that we previously limited critical care
consultations through telehealth to only once per day, given the
patient acuity involved in critical care. However, we also understand
that critical care patients have significant exposure risks such that
more frequent services furnished via telehealth may reflect the best
available care in the context and for the duration of the PHE for the
COVID-19 pandemic. For this reason, we are also removing the
restriction that critical care consultation codes may only be furnished
to a Medicare beneficiary once per day. These restrictions were
established through rulemaking and implemented through systems edits.
1. Subsequent Inpatient Visits: CPT Codes
99231 (Subsequent hospital care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: A problem focused interval history; A problem
focused examination; Medical decision making that is straightforward or
of low complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the patient is stable, recovering or
improving. Typically, 15 minutes are spent at the bedside and on the
patient's hospital floor or unit.)
99232 (Subsequent hospital care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: An expanded problem focused interval history;
An expanded problem focused examination; Medical decision making of
moderate complexity. Counseling and/or coordination of care with other
physicians, other qualified health care professionals, or agencies are
provided consistent with the nature of the problem(s) and the patient's
and/or family's needs. Usually, the patient is responding inadequately
to therapy or has developed a minor complication. Typically, 25 minutes
are spent at the bedside and on the patient's hospital floor or unit.)
99233 (Subsequent hospital care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: A detailed interval history; A detailed
examination; Medical decision making of high complexity. Counseling
and/or coordination of care with other physicians, other qualified
health care professionals, or agencies are provided consistent with the
nature of the problem(s) and the patient's and/or family's needs.
Usually, the patient is unstable or has developed a significant
complication or a significant new problem. Typically, 35 minutes are
spent at the bedside and on the patient's hospital floor or unit.)
2. Subsequent Nursing Facility Visits: CPT Codes
99307 (Subsequent nursing facility care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: A problem focused interval history; A problem
focused examination; Straightforward medical decision making.
Counseling and/or coordination of care with other physicians, other
qualified health care professionals, or agencies are provided
consistent with the nature of the problem(s) and the patient's and/or
family's needs. Usually, the patient is stable, recovering, or
improving. Typically, 10 minutes are spent at the bedside and on the
patient's facility floor or unit.)
99308 (Subsequent nursing facility care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: An expanded problem focused interval history;
An expanded problem focused examination; Medical decision making of low
complexity.
[[Page 19242]]
Counseling and/or coordination of care with other physicians, other
qualified health care professionals, or agencies are provided
consistent with the nature of the problem(s) and the patient's and/or
family's needs. Usually, the patient is responding inadequately to
therapy or has developed a minor complication. Typically, 15 minutes
are spent at the bedside and on the patient's facility floor or unit.)
99309 (Subsequent nursing facility care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: A detailed interval history; A detailed
examination; Medical decision making of moderate complexity. Counseling
and/or coordination of care with other physicians, other qualified
health care professionals, or agencies are provided consistent with the
nature of the problem(s) and the patient's and/or family's needs.
Usually, the patient has developed a significant complication or a
significant new problem. Typically, 25 minutes are spent at the bedside
and on the patient's facility floor or unit.)
99310 (Subsequent nursing facility care, per day, for the
evaluation and management of a patient, which requires at least 2 of
these 3 key components: A comprehensive interval history; A
comprehensive examination; Medical decision making of high complexity.
Counseling and/or coordination of care with other physicians, other
qualified health care professionals, or agencies are provided
consistent with the nature of the problem(s) and the patient's and/or
family's needs. The patient may be unstable or may have developed a
significant new problem requiring immediate physician attention.
Typically, 35 minutes are spent at the bedside and on the patient's
facility floor or unit.)
3. Critical Care Consultation Services: HCPCS Codes
G0508 (Telehealth consultation, critical care, initial,
physicians typically spend 60 minutes communicating with the patient
and providers via telehealth.)
G0509 (Telehealth consultation, critical care, subsequent,
physicians typically spend 50 minutes communicating with the patient
and providers via telehealth.)
We are seeking information on how these services are furnished via
telecommunications technology to ensure that patients are safe and
receiving adequate care.
4. Required ``Hands-On'' Visits for ESRD Monthly Capitation Payments
In the ``Medicare Program; Revisions to Payment Policies Under the
Physician Fee Schedule for Calendar Year 2005'' final rule with comment
period (69 FR 66236, November 15, 2004) (hereinafter referred to the CY
2005 PFS final rule with comment period), we added ESRD related
services to the Medicare telehealth list; however, we specified that
the required clinical examination of the vascular access site must be
furnished face-to-face ``hands on'' (without the use of an interactive
telecommunications system) by physician, clinical nurse specialist
(CNS), nurse practitioner (NP), or physician assistant (PA) (69 FR
66278). On an interim basis in light of the PHE for the COVID-19
pandemic, we are instead permitting the required clinical examination
to be furnished as a Medicare telehealth service during the PHE for the
COVID-19 pandemic. We note that sections 1881(b)(3) and 1834(m) of the
Act allow an individual determined to have ESRD receiving home dialysis
to choose to receive certain monthly ESRD-related clinical assessments
via telehealth on or after January 1, 2019. The Bipartisan Budget Act
of 2018 (Pub. L. 115-123, enacted on February 9, 2018) (BBA of 2018)
amended section 1881(b)(3)(B) of the Act to require that such an
individual must receive a face-to-face visit, without the use of
telehealth, at least monthly in the case of the initial 3 months of
home dialysis and at least once every 3 consecutive months after the
initial 3 months. Due to the conditions presented by the PHE, we are
also exercising enforcement discretion on an interim basis to relax
enforcement in connection with the requirements under section
1881(b)(3)(B) of the Act that certain visits be furnished without the
use of telehealth for services furnished during the PHE. Specifically,
CMS will not conduct review to consider whether those visits were
conducted face-to-face, without the use of telehealth. The following
CPT codes, when furnished via Medicare telehealth, are impacted by
these policies:
90951 (End-stage renal disease (ESRD) related services
monthly, for patients younger than 2 years of age to include monitoring
for the adequacy of nutrition, assessment of growth and development,
and counseling of parents; with 4 or more face-to-face visits by a
physician or other qualified health care professional per month)
90952 (End-stage renal disease (ESRD) related services
monthly, for patients younger than 2 years of age to include monitoring
for the adequacy of nutrition, assessment of growth and development,
and counseling of parents; with 2-3 face-to-face visits by a physician
or other qualified health care professional per month)
90953 (End-stage renal disease (ESRD) related services
monthly, for patients younger than 2 years of age to include monitoring
for the adequacy of nutrition, assessment of growth and development,
and counseling of parents; with 1 face-to-face visit by a physician or
other qualified health care professional per month)
90954 (End-stage renal disease (ESRD) related services
monthly, for patients 2-11 years of age to include monitoring for the
adequacy of nutrition, assessment of growth and development, and
counseling of parents; with 4 or more face-to-face visits by a
physician or other qualified health care professional per month)
90955 (End-stage renal disease (ESRD) related services
monthly, for patients 2-11 years of age to include monitoring for the
adequacy of nutrition, assessment of growth and development, and
counseling of parents; with 2-3 face-to-face visits by a physician or
other qualified health care professional per month)
90957 (End-stage renal disease (ESRD) related services
monthly, for patients 12-19 years of age to include monitoring for the
adequacy of nutrition, assessment of growth and development, and
counseling of parents; with 4 or more face-to-face visits by a
physician or other qualified health care professional per month)
90958 (End-stage renal disease (ESRD) related services
monthly, for patients 12-19 years of age to include monitoring for the
adequacy of nutrition, assessment of growth and development, and
counseling of parents; with 2-3 face-to-face visits by a physician or
other qualified health care professional per month)
90959 (End-stage renal disease (ESRD) related services
monthly, for patients 12-19 years of age to include monitoring for the
adequacy of nutrition, assessment of growth and development, and
counseling of parents; with 1 face-to-face visit by a physician or
other qualified health care professional per month)
90960 (End-stage renal disease (ESRD) related services
monthly, for patients 20 years of age and older; with 4 or more face-
to-face visits by a physician or other qualified health care
professional per month)
90961 (End-stage renal disease (ESRD) related services
monthly, for patients 20 years of age and older; with
[[Page 19243]]
2-3 face-to-face visits by a physician or other qualified health care
professional per month)
90962 (End-stage renal disease (ESRD) related services
monthly, for patients 20 years of age and older; with 1 face-to-face
visit by a physician or other qualified health care professional per
month)
90963 (End-stage renal disease (ESRD) related services for
home dialysis per full month, for patients younger than 2 years of age
to include monitoring for the adequacy of nutrition, assessment of
growth and development, and counseling of parents)
90964 (End-stage renal disease (ESRD) related services for
home dialysis per full month, for patients 2-11 years of age to include
monitoring for the adequacy of nutrition, assessment of growth and
development, and counseling of parents)
90965 (End-stage renal disease (ESRD) related services for
home dialysis per full month, for patients 12-19 years of age to
include monitoring for the adequacy of nutrition, assessment of growth
and development, and counseling of parents)
90966 (End-stage renal disease (ESRD) related services for
home dialysis per full month, for patients 20 years of age and older)
90967 (End-stage renal disease (ESRD) related services for
dialysis less than a full month of service, per day; for patients
younger than 2 years of age)
90968 (End-stage renal disease (ESRD) related services for
dialysis less than a full month of service, per day; for patients 2-11
years of age)
90969 (End-stage renal disease (ESRD) related services for
dialysis less than a full month of service, per day; for patients 12-19
years of age)
90970 (End-stage renal disease (ESRD) related services for
dialysis less than a full month of service, per day; for patients 20
years of age and older)
C. Telehealth Modalities and Cost-Sharing
1. Clarifying Telehealth Technology Requirements
Our regulation at Sec. 410.78(a)(3) states that telephones,
facsimile machines, and electronic mail systems do not meet the
definition of an interactive telecommunications systems for purposes of
Medicare telehealth services. As we interpret it, this regulation does
not apply to mobile computing devices that include audio and video
real-time interactive capabilities, even though such devices are now
referred to colloquially as ``phones'' since they can also be used for
audio-only telecommunications. In light of the PHE for the COVID-19
pandemic, we believe it is important to avoid the potential perception
that this language might prohibit use of any device that could
otherwise meet the interactive requirements for Medicare telehealth,
especially given that leveraging use of such readily available
technology may be of critical importance.
Therefore, we are revising Sec. 410.78(a)(3) to add an exception
to this language on an interim basis for the duration of the PHE for
the COVID-19 pandemic providing that for the duration of the public
health emergency as defined in Sec. 400.200, ``interactive
telecommunications system'' means multimedia communications equipment
that includes, at a minimum, audio and video equipment permitting two-
way, real-time interactive communication between the patient and
distant site physician or practitioner.
In addition, the HHS Office for Civil Rights (OCR) is exercising
enforcement discretion and waiving penalties for HIPAA \4\ violations
against health care providers that serve patients in good faith through
everyday communications technologies, such as FaceTime or Skype, during
the PHE for the COVID-19 pandemic. For more information, see https://www.hhs.gov/hipaa/for-professionals/special-topics/emergency-preparedness/. While OCR is not imposing penalties for
noncompliance with the regulatory requirements under HIPAA against
covered providers in connection with the good faith provision of
telehealth during the PHE for the COVID-19 pandemic, HHS, OIG, and DOJ
continue to actively monitor for any healthcare fraud and abuse,
including potential Medicare coronavirus scams.
---------------------------------------------------------------------------
\4\ Health Insurance Portability and Accountability Act of 1996
(Pub. L. 104-191, enacted August 21, 1996).
---------------------------------------------------------------------------
2. Beneficiary Cost-Sharing
In response to the unique circumstances resulting from the outbreak
of COVID-19 and the Secretary's January 31, 2020 determination under
section 319 of the Public Health Service Act that a PHE exists and has
existed since January 27, 2020 (COVID-19 Declaration), the Office of
Inspector General (OIG) issued a Policy Statement \5\ to notify
physicians and other practitioners that they will not be subject to
administrative sanctions for reducing or waiving any cost-sharing
obligations Federal health care program beneficiaries may owe for
telehealth services furnished consistent with the then applicable
coverage and payment rules. OIG's Policy Statement is not limited to
the services governed by Sec. 410.78 but applies to a broad category
of non-face-to-face services furnished through various modalities,
including telehealth visits, virtual check-in services, e-visits,
monthly remote care management, and monthly remote patient monitoring.
The Policy Statement applies to a physician or other practitioner
billing for services provided remotely through information or
communication technology or a hospital or other eligible individual or
entity billing on behalf of the physician or practitioner for such
services when the physician or other practitioner has reassigned his or
her right to receive payments to such individual or entity.
---------------------------------------------------------------------------
\5\ https://oig.hhs.gov/fraud/docs/alertsandbulletins/2020/policy-telehealth-2020.pdf.
---------------------------------------------------------------------------
D. Communication Technology-Based Services (CTBS)
In the ``Medicare Program; Revisions to Payment Policies Under the
Physician Fee Schedule and Other Revisions to Part B for CY 2019;
Medicare Shared Savings Program Requirements; Quality Payment Program;
Medicaid Promoting Interoperability Program; Quality Payment Program-
Extreme and Uncontrollable Circumstance Policy for the 2019 MIPS
Payment Year; Provisions From the Medicare Shared Savings Program-
Accountable Care Organizations-Pathways to Success; and Expanding the
Use of Telehealth Services for the Treatment of Opioid Use Disorder
Under the Substance Use-Disorder Prevention That Promotes Opioid
Recovery and Treatment (SUPPORT) for Patients and Communities Act''
final rule (83 FR 59452 through 60303) (hereinafter referred to as the
CY 2019 PFS final rule), we noted that under current PFS payment rules,
Medicare routinely pays for many kinds of services that are furnished
via telecommunications technology (83 FR 59482), but are not considered
Medicare telehealth services. These communication technology-based
services (CTBS) include, for example, certain kinds of remote patient
monitoring (either as separate services or as parts of bundled
services), and interpretations of diagnostic tests when furnished
remotely. These services are different than the kinds of services
specified in section 1834(m) of the Act, in that they are not the kind
of services that are ordinarily furnished in person but are routinely
furnished using a telecommunications system.
In the CY 2019 PFS final rule, we finalized separate payment for a
number
[[Page 19244]]
of services that could be furnished via telecommunications technology,
but that are not Medicare telehealth services. Specifically, we
finalized Healthcare Common Procedure Coding System (HCPCS) code G2010
(Remote evaluation of recorded video and/or images submitted by an
established patient (e.g., store and forward), including interpretation
with follow-up with the patient within 24 business hours, not
originating from a related E/M service provided within the previous 7
days nor leading to an E/M service or procedure within the next 24
hours or soonest available appointment), and HCPCS code G2012 (Brief
communication technology-based service, e.g. virtual check-in, by a
physician or other qualified health care professional who can report
evaluation and management services, provided to an established patient,
not originating from a related E/M service provided within the previous
7 days nor leading to an E/M service or procedure within the next 24
hours or soonest available appointment; 5-10 minutes of medical
discussion). We finalized these codes as part of the set of codes that
is only reportable by the physicians and practitioners who can furnish
evaluation and management (E/M) services. We stated that we believed
this was appropriate since the service describes a check-in directly
with the billing practitioner to assess whether an office visit is
needed. However, we did note that similar check-ins provided by nurses
and other clinical staff can be important aspects of coordinated
patient care (83 FR 59486).
We also finalized that these services be limited to established
patients, and that beneficiary consent must be documented in the
patient's medical record for each service (83 FR 59487). This latter
provision was amended in the CY PFS 2020 final rule to allow for a
single beneficiary consent to be obtained annually (84 FR 62699). These
requirements also apply to monthly care management and remote patient
monitoring services.
In the context of the PHE for the COVID-19 pandemic, when brief
communications with practitioners and other non-face-to-face services
might mitigate the need for an in-person visit that could represent an
exposure risk for vulnerable patients, we believe that these services
should be available to as large a population of Medicare beneficiaries
as possible. In some cases, use of telecommunication technology could
mitigate the exposure risk, and in such cases, the clinical benefit of
using technology to furnish the service is self-apparent. This would be
especially true should a significant increase in the number of people
or health care professionals needing treatment or isolation occur in a
way that would limit access to brief communications with established
providers. Therefore, on an interim basis, during the PHE for the
COVID-19 pandemic, we are finalizing that these services, which may
only be reported if they do not result in a visit, including a
telehealth visit, can be furnished to both new and established
patients. We are also making clear that the consent to receive these
services can be documented by auxiliary staff under general
supervision. While we continue to believe that beneficiary consent is
necessary so that the beneficiary is notified of any applicable cost
sharing, we do not believe that the timing or manner in which
beneficiary consent is acquired should interfere with the provision of
one of these services. Therefore, we are finalizing on an interim basis
during the PHE for the COVID-19 pandemic that, while consent to receive
these services must be obtained annually, it may be obtained at the
same time that a service is furnished. We are also re-emphasizing that
this consent may be obtained by auxiliary staff under general
supervision, as well as by the billing practitioner. We are retaining
the requirement that in instances when the brief communication
technology-based service originates from a related E/M service
(including one furnished as a telehealth service) provided within the
previous 7 days by the same physician or other qualified health care
professional, that this service would be considered bundled into that
previous E/M service and would not be separately billable.
In the ``Medicare Program; CY 2020 Revisions to Payment Policies
Under the Physician Fee Schedule and Other Changes to Part B Payment
Policies; Medicare Shared Savings Program Requirements; Medicaid
Promoting Interoperability Program Requirements for Eligible
Professionals; Establishment of an Ambulance Data Collection System;
Updates to the Quality Payment Program; Medicare Enrollment of Opioid
Treatment Programs and Enhancements to Provider Enrollment Regulations
Concerning Improper Prescribing and Patient Harm; and Amendments to
Physician Self-Referral Law Advisory Opinion Regulations Final Rule''
(84 FR 62568, November 15, 2019) (hereinafter referred to as the CY
2020 PFS final rule), we finalized separate payment for CPT codes 99421
(Online digital evaluation and management service, for an established
patient, for up to 7 days, cumulative time during the 7 days; 5-10
minutes), 99422 (Online digital evaluation and management service, for
an established patient, for up to 7 days, cumulative time during the 7
days; 11-20 minutes), and 99423 (Online digital evaluation and
management service, for an established patient, for up to 7 days,
cumulative time during the 7 days; 21 or more minutes). We also
finalized separate payment for HCPCS codes G2061 (Qualified
nonphysician healthcare professional online assessment and management,
for an established patient, for up to seven days, cumulative time
during the 7 days; 5-10 minutes), G2062 (Qualified nonphysician
healthcare professional online assessment and management service, for
an established patient, for up to seven days, cumulative time during
the 7 days; 11-20 minutes), and G2063 (Qualified nonphysician qualified
healthcare professional assessment and management service, for an
established patient, for up to seven days, cumulative time during the 7
days; 21 or more minutes) (84 FR 62796).
In the context of the PHE for the COVID-19 pandemic, where
communications with practitioners might mitigate the need for an in-
person visit that could represent an exposure risk for vulnerable
patients, we do not believe the limitation of these services to
established patients is warranted. While some of the code descriptors
refer to ``established patient,'' during the PHE, we are exercising
enforcement discretion on an interim basis to relax enforcement of this
aspect of the code descriptors. Specifically, we will not conduct
review to consider whether those services were furnished to established
patients.
Additionally, in the CY 2020 PFS final rule (84 FR 62796), we
stated that HCPCS codes G2061-G2063, specific to practitioners who do
not report E/M codes, may describe services outside the scope of
current Medicare benefit categories and as such, may not be eligible
for Medicare payment. We have received a number of questions regarding
which benefit categories HCPCS codes G2061-G2063 fall under. In
response to these requests, we are clarifying here that there are
several types of practitioners who could bill for these service. For
example, the services described by these codes could be furnished as
licensed clinical social worker services, clinical psychologist
services, physical therapist services, occupational therapist services,
or speech language pathologist services, so practitioners that report
services in
[[Page 19245]]
those benefit categories could also report these online assessment and
management services.
On an interim basis, during the PHE for the COVID-19 pandemic, we
are also broadening the availability of HCPCS codes G2010 and G2012
that describe remote evaluation of patient images/video and virtual
check-ins. We recognize that in the context of the PHE for the COVID-19
pandemic, practitioners such as licensed clinical social workers,
clinical psychologists, physical therapists, occupational therapists,
and speech-language pathologists might also utilize virtual check-ins
and remote evaluations instead of other, in-person services within the
relevant Medicare benefit to facilitate the best available appropriate
care while mitigating exposure risks. We note that this is not an
exhaustive list and we are seeking input on other kinds of
practitioners who might be furnishing these kinds of services as part
of the Medicare services they furnish in the context of the PHE for the
COVID-19 pandemic.
Further, to facilitate billing of the CTBS services by therapists
for the reasons described above, we are designating HCPCS codes G2010,
G2012, G2061, G2062, or G2063 as CTBS ``sometimes therapy'' services
that would require the private practice occupational therapist,
physical therapist, and speech-language pathologist to include the
corresponding GO, GP, or GN therapy modifier on claims for these
services. CTBS therapy services include those furnished to a new or
established patients that the occupational therapist, physical
therapist, and speech-language pathologist practitioner is currently
treating under a plan of care.
E. Direct Supervision by Interactive Telecommunications Technology
Many services paid under the PFS can be paid when provided under a
level of physician or nonphysician practitioner (NPP) supervision
rather than personal performance. In many cases, the supervision
requirements in physician office settings necessitate the presence of
the physician or NPP in a particular location, usually in the same
location as the beneficiary when the service is provided. For example,
as described at Sec. 410.26, services incident to a physicians'
service usually require the direct supervision of a physician. As
currently defined in Sec. 410.32(b)(3)(ii), direct supervision means
that the physician must be present in the office suite and immediately
available to furnish assistance and direction throughout the
performance of the procedure. It does not mean that the physician must
be present in the room when the procedure is performed.
Given the circumstances of the PHE for the COVID-19 pandemic, we
recognize that in some cases, the physical proximity of the physician
or practitioner might present additional exposure risks, especially for
high risk patients isolated for their own protection or cases where the
practitioner has been exposed to the virus but could otherwise safely
supervise from another location using telecommunications technology. In
these cases, we believe that the current requirement would necessarily
limit access to procedures and tests that could be appropriately
supervised by a physician isolated for purposes of limiting exposure to
COVID-19. For example, we consider the possibility that patients
routinely receiving medically necessary physician-administered drugs at
the office of a physician may lose access to the provision of that drug
should the physician who regularly supervises the provision of that
drug be isolated for purposes of minimizing exposure risks. Likewise,
should that same patient need to be isolated for purposes of exposure
risk based on presumed or confirmed COVID-19 infection, administering
such a drug in the patient's home would require the billing
professional to accompany the clinical staff to the patient's home,
presumably with the necessary personal protective equipment (PPE)
available to both the physician and the clinical staff.
In some cases, depending upon the unique circumstances of
individual patients and billing physicians, we believe that
telecommunications technology could be used in a manner that would
facilitate the physician's immediate availability to furnish assistance
and direction without necessarily requiring the physician's physical
presence in the location where the service is being furnished, such as
the office suite or the patient's home. For example, we believe that
use of real-time, audio and video telecommunications technology allows
for a billing practitioner to observe the patient interacting with or
responding to the in-person clinical staff through virtual means, and
thus, their availability to furnish assistance and direction could be
met without requiring the physician's physical presence in that
location. We note that to be covered under Part B, drugs furnished
``incident to'' are typically injectable drugs that are bought by the
physician, in ordinary circumstances are administered in the
physician's office, and then billed by the physician to the Medicare
Administrative Contractor (MAC). By definition, ``incident to a
physician's professional service'' requires the item or service to be
billed by the physician. We also note that the supervision requirements
that apply to both services incident to a physicians' service and
diagnostic tests do not necessarily reflect the appropriate level of
supervision for particular patients, services, and health care workers.
Instead, we view these levels as the minimum possible requirement for
provision of the service for purposes of Medicare payment. Likewise,
even in the context of the PHE for the COVID-19 pandemic and the
inherent exposure risks for Medicare beneficiaries, physicians and
other health care providers, we believe that in many cases furnishing
services without the physical presence of the physician in the same
location would not be appropriate. However, we recognize that in some
cases, technology would allow appropriate supervision without the
physical presence of a physician. In the context of the PHE for the
COVID-19 pandemic, given the risks of exposure, the immediate potential
risk to needed medical care, the increased demand for health care
professionals in the context of the PHE for the COVID-19 pandemic, and
the widespread use of telecommunications technology, we believe that
individual practitioners are in the best position to make decisions
based on their clinical judgement in particular circumstances.
Consequently, we are revising the definition of direct supervision to
allow, for the duration of the PHE for the COVID-19 pandemic, direct
supervision to be provided using real-time interactive audio and video
technology. We are seeking information from commenters as to whether
there should be any guardrails and what kind of risk might this policy
introduce for beneficiaries while reducing risk of COVID-19 spread. We
note that this change is limited to only the manner in which the
supervision requirement can be met, and does not change the underlying
payment or coverage policies related to the scope of Medicare benefits,
including Part B drugs. We also note that any and all applicable rules
regarding safe transportation and proper waste disposal continue to
apply.
We note that in specifying that direct supervision includes virtual
presence through audio/video real-time communications technology during
the PHE for the COVID-19 pandemic, this can include instances where the
physician enters into a contractual arrangement for auxiliary personnel
as
[[Page 19246]]
defined in Sec. 410.26(a)(1), to leverage additional staff and
technology necessary to provide care that would ordinarily be provided
incident to a physicians' service (including services that are allowed
to be performed via telehealth). For example, physicians may enter into
contractual arrangements with a home health agency (defined under
section 1861(o) of the Act), a qualified infusion therapy supplier
(defined under section 1861(iii)(3)(D) of the Act), or entities that
furnish ambulance services in order to utilize their nurses or other
clinical staff as auxiliary personnel under leased employment (Sec.
410.26(a)(5)). In such instances, the provider/supplier would seek
payment for any services they provided from the billing practitioner
and would not submit claims to Medicare for such services. For
telehealth services that need to be personally provided by a physician,
such as an E/M visit, the physician would need to personally perform
the E/M visit and report that service as a Medicare telehealth service.
However, we acknowledge that there may be instances where the physician
may want to use auxiliary personnel to be present in the home with the
patient during the telehealth service, though this is not required for
telehealth services under section 1834(m) of the Act. Other services,
including both face-to-face and non-face-to-face services, could be
provided incident to a physicians' service by a nurse or other
auxiliary personnel, as long as the billing practitioner is providing
appropriate supervision through audio/video real-time communications
technology (or in person), when needed. We would not expect that
services furnished at a patient's home incident to a physician service
would usually occur during the same period as a home health episode of
care, and we will be monitoring claims to ensure that services are not
being inappropriately unbundled from payments under the home health
PPS.
For the reasons discussed above, on an interim basis for the
duration of the PHE for the COVID-19 pandemic, we are altering the
definition of direct supervision at Sec. 410.32(b)(3)(ii), to state
that necessary presence of the physician for direct supervision
includes virtual presence through audio/video real-time communications
technology when use of such technology is indicated to reduce exposure
risks for the beneficiary or health care provider. We are revising
Sec. 410.32(b)(3)(ii) to include, during a PHE, as defined in Sec.
400.200 of this chapter, the presence of the physician includes virtual
presence through audio/video real-time communications technology when
use of such technology is indicated to reduce exposure risks for the
beneficiary or health care provider.
1. Supervision Changes for Certain Hospital and CAH Diagnostic and
Therapeutic Services
For all of the same reasons described above, we are adopting
similar changes in the regulations at Sec. 410.28(e)(1) with respect
to the supervision of diagnostic services furnished directly or under
arrangement in the hospital or in an on-campus or off-campus outpatient
department of the hospital, as defined in Sec. 413.65. We note that
under current Medicare rules, most therapeutic services in the hospital
require only general supervision and the supervision requirements for
diagnostic services generally conform to the service-level supervision
levels required for payment under the PFS. Because we have every reason
to believe that potential exposure risks and limits on the availability
of medical professionals could equally apply to hospital services, we
are amending the definition of direct supervision for hospital services
for the duration of the PHE for the COVID-19 pandemic so it continues
to conform with the applicable definitions for services paid under the
PFS. As stated above, we believe this change is necessary due to the
circumstances of the PHE for the COVID-19 pandemic. Specifically, we
recognize that in some cases, the physical proximity of the physician
or practitioner might present additional exposure risks, especially for
high risk patients isolated for their own protection or cases where the
practitioner has been exposed to the virus but could otherwise safely
supervise from another location using telecommunications technology. In
these cases, we believe that the current definition would necessarily
limit access to diagnostic procedures and tests that could be
appropriately supervised by a physician, including one who is isolated
for purposes of limiting exposure to COVID-19.
In addition, with respect to pulmonary rehabilitation, cardiac
rehabilitation, and intensive cardiac rehabilitation services described
in the regulations at Sec. Sec. 410.47 and 410.49, respectively, we
are adopting a similar change under Sec. 410.27(a)(1)(iv)(D), for the
duration of the PHE for the COVID-19 pandemic, for all the reasons
described above, to specify that direct supervision for these services
includes virtual presence through audio/video real-time communications
technology when use of such technology is indicated to reduce exposure
risks for the beneficiary or health care provider.
F. Clarification of Homebound Status Under the Medicare Home Health
Benefit
Sections 1814(a)(2)(C) and 1835(a)(2)(A) of the Act state that
payment for home health services is made when a physician certifies
that such services are or were required because the individual is or
was confined to his home and needs or needed skilled nursing care
(other than solely venipuncture for the purpose of obtaining a blood
sample) on an intermittent basis or physical or speech therapy or, in
the case of an individual who has been furnished home health services
based on such a need and who no longer has such a need for such care or
therapy, continues or continued to need occupational therapy. In
addition, the physician must certify that a plan for furnishing such
services to such individual has been established and is periodically
reviewed by the physician and that such services are or were furnished
while the individual was under the care of a physician. Also, in the
case of a certification made by a physician after January 1, 2010,
prior to making such certification the physician must document that the
physician himself or herself, or an NP or clinical nurse specialist
(CNS) (as those terms are defined in section 1861(aa)(5) of the Act)
who is working in collaboration with the physician in accordance with
State law, or a certified nurse-midwife (as defined in section 1861(gg)
of the Act) as authorized by State law, or a PA (as defined in section
1861(aa)(5) of the Act) under the supervision of the physician, has had
a face-to-face encounter (including through use of telehealth, subject
to the requirements in section 1834(m) of the Act, and other than for
encounters that are incident to services involved, as described in
section II.E. of this IFC) with the individual within a reasonable
timeframe as determined by the Secretary.
Most recently, we have been asked by stakeholders to provide more
clarity on whether patients who are instructed to remain in their homes
or are under ``self-quarantine'' are considered ``confined to the
home'' or ``homebound'' for purposes of the Medicare home health
benefit in the context of the PHE for the COVID-19 pandemic. Per
sections 1814(a) and 1835(a) of the Act, an individual shall be
considered to be ``confined to his home'' if the individual has a
condition, due to an illness or injury, that restricts the ability of
the individual to leave his
[[Page 19247]]
or her home except with the assistance of another individual or the aid
of a supportive device (such as crutches, a cane, a wheelchair, or a
walker), or if the individual has a condition such that leaving his or
her home is medically contraindicated. While an individual does not
have to be bedridden to be considered ``confined to his home'', the
condition of the individual should be such that there exists a normal
inability to leave home and, that leaving home requires a considerable
and taxing effort by the individual.
The definition of ``confined to the home'' (that is, ``homebound'')
allows patients to be considered ``homebound'' if it is medically
contraindicated for the patient to leave the home. As an example for
the PHE for COVID-19 pandemic, this would apply for those patients: (1)
Where a physician has determined that it is medically contraindicated
for a beneficiary to leave the home because he or she has a confirmed
or suspected diagnosis of COVID-19; or (2) where a physician has
determined that it is medically contraindicated for a beneficiary to
leave the home because the patient has a condition that may make the
patient more susceptible to contracting COVID-19. A patient who is
exercising ``self-quarantine'' for one's own safety would not be
considered ``confined to the home'' unless a physician certifies that
it is medically contraindicated for the patient to leave the home. For
the PHE for the COVID-19 pandemic, the CDC is currently advising that
older adults and individuals with serious underlying health conditions
stay home (CDC's guidance is interim and is expected to continue to be
updated as warranted).\6\ As such, we expect that many Medicare
beneficiaries could be considered ``confined to the home''. However,
determinations of whether home health services are reasonable and
necessary, including whether the patient is homebound and needs skilled
services, must be based on an assessment of each beneficiary's
individual condition and care needs.
---------------------------------------------------------------------------
\6\ https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html.
---------------------------------------------------------------------------
In cases where it is medically contraindicated for the patient to
leave the home, the medical record documentation for the patient must
include information as to why the individual condition of the patient
is such that leaving the home is medically contraindicated. With
regards to a pandemic outbreak of an infectious disease, this can
include reviewing and applying any guidance on risk assessment and
public health management issued by the CDC. For example, the CDC
interim guidance ``Preventing the Spread of Coronavirus Disease 2019 in
Homes and Residential Communities'' applies for both confirmed or
suspected COVID-19 states that patients who are medically stable enough
to receive care in the home must isolate at home during their
illness.\7\ Additionally, these guidelines state that patients should
restrict activities outside the home, except for getting medical care.
These restrictions include that the individual not go to work, school,
or public areas, as well as avoiding use of public transportation,
ride-sharing, or taxis; making it such that there exists a normal
inability for an individual to leave home and leaving home would
require a considerable and taxing effort.
---------------------------------------------------------------------------
\7\ https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html.
---------------------------------------------------------------------------
In regards to those circumstances in which the patient does not
have confirmed or suspected diagnosis of an infectious disease, such as
COVID-19, but the patient's physician states that it is medically
contraindicated for the patient to leave the home because the patient's
condition may make the patient more susceptible to contracting a
pandemic disease, the patient would be considered ``confined to the
home'' or ``homebound'' for purposes of this eligibility requirement.
For example, if a patient is having an exacerbation of chronic
obstructive pulmonary disease (COPD) and the physician certifies that
it is medically contraindicated to leave the home because the patient's
compromised respiratory system makes him or her more likely to contract
an infectious disease, such as COVID-19, the patient would be
considered ``confined to the home'' in alignment with Medicare home
health eligibility criteria. Another example of this type of scenario
would be a cancer patient receiving chemotherapy treatment and where
the physician states that it is medically contraindicated for the
patient to leave the home because the patient may be more at risk of
contracting an infectious disease because of the patient's
immunocompromised state. In both examples, the medical contraindication
makes it such that there exists a normal inability for an individual to
leave home and leaving home safely would require a considerable and
taxing effort.
In addition to being considered ``confined to the home'' or
``homebound'', the patient must meet the other Medicare home health
eligibility requirements to receive Medicare home health services. That
is, the beneficiary must be under the care of a physician; receiving
services under a plan of care established and periodically reviewed by
a physician; be in need of skilled nursing care on an intermittent
basis or physical therapy or speech-language pathology; or have a
continuing need for occupational therapy. Even if the patient is
confined to the home because of a suspected diagnosis of an infectious
disease as part of a pandemic event, a home health visit solely to
obtain a nasal or throat culture would not be considered a skilled
service because it would not require the skills of a nurse to obtain
the culture as the specimen could be obtained by an appropriately-
trained medical assistant or laboratory technician. However, a home
health nurse, during an otherwise covered skilled visit, could obtain
the nasal or throat culture to send to the laboratory for testing.
Please see section II.M. of this IFC for further discussion about how a
Medicare patient without a skilled need who is under self-quarantine
may be tested at home.
We believe this clarification is not limited to the PHE for the
COVID-19 pandemic, but would also apply for other outbreaks of an
infectious disease and instances where the condition of a patient is
such that it is medically contraindicated for the patient to leave his
or her home. We solicit comments on this clarification.
G. The Use of Technology Under the Medicare Home Health Benefit During
the PHE for the COVID-19 Pandemic
Section 1895 of the Act outlines the statutory parameters of the
home health prospective payment system (HH PPS) that was implemented on
October 1, 2000. The HH PPS provides payment for all services furnished
under the Medicare home health benefit as outlined in section 1861(m)
of the Act in the form of a ``bundled'' 30-day unit of payment that is
adjusted for case-mix and area wage differences in accordance with
section 1895(b) of the Act. Section 1895(e)(1)(A) of the Act states
that nothing under section 1895 of the Act prevents a home health
agency (HHA) from furnishing services via a telecommunications system,
as long as such services do not: (1) Substitute for in-person home
health services ordered as part of a plan of care certified by a
physician; and (2) are not considered a home health visit for purposes
of eligibility or payment. In the CY 2019 HH PPS proposed rule (83 FR
32425), we stated that ``remote patient monitoring'' is one type of
service that can be furnished via a telecommunications system to
augment a home health plan of care without
[[Page 19248]]
substituting for an in-person visit. In the CY 2019 HH PPS final rule
with comment (83 FR 56527), for purposes of the Medicare home health
benefit, we finalized the definition of ``remote patient monitoring''
in regulation at 42 CFR 409.46(e) as the collection of physiologic data
(for example, ECG, blood pressure, glucose monitoring) digitally stored
and/or transmitted by the patient and/or caregiver to the HHA. We also
included in regulation at Sec. 409.46(e) that the costs of remote
patient monitoring are considered allowable administrative costs
(operating expenses) if remote patient monitoring is used by the HHA to
augment the care planning process (83 FR 56527).
We received positive feedback from the policy changes finalized in
the CY 2019 HH PPS final rule with comment period. Commenters
encouraged us to even go further in adopting and promoting technology
use in home health. Recently, we have been asked by stakeholders to
provide more clarity on how HHAs can leverage technology to keep home
health clinicians and patients safe during outbreaks of an infectious
disease, such as the PHE for the COVID-19 pandemic. While we remain
statutorily-prohibited from paying for home health services furnished
via a telecommunications system if such services substitute for in-
person home health services ordered as part of a plan of care and for
paying directly for such services under the home health benefit, for
the duration of the PHE for the COVID-19 pandemic, we are amending the
regulations at Sec. 409.43(a) on an interim basis to provide HHAs with
the flexibility, in addition to remote patient monitoring, to use
various types of telecommunications systems (that is, technology) in
conjunction with the provision of in-person visits. Specifically, we
are amending the regulations at Sec. 409.43(a) on an interim basis to
state that the use of technology must be related to the skilled
services being furnished by the nurse/therapist/therapy assistant to
optimize the services furnished during the home visit or when there is
a home visit. We are also amending the regulations at Sec. 409.43(a)
on an interim basis to state that the use of technology must be
included on the home health plan of care along with a description of
how the use of such technology will help to achieve the goals outlined
on the plan of care without substituting for an in-person visit as
ordered on the plan of care. As a reminder, the plan of care must be
signed prior to submitting a final claim to Medicare for payment (Sec.
409.43(c)(2)); therefore, HHAs have flexibility on the timing in which
they obtain physician signatures for changes to the plan of care when
incorporating the use of technology into the patient's plan of care. In
addition, HHAs may also provide services based on verbal orders in
accordance with the regulations at Sec. Sec. 484.60(b) and 409.43(d).
Finally, on an interim basis HHAs can report the costs of
telecommunications technology as allowable administrative and general
(A&G) costs by identifying the costs using a subscript between line
5.01 through line 5.19.
We reiterate that by law the use of technology may not substitute
for an in-person home visit ordered as part of the plan of care and
services furnished via a telecommunications system cannot be considered
a home health visit for purposes of eligibility or payment. However, we
acknowledge that the use of such technology may result in changes to
the frequency or types of visits outlined on the plan of care,
especially to combat the PHE for the COVID-19 pandemic. For example, a
patient recently discharged from the hospital after coronary bypass
surgery was receiving home health skilled nursing visits three times a
week for medication management, teaching and assessment. The patient
developed a fever, cough, sore throat and moderate shortness of breath
and now has a confirmed COVID-19 diagnosis, which the doctor has
determined can be safely managed at home with home health services. The
patient has been prescribed new medications for symptom management and
oxygen therapy to support the patient's respiratory status. The
patient's home health plan of care was updated to include an in-person
skilled nursing visit once a week to assess the patient and to monitor
for worsening symptoms. The plan of care was updated also to include a
video consultation twice a week between the skilled nurse and the
patient for medication management, teaching and assessment, as well as
to obtain oxygen saturation readings that the patient relays to the
nurse during the consultation.
With regards to payment under the HH PPS, if the primary reason for
home health care is to provide care to manage the symptoms resulting
from COVID-19, this 30-day period of care would be grouped into the
Medication, Management, Teaching and Assessment (MMTA)--Respiratory
clinical group, and it would be an early 30-day period of care with an
institutional admission source. Assuming a medium functional impairment
level with ``low'' comorbidities, the low-utilization payment
adjustment (LUPA) threshold would be 4 visits. Regardless if the
patient continued to receive the original 3 in-person skilled nursing
visits per week (12 visits total in the 30-day period) rather than the
once per-week in-person skilled nursing visits (4 visits total in the
30-day period) the HHA would still receive the full 30-day payment
amount (rather than paying per visit if the total number of visits was
below the LUPA threshold). In this example, the use of technology is
not a substitute for the provision of in-person visits as ordered on
the plan of care, as the plan of care was updated to reflect a change
in the frequency of the in-person visits and to include ``virtual
visits'' as part of the management of the home health patient.
As discussed previously in section II.E ``Direct Supervision by
Interactive Telecommunications Technology'' in this IFC, there may be
instances during the PHE for the COVID-19 pandemic where physicians can
enter into a contractual arrangement, that meets the definition of
auxiliary personnel at Sec. 410.26, with another provider/supplier
type. For example, physicians may enter into contractual arrangements
with a HHA, a qualified infusion therapy supplier, or other entity to
leverage auxiliary personnel under leased employment (Sec.
410.26(a)(5)), including nurses or other clinical staff, to provide
virtual visits for patients in their homes. These virtual visits are
considered provided incident to a physician's service, as long as the
billing practitioner is providing appropriate supervision through
audio/video real-time communications technology, when needed. Payment
for such services would be made to the billing practitioner who would
then make the appropriate payment to the contracted entity (for
example, the HHA). This payment would be made in accordance with the
PFS and would not be considered a home health service under the
Medicare home health benefit. This particular flexibility can enable
more patients to receive services at home via telehealth for instances
in which there are no in-person visits that would trigger payment under
the Medicare HH PPS. As such, we would not expect that services
furnished at a patient's home incident to a physician service will
usually occur during the same period as a home health episode of care,
and we will be monitoring claims that practitioners are billing under
arrangement to ensure appropriate
[[Page 19249]]
services are being billed by the practitioner and not being
inappropriately unbundled from payments under the HH PPS.
The remainder of this section includes information on examples of
technology that can be leveraged in providing care in the home setting,
such as telemedicine, interactive clinician ``consulting'' and other
patient-facing technologies; and provides a summary of the regulations
text we are amending in this IFC.
In general, technology has become an integral part of medicine
across the entire spectrum of healthcare. Telemedicine, in particular
has the potential to play a large role in enhancing the delivery of
healthcare in the home for Medicare beneficiaries, including the
provision of information, education, and services provided via
telecommunications systems. One of the biggest benefits of
telemedicine, separate from its potential to minimize risk to
clinicians and patients during an outbreak of an infectious disease, is
to increase access to healthcare to geographically disadvantaged and
medically underserved populations, providing an improved quality of
care.\8\ Telemedicine and remote monitoring can also be used to
encourage patient involvement and autonomy, and to increase the tools
available for the home health provider.
---------------------------------------------------------------------------
\8\ Int J Environ Res Public Health. 2013 Dec; 10(12): 6472-
6484. Published online 2013 Nov 28. doi: 10.3390/ijerph10126472.
---------------------------------------------------------------------------
Recent CMS site visits with HHAs, as well as meetings with industry
associations detailed the extent to which HHAs are researching and
integrating technology into their care. These organizations provided
examples of technology they have tested and/or are currently using,
ranging from patient facing apps on cell phones to robotics.
Additionally, they provided examples of patients with specific home
health needs that they believe would benefit most from leveraging
technology in home health care. They indicated a wide variety of uses
for technology in home health including medication management and
teaching, behavioral/crisis or social work counseling, post-transplant
monitoring, dietary counseling, and even functional training through
remote occupational or physical therapy. In particular, they
highlighted certain diagnoses and conditions for which they are already
utilizing telecommunications systems. For diagnoses/conditions such as
COPD, congestive heart failure (CHF), sepsis, and wounds, technology
can offer an efficient way of monitoring chronic respiratory and
cardiovascular diseases that represent an increasingly high burden on
healthcare systems.\9\ We referenced some of the benefits of remote
patient monitoring of chronic diseases in the CY 2019 HH PPS proposed
rule (83 FR 32425), including readmission prevention and improved
patient involvement and accountability.
---------------------------------------------------------------------------
\9\ Breathe (Sheff). 2016 Dec; 12(4): 350-356. doi: 10.1183/
20734735.014616.
---------------------------------------------------------------------------
Certain HHAs and industry groups have implemented technology that
goes beyond remote patient monitoring for the treatment of chronic
diseases. One such HHA utilizes two-way, interactive ``consulting''
between the nurse furnishing the home visit and a specialty clinician
at the agency. The nurse furnishing the home visit can use a tablet to
visually connect the patient with the specialty clinician or advanced
practice nurse at the agency to assess swelling, breathing, or to
review and reconcile medications. These specialty clinicians are also
beneficial in treating acute conditions, such as wounds, or monitoring
for the prevention of sepsis. Wound, Ostomy, and Continence Nurses
(WOCNs) are being utilized for their specialized skills as consultants
for the nurse in the home. The nurse furnishing the home visit can use
a tablet to connect visually with the WOCN at the agency to consult on
the management of the wound. If necessary, the WOCN can contact the
physician or surgeon to relay progress or request a change in
treatment. Specialized software can even be utilized to assess the
wound with precision and accuracy, including measuring surface area and
depth, to improve consistency of care.\10\ Additionally, incorporating
technology into home health may be beneficial in attracting these
specialty clinicians, such as cardiac nurses and WOCNs, to homecare,
which promotes the provision of a more advanced level of care; a
benefit that will become imperative if the home health patient
population, as a whole, exhibits more characteristics of an acute care
population. Allowing advanced practice clinicians to consult virtually
with the RN in the home may minimize transportation and labor costs and
potentially improve patient access to specialty care.
---------------------------------------------------------------------------
\10\ https://parablehealth.com/post-acute-inpatient.
---------------------------------------------------------------------------
Telecommunications systems are also playing a valuable role in
managing patients at risk for sepsis after a hospitalization. Sepsis
continues to be a top diagnosis for hospital 30-day readmission rates
amongst Medicare patients.\11\ Utilizing individualized software
platforms to monitor appetite, mental changes, biometrics, etc., which
alert care providers of any changes that may indicate a problem, can be
helpful in treating the patient in the home prior to the patient
requiring hospitalization. These patient-facing devices (tablets or
apps) can be programmed to require the patient to perform a virtual
daily ``check-in'' to monitor for potential issues. If the ``check-in''
goes beyond specified individualized parameters, an alert will signal
the HHA to follow-up with the critical care team following the patient
to accelerate treatment. The software can also be programmed to deliver
specific care instructions and reminders regarding hygiene or
medications. In addition to disease-specific monitoring, patient-facing
technologies can also be integral in promoting patient involvement and
compliance. Certain scheduling and communication platforms allow HHAs
to interface with patients in more ways than in-person visits or
telephone calls. Some devices can ``talk'' to the patient, even
utilizing multiple languages. Others can provide medication reminders,
daily health tips, and assist in arranging for community or caregiver
support.
---------------------------------------------------------------------------
\11\ https://www.hcup-us.ahrq.gov/reports/statbriefs/sb225-Inpatient-US-Stays-Trends.pdf.
---------------------------------------------------------------------------
Overall, we have seen how technology can expand the reach of
healthcare into the home, through consultation with specialized
clinicians and critical care teams, as well as through the integration
of devices designed to increase patient involvement and compliance. As
outlined above, incorporating these various forms of technology, in
addition to remote patient monitoring as defined under the home health
benefit (Sec. 409.46(e)), can be appropriate in furnishing home health
services when used in conjunction with the provision of in-person
visits. In addition, technology can be used to minimize the risk of
exposure to clinicians, patients, and the public during an outbreak of
an infectious disease, such as the PHE for the COVID-19 pandemic.
Although HHAs have the flexibility, in addition to remote patient
monitoring, to use various types of technology, payment for home health
services remains contingent on the furnishing of a visit. Therefore,
the use of technology must be related to the skilled services being
furnished by the nurse or therapist or therapy assistant to optimize
the services furnished during the home visit or when there is a home
visit. To be eligible for the home health benefit, beneficiaries must
need intermittent
[[Page 19250]]
skilled nursing or therapy services and must be considered homebound.
Covered home health services include skilled nursing, home health aide,
physical therapy, speech-language pathology, occupational therapy,
medical social services, and medical supplies, provided on a visiting
basis in a place of residence such as the individual's home (section
1861(m) of the Act). A visit is defined at Sec. 409.48(c) as an
episode of personal contact with the beneficiary by staff of the HHA or
others under arrangements with the HHA, for the purpose of providing a
covered service. Generally, one visit may be covered each time an HHA
employee or someone providing home health services under arrangement
with the HHA enters the beneficiary's home and provides a covered
service to a beneficiary.
To appropriately recognize the role of technology in furnishing
services under the Medicare home health benefit, the use of such
technology must be included on the plan of care. The inclusion of
technology on the plan of care must continue to meet the requirements
at Sec. 484.60, and must be tied to the patient-specific needs as
identified in the comprehensive assessment and the measurable outcomes
that the HHA anticipates will occur as a result of implementing the
plan of care. For example, if a physician orders an in-person skilled
nursing visit once a week to assess the patient and to monitor for
worsening symptoms and a video consultation twice a week between the
skilled nurse and the patient for medication management, teaching and
assessment, as well as to obtain oxygen saturation readings that the
patient relays to the nurse during the consult; the plan of care could
specify that the goal of the video consultation is to increase patient
adherence with medication regimen and oxygen use with no worsening
respiratory symptoms.
In summary, we are amending the plan of care requirements at Sec.
409.43(a) on an interim basis, for the purposes of Medicare payment, to
state that the plan of care must include any provision of remote
patient monitoring or other services furnished via a telecommunications
system, and that these services cannot substitute for a home visit
ordered as part of the plan of care and cannot be considered a home
visit for the purposes of patient eligibility or payment. The plan of
care must include a description of how the use of such technology will
help to achieve the goals outlined on the plan of care. We believe that
this change will help to increase access to technologies, such as
telemedicine and remote patient monitoring, that enable the necessary
flexibility for Medicare beneficiaries to be able to receive medically
necessary services without jeopardizing their health or the health of
those who are providing such services, while minimizing the overall
risk to public health during the PHE for the COVID-19 pandemic. As we
stated above, HHAs can report the costs of telecommunications
technology as allowable A&G costs on an interim basis by identifying
the costs using a subscript between line 5.01 through line 5.19. We
invite feedback on our interim changes to the plan of care requirements
at Sec. 409.43(a).
H. The Use of Telecommunications Technology Under the Medicare Hospice
Benefit
As outlined in section II.G. of this IFC, The Use of Technology
Under the Medicare Home Health Benefit, technology has become an
integral part of medicine across the entire spectrum of healthcare.
Telemedicine, in particular has the potential to play a large role in
enhancing the delivery of healthcare in the home, including the
provision of information, education, and services provided via
telecommunications systems. One of the benefits of telemedicine is its
potential to minimize risk to clinicians and patients during an
outbreak of an infectious disease, such as the PHE for the COVID-19
pandemic. Recently, we have been asked by stakeholders to provide more
clarity on how hospices can leverage technology to keep clinicians and
patients safe during the PHE for the COVID-19 pandemic.
For the duration of the PHE for the COVID-19 pandemic, we are
amending the hospice regulations at 42 CFR 418.204 on an interim basis
to specify that when a patient is receiving routine home care, hospices
may provide services via a telecommunications system if it is feasible
and appropriate to do so to ensure that Medicare patients can continue
receiving services that are reasonable and necessary for the palliation
and management of a patients' terminal illness and related conditions
without jeopardizing the patients' health or the health of those who
are providing such services during the PHE for the COVID-19 pandemic.
To appropriately recognize the role of technology in furnishing
services under the hospice benefit, the use of such technology must be
included on the plan of care. The inclusion of technology on the plan
of care must continue to meet the requirements at Sec. 418.56, and
must be tied to the patient-specific needs as identified in the
comprehensive assessment and the measurable outcomes that the hospice
anticipates will occur as a result of implementing the plan of care.
The following is an example of where it could be appropriate to furnish
hospice services via a telecommunications system during the PHE for the
COVID-19 pandemic:
A terminally ill 85-year-old male with heart failure has been
receiving hospice services and recently developed a fever, sore
throat and cough. The patient has been diagnosed with suspected
COVID-19 and his hospice plan of care now includes medications for
symptom management. He is mildly short of breath but does not
require supportive oxygen therapy. The patient's wife is concerned
about potential for worsening cardiac and respiratory symptoms as a
result of the patient's risk for increased complications due to
COVID-19. The hospice plan of care has been updated to include
remote patient monitoring with a telecommunications system to assess
the patient's daily weight and oxygen saturation levels. The plan of
care identifies the measurable goal that the patient will maintain
an oxygen level above 92 percent and the patient will not gain more
than 2 pounds in a 24-hour period. The plan of care identifies
interventions if either of these goals are not met. The remote
patient monitoring allows for more expedited modifications to the
plan of care in response to the patient's changing needs.
We believe that this clarification in the regulations at Sec.
418.204 will help to increase access to technologies, such as
telemedicine and remote patient monitoring, that enable the necessary
flexibility for patients to be able to receive necessary services
without jeopardizing their health or the health of those who are
providing those services, while minimizing the overall risk to public
health during the PHE for the COVID-19 pandemic. Hospices are paid a
per diem payment amount based on the level of care for each day that a
patient is under a hospice election (Sec. 418.302). There is no
payment beyond the per diem amount for the use of technology in
providing services under the hospice benefit. For the purposes of the
hospice claim submission, only in-person visits (with the exception of
social work telephone calls) should be reported on the claim. However,
hospices can report the costs of telecommunications technology used to
furnish services under the routine home care level of care during the
PHE for the COVID-19 pandemic as ``other patient care services'' using
Worksheet A, cost center line 46, or a subscript of line 46 through
46.19, cost center code 4600 through 4619, and identifying this cost
center as ``PHE for COVID-19''. We invite feedback on our changes to
the
[[Page 19251]]
special requirements for coverage at Sec. 418.204.
I. Telehealth and the Medicare Hospice Face-to-Face Encounter
Requirement
To receive hospice services under the Medicare hospice benefit, a
beneficiary must be certified as terminally ill with a medical
prognosis of a life expectancy of 6 months or less if the illness runs
its normal course, in accordance with section 1814(a)(7) of the Act and
as codified in Sec. 418.22. A written certification is required at the
beginning of the first 90-day period of hospice care, a subsequent 90-
day period and each 60-day period thereafter. The hospice must obtain
written certification of terminal illness for each benefit period, even
if a single election continues in effect. In accordance with section
1814(a)(7)(D)(i) of the Act, a hospice physician or hospice NP must
have a face-to-face encounter with each Medicare hospice patient whose
total stay across all hospices is anticipated to reach the 3rd benefit
period. The face-to-face encounter must occur prior to, but no more
than 30 calendar days prior to, the 3rd benefit period recertification,
and every benefit period recertification thereafter, to gather clinical
findings to determine continued eligibility for hospice care.
The Medicare hospice face-to-face encounter is an administrative
requirement related to certifying the terminal illness as required in
section 1814(a)(7)(D)(i) of the Act. By itself, it is not billable, as
it is considered administrative (see Pub. 100-04, Medicare Claims
Processing Manual, chapter 11, section 40.1.1). However, if a hospice
physician, or a hospice NP who is also the patient's designated
attending physician, provides reasonable and necessary non-
administrative patient care during the face-to-face visit, that portion
of the visit would be billable under the Medicare rules. There are
additional requirements for billing physician services provided by NPs
(see Pub. 100-04, chapter 11, section 40.1.3.2). Therefore, if a
hospice physician or the hospice NP acting as the patient's designated
attending physician provides direct patient care during the course of
the face-to-face encounter, the physician or NP may bill for such
direct care services for Medicare beneficiaries under the PFS. As a
reminder, the hospice benefit defines an ``attending physician'' as a
doctor of medicine or osteopathy, an NP, or a PA designated by the
individual at the time he or she elects to receive hospice care as
having the most significant role in the determination and delivery of
the individual's medical care (Sec. 418.3). However, we note that PAs
are not authorized to perform the required face-to-face encounter under
section 1814(a)(7)(D)(i) of the Act. In the event of a pandemic
outbreak of an infectious disease, such as COVID-19, an example of
direct patient care during the course of an in-person face-to-face
visit for recertification for Medicare beneficiaries could be as
follows:
An 85-year-old male with a primary diagnosis of end stage heart
failure with diabetes, peripheral vascular disease, and hypertension
is being seen by the hospice physician for hospice recertification
and has developed a fever, cough and mild shortness of breath over
the last 24 hours. After discussion with his caregiver, the hospice
physician discovers that the patient had a visit from his niece who
was found to be COVID-19 positive. The physician washes his hands,
puts on gloves and then places a mask on himself, the patient and
caregiver. After examining the patient, the physician discusses with
the patient and caregiver if he would like to be tested for COVID-19
and if he would like to continue to be treated at home. The patient
decides that he would like to be treated at home and that he would
like to be tested. The nasopharyngeal and oropharyngeal swabs are
performed. The hospice physician discusses with the patient's
caregiver infection control techniques, symptomatic treatment, and
provides them with gloves and disposable masks. During the course of
this recertification visit, the hospice physician provided direct
patient care, and therefore, can bill for such services.
While we do not believe that direct patient care for Medicare
hospice patients will typically be furnished via telehealth, we note
that nothing in statute or regulation precludes a hospice designated
attending physician from furnishing services via telehealth in
accordance with section 1834(m) of the Act. In response to the PHE for
the COVID-19 pandemic, The Coronavirus Preparedness and Response
Supplemental Appropriations Act, 2020 was signed into law on March 6,
2020. Section 102 of the Coronavirus Preparedness and Response
Supplemental Appropriations Act, 2020 gives the Secretary the authority
to waive: (1) The telehealth originating site requirements under
section 1834(m)(4)(C) of the Act (both geographic and site of service)
for telehealth services furnished in an emergency area; and (2) the
restriction on use of a telephone for furnishing telehealth services
(in Sec. 410.78(a)(3)), but only if the telephone has audio and video
capabilities that are used for two-way, real-time interactive
communication. The originating site facility fee would be paid to
originating sites on the current list of permissible sites (except for
the patient's home) in any geographic location. The provision
established a definition of ``qualified providers'' that specifies the
practitioners eligible for furnishing distant site services under the
waiver. Specifically, the practitioners currently permitted to furnish
distant site telehealth services under section 1834(m) of the Act--
physicians (as defined in section 1861(r) of the Act) and NPPs (as
defined in section 1842(b)(18)(C) of the Act)--would be eligible to
furnish telehealth services under the waiver to patients with an
established relationship with the practitioner or a practitioner in the
same practice (defined by tax identification number (TIN)). This would
be determined based on a patient for whom Medicare payment was made for
an item or service furnished by the practitioner (or another
practitioner within the same practice) within the previous 3 years.\12\
The telehealth waiver is in effect and is limited to the PHE for the
COVID-19 pandemic.
---------------------------------------------------------------------------
\12\ We note that HHS will not conduct audits to ensure that
such prior relationship existed for claims submitted during this
PHE. Also, effective immediately, the HHS Office for Civil Rights
(OCR) will exercise enforcement discretion and waive penalties for
HIPAA violations against health care providers that serve patients
in good faith through everyday communications technologies, such as
FaceTime or Skype, during the COVID-19 nationwide PHE.
---------------------------------------------------------------------------
The statute is silent as to whether a face-to-face encounter solely
for the purpose of Medicare hospice recertification (meaning there is
no direct patient care) could be conducted via telecommunications
technology by the hospice physician or NP. Given that a face-to-face
visit solely for the purpose of recertification for Medicare hospice
services is considered an administrative requirement related to
certifying the terminal illness as required in section 1814(a)(7)(D)(i)
of the Act, we believe that such visit could be performed via
telecommunications technology as a result of the PHE for the COVID-19
pandemic. We recognize that public exposure during a pandemic event of
an infectious disease greatly increases the overall risk to public
health and terminally ill patients are exceptionally vulnerable to
complications associated with COVID-19. Therefore, we are amending the
regulations at Sec. 418.22(a)(4) on an interim basis to allow the use
of telecommunications technology by the hospice physician or NP for the
face-to-face visit when such visit is solely for the purpose of
recertifying a patient for hospice services during the PHE for the
COVID-19 pandemic. By telecommunications
[[Page 19252]]
technology, we mean the use of multimedia communications equipment that
includes, at a minimum, audio and video equipment permitting two-way,
real-time interactive communication between the patient (from home, or
any other site permissible for receiving services under the hospice
benefit) and distant site hospice physician or hospice NP.\13\ Such
encounters solely for the purpose of recertification would not be a
separately billed service, but rather considered an administrative
expense. We request feedback on the amendments to the face-to-face
visit requirement for hospice recertification during the PHE for the
COVID-19 pandemic.
---------------------------------------------------------------------------
\13\ Section 410.78(a)(2) defines a ``distant site'' as the site
at which the physician or practitioner delivering the service is
located at the time the service is provided via a telecommunications
system.
---------------------------------------------------------------------------
J. Modification of the Inpatient Rehabilitation Facility (IRF) Face-to-
Face Requirement for the PHE During the COVID-19 Pandemic
Under 42 CFR 412.622(a)(3)(iv), for an inpatient rehabilitation
facility (IRF) claim to be considered reasonable and necessary under
section 1862(a)(1) of the Act, there must be a reasonable expectation
at the time of the patient's admission to the IRF that the patient
requires physician supervision by a rehabilitation physician, defined
as a licensed physician with specialized training and experience in
inpatient rehabilitation. The requirement for medical supervision means
that the rehabilitation physician must conduct face-to-face visits with
the patient at least 3 days per week throughout the patient's stay in
the IRF to assess the patient both medically and functionally, as well
as modify the course of treatment as needed to maximize the patient's
capacity to benefit from the rehabilitation process.
The purpose of the physician supervision requirement is to ensure
that the patient's medical and functional statuses are being
continuously monitored as the patient's overall plan of care is being
carried out.
We continue to believe it is in the patient's best interest to be
seen in person by a rehabilitation physician to assess their medical
and functional statuses while at the IRF, and we encourage
rehabilitation physicians to continue to visit IRF patients in person
as long as all necessary precautions, including the use of PPE, are
taken to ensure the health and safety of the patient and the physician.
However, during the PHE for the COVID-19 pandemic, we believe that it
is essential to temporarily allow the face-to-face visit requirements
at Sec. Sec. 412.622(a)(3)(iv) and 412.29(e) to be conducted via
telehealth to safeguard the health and safety of Medicare beneficiaries
and the rehabilitation physicians treating them. This allows
rehabilitation physicians to use telehealth services as defined in
section 1834(m)(4)(F) of the Act, to conduct the required 3 physician
visits per week during the PHE for the COVID-19 pandemic. By increasing
access to telehealth, this IFC will provide the necessary flexibility
for Medicare beneficiaries to be able to receive medically necessary
services without jeopardizing their health or the health of those who
are providing those services, while minimizing the overall risk to
public health.
To effectuate these changes, on an interim basis we are finalizing
revisions to the regulations at Sec. Sec. 412.622(a)(3)(iv) and
412.29(e) during the PHE for the COVID-19 pandemic.
In Sec. 412.622(a)(3)(iv), we are revising this paragraph to state
that physician supervision by a rehabilitation physician is required,
except that during the PHE, as defined in Sec. 400.200, such visits
may be conducted using telehealth services (as defined in section
1834(m)(4)(F) of the Act). The requirement for medical supervision
means that the rehabilitation physician must conduct face-to-face
visits with the patient at least 3 days per week throughout the
patient's stay in the IRF to assess the patient both medically and
functionally, as well as to modify the course of treatment as needed to
maximize the patient's capacity to benefit from the rehabilitation
process. The post-admission physician evaluation described in paragraph
(a)(4)(ii) may count as one of the face-to-face visits.
In Sec. 412.29(e), we are revising this paragraph to state that a
procedure must be in effect to ensure that patients receive close
medical supervision, as evidenced by at least 3 face-to-face visits per
week by a licensed physician with specialized training and experience
in inpatient rehabilitation to assess the patient both medically and
functionally, as well as to modify the course of treatment as needed to
maximize the patient's capacity to benefit from the rehabilitation
process, except that during the PHE, as defined in Sec. 400.200, such
visits may be conducted using telehealth services (as defined in
section 1834(m)(4)(F) of the Act).
We welcome feedback on these revisions to the regulations at
Sec. Sec. 412.622(a)(3)(iv) and 412.29(e) for the duration of the PHE.
K. Removal of the IRF Post-Admission Physician Evaluation Requirement
for the PHE for the COVID-19 Pandemic and Clarification Regarding the
``3-Hour'' Rule
IRF care is only considered by Medicare to be reasonable and
necessary under section 1862(a)(1) of the Act if the patient meets all
of the IRF coverage requirements outlined in Sec. 412.622(a)(3), (4),
and (5). Failure to meet the IRF coverage criteria in a particular case
results in denial of the IRF claim. Under Sec. 412.622(a)(4)(ii), to
document that each patient for whom the IRF seeks payment is reasonably
expected to meet all of the requirements in Sec. 412.622(a)(3) at the
time of admission, the patient's medical record at the IRF must contain
a post-admission physician evaluation that meets ALL of the following
requirements:
It is completed by the rehabilitation physician within 24
hours of the patient's admission to the IRF.
It documents the patient's status on admission to the IRF,
includes a comparison with the information noted in the preadmission
screening documentation, and serves as the basis for the development of
the overall individualized plan of care.
It is retained in the patient's medical record at the IRF.
In an effort to provide rehabilitation physicians with as much
flexibility as possible, we are removing the post-admission physician
evaluation requirement at Sec. 412.622(a)(4)(ii) for all IRFs during
the PHE for the COVID-19 pandemic. We believe that removal of this
requirement will greatly reduce the amount of time rehabilitation
physicians in IRFs spend on completing paperwork requirements when a
patient is admitted to the IRF, and will free up their time to focus
instead on caring for patients and helping where they may be needed
with the PHE for the COVID-19 pandemic. Accordingly, we are amending
Sec. 412.622(a)(4)(ii) to note that the post-admission physician
evaluation is not required during the PHE for the COVID-19 pandemic. To
effectuate this change, on an interim basis, we are revising Sec.
412.622(a)(4)(ii) to specify that the post-admission physician
evaluation is not required during the PHE for the COVID-19 pandemic.
We note that this does not preclude an IRF patient from being
evaluated by a rehabilitation physician within the first 24 hours of
admission if the IRF believes that the patient's condition warrants
such an evaluation.
We invite feedback on our removal of the post-admission physician
evaluation
[[Page 19253]]
documentation requirement at Sec. 412.622(a)(4)(ii) for all IRFs
during the PHE for the COVID-19 pandemic.
In addition, we are providing clarity for all IRFs during the PHE
for the COVID-19 pandemic with regard to the intensive rehabilitation
therapy requirements for IRF coverage at Sec. 412.622(a)(3)(ii),
commonly known as the ``3-hour'' rule. Section 412.622(a)(3)(ii)
generally requires that a beneficiary be reasonably expected to
actively participate in, and benefit from, an intensive rehabilitation
therapy program on admission to the IRF. Under current industry
standards, this intensive rehabilitation therapy program generally
consists of at least 3 hours of therapy (physical therapy, occupational
therapy, speech-language pathology, or prosthetics/orthotics therapy)
per day at least 5 days per week. In certain well-documented cases,
this intensive rehabilitation therapy program might instead consist of
at least 15 hours of intensive rehabilitation therapy within a 7-
consecutive day period, beginning with the date of admission to the
IRF. Benefit from this intensive rehabilitation therapy program is
demonstrated by measurable improvement that will be of practical value
to the patient in improving the patient's functional capacity or
adaptation to impairments. The required therapy treatments must begin
within 36 hours from midnight of the day of admission to the IRF.
We recognize that IRFs may have difficulties in meeting these
requirements because normal staffing shifts may be disrupted as staff
who would conduct the therapy program may have COVID-19, be self-
isolated, or be unavailable for other reasons related to the PHE. As
such, while these requirements remain in place, we are clarifying that
in cases where an IRF's intensive rehabilitation therapy program is
impacted by the PHE for the COVID-19 pandemic (for example, due to
staffing disruptions resulting from self-isolation, infection, or other
circumstances related to the PHE), the IRF should not feel obligated to
meet the industry standards referenced in Sec. 412.622(a)(3)(ii), but
should instead make a note to this effect in the medical record.
L. Rural Health Clinics (RHCs) and Federally Qualified Health Centers
(FQHCs)
1. Expansion of Virtual Communication Services Furnished by RHCs and
FQHCs
a. Background
RHC and FQHC visits are face-to-face (in-person) encounters between
a patient and an RHC or FQHC practitioner during which time one or more
RHC or FQHC qualifying services are furnished. RHC and FQHC
practitioners are physicians, NPs, PAs, certified nurse midwives,
clinical psychologists, and clinical social workers, and under certain
conditions, a registered nurse (RN) or licensed practical nurse
furnishing care to a homebound RHC or FQHC patient. A Transitional Care
Management service can also be an RHC or FQHC visit. A Diabetes Self-
Management Training (DSMT) service or a Medical Nutrition Therapy (MNT)
service furnished by a certified DSMT or MNT provider may also be an
FQHC visit.
RHCs are paid an all-inclusive rate (AIR) for medically-necessary,
face-to-face visits with an RHC practitioner. The rate is subject to a
payment limit, except for those RHCs that have an exception to the
payment limit for being ``provider-based'' (see Sec. 413.65). FQHCs
are paid the lesser of their actual charges or the FQHC PPS rate for
medically-necessary, face-to-face visits with an FQHC practitioner.
Only medically-necessary medical, mental health, or qualified
preventive health services that require the skill level of an RHC or
FQHC practitioner can be RHC or FQHC billable visits.
The RHC and FQHC payment rates reflect the cost of all services and
supplies that an RHC or FQHC furnishes to a patient in a single day,
and are not adjusted for the complexity of the patient health care
needs, the length of the visit, or the number or type of practitioners
involved in the patient's care. Services furnished by auxiliary
personnel (such as nurses, medical assistants, or other clinical
personnel acting under the supervision of the RHC or FQHC practitioner)
are considered to be incident to the visit and are included in the per-
visit payment. This may include services furnished prior to or after
the billable visit that occur within a medically appropriate time
period, which is usually 30 days or less.
RHCs and FQHCs are also paid for care management services,
including chronic care management services, general behavioral health
integration services, and psychiatric Collaborative Care Model
services. These are typically non-face-to-face services that do not
require the skill level of an RHC or FQHC practitioner and are not
included in the RHC or FQHC payment methodologies.
In the CY 2019 PFS proposed rule (83 FR 35863), we proposed
separate payments to RHCs and FQHCs for certain CTBS referred to as
``Brief Communication Technology-Based Services'' for a ``virtual
check-in'' and separate payment for remote evaluation of recorded video
and/or images. ``Virtual check-ins'' are brief (5 to 10 minutes), non-
face-to-face check ins with a patient via communication technology to
assess whether the patient's condition necessitates an office visit.
This service could be billed only in situations where the medical
discussion was for a condition not related to an RHC or FQHC visit
furnished within the previous 7 days, and does not lead to an RHC or
FQHC visit within the next 24 hours or at the soonest available
appointment. We also proposed payment for remote evaluation of patient-
transmitted information conducted via pre-recorded ``store and
forward'' video or image technology, including interpretation with
verbal follow-up with the patient within 24 business hours. We had
proposed that payment would be made if the remote evaluation did not
originate from a related RHC or FQHC visit furnished within the
previous 7 days, or lead to an RHC or FQHC visit within the next 24
hours or soonest available appointment.
In the CY 2019 PFS final rule (83 FR 59683), we finalized
requirements and payment for RHCs and FQHCs furnishing Virtual
Communication Services. Effective January 1, 2019, RHCs and FQHCs are
paid for Virtual Communication Services HCPCS code G0071 (Payment for
communication technology-based services for 5 minutes or more of a
virtual (non-face-to-face) communication between an RHC or FQHC
practitioner and RHC or FQHC patient, or 5 minutes or more of remote
evaluation of recorded video and/or images by an RHC or FQHC
practitioner, occurring in lieu of an office visit; RHC or FQHC only).
HCPCS code G0071 is on an RHC or FQHC claim, either alone or with other
payable services, and at least 5 minutes of communication technology-
based or remote evaluation services are furnished by an RHC or FQHC
practitioner to a patient who has had an RHC or FQHC billable visit
within the previous year, and the medical discussion or remote
evaluation is for a condition not related to an RHC or FQHC service
provided within the previous 7 days, and does not lead to an RHC or
FQHC visit within the next 24 hours or at the soonest available
appointment. We added a new paragraph (e) to 42 CFR 405.2464 to reflect
this payment.
HCPCS code G0071 is set at the average of the national non-facility
PFS payment rates for HCPCS code G2012 (communication technology-based
services) and HCPCS code G2010
[[Page 19254]]
(remote evaluation services) and is updated annually based on the PFS
national non-facility payment rate for these codes. RHC and FQHC face-
to-face requirements are waived when these services are furnished to an
RHC or FQHC patient. Coinsurance and deductibles apply to RHC claims
for HCPCS code G0071 and coinsurance applies to FQHC claims for HCPCS
code G0071.
b. Improving Access to Care Management and Virtual Communication
Services Furnished by RHCs and FQHCs
RHCs and FQHCs furnish services in rural and urban areas that have
been determined to be medically underserved areas or health
professional shortage areas. They are an integral component of the
Nation's health care safety net, and we want to ensure that Medicare
patients who are served by RHCs and FQHCs are able to communicate with
their RHC or FQHC practitioner in a manner that enhances access to
care, consistent with evolving medical care.
Particularly in rural areas where transportation is limited and
distances may be far, we believe the use of CTBS may help some patients
to determine if they need to schedule a visit at the RHC or FQHC. If it
is determined that a visit is not necessary, the RHC or FQHC
practitioner would be available for other patients who need their care.
In the CY 2019 PFS final rule (83 FR 59452), we finalized payment
for new online digital assessment services, also referred to as ``E-
Visits,'' for practitioners billing under the PFS. These are non-face-
to face, patient-initiated communications using online patient portals.
An online patient portal is a secure online website that gives patients
24-hour access to personal health information from anywhere with an
internet connection by using a secure username and password. These
digital assessment services are for established patients who require a
clinical decision that otherwise typically would have been provided in
the office. To minimize risks associated with exposure to COVID-19, and
to provide the best care possible during the PHE for the COVID-19
pandemic, we believe that RHCs and FQHC practitioners, like many other
health care providers, should explore the use of interactive
communications technology in the place of services that would have
otherwise been furnished in person and reported and paid under the
established methodologies.
To facilitate the ability of RHCs and FQHCs to take such measures
when appropriate, on an interim basis, we are expanding the services
that can be included in the payment for HCPCS code G0071, and update
the payment rate to reflect the addition of these services.
Specifically, we are adding the following three CPT codes:
99421 (Online digital evaluation and management service,
for an established patient, for up to 7 days, cumulative time during
the 7 days; 5-10 minutes)
99422 (Online digital evaluation and management service,
for an established patient, for up to 7 days, cumulative time during
the 7 days; 11-20 minutes)
99423 (Online digital evaluation and management service,
for an established patient, for up to 7 days, cumulative time during
the 7 days; 21 or more minutes)
We are revising the payment rate for HCPCS code G0071 to include
the national non-facility payment rates for these three new codes.
Effective for services furnished on or after March 1, 2020 and
throughout the PHE for the COVID pandemic, the payment rate for HCPCS
code G0071 will be the average of the PFS national non-facility payment
rate for HCPCS code G2012 (communication technology-based services),
HCPCS code G2010 (remote evaluation services), CPT code 99421, CPT code
99422, and CPT code 99423. The RHC and FQHC face-to-face requirements
are be waived for these services. Section 405.2464(e) establishes
payment for communication technology-based and remote evaluation
services, and no regulatory changes are required.
The services that are payable using HCPCS code G0071 require that
the beneficiary has been seen by an RHC or FQHC practitioner during the
previous 12 months. Under the current PHE for the COVID-19 pandemic, we
believe that it is necessary to make these services available to
beneficiaries who would otherwise not have access to clinically
appropriate in-person treatment. Therefore, during the PHE for the
COVID-19 pandemic, we are finalizing that all virtual communication
services that are billable using HCPCS code G0071 will also be
available to new patients that have not been seen in the RHC or FQHC
within the previous 12 months. Also, in situations where obtaining
prior beneficiary consent would interfere with the timely provision of
these services, or the timely provision of the monthly care management
services, during the PHE for the COVID-19 pandemic consent can obtained
when the services are furnished instead of prior to the service being
furnished, but must be obtained before the services are billed. We will
also allow patient consent to be acquired by staff under the general
supervision of the RHC or FQHC practitioner for the virtual
communication and monthly care management codes during the PHE for the
COVID-19 pandemic. These changes are consistent with the flexibilities
were are establishing for similar services paid under the PFS as
described in section II.D. of this IFC.
2. Revision of Home Health Agency Shortage Area Requirements for
Furnishing Visiting Nursing Services
a. Background
Sections 1861(aa)(1)(A) and (B) of the Act describes RHC and FQHC
services as services and supplies furnished by a physician, PA, NP,
clinical psychologist clinical social worker; and items and services
furnished incident to these services, and specifies requirements for
these practitioners and services.
In the case of an RHC or FQHC that is located in an area in which
there exists a shortage of HHAs, part-time or intermittent nursing care
and related medical supplies (other than drugs and biologicals) are
authorized under section 1861(aa)(1)(C) of the Act. These services can
be furnished by a registered professional nurse or licensed practical
nurse to a homebound individual under a written plan of treatment that
is established and periodically reviewed by an RHC or FQHC physician,
or established by a NP or PA and periodically reviewed and approved by
the RHC or FQHC physician.
In Sec. 405.2416, we specify that visiting nurse services are
covered if all of the following are met:
The RHC or FQHC is located in an area in which the
Secretary has determined that there is a shortage of HHAs;
The services are rendered to a homebound individual;
The services are furnished by a registered professional
nurse or licensed practical nurse that is employed by, or receives
compensation for the services from the RHC or FQHC;
The services are furnished under a written plan of
treatment that is established and reviewed at least every 60 days by a
supervising physician of the RHC or FQHC; or established by an NP, PA
or certified nurse midwife (CNM); and reviewed at least every 60 days
by a supervising physician. The written plan of treatment must be
signed by the supervising physician, NP, PA or CNM of the RHC or FQHC.
Nursing care that is covered by this section includes services that
must be
[[Page 19255]]
performed by a registered professional nurse or licensed practical
nurse if the safety of the patient is to be assured and the medically
desired results achieved; and personal care services, to the extent
covered under Medicare as home health services. These services include
helping the patient to bathe, to get in and out of bed, to exercise and
to take medications. Household and housekeeping services or other
services that would constitute custodial care are not covered.
Section 405.2416 also defines ``homebound'' as an individual who is
permanently or temporarily confined to his or her place of residence
because of a medical or health condition, or if the individual leaves
the place of residence infrequently. It does not include a hospital or
long term care facility.
In Pub. 100-02, Medicare Benefit Policy Manual, Chapter 13, section
190, we further describe RHC and FQHC visiting nursing services as
skilled nursing services that require the skills of a nurse based on
the complexity of the service (for example, intravenous and
intramuscular injections or insertion of catheters), the condition of
the patient (for example, a non-skilled service that, because of the
patient's condition, can only be safely and effectively provided by a
nurse), and accepted standards of medical and nursing practice. All
services must be reasonable and necessary to the diagnosis and
treatment of the patient's illness or injury within the context of the
patient's unique medical condition, and a service that can be safely
and effectively self-administered or performed by a nonmedical person
without the direct supervision of a nurse, is not considered a skilled
nursing service, even if provided by a nurse. A service which, by its
nature, requires the skills of a nurse to be provided safely and
effectively continues to be a skilled service even if it is taught to
the patient, the patient's family, or other caregivers. If a patient
needs skilled nursing care and there is no one trained or able and
willing to provide it, the services of a nurse would be reasonable and
necessary to the treatment of the illness or injury. We also specify
that the determination of whether visiting nurse services are
reasonable and necessary is made by the physician based on the
condition of the patient when the services were ordered and what is
reasonably expected to be appropriate treatment for the illness or
injury throughout the certification period.
The requirements for furnishing visiting nursing services include
that the patient is considered to be ``confined to the home'' as
defined in section 1835(a) of the Act and that the RHC or FQHC is
located in an area that has a shortage of HHAs. The services and
supplies must be provided under a written plan of treatment; are
furnished on a part-time or intermittent basis only; and drugs and
biological products are not provided.
Chapter 13 of the Medicare Benefit Policy Manual, section 190,
specifies the requirements for HHA shortage areas for purposes of
visiting nursing services furnished by RHCs and FQHCs. The RHC or FQHC
must be currently located in a county, parish or similar geographic
area in which the Secretary has determined that there is no
participating HHA under Medicare; or adequate home health services are
not available to RHC or FQHC patients even though a participating HHA
is in the area; or, there are patients whose homes are not within the
area serviced by a participating HHA; or considering the area's climate
and terrain, whose homes are not within a reasonable traveling distance
to a participating HHA. RHCs and FQHCs that are located in an area that
has not been determined to have a current HHA shortage and are seeking
to provide visiting nurse services must make a written request to the
appropriate CMS Regional Office along with written justification that
the area it serves meets the required conditions.
b. Revision of Home Health Agency Shortage Area Requirements for
Furnishing Visiting Nursing Services
To address the PHE for the COVID-19 pandemic and its impact on
underserved rural and urban communities, we are implementing, on an
interim basis, changes to the requirements for visiting nursing
services furnished in the home by RHCs and FQHCs.
Section 405.2416(a)(1) states that visiting nurse services are
covered if the RHC or FQHC is located in an area in which the Secretary
has determined that there is a shortage of HHAs, and Sec. 405.2417
provides additional requirements for an area to be determined to have a
shortage of HHAs. During the PHE for the COVID-19 pandemic, we believe
the need for visiting nursing services furnished by RHCs or FQHCs may
increase. Therefore, for the duration of the PHE for the COVID-19
pandemic, we are determining that any area typically served by the RHC,
and any area that is included in the FQHCs service area plan, is
determined to have a shortage of HHAs, and no request for this
determination is required.
We believe this flexibility is important for patient access to
nursing services in the home and the potential for HHAs to be
overwhelmed during PHE for the COVID-19 pandemic. However, RHCs and
FQHCs should check the HIPAA Eligibility Transaction System (HETS)
before providing visiting nurse services to ensure that the patient is
not already under a home health plan of care. If a patient is under a
home health plan of care, the HHA must provide optimal care to achieve
the goals and outcomes identified in the patient's plan of care, for
each patient's medical, nursing, and rehabilitative needs (Sec.
484.105). Therefore, RHC/FQHC visiting nurse services would not be
covered by Medicare if such services are found to overlap with a 30-day
period of home health care. We note that an RHC/FQHC visiting nurse
service solely to obtain a nasal or throat culture would not be
considered a nursing service because it would not require the skills of
a nurse to obtain the culture as the specimen could be obtained by an
appropriately-trained medical assistant or laboratory technician.
However, during an otherwise covered RHC/FQHC visiting nurse service,
the nurse could obtain the nasal or throat culture to send to the
laboratory for testing.
Section 405.2416(a)(2) states that visiting nursing services are
rendered to a homebound individual, and Sec. 405.2416(d) states that
homebound means an individual who is permanently or temporarily
confined to his or her place of residence because of a medical or
health condition, and that the individual may be considered homebound
if he or she leaves the place of residence infrequently. We refer the
reader to the definition of ``homebound'' as it pertains the PHE for
the COVID-19 pandemic in section II.F. of this IFC, Clarification of
Homebound Status under the Medicare Home Health Benefit.
c. Regulatory Changes
To make available additional visiting nursing services during the
PHE for the COVID-19 pandemic in areas served by RHCs and FQHCs, we are
revising, on an interim basis, Sec. 405.2416 to add paragraph (a)(5),
to state that during the PHE for the COVID-19 pandemic, an area
typically served by the RHC, and an area that is included in the FQHC's
service area plan, is determined to have a shortage of HHAs, and no
request for this determination is required.
[[Page 19256]]
M. Medicare Clinical Laboratory Fee Schedule: Payment for Specimen
Collection for Purposes of COVID-19 Testing
In response to the PHE for the COVID-19 pandemic and in an effort
to be as expansive as possible within the current authorities to have
testing available to Medicare beneficiaries who need it, we are
changing Medicare payment policies during the PHE for the COVID-19
pandemic to provide payment to independent laboratories for specimen
collection for COVID-19 testing under certain circumstances.
In general, section 1833(h)(3) of the Act requires the Secretary to
provide for and establish a nominal fee for specimen collection for
laboratory testing and a fee to cover transportation and personnel
expenses for trained personnel to collect specimens from homebound
patients and inpatients (not in a hospital), in addition to the amounts
provided under the Medicare Clinical Laboratory Fee Schedule (CLFS).
Section 1833(h)(3)(A) of the Act provides that the Secretary must
establish a nominal fee to cover the appropriate costs in collecting
the sample on which a clinical diagnostic laboratory test was performed
and for which payment is made under Medicare Part B, except that not
more than one such fee may be provided with respect to samples
collected in the same encounter. The HCPCS codes for the nominal
specimen fees currently listed on the CLFS (HCPCS codes 36415, P9612,
and P9615) have a payment rate of $3. Section 216(a) of the Protecting
Access to Medicare Act of 2014 (Pub. L. 113-93, enacted April 1, 2014)
added section 1834A(b)(5) to the Act which increases by $2 the nominal
fee that would otherwise apply under section 1833(h)(3)(A) of the Act
for a sample collected from an individual in a skilled nursing facility
(SNF) or by a laboratory on behalf of an HHA. Therefore, effective
April 1, 2014, the nominal fee that would otherwise apply for a sample
collected from an individual in a SNF or by a laboratory on behalf of a
HHA is $5 (see Sec. 414.507(f)), and the relevant HCPCS code is G0471.
In addition, section 1833(h)(3)(B) of the Act requires the
Secretary to provide for and establish a fee to cover the
transportation and personnel expenses for trained personnel to travel
to the location of an individual to collect the sample, except that
such a fee may be provided only with respect to an individual who is
homebound or an inpatient in an inpatient facility (other than a
hospital). In accordance with this provision, Medicare established a
travel allowance for a laboratory technician to draw a specimen from
homebound patients and non-hospital inpatients. Under current guidance,
the travel allowance is intended to cover the estimated travel costs of
collecting a specimen from a Medicare beneficiary and to reflect the
technician's salary and travel costs. It is paid only when the nominal
specimen collection is also payable and is not available if the
technician is merely performing a messenger service to pick a specimen
drawn by a physician or nursing home personnel. The methodology for
determining the travel allowance varies depending on the round trip
mileage to patients' homes. For instance, a per mile travel allowance
methodology applies when the round trip to patients' homes is greater
than 20 miles and a flat rate travel allowance methodology applies when
the round trip to patients' homes is less than 20 miles. Medicare Part
B MACs calculate the travel allowance for each claim. We have heard
from stakeholders that in some cases the MAC requires them to maintain
paper logs of miles traveled to receive the travel allowance.
CMS' current policies for payment of the nominal specimen
collection fee and the fee to cover transportation and expenses for
trained personnel to collect specimens from homebound patients and non-
hospital inpatients are set forth in Pub. 100-04, Medicare Claims
Processing Manual, chapter 16, section 60. We also implemented the
increased nominal specimen collection fee under section 1834A(b)(5) of
the Act in our regulations at Sec. 414.507(f). The manual instructions
regarding payment of these fees are available on the CMS website at
https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c16.pdf. Neither the annual cash deductible nor the 20
percent coinsurance for Medicare apply to the specimen collection fees
or travel allowance for laboratory tests.
This IFC is establishing the following changes to the specimen
collection fee policy for the duration of the PHE for the COVID-19
pandemic. We will provide for Medicare payment of a nominal specimen
collection fee and associated travel allowance to independent
laboratories for collection of specimens related to COVID-19 clinical
diagnostic laboratory testing for homebound and non-hospital
inpatients. Stakeholders have informed us that access to COVID-19
testing in facilities especially is limited due to the resource costs
associated with acquiring the samples in a manner that prevents
exposure for patients and health care workers. With patients confined
to their homes for their own safety or the safety of others, there is
an additional need to have patients tested in their homes and minimize
exposure to others. We believe that providing a specimen collection fee
for COVID-19 testing during the PHE will provide independent
laboratories with additional resources to provide this testing and at
the same time help with efforts to limit patients' exposure to the
general population and alleviate patients' unease with leaving the
home.
Under this policy, the nominal specimen collection fee for COVID-19
testing for homebound and non-hospital inpatients generally will be
$23.46 and for individuals in a SNF or individuals whose samples will
be collected by laboratory on behalf of an HHA will be $25.46.
Medicare-enrolled independent laboratories can bill Medicare for the
specimen collection fee using one of two new HCPCS codes for specimen
collection for COVID-19 testing and bill for the travel allowance with
the current HCPCS codes set forth in section 60.2 of the Medicare
Claims Processing Manual (P9603 and P9604). Our policy will also
incorporate the clarification in the definition of homebound as
discussed in section II.F. of this IFC, relating to the clarification
of homebound status under the Medicare home health benefit.
In establishing a nominal fee for COVID-19 specimen collection, we
considered the type of trained laboratory personnel required to collect
the specimen and the resources this type of collection could require.
As noted previously, the current specimen collection fee HCPCS codes on
the CLFS for homebound and non-hospital inpatients are $3 and $5, but
we recognize that these fees are not intended to address additional
resources needed during the PHE for the COVID-19 pandemic. Absent
concrete information regarding the costs associated with independent
laboratories collecting such specimens for COVID-19 tests in the
context of the PHE, we looked to similar services in other settings of
care as a potential benchmark. In looking at other Medicare payment
systems, we believe the PFS is the best source for a potential payment
amount since physicians and other practitioners often bill for services
that involve specimen collection by trained, non-institutional staff.
Under the PFS, a Level 1 office visit (CPT code 99211) typically
does not require the presence of a physician or other qualified health
care professional and the usual presenting problem(s) are minimal. This
code is what is typically reported by physician practices when the
patient only sees clinical office staff
[[Page 19257]]
for services like acquiring a routine specimen sample. CPT code 99211,
describes an:
Office visit for E/M of an established patient that may be
performed by clinical staff under supervision (may not require a
physician's presence). Usually the presenting problem(s) are minimal
and typically 5 minutes are spent supervising or performing the
service.
The CY 2020 national PFS payment amount for Level 1 established
patient office visits is $23.46 on the PFS. We also considered
establishing a higher payment amount that considered the Level 1 E/M
visit plus the payment amount for CPT code 89220, Sputum obtaining
specimen aerosol induced technique, for a specimen collection fee of
$40.06, but we believe there is likely overlapping costs in staff time
for these two services and the Level 1 office visit payment rate is
adequate.
For initial diagnostic testing for COVID-19, the CDC issued interim
guidelines that recommend collecting and testing for the virus using an
upper respiratory nasopharyngeal swab (NP). The CDC guidance also
states that collection of oropharyngeal swabs (OP) is a lower priority
and if collected should be combined in the same tube as the NP. The CDC
guidance advises that collection of sputum should only be done for
those patients with productive coughs. See https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html. Similar
collection method types, that is, NP or OP swabs are also used in other
laboratory developed tests for COVID-19.
Section 1833(h)(3) of the Act does not specifically describe the
types of specimen collection methods that are eligible for the nominal
fee and transportation and personnel expenses. However, section
1833(h)(3)(B) of the Act does refer to ``trained personnel'' that would
collect the sample from homebound individuals and inpatients in non-
hospital inpatient facilities. This suggests that to be medically
necessary and for payment to be made for sample collection, the method
of sample collection must require some training or skill on the part of
the laboratory technician and cannot be conducted by the beneficiary,
the beneficiary's caregiver, or facility staff if the facility does not
have a laboratory, and therefore, is using an outside laboratory to
perform its testing of patients. The Medicare Claims Processing Manual
provides additional guidance on the medical necessity requirements for
specimen collection. Specifically, the manual states that ``Medicare
allows payment for a specimen collection fee when it is medically
necessary for a laboratory technician to draw a specimen from either a
nursing home patient or homebound patient'' and that ``the technician
must personally draw the specimen.'' It also states that ``[t]his fee
will not be paid to anyone who has not extracted the specimen'' and
lists ``venipuncture or urine sample by catheterization'' as examples
of a technician personally drawing the specimen. The manual further
clarifies what it means for a specimen collection to be medically
necessary stating that ``. . .where the specimen is a type that would
require only the services of a messenger and would not require the
skills of a laboratory technician, for example, urine or sputum, a
specimen pickup service would not be considered medically necessary.''
We note that venipuncture and urine sample by catheterization are
currently provided in the Medicare Claims Processing Manual as examples
of a technician personally drawing a specimen, however, they are not an
exhaustive list of all possible scenarios that require trained
personnel to collect a specimen. In the case of collecting a specimen
for COVID-19 testing, we believe that in the context of and for the
duration of the PHE for the COVID-19 pandemic, collecting specimens
using NP or OP swabs or collection of sputum will require a trained
laboratory professional, as well as additional precautions that must be
taken to minimize exposure risks in handling specimens that are
suspected or confirmed for COVID-19. Thus, we believe that collecting a
specimen for COVID-19 testing will incur higher costs than similar
specimen collection services which require a trained laboratory
professional but not additional precautions, to minimize exposure
risks. The CDC advises that specimen collection must be performed
correctly the first time the specimen is collected. A focus of the
response to the PHE for the COVID-19 pandemic is to quickly identify
individuals who are infected so that appropriate treatment for the
patients being tested is provided in a timely manner. At the same time,
another goal is to appropriately isolate those patients and quarantine
those exposed to the patients to prevent further spread of the virus.
We believe laboratory personnel will need to be trained on how to
handle the specimen to maximize accurate test results for COVID-19.
Laboratory personnel also will need to be trained on how to minimize
risks for spreading the virus to themselves and/or others in the chain
of handling the specimen before it arrives at the laboratory for
analysis. The CDC guidance states that specimens should be collected as
soon as possible once a person under investigation (PUI) is identified,
regardless of the time of symptom onset, and that proper infection
control must be maintained when collecting specimens. We believe that
specimens for COVID-19 testing using NP, OP, or sputum must be
collected by trained laboratory personnel, and the specimens are a type
that would not require only the services of a messenger or specimen
pick up service. The manual currently lists collection of sputum as a
type that would require only the services of a messenger, and
therefore, is not considered medically necessary. However, for the PHE
for the COVID-19 pandemic only, we believe a specimen collection fee
for sputum collection would be warranted and medically necessary due to
the reasons discussed previously. If in the future other types of
COVID-19 tests are available, such as serological tests or point of
care tests, we note that the specimen collection fee would apply if the
specimen collection method must be performed by trained laboratory
personnel. However, COVID-19 tests that allow patients to collect the
specimen themselves would not be eligible for the specimen collection
fee.
To identify specimen collection for COVID-19 testing, we are
establishing two new level II HCPCS codes. Independent laboratories
must use one of these HCPCS codes when billing Medicare for the nominal
specimen collection fee for COVID-19 testing for the duration of the
PHE for the COVID-19 pandemic. These new HCPCS codes are:
G2023, specimen collection for severe acute respiratory
syndrome coronavirus [hairsp]2 (SARS-CoV-2) (Coronavirus disease
[COVID-19]), any specimen source.
G2024, specimen collection for severe acute respiratory
syndrome coronavirus [hairsp]2 (SARS-CoV-2) (Coronavirus disease
[COVID-19]), from an individual in a SNF or by a laboratory on behalf
of a HHA, any specimen source.
We created the second Level II HCPCS code, G2024, because section
1834A(b)(5) of the Act and our regulations at Sec. 414.507(f) require
a higher fee for collecting a specimen from an individual in a SNF or
by a laboratory on behalf of an HHA, as described previously in this
section of the IFC. We will issue guidance when the PHE for the COVID-
19 pandemic is over and when these codes are no longer valid and
terminated in the HCPCS file and/or the CLFS as appropriate.
[[Page 19258]]
In addition, Medicare payment for transportation and expenses for
trained personnel to collect specimens from homebound patients (as
discussed in section II.F. of this IFC, relating to the clarification
of homebound status under the Medicare home health benefit) and
inpatients (not in a hospital) for purposes of COVID-19 testing will be
made in accordance with existing instructions found in the Medicare
Claims Processing Manual. Independent laboratories must use the
existing level II HCPCS codes when billing for the travel allowance,
that is, the per mile travel allowance as described by HCPCS code P9603
and the flat rate travel allowance as described by HCPCS code P9604.
Additionally, we are clarifying that paper documentation of miles
traveled is not required and laboratories can maintain electronic logs
with that information. However, laboratories will need to be able to
produce these electronic logs in a form and manner that can be shared
with MACs. As stated previously, we have heard from stakeholders that
maintaining paper logs of miles is burdensome, especially with the
development of GPS systems and various applications for cellular phones
in recent years that can track miles traveled. Thus, we are clarifying
that there is no requirement that laboratories maintain logs on paper
to document travel, and that laboratories may use digital documentation
of this information if preferred. The MACs may provide more information
on acceptable formats.
In defining an individual who is homebound for purposes of the
specimen collection fee and the travel allowance under section
1833(h)(3) of the Act, the manual refers to Chapters 7 and 15 of Pub.
100-02, the Medicare Benefit Policy Manual. The definition of
``homebound'' in Chapters 7 and 15 of Pub. 100-02 originate from the
statutory definition of ``confined to the home'' (that is,
``homebound'') under sections 1814(a) and 1835(a) of the Act. As
discussed in section II.F. of this IFC, relating to the clarification
of homebound status under the Medicare home health benefit patients are
considered ``confined to the home'' (that is, ``homebound'') if it is
medically contraindicated for the patient to leave the home. When it is
medically contraindicated for a patient to leave the home, there exists
a normal inability for an individual to leave home and leaving home
safely would require a considerable and taxing effort.
As an example for the PHE for COVID-19 pandemic, this would apply
for those patients: (1) Where a physician has determined that it is
medically contraindicated for a beneficiary to leave the home because
he or she has a confirmed or suspected diagnosis of COVID-19; or (2)
where a physician has determined that it is medically contraindicated
for a beneficiary to leave the home because the patient has a condition
that may make the patient more susceptible to contracting COVID-19. A
patient who is exercising ``self-quarantine'' for his or her own
safety, would not be considered ``homebound'' unless it is also
medically contraindicated for the patient to leave the home.
Determinations of whether the patient is homebound must be based on an
assessment of each beneficiary's individual condition. For the PHE for
the COVID-19 pandemic, the CDC is currently advising that older adults
and individuals with serious underlying health conditions stay home
(CDC's guidance is interim and is expected to continue to be updated as
warranted).\14\ As such, during the PHE for the COVID-19 pandemic, we
expect that many Medicare beneficiaries could be considered
``homebound''. In light of this clarification regarding the definition
of homebound, we are noting this clarification pertains to the specimen
collection fee and travel allowance in the PHE for COVID-19 pandemic
testing for homebound patients; that is, a patient is considered
homebound for purposes of the fees under sections 1833(h)(3) and
1834A(b)(5) of the Act if it is medically contraindicated for the
patient to leave home.
---------------------------------------------------------------------------
\14\ https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html.
---------------------------------------------------------------------------
In summary, to address the PHE for the COVID-19 pandemic, we are
using this IFC as a vehicle to provide additional payment during the
PHE in the form of a specimen collection fee of $23.46 generally, and
$25.46 for an individual in a SNF or by a laboratory on behalf of a
HHA, for COVID-19 testing and to provide a travel allowance for a
laboratory technician to collect a specimen for COVID-19 testing from a
non-hospital inpatients or homebound patients under section 1833(h)(3)
of the Act.
N. Requirements for Opioid Treatment Programs (OTP)
In the CY 2020 PFS final rule (84 FR 62645 and 62646), we finalized
allowing the use of interactive two-way audio/video communication
technology to furnish the counseling and therapy portions of the weekly
bundle of services furnished by OTPs. In light of the PHE for the
COVID-19 pandemic, during which the public has been instructed to
practice self-isolation or social distancing, and because interactive
audio-video communication technology may not be available to all
beneficiaries, we are revising Sec. 410.67(b)(3) and (4) to allow the
therapy and counseling portions of the weekly bundles, as well as the
add-on code for additional counseling or therapy, to be furnished using
audio-only telephone calls rather than via two-way interactive audio-
video communication technology during the PHE for the COVID-19 pandemic
if beneficiaries do not have access to two-way audio/video
communications technology, provided all other applicable requirements
are met. We believe this change is necessary to ensure that
beneficiaries with opioid use disorders are able to continue to receive
these important services during the current PHE.
O. Application of Teaching Physician and Moonlighting Regulations
During the PHE for the COVID-19 Pandemic
a. Background
In context of the PHE for the COVID-19 pandemic, we have been asked
by stakeholders to relax supervision requirements related to the
provision of teaching physician services under the PFS. For teaching
physicians, section 1842(b) of the Act specifies that in the case of
physicians' services furnished to a patient in a hospital with a
teaching program, the Secretary shall not provide payment for such
services unless the physician renders sufficient personal and
identifiable physicians' services to the patient to exercise full,
personal control over the management of the portion of the case for
which payment is sought. We have also been asked to allow residents to
independently furnish services in their capacity as fully licensed
physicians outside of the scope of their approved GME residency in the
inpatient setting of the hospital at which they provide services.
b. Revisions to Teaching Physician Regulations During a PHE for the
COVID-19 Pandemic
Regulations regarding PFS payment for teaching physician services
and moonlighting are codified in 42 CFR part 415. Under Sec. 415.172,
if a resident participates in a service furnished in a teaching
setting, PFS payment is made only if the teaching physician is present
during the key portion of any service or procedure for which payment is
sought. The provisions in Sec. 415.174 exempt certain office/
outpatient E/M services provided in the outpatient department of a
hospital or another ambulatory care
[[Page 19259]]
entity (that is, primary care centers) from the physical presence
requirement for the key portion of the service, pending all provisions
of the regulation are met. The regulations in Sec. 415.180 state that
for the interpretation of diagnostic radiology and other diagnostic
tests, PFS payment is made if the interpretation is performed or
reviewed by a physician other than a resident. For Sec. 415.184, the
requirement for the presence of the teaching physician during
psychiatric services in which a resident is involved may be met by
observation of the service by use of a one-way mirror, video equipment,
or similar device.
In context of the PHE for the COVID-19 pandemic, teaching hospitals
have expressed a need to increase their capacity to respond to the PHE
for the COVID-19 pandemic because there has been increased demand for
physicians to respond to patient needs. For example, we have been asked
by stakeholders to allow Medicare to make payment under the PFS for
services billed by teaching physicians when residents have furnished
the entirety of a service in the inpatient setting in the area of their
approved GME program and have a teaching physician review and sign off
on the service, rather than requiring the teaching physician be
physically present for the key portion of the service.
Given the circumstances of the PHE for the COVID-19 pandemic, we
believe that the requirements for the physical presence of the teaching
physician during the key portion of the service would necessarily limit
access to services paid under the PFS. We recognize that in some cases,
the physical proximity of the physician might present additional
exposure risks, especially for high risk patients isolated for their
own protection or in cases where the teaching physician and/or the
resident has been exposed to the virus and must be under quarantine, or
who may be at home caring for family members or providing childcare. If
the teaching physician and/or the resident is under quarantine or at
home, it could unintentionally limit the number of licensed
practitioners available to furnish services to Medicare patients and
could have the unintended consequence of limiting access to services
paid under the PFS.
To increase the capacity of teaching settings to respond to the PHE
for the COVID-19 pandemic as more practitioners are increasingly being
asked to assist with the COVID-19 response, on an interim basis, for
the duration of the PHE for the COVID-19 pandemic, we are amending the
teaching physician regulations to allow that as a general rule under
Sec. 415.172, the requirement for the presence of a teaching physician
can be met, at a minimum, through direct supervision by interactive
telecommunications technology, as described in section II.E. of this
IFC. In other words, the teaching physician must provide supervision
either with physical presence or be present through interactive
telecommunications technology during the key portion of the service.
Specifically, we believe that when use of such real-time, audio and
video telecommunications technology allows for the teaching physician
to interact with the resident through virtual means, their ability to
furnish assistance and direction could be met without requiring the
teaching physician's physical presence for the key portion of the
service.
Currently, under the primary care exception in Sec. 415.174,
certain lower and mid-level office/outpatient E/M services provided in
primary care centers are exempt from the physical presence requirement
for the key portion of the service. The teaching physician must direct
the care from such proximity as to constitute immediate availability
(that is, provide direct supervision). In context of the PHE for the
COVID-19 pandemic, the teaching physician may be under quarantine or
otherwise at home, or the physical proximity of the teaching physician
might present additional exposure risks. Additionally, during the PHE
for the COVID-19 pandemic, more patients may present with more complex
needs, such as an underlying condition that places them at high risk
for COVID-19 and that necessitate a high level office/outpatient E/M
service (that is, level 4 or 5 visit). Consequently, on an interim
basis, for the duration of the PHE for the COVID-19 pandemic, we are
amending Sec. 415.174 to allow that all levels of an office/outpatient
E/M service provided in primary care centers may be provided under
direct supervision of the teaching physician by interactive
telecommunications technology. We believe use of real-time, audio and
video telecommunications technology allows for the teaching physician
to interact with the resident through virtual means, and thus would
meet the requirement for teaching physician presence for office/
outpatient E/M services furnished in primary care centers. For Sec.
415.180, for the duration of the PHE for the COVID-19 pandemic, we will
allow PFS payment to be made for the interpretation of diagnostic
radiology and other diagnostic tests when the interpretation is
performed by a resident under direct supervision of the teaching
physician by interactive telecommunications technology. The teaching
physician must still review the resident's interpretation. For Sec.
415.184, for the duration of the PHE for the COVID-19 pandemic, the
requirement for the presence of the teaching physician during the
psychiatric service in which a resident is involved may be met by the
teaching physician's direct supervision by interactive
telecommunications technology. For both Sec. Sec. 415.180 and 415.184,
allowing residents to furnish these services under direct supervision
of the teaching physician by interactive telecommunications technology
would allow for the presence requirement to be met. These diagnostic
radiology, diagnostic tests, and psychiatry services could continue to
be provided to patients that need them in the event the teaching
physician is in quarantine or otherwise at home, or where the physical
proximity of the teaching physical might present additional exposure
risk.
The regulations describing PFS payment for teaching physician
services do have additional exceptions for specific policies. For
example, as described in Sec. 415.172, in the case of surgical, high-
risk, or other complex procedures, the teaching physician must be
present during all critical portions of the procedure and immediately
available to furnish services during the entire service or procedure.
In the case of procedures performed through an endoscope, the teaching
physician must be present during the entire viewing. As described in
Sec. 415.178 for anesthesia services, the teaching anesthesiologist
must be present during all critical or key portions of the anesthesia
service or procedure involved and the teaching anesthesiologist must be
immediately available to furnish anesthesia services during the entire
procedure. Given the complex nature of these procedures and the
potential danger to the patient, even in the context of the PHE for the
COVID-19 pandemic and the inherent exposure risks for patients and
physicians, we believe that the requirements for physical presence for
either the entire procedure or the key portions of the service,
whichever are applicable, are necessary for patient safety. Thus, the
PHE for the COVID-19 pandemic exceptions previously described will not
apply in the case of surgical, high risk, interventional, or other
complex procedures, services performed through an endoscope, and
anesthesia services. We seek comment
[[Page 19260]]
on whether other procedures should also be exempt from this policy
given the complex nature or potential danger to the patient.
Collectively, the flexibilities described for Sec. Sec. 415.172,
415.174, 415.180, and 415.184 are intended to ensure there are as many
qualified practitioners as possible. They are also intended to minimize
the number of people coming into contact with one another by removing
the need for in-person direct supervision. We view direct supervision
by interactive telecommunications technology as the minimum requirement
for provision of the service for purposes of Medicare payment. However,
teaching physicians may continue to exercise their clinical judgment to
decide whether it is appropriate to utilize these flexibilities in
furnishing their services involving residents. We also seek comment on
our belief that direct supervision by interactive telecommunications
technology is appropriate in the context of this PHE, as well as
whether any guardrails should be included, and how it balances risks
that might be introduced for beneficiaries with reducing exposure risk
and the increased spread of the disease, in the context of this PHE.
c. Application of the Expansion of Telehealth Services to Teaching
Physician Services
On March 17, 2020, we announced the expansion of telehealth
services on a temporary and emergency basis pursuant to waiver
authority added under section 1135(b)(8) by the Coronavirus
Preparedness and Response Supplemental Appropriations Act.\15\ Starting
on March 1, 2020, Medicare can pay for telehealth services, including
office, hospital, and other visits furnished by physicians and other
practitioners to patients located anywhere across the country including
in a patient's place of residence. We have been asked by stakeholders
to clarify whether this expansion applies to teaching physician
services, including those furnished under the primary care exception.
We believe that allowing Medicare payment for services billed by the
teaching physician when the resident is furnishing services, including
office/outpatient E/M services provided in primary care centers, via
telehealth under direct supervision by interactive telecommunications
technology would allow residents to furnish services remotely to
patients who may need to be isolated for purposes of exposure risk
based on presumed or confirmed COVID-19 infection, and as a result,
would increase access to services for patients. To increase the
capacity of teaching settings to respond to the PHE for the COVID-19
pandemic as more practitioners are increasingly being asked to assist
with the COVID-19 response, we believe that, for telehealth services
involving residents, the requirement that a teaching physician be
present for key portions of the service can be met through virtual
means. We also believe same is true for telehealth services furnished
by the resident in primary care centers. The use of real-time, audio
and video telecommunications technology allows for the teaching
physician to interact with the resident through virtual means while the
resident is furnishing services via telecommunications technology, and
thus, in the circumstances of the PHE, would meet the requirement for
teaching physician presence for office/outpatient E/M services
furnished in primary care centers. Consequently, on an interim basis
for the duration of the PHE for the COVID-19 pandemic, we are revising
our regulations to specify that Medicare may make payment under the PFS
for teaching physician services when a resident furnishes telehealth
services to beneficiaries under direct supervision of the teaching
physician which is provided by interactive telecommunications
technology. Additionally, on an interim basis, for the duration of the
PHE for the COVID-19 pandemic, Medicare may make payment under the PFS
for services billed under the primary care exception by the teaching
physician when a resident furnishes telehealth services to
beneficiaries under the direct supervision of the teaching physician by
interactive telecommunications technology. We also seek comment on our
belief that direct supervision by interactive telecommunications
technology is appropriate in the context of this PHE, as well as
whether and how it balances risks that might be introduced for
beneficiaries with reducing exposure risk and the increased spread of
the disease, in the context of this PHE.
---------------------------------------------------------------------------
\15\ https://www.cms.gov/newsroom/press-releases/president-trump-expands-telehealth-benefits-medicare-beneficiaries-during-covid-19-outbreak.
---------------------------------------------------------------------------
d. Payment Under the PFS for Teaching Physician Services When Resident
Under Quarantine
There also may be circumstances in which the resident may need to
furnish services while under quarantine (for example, while at home).
We have been asked by stakeholders if residents who have been exposed
to COVID-19 and are under quarantine, and otherwise well and able to
work, are able to furnish services that do not require face-to-face
patient care, such as reading the results of tests and other imaging
studies. Because current regulations require the physical presence of
the teaching physician during the key portion of the service, residents
would not be able to furnish services from quarantine, which could
limit the number of licensed practitioners available to furnish
services to Medicare patients and could have the unintended consequence
of limiting access to services paid under the PFS. Because we are
amending the teaching physician regulations to allow that as a general
rule under Sec. 415.172, the requirement for the presence of a
teaching physician can be met through direct supervision by interactive
telecommunications technology, on an interim basis, for the duration of
the PHE for the COVID-19 pandemic, Medicare may also make payment under
the PFS for teaching physician services when the resident is furnishing
these services while in quarantine under direct supervision of the
teaching physician by interactive telecommunications technology. We
believe this policy will limit exposure to COVID-19 and to allow for
the continued access to physicians' services of residents while in
quarantine.
e. Revisions to Moonlighting Regulations During a PHE for the COVID-19
Pandemic
A licensed resident physician is considered to be ``moonlighting''
when they furnish physicians' services to outpatients outside the scope
of an approved graduate medical education (GME) program. Under current
regulations, the services of residents in hospitals in which the
residents have their approved GME program are not considered separately
billable as physicians' services and instead are payable under
Sec. Sec. 413.75 through 413.83 regarding direct GME payments, whether
or not the services are related to the approved GME training program.
When a resident furnishes services that are not related to their
approved GME programs in an outpatient department or emergency
department of a hospital in which they have their training program,
those services can be billed separately as physicians' services and
payable under the PFS if they meet the criteria described in our
regulation at Sec. 415.208(b)(2).
In light of the PHE for the COVID-19 pandemic, teaching hospitals
need to secure as much physician coverage as possible because there has
been increased demand for physicians to
[[Page 19261]]
respond to patient needs, such as furnishing services to patients in
inpatient settings who have either a presumed or confirmed COVID-19
infection. Stakeholders have requested that residents be able to
furnish physicians' services to patients in the inpatient setting
outside of the scope of their approved GME programs in the hospital
where they have their training.
We believe that our regulation at Sec. 415.208(b), which limits
the scope of services that can be separately billable by moonlighting
residents when furnished outside their approved GME programs to
patients in an outpatient department or emergency department of a
hospital in which they have their training program, does not adequately
meet the needs of teaching hospitals to ensure there are as many
qualified practitioners available as possible given the circumstances
of the PHE for the COVID-19 pandemic. Under current policy, for
example, a resident in a hospital's approved GME program for anesthesia
who typically furnishes only anesthesia-related services in an
operating room would not be able to provide separately billable
physicians' services when treating inpatients in the intensive care
unit for COVID-19 infection, even if these services were not part of
the resident's approved GME program. As a result, this regulation could
unintentionally limit the number of licensed practitioners available to
furnish services to Medicare patients and could have the unintended
consequence of limiting access to critically needed care. Consequently,
on an interim basis, for the duration of the PHE for the COVID-19
pandemic, we are amending our regulation in Sec. 415.208 to state that
the services of residents that are not related to their approved GME
programs and are performed in the inpatient setting of a hospital in
which they have their training program are separately billable
physicians' services for which payment can be made under the PFS
provided that the services are identifiable physicians' services and
meet the conditions of payment for physicians' services to
beneficiaries in providers in Sec. 415.102(a), the resident is fully
licensed to practice medicine, osteopathy, dentistry, or podiatry by
the State in which the services are performed, and the services are not
performed as part of the approved GME program.
P. Special Requirements for Psychiatric Hospitals (Sec. 482.61(d))
In the June 16, 2016 Federal Register, we published the ``Medicare
and Medicaid Programs; Hospital and Critical Access Hospital (CAH)
Changes To Promote Innovation, Flexibility, and Improvement in Patient
Care'' proposed rule (81 FR 39447), which outlined a number of proposed
hospital and CAH Condition of Participation (CoP) requirements,
including those focused on infection control, antibiotic use, and scope
of practice for NPPs (that is, advanced practice providers (APPs) such
as PAs, NPs, psychologists, and CNSs, as well as other qualified,
licensed practitioners to whom this revision might also be applicable).
Subsequently, in the September 30, 2019 Federal Register, we
published the ``Medicare and Medicaid Programs; Hospital and Critical
Access Hospital (CAH) Changes To Promote Innovation, Flexibility, and
Improvement in Patient Care'' final rule (84 FR 51775) that finalized
several of these proposed changes to modernize the hospital and CAH
requirements, improve quality of care, and support HHS and CMS
priorities. In that final rule, we deleted the modifying term
``independent'' from the Patient's Rights CoP at 42 CFR 482.13(e)(5)
and (e)(8)(ii) regarding which practitioners may order the use of
restraints and seclusion. These revisions to the regulatory text were
intended to finally make the language of the hospital CoPs consistent
with the language of the Children's Health Act of 2000 (CHA) (Pub. L.
106-310, enacted October 17, 2000) regarding restraint and seclusion
orders and licensed practitioners, and upon which the CoP language was
originally intended to be based. Additionally, and to remain consistent
throughout this CoP, we revised Sec. 482.13(e)(10) and (11),
(e)(12)(i)(A), (e)(14), and (g)(4)(ii) that contained the term
``licensed independent practitioner'' by changing the term from
``licensed independent practitioner'' to simply ``licensed
practitioner.''
In the final rule, we stated that the revision reflected our goal
to have health professionals operate within the scope of practice
allowed by state law, and that it also recognized the need to fully
utilize the healthcare workforce. We also stated that we believe that
this change will reduce unnecessary burden for hospitals and remove
obstacles APPs face when ordering seclusion and restraints. However, we
stated that we disagreed with the commenters who stated that the
removal of the term ``independent'' will cause confusion over the
applicability of this requirement. Our removal of the term
``independent'' is consistent with the language used in the CHA, which
utilizes the term ``other licensed practitioner,'' without the
independent modifying term. In addition, the order of restraint or
seclusion must be ordered by a licensed practitioner who is authorized
by hospital policy in accordance with State law to do so.
In the September 30, 2019 final rule, we made additional revisions
to address other areas of the hospital CoPs that we viewed as being
either conflicting with, or more stringent than, existing state scope-
of-practice laws and licensing requirements, and which, if
appropriately revised, would give APPs greater flexibility to practice
more broadly in the current healthcare system while still being in
accordance with respective state scope-of-practice laws.
Therefore, in our review of the Hospital CoPs for the proposed
rule, we discovered that there were several provisions that incorrectly
reference Sec. 482.12(c)(1), which lists the types of physicians and
applies only to patients who are Medicare beneficiaries. Section
482.12(c) states that the governing body of the hospital must ensure
that every Medicare patient is under the care of one of the following
practitioners:
A doctor of medicine or osteopathy;
A doctor of dental surgery or dental medicine who is
legally authorized to practice dentistry by the State and who is acting
within the scope of his or her license;
A doctor of podiatric medicine, but only with respect to
functions which he or she is legally authorized by the State to
perform;
A doctor of optometry who is legally authorized to
practice optometry by the State in which he or she practices;
A chiropractor who is licensed by the State or legally
authorized to perform the services of a chiropractor, but only with
respect to treatment by means of manual manipulation of the spine to
correct a subluxation demonstrated by X-ray to exist; and
A clinical psychologist as defined in Sec. 410.71, but
only for a clinical psychologist services as defined in Sec. 410.71
and only to the extent permitted by State law.
The reference of this ``Medicare beneficiary-only'' requirement in
certain other provisions of the hospital CoPs (which we have listed
below) inappropriately links it to all patients and not Medicare
beneficiaries exclusively. In fact, per section 1861(e)(4) of the Act,
every patient with respect to whom payment may be made under this title
must be under the care of a physician except that a patient receiving
qualified psychologist services (as defined in subsection (ii)) may be
under the care of a clinical psychologist with respect to such services
to the extent permitted under State law. In
[[Page 19262]]
accordance with that provision, we have chosen to apply Sec. 482.12(c)
to Medicare patients. With the exception of a few provisions in the
CoPs such as those directly related to Sec. 482.12(c) described here,
the remainder of the CoPs apply to all patients, regardless of payment
source, and not just Medicare beneficiaries. For example, the Nursing
Services CoP, at Sec. 482.23(c)(1), requires that all drugs and
biologicals must be prepared and administered in accordance with
Federal and State laws, the orders of the practitioner or practitioners
responsible for the patient's care as specified under Sec. 482.12(c),
and accepted standards of practice. Since the CoPs clearly allow
hospitals to determine which categories of practitioners would be
responsible for the care of other patients, outside the narrow Medicare
beneficiary restrictions of Sec. 482.12(c), this reference is
inappropriate and unnecessarily restrictive of hospitals and their
medical staffs to make these determinations based on State law and
practitioner scope of practice.
To clarify that these provisions apply to all patients and not only
Medicare beneficiaries, we deleted any inappropriate references to
Sec. 482.12(c) in the final rule. Therefore, we deleted references to
Sec. 482.12(c) found in the following provisions: Sec. 482.13(e)(5),
(e)(8)(ii), (e)(14), and (g)(4)(ii) in the Patients' Rights CoP; and
Sec. 482.23(c)(1) and (3) in the Nursing Services CoP. We note here
that we did not receive any comments on these changes as they proposed
in the June 2016 proposed rule, and therefore, we finalized them
without change.
In performing our most recent review of the hospital CoPs,
including the Requirements for Specialty Hospitals at subpart E of 42
CFR part 482, we discovered that we inadvertently failed to propose to
delete another inappropriate reference to Sec. 482.12(c), which is
contained in the current provision at Sec. 482.61(d) in the Special
Medical Record Requirements for Psychiatric Hospitals CoP (pertaining
to which hospital personnel may complete progress notes for patients).
The current provision also contains the term ``licensed independent
practitioner.'' Therefore, in the interests of consistency with the
other recent revisions we have noted here, we are now deleting the
reference to Sec. 482.12(c) along with the modifier ``independent'' in
this IFC.
We believe that as currently written and implemented, this
requirement requires some clarification for the reasons that we have
discussed. As we have already stated and made clear through our recent
revisions to the hospital CoPs, we believe that APPs, including PAs,
NPs, psychologists, and CNSs (as well as other qualified, licensed
practitioners to whom this revision might also be applicable), when
acting in accordance with State law, their scope of practice, and
hospital policy, should have the authority to practice more broadly and
to the highest level of their education, training, and qualifications
as allowed under their respective state requirements and laws in this
area.
We believe that NPPs practicing in the psychiatric hospital setting
should be able to record progress notes of psychiatric patients for
whom they are responsible. Therefore, we will allow the use of NPPs, or
APPs, to document progress notes of patients receiving services in
psychiatric hospitals, in addition to MDs/DOs as is currently allowed.
Given the changes made to the requirements under Sec. 482.13
regarding the removal of the word ``independent'' from the phrase
``licensed independent practitioner'' when referencing NPPs that we
have previously discussed, we are making the same change for this
provision. We believe that the regulatory language should be as
consistent as possible throughout the hospital CoPs and, in addition,
as was the case with the requirement under Sec. 482.13, using the term
``licensed independent practitioner'' may inadvertently exacerbate
workforce shortage concerns, might unnecessarily impose regulatory
burden on hospitals by restricting a hospital's ability to allow APPs
and other NPPs to operate within the scope of practice allowed by state
law, and does not recognize the benefits to patient care that might be
derived from fully utilizing APPs and their clinical skills to the
highest levels of their training, education, and experience as allowed
by hospital policy in accordance with state law. We believe that this
change permits a greater scope of practice for these professionals in
the psychiatric hospital context.
Q. Innovation Center Models
1. Medicare Diabetes Prevention Program (MDPP) Expanded Model Emergency
Policy
Through this IFC, we are amending the Medicare Diabetes Prevention
Program (MDPP) expanded model to modify certain MDPP policies during
the PHE. Specifically, this IFC will permit certain beneficiaries to
obtain the set of MDPP services more than once per lifetime, increase
the number of virtual make-up sessions, and allow certain MDPP
suppliers to deliver virtual MDPP sessions on a temporary basis. These
changes are in response to COVID-19, which resulted in an interruption
to expanded model services delivered by MDPP suppliers and/or prevented
MDPP beneficiaries from attending sessions. Throughout the rulemaking
for the MDPP expanded model, we sought to ensure that the MDPP set of
services would be delivered in-person, in a classroom based setting,
within an established timeline. At the time, the priority was placed on
establishing a structured service that, when delivered within the
confines of the rule, would create the least risk of fraud and abuse,
increase the likelihood of success, and maintain the integrity of the
data collected for evaluation purposes. However, the COVID-19 pandemic
has led to suspension of in-person class sessions and guidance from CDC
that Medicare-age beneficiaries stay home. In response, we will
implement provisions that allow for temporary flexibilities that
prioritize availability and continuity of services for MDPP suppliers
and MDPP beneficiaries impacted by extreme and uncontrollable
circumstances during the COVID-19 PHE. The changes in this IFC are
applicable to MDPP suppliers, as defined in Sec. 410.79(b), that are
enrolled in MDPP as March 1, 2020, and MDPP beneficiaries as defined in
Sec. 410.79(b) who were receiving MDPP set of services as of March 1,
2020. Under these temporary flexibilities, the requirement for in-
person attendance at the first core-session will remain in effect. As a
result, if beneficiaries are prohibited from attending the first core
session in person, suppliers will be unable to start any new cohorts
with MDPP beneficiaries. All flexibilities described in this IFC will
cease to be available at the conclusion of the PHE. The CDC issued
guidance to all National Diabetes Prevention Program suppliers on or
about March 12, 2020, providing alternative delivery options during the
COVID-19 national emergency, including encouraging organizations to use
virtual make-up sessions as necessary, regardless of usual delivery
mode; if virtual make-up sessions are not possible, organizations may
pause offering classes. When classes resume, the CDC is allowing
suppliers to pick up where they left off, or to restart the expanded
model program from week one. It is our intent to conform with the CDC
guidance where feasible, with the overall intent to minimize disruption
of services for MDPP suppliers and MDPP beneficiaries; by allowing MDPP
beneficiaries to maintain their
[[Page 19263]]
eligibility. We are amending the MDPP regulations to provide for
certain changes, including allowing MDPP suppliers to either deliver
MDPP services virtually or suspend in-person services and resume
services at a later date. The limit to the number of virtual make-up
sessions is waived for MDPP suppliers with existing capabilities to
provide services virtually, so long as the virtual services are
furnished in a manner that is consistent with the CDC Diabetes
Prevention Recognition Program (DPRP) standards for virtual sessions,
follow the CDC-approved DPP curriculum requirements, and are provided
upon the individual MDPP beneficiary's request. In addition, the MDPP
supplier may only furnish to the MDPP beneficiary a maximum of one
session on the same day as a regularly scheduled session and a maximum
of one virtual make-up session per week. Virtual make-up sessions may
only be furnished to achieve attendance goals and may not be furnished
to achieve weight-loss goals. An MDPP supplier may offer to an MDPP
beneficiary no more than: 15 virtual make-up sessions offered weekly
during the core session period; 6 virtual make-up sessions offered
monthly during the core maintenance session interval periods; and 12
virtual make-up sessions offered monthly during the ongoing maintenance
session interval periods.
In addition, these changes permit certain MDPP beneficiaries to
obtain the set of MDPP services more than once per lifetime, for the
limited purposes of allowing a pause in service and to provide the
flexibilities that will allow MDPP beneficiaries to maintain
eligibility for MDPP services despite a break in service, attendance,
or weight loss achievement.
We are amending our provisions at Sec. 410.79 by adding paragraph
(e).
2. Changes to the Comprehensive Care for Joint Replacement (CJR) Model
To Extend the Length of Performance Year 5 by Three Additional Months
and To Change the Extreme and Uncontrollable Circumstances Policy To
Account for the COVID-19 Pandemic
Through this IFC, we are implementing two changes to the
Comprehensive Care for Joint Replacement (CJR) model to support the
continuity of model operations and to ensure that CJR participants do
not unfairly suffer financial consequences from the impact of COVID-19
due to their participation in CJR. Specifically, we are implementing a
3-month extension to CJR performance year (PY) 5 such that the model
will now end on March 31, 2021, rather than ending on December 31,
2020. On February 24, 2020, we published a proposed rule titled
``Medicare Program: Comprehensive Care for Joint Replacement Model
Three-Year Extension and Changes to Episode Definition and Pricing''
(85 FR 10516; CMS-5529-P). We wish to ensure continuity of CJR model
operations in participant hospitals during this PHE for the COVID-19
pandemic so that we do not create any additional disruptions to the
standard care procedures hospitals have in place during this
challenging time. Therefore, we are implementing a 3-month extension of
CJR PY 5 and amending the provisions at 42 CFR 510.2 and 510.200(a) to
reflect that extension.
Further, recognizing that the current CJR model policy for extreme
and uncontrollable circumstances policy is not applicable to the PHE
for the COVID-19 pandemic, we also are implementing a change to that
policy in this IFC such that it will be applicable to episodes impacted
by the COVID-19 pandemic. Currently, the CJR extreme and uncontrollable
circumstances policy, which is codified at Sec. 510.305(k), applies
only during major disaster declarations where a participant hospital
and its beneficiaries are affected by natural disasters, such as,
hurricanes, earthquakes, wildfires.\16\ Although the COVID-19 outbreak
in the United States was declared as a national emergency on March 13,
2020,\17\ the current CJR extreme and uncontrollable circumstances
policy does not apply to this national emergency. Although we do not
expect many new CJR episodes to initiate as we have recently issued
guidance \18\ stressing the need to avoid elective surgeries in light
of the COVID-19 virus, we recognize that a number of beneficiaries are
in active CJR episodes that initiated prior to March 2020. Further, we
acknowledge that CJR hip fracture episodes, which generally result from
emergent accidents and are not necessarily avoidable, will continue to
occur. Given the challenges to the health care delivery system in
responding to COVID-19 cases and the expenses associated with treating
this highly contagious virus, we want to avoid inadvertently creating
incentives to place cost considerations above patient safety within the
CJR model during this COVID-19 pandemic. Therefore, to enable the CJR
model to adjust for the effect of COVID-19, we are broadening the
extreme and uncontrollable circumstances policy by applying certain
financial safeguards to participant hospitals that have a CCN primary
address that is located in an emergency area for episodes that overlap
with the emergency period, as those terms are defined in section
1135(g) of the Act, for which the Secretary issued a waiver or
modification of requirements under section 1135 of the Act on March 13,
2020, which applies nationwide.\19\ Accordingly, all participant
hospitals are located in the emergency area and qualify for applicable
financial safeguards during the emergency period.
---------------------------------------------------------------------------
\16\ 82 FR 57066.
\17\ See: https://www.whitehouse.gov/presidential-actions/proclamation-declaring-national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/.
\18\ See: https://www.cms.gov/files/document/31820-cms-adult-elective-surgery-and-procedures-recommendations.pdf.
\19\ See https://www.phe.gov/emergency/news/healthactions/section1135/Pages/covid19-13March20.aspx.
---------------------------------------------------------------------------
Amending the extreme and uncontrollable circumstances policy to
account for all participant hospitals affected by the COVID-19 pandemic
allows participant hospitals to concentrate on patient care and ensures
that participant hospitals are not held financially liable for episode
costs that escalate due to effects from the COVID-19 pandemic. While
this amendment greatly broadens the extreme and uncontrollable
circumstances policy, the significant impact the health care delivery
system faces in responding to COVID-19 cases and the expenses
associated with treating this highly-contagious virus justifies
modifying the extreme and uncontrollable circumstances policy and
increasing the financial safeguards. Specifically, we are stating that
for a fracture or non-fracture episode with a date of admission to the
anchor hospitalization that is on or within 30 days before the date
that the emergency period (as defined in section 1135(g) of the Act)
begins or that occurs through the termination of the emergency period
(as described in section 1135(e) of the Act), actual episode payments
are capped at the target price determined for that episode under Sec.
[thinsp]510.300. Though different financial safeguards apply for
fracture and non-fracture episodes when a major disaster declaration is
declared, we believe applying equal financial safeguards for both
episodes during the COVID-19 pandemic is more appropriate due to its
nationwide impact on hospitals and post-acute care facilities ability
to provide care for beneficiaries during this PHE.
We are codifying these provisions at Sec. 510.305 (k)(3) and (4).
[[Page 19264]]
3. Alternative Payment Model Treatment Under the Quality Payment
Program
As has been described previously in this IFC, we are seeking to
give entities and individuals that provide services to Medicare
beneficiaries needed flexibilities to respond effectively to the
serious public health threats posed by the spread of the COVID-19, and
to address the needs of health care providers specific to this declared
national emergency. We further recognize that flexibilities may be
necessary and appropriate in the context of Alternative Payment Models
(APMs), including applicable model tests conducted under section 1115A
of the Act by the CMS Center for Medicare and Medicaid Innovation
(Innovation Center), as well as the Medicare Shared Savings Program. We
note that aspects of APM policies under the Quality Payment Program are
designed to follow on from the specific designs, policies, and
operations of individual APMs. We recognize that our current
regulations may be insufficient for purposes of adequately responding
to the still-emerging COVID-19 national emergency and that additional
action may be necessary and appropriate to prevent APM participants
from facing undue burden in or negative consequences through the
Quality Payment Program.
We acknowledge that possible changes might be needed to address
issues that may arise for APM participants in light of the current
emergency. We will consider undertaking additional rulemaking,
including possibly another interim final rule, to amend or suspend APM
QPP policies as necessary to ensure accurate and appropriate
application of Quality Payment Program policies in light of the PHE due
to COVID-19.
R. Remote Physiologic Monitoring
In recent years, we have finalized payment for seven CPT codes in
the Remote Physiologic Monitoring (RPM) code family. We finalized
payment in the CY 2018 PFS final rule for CPT code 99091 (Collection
and interpretation of physiologic data digitally stored and/or
transmitted by the patient and/or caregiver to the physician or other
qualified health care professional, qualified by education, training,
licensure/regulation requiring a minimum of 30 minutes of time). The
following year, we finalized payment for CPT codes 99453 (Remote
monitoring of physiologic parameter(s)(e.g., weight, blood pressure,
pulse oximetry, respiratory flow rate), initial; set-up and patient
education on use of equipment), 99454 (Remote monitoring of physiologic
parameter(s)(e.g., weight, blood pressure, pulse oximetry, respiratory
flow rate), initial; device(s) supply with daily recording(s) or
programmed alert(s) transmission, each 30 days), and 99457 (Remote
physiologic monitoring treatment management services, clinical staff/
physician/other qualified health care professional time in a calendar
month requiring interactive communication with the patient/caregiver
during the month; first 20 minutes)). Most recently, for the CY 2020
PFS final rule (84 FR 62645 and 62646), we finalized a treatment
management add-on code CPT code 99458 (Remote physiologic monitoring
treatment management services, clinical staff/physician/other qualified
health care professional time in a calendar month requiring interactive
communication with the patient/caregiver during the month; each
additional 20 minutes) and two self-measured blood pressure monitoring
codes, CPT code 99473 (Self-measured blood pressure using a device
validated for clinical accuracy; patient education/training and device
calibration) and CPT code 99474 (Separate self-measurements of two
readings one minute apart, twice daily over a 30-day period (minimum of
12 readings), collection of data reported by the patient and/or
caregiver to the physician or other qualified health care professional,
with report of average systolic and diastolic pressures and subsequent
communication of a treatment plan to the patient).
We are concerned that under the PHE for the COVID-19 pandemic,
physicians and other health care professionals are faced with
challenges regarding potential exposure risks for themselves and their
patients. In response, the CDC has urged health care professionals to
make every effort to interview patients by telephone, text monitoring,
or video conferencing instead of in-person. We believe that RPM
services support the CDC's goal of reducing human exposure to the novel
coronavirus while also increasing access to care and improving patient
outcomes.
RPM services are considered to be CTBS and, as such, would be
billable only for established patients. Our goal during the PHE for the
COVID-19 pandemic is to reduce exposure risks to the novel coronavirus
for practitioners and patients and to increase access to services by
eliminating as many obstacles as possible to delivering necessary
services. Allowing RPM services to be furnished only to established
patients could be an obstacle to delivery of reasonable and necessary
care particularly during current conditions. Thus, in response to the
PHE for the COVID-19 pandemic, we are finalizing on an interim basis,
that RPM services can be furnished to new patients, as well as to
established patients.
In addition to current policy that there be an established patient-
practitioner relationship, we require for CTBS at least verbal consent
from a Medicare beneficiary to receive the services. We finalized this
requirement to avoid scenarios where beneficiaries are unexpectedly
responsible for copays for services that do not involve the typical in-
person, face-to-face service that a patient receives during an office
visit. We continue to believe that patient consent is important.
However, we also believe that acquiring patient consent should not
interfere with the provision of RPM services during the PHE for the
COVID-19 pandemic. Therefore, we are finalizing on an interim basis
that consent to receive RPM services can be obtained once annually,
including at the time services are furnished, during the duration of
the PHE for the COVID-19 pandemic. However, to enhance beneficiary
protection, for both new and established patients, we suggest that the
physician or other health care practitioner review consent information
with a beneficiary, obtain the beneficiary's verbal consent, and
document in the medical record that consent was obtained.
Finally, we are clarifying that RPM codes can be used for
physiologic monitoring of patients with acute and/or chronic
conditions. The typical patient needing RPM services may have a chronic
condition (for example, high blood pressure, diabetes, COPD). However,
RPM can be used for other conditions. For example, RPM services allow a
patient with an acute respiratory virus to monitor pulse and oxygen
saturation levels using pulse oximetry. Nurses, working with
physicians, can check-in with the patient and then using patient data,
determine whether home treatment is safe, all the while reducing
exposure risk and eliminating potentially unnecessary emergency
department and hospital visits.
S. Telephone Evaluation and Management (E/M) Services
For CY 2008, the CPT Editorial Panel created CPT codes to describe
E/M services furnished by a physician or qualified healthcare
professional via telephone or online, including CPT codes 98966
(Telephone assessment and management service provided by a qualified
nonphysician health care professional to an established patient,
[[Page 19265]]
parent, or guardian not originating from a related assessment and
management service provided within the previous 7 days nor leading to
an assessment and management service or procedure within the next 24
hours or soonest available appointment; 5-10 minutes of medical
discussion), 98967 (Telephone assessment and management service
provided by a qualified nonphysician health care professional to an
established patient, parent, or guardian not originating from a related
assessment and management service provided within the previous 7 days
nor leading to an assessment and management service or procedure within
the next 24 hours or soonest available appointment; 11-20 minutes of
medical discussion), 98968 (Telephone assessment and management service
provided by a qualified nonphysician health care professional to an
established patient, parent, or guardian not originating from a related
assessment and management service provided within the previous 7 days
nor leading to an assessment and management service or procedure within
the next 24 hours or soonest available appointment; 21-30 minutes of
medical discussion), 99441 (Telephone evaluation and management service
by a physician or other qualified health care professional who may
report evaluation and management services provided to an established
patient, parent, or guardian not originating from a related E/M service
provided within the previous 7 days nor leading to an E/M service or
procedure within the next 24 hours or soonest available appointment; 5-
10 minutes of medical discussion), 99442 (Telephone evaluation and
management service by a physician or other qualified health care
professional who may report evaluation and management services provided
to an established patient, parent, or guardian not originating from a
related E/M service provided within the previous 7 days nor leading to
an E/M service or procedure within the next 24 hours or soonest
available appointment; 11-20 minutes of medical discussion), and 99443
(Telephone evaluation and management service by a physician or other
qualified health care professional who may report evaluation and
management services provided to an established patient, parent, or
guardian not originating from a related E/M service provided within the
previous 7 days nor leading to an E/M service or procedure within the
next 24 hours or soonest available appointment; 21-30 minutes of
medical discussion). We assigned a status indicator of ``N''
(Noncovered) to these services because: (1) These services are non-
face-to-face; and (2) the code descriptors include language that
recognizes the provision of services to parties other than the
beneficiary for whom Medicare does not provide coverage (for example, a
guardian).
We do not believe that we should continue to consider these to be
categorically non-covered services. In PFS rulemaking subsequent to CY
2008, we established separate payment for numerous non-face-to-face
services, including care management services and prolonged non-face-to-
face E/M services. We have also noted, for example in CY 2017, that we
recognize that in current medical practice, practitioner interaction
with caregivers is an integral part of treatment for some patients.
Accordingly, the descriptions for several payable codes under the PFS
include direct interactions between practitioners and caregivers (81 FR
80331).
When we established separate payment for services like virtual
check-ins and e-visits, we recognized that non-face-to-face services
had become an important part of overall physician care of Medicare
beneficiaries, especially relative to care for chronic conditions. The
current Medicare policy regarding the CPT codes that describe telephone
E/M services predated our ongoing recognition of the need to pay
separately for these kinds of services. Despite the fact that these are
classified as E/M services in the coding, we do not believe that these
codes describe full E/M services, but rather are closely analogous to
the virtual check-in services. Although we assigned a ``Noncovered''
status indicator for the telephone E/M codes, we still established the
American Medical Association's RUC-recommended RVUs for them. To
establish the payment rate for the virtual check-in service, we used
the RUC-recommended valuation for the lowest level telephone E/M code.
However, the telephone E/M codes provide additional stratification by
time for circumstances when a practitioner spends more than a brief
amount of time in direct communication with the patient. We believe
that under ordinary circumstances outside of the PHE, if the needs of
the patient are significant enough to require the amount of time and
attention from the practitioner specified in the codes for higher level
telephone evaluations or assessments, either an in-person visit or a
telehealth visit would be required. Alternatively, if the needs of the
patient are less acute and lengthy, a virtual check-in would suffice.
However, in the context of the goal of reducing exposure risks
associated with the PHE for the COVID-19 pandemic, especially in the
case that two-way, audio and video technology required to furnish a
Medicare telehealth service might not be available, we believe there
are many circumstances where prolonged, audio-only communication
between the practitioner and the patient could be clinically
appropriate yet not fully replace a face-to-face visit. We believe that
the existing telephone E/M codes, in both description and valuation,
are the best way to recognize the relative resource costs of these
kinds of services. Therefore, we are finalizing, on an interim basis
for the duration of the PHE for the COVID-19 pandemic, separate payment
for CPT codes 98966-98968 and CPT codes 99441-99443. For these codes,
we are finalizing on an interim basis for the duration of the PHE for
the COVID-19 pandemic, work RVUs as recommended by the AMA Health Care
Professionals Advisory Committee (HCPAC) for CY PFS 2008 rulemaking as
discussed in the CY 2008 PFS final rule (72 CFR 66371) of 0.25 for CPT
code 98966, 0.50 work RVUs for CPT code 98967, and 0.75 for CPT code
98968, and work RVUs as recommended by the AMA Relative Value Scale
Update Committee (RUC) of 0.25 for CPT code 99441, 0.50 for CPT code
99442, and 0.75 for CPT code 99443. We are finalizing the HCPAC and
RUC-recommended direct PE inputs which consist of 3 minutes of post-
service RN/LPN/MTA clinical labor time for each code.
Similar to the CTBS described in section II.D. of this IFC, we
believe it is important during the PHE to extend these services to both
new and established patients. While some of the code descriptors refer
to ``established patient,'' during the PHE we are exercising
enforcement discretion on an interim basis to relax enforcement of this
aspect of the code descriptors. Specifically, we will not conduct
review to consider whether those services were furnished to established
patients. CPT codes 98966-98968 described assessment and management
services performed by practitioners who cannot separately bill for E/
Ms. We are noting that these services may be furnished by, among
others, LCSWs, clinical psychologists, and physical therapists,
occupational therapists, and speech language pathologists when the
visit pertains to a service that falls within the benefit category of
those practitioners.
To facilitate billing of these services by therapists, we are
designating CPT codes 98966-98968 as CTBS ``sometimes therapy''
services that
[[Page 19266]]
would require the private practice occupational therapist, physical
therapist, and speech-language pathologist to include the corresponding
GO, GP, or GN therapy modifier on claims for these services.
T. Physician Supervision Flexibility for Outpatient Hospitals--
Outpatient Hospital Therapeutic Services Assigned to the Non-Surgical
Extended Duration Therapeutic Services (NSEDTS) Level of Supervision
Non-surgical extended duration therapeutic services (NSEDTS)
describe services that have a significant monitoring component that can
extend for a sizable period of time, that are not surgical, and that
typically have a low risk of complications after the assessment at the
beginning of the service. The minimum default supervision level of
NSEDTS was established in the CY 2011 OPPS/ASC final rule with comment
period (75 FR 72003 through 72013) as being direct supervision during
the initiation of the service, which may be followed by general
supervision at the discretion of the supervising physician or the
appropriate NPP (Sec. 410.27(a)(1)(iv)(E)). In this case, initiation
means the beginning portion of the NSEDTS which ends when the patient
is stable and the supervising physician or the appropriate NPP
determines that the remainder of the service can be delivered safely
under general supervision. We established general supervision as the
appropriate level of supervision after the initiation of the service
because it is challenging for hospitals to ensure direct supervision
for services with an extended duration and a significant monitoring
component, particularly for CAHs and small rural hospitals.
In the CY 2020 OPPS/ASC final rule with comment period (84 FR 61359
through 61363), we changed the generally applicable minimum required
level of supervision for most hospital outpatient therapeutic services
from direct supervision to general supervision for hospitals and CAHs.
Given the circumstances of the PHE for the COVID-19 pandemic, we
believe it is critical that hospitals have the most flexibility as
possible to provide the services Medicare beneficiaries need during
this challenging time. Changing the minimum default level of
supervision to general supervision for NSEDTS during the initiation of
the service will give providers additional flexibility they will need
to handle the burdens created by the PHE for the COVID-19 pandemic.
Therefore, we are assigning, on an interim basis, all outpatient
hospital therapeutic services that fall under Sec.
410.27(a)(1)(iv)(E), a minimum level of general supervision to be
consistent with the minimum default level of general supervision that
applies for most outpatient hospital therapeutic services, and we are
revising Sec. 410.27(a)(1)(iv)(E) to reflect this change in the
minimum level of supervision. General supervision, as defined in our
regulation at Sec. 410.32(b)(3)(i) means that the procedure is
furnished under the physician's overall direction and control, but that
the physician's presence is not required during the performance of the
procedure.
U. Application of Certain National Coverage Determination and Local
Coverage Determination Requirements During the PHE for the COVID-19
Pandemic
National Coverage Determinations (NCDs) are determinations by the
Secretary with respect to whether or not a particular item or service
is covered nationally under Title XVIII. Local Coverage Determinations
(LCDs) are determinations by a Medicare Administrative Contractor (MAC)
with respect to whether or not a particular item or service is covered
under section 1862(a)(1)(A) of the Act in the particular MAC's
geographical areas. Articles are often published alongside LCDs and
contain coding or other guidelines that complement an LCD. NCDs and
LCDs contain clinical conditions a patient must meet to qualify for
coverage of the item or service. Some NCDs and LCDs may also contain
requirements for face-to-face, timely evaluations or re-evaluations for
a patient to initially qualify for coverage or to qualify for
continuing coverage of the item or service. These requirements are more
often present in NCDs and LCDs for durable medical equipment than for
other items and services.
1. Face-to-Face and In-Person Requirements
For the duration of this PHE for the COVID-19 pandemic, it is in
the best interest of patients, health care professionals and suppliers
to limit face-to-face encounters and avoid exposure of vulnerable
Medicare beneficiaries to COVID-19. Therefore, on an interim basis, we
are finalizing that to the extent an NCD or LCD (including articles)
would otherwise require a face-to-face or in-person encounter for
evaluations, assessments, certifications or other implied face-to-face
services, those requirements would not apply during the PHE for the
COVID-19 pandemic.
We note that some face-to-face encounter requirements for DMEPOS
Power Mobility Devices (PMDs) are mandated by statute for program
integrity purposes. This IFC does not apply to those statutory
requirements. For example, PMD face-to-face encounter requirements are
found in section 1834(a)(1)(E)(iv) of the Act, as codified in Sec.
410.38, and our regulation already permits the use of telehealth in
accordance with Medicare guidelines. We have extended flexibilities to
permit a broader use of telehealth services during the PHE for the
COVID-19 pandemic. It should be noted that this does not confer changes
to the clinical indications of coverage for any LCD or NCD unless
specifically indicated below.
2. Clinical Indications for Certain Respiratory, Home Anticoagulation
Management and Infusion Pump Policies
During the PHE for the COVID-19 pandemic, it is possible that
patients receiving services for respiratory related indications will be
required to receive care in unexpected settings, including the home.
This may be necessary as COVID-19 and other patients are shifted across
healthcare settings to accommodate an increase in patient volume.
Therefore, we are finalizing on an interim basis that we will not
enforce the clinical indications for coverage across respiratory, home
anticoagulation management and infusion pump NCDs and LCDs (including
articles) allowing for maximum flexibility for practitioners to care
for their patients. This enforcement discretion will only apply during
the PHE for the COVID-19 pandemic. These policies include, but are not
limited to:
NCD 240.2 Home Oxygen.
NCD 240.4 Continuous Positive Airway Pressure for
Obstructive Sleep Apnea.
LCD L33800 Respiratory Assist Devices (ventilators for
home use).
NCD 240.5 Intrapulmonary Percussive Ventilator.
LCD L33797 Oxygen and Oxygen Equipment (for home use).
NCD 190.11 Home Prothrombin Time/International Normalized
Ratio (PT/INR) Monitoring for Anticoagulation Management.
NCD 280.14 Infusion Pumps.
LCD L33794 External Infusion Pumps.
At the conclusion of the PHE for the COVID-19 pandemic, we will
return to enforcement of these clinical indications for coverage.
[[Page 19267]]
3. Requirements for Consultations or Services Furnished by or With the
Supervision of a Particular Medical Practitioner or Specialist
Staffing is being adjusted in both facility and non-facility
settings to accommodate for the needs of patients during the PHE for
the COVID-19 pandemic. These staffing decisions may impact the
availability of physicians and physician specialists to furnish
evaluations, consultations and procedures or to supervise others. To
the extent NCDs and LCDs require a specific practitioner type or
physician specialty to furnish a service, procedure or any portion
thereof, we are finalizing on an interim basis the chief medical
officer or equivalent of the facility can authorize another physician
specialty or other practitioner type to meet those requirements during
the PHE for the COVID-19 pandemic. Additionally, to the extent NCDs and
LCDs require a physician or physician specialty to supervise other
practitioners, professionals or qualified personnel, the chief medical
officer of the facility can authorize that such supervision
requirements do not apply during the PHE for the COVID-19 pandemic.
V. Change to Medicare Shared Savings Program Extreme and Uncontrollable
Circumstances Policy
In December 2017, we issued an interim final rule with comment
period, titled ``Medicare Shared Savings Program: Extreme and
Uncontrollable Circumstances Policies for Performance Year 2017''
(hereinafter referred to as the ``December 2017 interim final rule with
comment period''), which appeared in the Federal Register on December
26, 2017 (82 FR 60912 through 60919). The December 2017 interim final
rule with comment period established a policy for determining quality
performance scores for accountable care organizations (ACOs)
participating in the Medicare Shared Savings Program (Shared Savings
Program), when the ACO, its participating ACO providers and suppliers,
and assigned beneficiaries were located in geographic areas that were
impacted by extreme and uncontrollable circumstances, such as
hurricanes, wildfires, or other triggering events, during performance
year (PY) 2017, including the applicable quality data reporting period
for the performance year if the quality reporting period was not
extended. In the CY 2019 PFS final rule we extended the extreme and
uncontrollable circumstances policy finalized for PY 2017 to PY 2018
and subsequent performance years. Under the policy adopted in that
final rule, for a given performance year, including the applicable
quality data reporting period for the performance year if the quality
reporting period is not extended, we will use an alternative approach
to calculating the quality score for ACOs affected by extreme and
uncontrollable circumstances (42 CFR 425.502(f)).
Under this current policy at Sec. 425.502(f), the Shared Savings
Program extreme and uncontrollable circumstances policy does not apply
for a performance year if an extreme and uncontrollable circumstance
occurs during the quality reporting period for that performance year
and the quality reporting period is extended. For all performance years
starting in 2019, the original quality reporting period was January 2,
2020, through March 31, 2020. In response to the PHE for the COVID-19
pandemic, we have determined that the 2019 MIPS data submission
deadline will be extended by 30 days until April 30, 2020, to give
eligible clinicians more time to report quality and other data for
purposes of MIPS. This extended timeline also applies to Shared Savings
Program ACOs because they are required to report quality data via the
CMS Web Interface and we align the Shared Savings Program data
submission timeline with the timeline for MIPS data submission. While
the extended timeframe for data submission is intended to give eligible
clinicians sufficient time to complete all the elements of MIPS
reporting during the PHE for the COVID-19 pandemic, we realize that
this extension alone may not be sufficient to ease the burden of
reporting given the increased burden of providing care to all patients
during this time. For this reason, under the Quality Payment Program,
we have determined that the MIPS automatic extreme and uncontrollable
circumstances policy will apply to MIPS eligible clinicians, who do not
submit their MIPS data by the extended timeline. Under this automatic
extreme and uncontrollable circumstances policy, MIPS eligible
clinicians, who are not participants in APMs, who do not submit any
MIPS data will have all performance categories reweighted to zero
percent, resulting in a score equal to the performance threshold, and a
neutral MIPS payment adjustment. However, under the policy, if a MIPS
eligible clinician submits data on two or more MIPS performance
categories, they will be scored and receive a 2021 MIPS payment
adjustment based on their final score.
The automatic extreme and uncontrollable circumstances policy
described above does not apply to MIPS eligible clinicians who are
subject to the APM scoring standard (82 FR 53899), such as MIPS
eligible clinicians participating in Shared Savings Program ACOs.
Instead, these MIPS eligible clinicians will continue to be scored
under the existing APM scoring standard. Generally, if no MIPS eligible
clinicians in an APM Entity submit data by the extended deadline for
the Quality and Promoting Interoperability performance categories due
to extreme and uncontrollable circumstances, the APM scoring standard
would apply as follows. The Cost performance category will be weighted
at zero percent, as usual. The Improvement Activities performance
category will be scored as usual. The Quality performance category will
be reweighted to zero percent where the APM has waived quality
reporting for purposes of the APM as in these circumstances CMS
determines that there are not sufficient measures or activities
applicable and available to MIPS eligible clinicians, consistent with
Sec. 414.1370(h). Finally, if all MIPS eligible clinicians in an APM
Entity have been excepted from reporting the Promoting Interoperability
performance category, then the Promoting Interoperability performance
category weight will be reweighted to zero for the APM Entity for that
MIPS performance period (Sec. 414.1370(g)(4)(iii)(A)). As a result, in
these circumstances, the Quality, Cost, and Promoting Interoperability
categories would all be weighted at zero percent. And as only one
performance category will be scored, the Improvement Activities
performance category, such MIPS eligible clinicians would receive a
neutral MIPS payment adjustment.
For MIPS eligible clinicians participating in Shared Savings
Program ACOs that do not report quality and obtain a neutral payment
adjustment under MIPS, according to the existing APM scoring standard
described above, the Shared Savings Program must determine that the
ACOs are impacted by an extreme and uncontrollable circumstance and
waive the quality reporting requirement under the Shared Savings
Program. As currently written, the Shared Savings Program extreme and
uncontrollable circumstances policy does not allow for the
determination that an ACO has been impacted by an extreme and
uncontrollable circumstance that occurs during the quality reporting
period if quality reporting period is extended, as
[[Page 19268]]
it has been for performance years starting in 2019.
In addition, under the Shared Savings Program, if an ACO fails to
report quality data by the submission deadline, the ACO will not have
met the quality performance standard and will receive a quality score
of zero, unless the extreme and uncontrollable circumstances policy
under Sec. 425.502(f) applies. In the event an ACO receives a quality
performance score of zero, the ACO would be ineligible to share in
savings, if earned and would owe maximum losses if participating under
Track 2 or the ENHANCED track. The current Medicare Shared Savings
Program extreme and uncontrollable circumstances policy for purposes of
determining an ACO's quality score for use in determining shared
savings or losses applies if twenty percent or more of an ACO's
assigned beneficiaries or its legal business entity are located in an
area identified under the Quality Payment Program as being affected by
an extreme and uncontrollable circumstance for the performance year,
including the quality reporting period if the quality reporting period
is not extended.
The effect of the MIPS quality reporting period extension is that
the current Shared Savings Program extreme and uncontrollable
circumstance policy does not apply, because the current extreme and
uncontrollable circumstances policy is only available for extreme and
uncontrollable circumstances that occur during the quality reporting
period, such as the current PHE for the COVID-19 pandemic, if the
quality reporting period is not extended. The inability to apply the
extreme and uncontrollable circumstances policy to waive the quality
reporting requirements under the Shared Savings Program during the PHE
may adversely impact ACOs and their participating ACO providers and
suppliers, because the extended timeline to submit data alone may not
be sufficient to support ACOs and their participating ACO providers and
suppliers, who are focused on care delivery during the national
emergency.
The intent of the Shared Savings Program extreme and uncontrollable
circumstance policy is to mitigate any impact on quality performance
and the resultant effect on financial reconciliation due to emergency
circumstances outside of the ACO's control. Accordingly, we believe it
is necessary to revise the policies governing the availability of the
Shared Savings Program extreme and uncontrollable circumstances
policies to extend the protection to ACOs that may not be able to
completely and accurately report their quality data for 2019, despite
the extension of the quality reporting period. To provide relief to all
ACOs participating in the Shared Savings Program during 2019, we need
to modify the extreme and uncontrollable circumstances policy as it
applies to disasters that occur during the reporting period to
eliminate the restriction that the extreme and uncontrollable
circumstances policy applies only if the reporting period is not
extended.
As explained above, the PHE for the COVID-19 pandemic was declared
during the quality reporting period for performance years starting in
2019. The PHE for the COVID-19 pandemic applies to all counties in the
United States, and we believe it is appropriate to offer relief under
the Shared Savings Program extreme and uncontrollable circumstances
policy to all Shared Savings Program ACOs that are unable to completely
and accurately report quality for 2019 by the extended deadline due to
the PHE for the COVID-19 pandemic. Due to the PHE for the COVID-19
pandemic and our desire to provide relief for Shared Savings ACOs who
need to focus resources on patient care at this time, we believe that
this policy must be effective starting with the quality reporting
period for performance years starting in 2019. Further, as illustrated
by the current PHE for the COVID-19 pandemic, there may be
unanticipated situations in the future, during which extension of a
quality reporting window alone would not provide sufficient relief from
reporting burden at a time when ACOs and their ACO providers and
suppliers need to focus on patient care. Accordingly, in this IFC, we
are revising the regulation at Sec. 425.502(f) to remove the
restriction which prevents the application of the Shared Savings
Program extreme and uncontrollable circumstances policy for disasters
that occur during the quality reporting period if the reporting period
is extended, to offer relief under the Shared Savings Program to all
ACOs that may be unable to completely and accurately report quality
data for 2019 due to the PHE for the COVID-19 pandemic. Specifically,
we are amending the regulation at Sec. 425.502(f) to remove the phrase
``if the quality reporting period is not extended,'' effective with
quality reporting for PY 2019.
We are considering whether the current policy, which assigns an ACO
the higher of the mean quality score across all ACOs and the ACO's own
quality score, in the event the ACO is determined to be impacted by an
extreme and uncontrollable circumstances, will continue to be
appropriate for PY 2020 and beyond. Any change to that current policy
would be made through future notice and comment rulemaking.
Regarding Shared Savings Program financial reconciliations for
performance years starting in 2019, we note that because the PHE for
the COVID-19 pandemic was declared during the reporting period for
those performance years, the provisions that allow for an adjustment to
the amount of shared losses for ACOs found to be affected by an extreme
and uncontrollable circumstance during a performance year would not
apply for performance years starting in 2019. However, for PY 2020
financial reconciliation, we will reduce the amount of an ACO's shared
losses by an amount determined by multiplying the shared losses by the
percentage of the total months in the performance year affected by an
extreme and uncontrollable circumstance, and the percentage of the
ACO's assigned beneficiaries who reside in an area affected by an
extreme and uncontrollable circumstance. At this time, the PHE for the
COVID-19 pandemic applies to all counties in the country; therefore,
100 percent of assigned beneficiaries for all Shared Savings Program
ACOs reside in an affected area and the total months affected by an
extreme and uncontrollable circumstance will begin with March and
continue through the end of the current PHE, as defined in Sec.
400.200.
Additionally, the Medicare Shared Savings Program financial
methodology includes updating each ACO's benchmark at the end of each
performance year based on the performance year expenditure trend. The
factors used to update ACOs' benchmarks will reflect the national and
regional trends related to spending and utilization changes during
2020, including any changes arising from the PHE for the COVID-19
pandemic.
W. Level Selection for Office/Outpatient E/M Visits When Furnished Via
Medicare Telehealth
In the CY 2020 PFS final rule (84 FR 62847 and 62848), we finalized
a number of changes to the framework of the office/outpatient E/M
requirements for CY 2021. Beginning January 1, 2021 for office/
outpatient E/M visits, the code level will be selected based on either
the level of MDM or the total time personally spent by the reporting
practitioner on the day of the visit
[[Page 19269]]
(including face-to-face and non-face-to-face time). We noted that there
was broad support for these changes from the AMA and other specialty
societies. Currently, telehealth office/outpatient E/Ms can be
furnished to beneficiaries in their homes only when they are for
individuals with a substance use disorder (SUD) diagnosis for purposes
of treatment of such disorder or co-occurring mental health disorder.
For these services, the primary factor in selecting the appropriate
level of E/M service to bill would be time spent counseling the
patient. Under the waiver issued by the Secretary pursuant to section
1135(b)(8) of the Act, telehealth office/outpatient E/Ms can be
furnished to any patient in their home regardless of their diagnosis or
medical condition. However, the current E/M coding guidelines would
preclude the billing practitioner from selecting the office/outpatient
E/M code level based on time in circumstances where the practitioner is
not engaged in counseling and/or care coordination.
On an interim basis, we are revising our policy to specify that the
office/outpatient E/M level selection for these services when furnished
via telehealth can be based on MDM or time, with time defined as all of
the time associated with the E/M on the day of the encounter; and to
remove any requirements regarding documentation of history and/or
physical exam in the medical record. This policy is similar to the
policy that will apply to all office/outpatient E/Ms beginning in 2021
under policies finalized in the CY 2020 PFS final rule. It remains our
expectation that practitioners will document E/M visits as necessary to
ensure quality and continuity of care. To reduce the potential for
confusion, we are maintaining the current definition of MDM. We note
that currently there are typical times associated with the office/
outpatient E/Ms, and we are finalizing those times as what should be
met for purposes of level selection. The typical times associated with
the office/outpatient E/Ms are available as a public use file at
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/PFS-Federal-Regulation-Notices-Items/CMS-1715-F. This
policy only applies to office/outpatient visits furnished via Medicare
telehealth, and only during the PHE for the COVID-19 pandemic.
X. Counting of Resident Time During the PHE for the COVID-19 Pandemic
In section II.O. of this IFC, ``Application of the Teaching
Physician Regulations During the PHE for the COVID-19 pandemic,'' we
state that the teaching supervision requirement can be met in certain
circumstances through direct supervision using interactive
telecommunications technology, including when a medical resident is
quarantined at home. Regarding claiming of the residents for indirect
medical education (IME) and Direct graduate medical education (DGME)
purposes, under current regulations, if a resident is training in a
hospital, that hospital claims the resident for IME and DGME (per Sec.
413.78(a)), and if a resident is training in a nonprovider site such as
a doctor's office or clinic, the hospital or hospitals that pays the
resident's salaries and fringe benefits claims the resident for IME and
DGME (per Sec. 413.78(g)). Currently, there is no provision in the
regulations for a hospital to claim a resident for IME or DGME if the
resident is performing patient care activities within the scope of his
or her approved program in his or her own home, or in a patient's home.
For the duration of this emergency situation, we are permitting the
hospital that is paying the resident's salary and fringe benefits for
the time that the resident is at home or in the home of a patient that
is already a patient of the physician or hospital, but performing
patient care duties within the scope of the approved residency program
(and meets appropriate physician supervision requirements as stated in
section II.O. of this IFC) to claim that resident for IME and DGME
purposes.
Y. Addressing the Impact of COVID-19 on Part C and Part D Quality
Rating Systems
1. Background
a. Legislative Authority for Star Ratings
Based on its authority to disseminate comparative information,
including about quality, to beneficiaries under sections 1851(d) and
1860D-1(c) of the Act and authority to collect various types of quality
data under section 1852(e) of the Act, CMS develops and publicly posts
a 5-star ratings system for MA and Part D plans. That system is also
the basis for determining quality bonus payment (QBP) status for MA
plans under section 1853(o) of the Act. Section 1876 cost plans are
also included in the MA and Part D Star Rating system as codified at 42
CFR 417.472(k) and are also required by Sec. 417.472(j) to make CAHPS
survey data available to CMS. In a final rule, ``Medicare Program;
Contract Year 2019 Policy and Technical Changes to the Medicare
Advantage, Medicare Cost Plans, Medicare Fee-for-Service, the Medicare
Prescription Drug Benefit Programs, and the PACE Program,'' published
on April 16, 2018 (83 FR 16519 through 16589), we adopted regulations
to govern this quality rating system for cost MA and Part D plans,
which are generally rated at the contract level. In a final rule,
``Medicare and Medicaid Program; Policy and Technical Changes to the
Medicare Advantage, Medicare Prescription Drug Benefit, Programs of
All-Inclusive Care for the Elderly (PACE), Medicaid Fee-for-Service,
and Medicaid Managed Care Programs for Years 2020 and 2021,'' published
April 16, 2019 (84 FR 15830 and 15831), we amended the regulations
governing the quality rating program for MA and Part D plans. Those
final rules contain a more detailed discussion of CMS' authority in
this area and we encourage readers to refer to those final rules.
In the CY 2020 Final Call Letter and the CY 2020 final rule,
published in the Federal Register on April 16, 2019 (84 FR 15830 and
15831), we finalized a set of rules for adjusting the calculation of
Star Ratings for the cost and Parts C and D organizations that are
impacted by extreme and uncontrollable circumstances. We provided in
the 2021 Advance Notice that the same policy as used for adjustments to
2020 Star Ratings based on extreme and uncontrollable circumstances
would be continued for CY 2021 Star Ratings. We did not envision the
unprecedented circumstances surrounding the PHE for the COVID-19
pandemic when we developed the adjustments for extreme and
uncontrollable circumstances for the Part C and D Star Ratings program;
as they exist currently, they are not sufficient in the case of the PHE
for the COVID-19 pandemic.
b. Overview of Star Ratings
The Star Ratings are generally based on measures of performance
during a period that is 2 calendar years before the year for which the
Star Ratings are issued; 2021 Star Ratings will generally be based on
performance during 2019 and the 2022 Star Ratings will similarly be
based on performance in 2020. We use multiple data sources to measure
quality and performance of contracts. Various regulations require plans
to report on quality improvement and quality assurance and to provide
data which we can use to help beneficiaries compare plans (for example,
Sec. Sec. 417.472(j) and (k), 422.152(b), 423.153(c), and 423.156). In
addition, we may require plans to report statistics and other
information in specific categories (Sec. Sec. 422.516 and 423.514).
Data from these sources and other sources are used to calculate
measures
[[Page 19270]]
of plan sponsor performance each year, as provided in Sec. Sec.
422.162 and 423.182. The Star Ratings serve an important purpose in
providing comparative information to enrollees and are also used to
identify whether an MA plan is eligible for a QBP under section 1853(o)
of the Act. The Patient Protection and Affordable Care Act (Pub. L.
111-148), as amended by the Healthcare and Education Reconciliation Act
(Pub. L. 111-152), provides for quality ratings, based on a 5-star
rating system and the information collected under section 1852(e) of
the Act, to be used in calculating payment to MA organizations
beginning in 2012. Specifically, sections 1853(o) and 1854(b)(1)(c) of
the Act were added and amended to provide, respectively, for an
increase in the benchmark against which MA organizations bid and in the
portion of the savings between the bid and the benchmark available to
the MA organization to use as a rebate. We assign both low and high
performing icons that are displayed on www.Medicare.gov to help
Medicare beneficiaries make plan decisions based on either consistently
low performance for 3 or more years or receiving 5 stars for the
highest rating, respectively. Additionally, plans that demonstrate
exceptional performance due to achieving a 5 Star Rating for their
highest rating can market year round and beneficiaries receive a
special election period that allows the eligible beneficiary to enroll
in a 5-star plan during the contract year. We also have the authority
to terminate plans that have below a 3-star rating for 3 or more years.
The Star Ratings therefore serve a number of important purposes for
cost, MA and Part D plans; we believe that plans engage in behavior
during the performance measurement period to improve their Star Ratings
and to achieve higher Star Ratings.
Healthcare Effectiveness Data and Information Set (HEDIS) and
Consumer Assessment of Healthcare Providers and Systems (CAHPS) data
are the basis for the calculation of the majority of measures for both
the Part C and Part D Star Ratings. HEDIS measures include clinical
measures assessing the effectiveness of care, access/availability
measures, and service use measures and are calculated by CMS through a
contract with the National Committee for Quality Assurance (NCQA). Many
of the HEDIS measures require plans to perform reviews of patients'
medical records or to obtain information directly from physician
offices, which is a time-intensive activity.
CAHPS refers to a comprehensive family of surveys that ask
consumers and patients to evaluate experiences of care. Cost plans,
Part C plans, and Part D plans are all required by regulation
(Sec. Sec. 417.472, 422.152, and 423.156, respectively) to contract
with approved Medicare CAHPS survey vendors to conduct the Medicare
CAHPS satisfaction survey of Medicare plan enrollees in accordance with
CMS specifications and submit the survey data to CMS. The Star Ratings
system uses measures from HEDIS and CAHPS extensively, and there are
negative consequences for a plan's Star Ratings (overall and on
specific measures) if the necessary data for the HEDIS and CAHPS
measures are not reported or validated. Although the 2021 Star Ratings
reflect performance in 2019 for most of the measures, data collection
for HEDIS and CAHPS is conducted in the first half of CY 2020 to feed
into the 2021 Star Ratings that are finalized by October 2020.
Similarly, the Health Outcomes Survey will occur in 2020 to collect
data used for the 2022 Star Ratings and the same concerns about survey
activities apply to that survey.
2. Impact of COVID-19 on Star Ratings Data Collection
The World Health Organization (WHO) has characterized COVID-19 as a
pandemic, and there are alarming levels of spread and severity of
COVID-19 across the United States. The CDC and medical professionals
recommend that the best way to prevent the spread of the virus is to
avoid contact with infected individuals. Social distancing is a method
that public health officials use to curb the transmission and spread of
infectious illnesses like COVID-19. Prior research has shown that these
measures help mitigate the spread of contagious viruses in the absence
of vaccines (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372334/), as
is the case with COVID-19.
To help curb the spread of COVID-19, governors around the country
are putting in place actions to protect public health and safety and
help mitigate the spread of the virus, including school closures,
limiting the size of gatherings and events, and restaurant closures.
Employers are moving to mandatory telework when feasible. The intent of
these actions is to save lives, keep people safe, and slow the rate of
infection. As of March 28, 2020, all 50 states were under a State of
Emergency. Additionally, areas of the country are being put under
shelter-in-place orders to further curtail the spread of the virus. CDC
has provided guidance to health care facilities (for example, https://www.cdc.gov/coronavirus/2019-ncov/healthcare-facilities/guidance-hcf.html) that range from rescheduling non-urgent outpatient visits and
elective surgeries, promoting telehealth visits, and managing mildly
ill COVID-19 patients at home. Also, on March 16, 2020, CDC issued
interim guidance (https://www.cdc.gov/coronavirus/2019-ncov/community/large-events/) advising the public against holding gatherings
of more than 10 individuals. On March 18, 2020, we released
recommendations related to delaying adult elective surgeries, non-
essential medical, surgical, and dental procedures during the COVID-19
outbreak to be able to focus health care professionals on those most in
need of healthcare (https://www.cms.gov/newsroom/press-releases/cms-releases-recommendations-adult-elective-surgeries-non-essential-medical-surgical-and-dental).
On March 13, 2020, President Trump declared a national emergency as
a result of the COVID-19 pandemic. The declaration of the PHE for the
COVID-19 pandemic allows certain Medicare requirements and conditions
of participation to be waived under section 1135 of the Act providing
more flexibility to providers in furnishing medically necessary health
care to beneficiaries.
Currently, data collection for HEDIS measures is ongoing for
services and performance during the 2019 measurement period. MA
contracts are required to submit their HEDIS summary-level data to the
NCQA by June 15, 2020, as well as to submit their HEDIS patient-level
data to CMS the same day. Currently, data collection activities are
underway to meet the June deadlines. Some of the HEDIS measures require
medical record review or obtaining information directly from physician
offices. We recognize that obtaining medical records from physician
offices and the necessary documentation from physician offices needed
for the plan to meet HEDIS requirements, and requiring plans to
participate in HEDIS audits will put a strain on the limited resources
available to these health care providers. Some of these activities are
generally done in person so compliance with social distancing efforts,
travel bans and quarantines raise additional challenges, as well as
risks to staff. CMS' top priority is to ensure public health and
safety, including that of beneficiaries, health and drug plan staff,
and providers, and to allow health and drug plans, providers, and
physician offices to focus on what is most important at this time: The
provision of care.
Under Sec. Sec. 417.472(i) and (j), 422.152(b)(5), and 423.156,
all
[[Page 19271]]
coordinated care MA plans, section 1876 contracts, and Part D sponsors,
respectively, are required to contract with a CMS-approved CAHPS survey
vendor to conduct the Medicare CAHPS satisfaction survey in accordance
CMS specifications and to submit the data to CMS. The administration of
the surveys and data collection are currently ongoing until the end of
May 2020 for the CAHPS survey data that would be used for the 2021 Star
Ratings. We are concerned that the COVID-19 pandemic will pose
significant challenges and safety concerns in successfully completing
the current CAHPS data collection. Most of the survey administration
protocols cannot be completed remotely, requiring staff to work in mail
facilities and call centers where telephone interviewers assemble in
close quarters to perform the telephone administration of the survey.
We are concerned that cost plans, MA organizations, and Part D plan
sponsors will not be able to complete this year's data collection
without jeopardizing the health and safety of survey vendor staff. We
have similar concerns about the Health Outcomes Survey (HOS) data
collection scheduled for later in 2020.
This IFC amends, as necessary, the calculations for the 2021 and
2022 Part C and D Star Ratings to incorporate changes to address the
expected impact of the PHE for the COVID-19 pandemic on data collection
and performance. Plans urgently need to know these changes so as not to
further exacerbate the PHE for the COVID-19 pandemic by continuing
efforts to complete the HEDIS and CAHPS data collection activities. The
HEDIS data collection diverts physicians' offices and health plans from
handling the day-to-day emergencies as a result of the PHE for the
COVID-19 pandemic. Additionally, we are concerned it is not possible to
safely continue the HEDIS and CAHPS data collection activities while
complying with the CDC recommendation for social distancing.
Under normal circumstances, if Part C and section 1876 plans do not
fully complete their HEDIS data collection activities and successfully
meet NCQA's HEDIS audit requirements, we assign each of the HEDIS Star
Ratings measures 1 star. Similarly, if the CAHPS data cannot be
completed and submitted on time by Part C, section 1876 cost, and Part
D plans, we historically have assigned each of the CAHPS Star Ratings
measures 1 star. Furthermore, unreliable CAHPS measure scores are
excluded from the Part C and D Star Ratings calculations. Without
knowing the changes made by this IFC to the methodology for calculating
the 2021 and 2022 Star Rating, plans could have conflicting incentives,
needing physician offices and plan staff to focus on caring for those
impacted by COVID-19 and keeping Medicare beneficiaries and those
involved in data collection activities safe, while at the same time
wanting to ensure that future Star Ratings and QBP ratings are not
impacted by the PHE for the COVID-19 pandemic which could negatively
impact future benefits offered by MA organizations. The changes to the
calculations for 2021 and 2022 Star Ratings are designed to avoid
inadvertently creating incentives for plans to place cost and Star
Rating considerations above efforts to address the COVID-19 pandemic.
3. Provisions of IFC
This IFC is modifying the calculation of the 2021 and 2022 Part C
and D Star Ratings to address the expected disruption to data
collection posed by the PHE for the COVID-19 pandemic. Specifically,
this IFC: (1) Replaces the 2021 Star Ratings measures calculated based
on HEDIS and Medicare CAHPS data collections with earlier values from
the 2020 Star Ratings (which are not affected by the public health
threats posed by COVID-19); (2) establishes how we will calculate or
assign Star Ratings for 2021 in the event that CMS' functions become
focused on only continued performance of essential Agency functions and
the Agency and/or its contractors do not have the ability to calculate
the 2021 Star Ratings; (3) modifies the current rules for the 2021 Star
Ratings to replace any measure that has a data quality issue for all
plans due to the COVID-19 outbreak with the measure-level Star Ratings
and scores from the 2020 Star Ratings; (4) in the event that we are
unable to complete HOS data collection in 2020 (for the 2022 Star
Ratings), replaces the measures calculated based on HOS data
collections with earlier values that are not affected by the public
health threats posed by COVID-19 for the 2022 Star Ratings; (5) removes
guardrails for the 2022 Star Ratings; and (6) expands the existing hold
harmless provision for the Part C and D Improvement measures to include
all contracts for the 2022 Star Ratings.
a. HEDIS, CAHPS, and HOS Data Collection and Submission for 2021 Star
Ratings and 2022 Star Ratings
We issued a Health Plan Management System (HPMS) memo, entitled
``Reporting Requirements for 2020 HEDIS[supreg], HOS, and CAHPS[supreg]
Measures,'' on September 9, 2019 to establish the due date for the 2019
measurement year for HEDIS. In light of the public safety issues in
continuing to require the submission of HEDIS data for the 2019
measurement year, we are eliminating the HEDIS 2020 submission
requirement that covers the 2019 measurement year and we are requesting
that Medicare health plans, including MA and section 1876
organizations, curtail HEDIS data collection work immediately. This
will allow health plans, providers, and physician offices to focus on
caring for Medicare beneficiaries during this PHE for the COVID-19
pandemic and will minimize risk of the spread of infection by
eliminating travel and in-person work for the collection of HEDIS data.
Our goal is to ensure that offices of health care providers remain
focused on patients needing care. Medicare health plans can use any
HEDIS data that they have collected for their internal quality
improvement efforts.
We are also amending the regulations requiring the submission of
the CAHPS survey data to CMS for Medicare health and drug plans to
relieve them of the requirement as it applies to the 2020 survey data
collection to ensure the safety of survey vendor staff and align with
the CDC's social distancing guidance. Both Part C and D plans can use
any CAHPS survey data already collected for their internal quality
improvement efforts. Accordingly, we are modifying regulations in parts
417, 422, and 423 to eliminate requirements for the collection of HEDIS
and CAHPS data that would otherwise occur in 2020. Specifically, we are
revising the Part C regulation at Sec. 422.152 by adding a new
paragraph (b)(6), which provides that MA organizations are not required
to submit HEDIS and CAHPS data that would otherwise be required for the
calculation of the 2021 Star Ratings. In addition, we are revising the
cost plan regulation at Sec. 417.472(i) and (j) in two ways: In
paragraph (i), to add a requirement for cost plans to comply with Sec.
422.152(b)(6) and in paragraph (j), to make the obligation for cost
plans to conduct CAHPS surveys subject to paragraph (i). Finally, we
are revising the Part D regulations at Sec. Sec. 423.156 and 423.182.
We are revising Sec. 423.156 to not require Part D sponsors to submit
CAHPS data that would otherwise be required for the calculation of the
2021 Star Ratings. We are also adding Sec. 423.182(c)(3) so that for
2021 Star Ratings only, Part D sponsors are not required to submit
CAHPS data that would otherwise be required for the calculation of the
2021 Star Ratings. While our revisions do not outright prohibit cost
plans, MA plans, and Part D plans from continuing efforts to
[[Page 19272]]
collect HEDIS data or conduct CAHPS surveys during 2020, such as to use
that data about plan performance in 2019 for the plan's own internal
quality initiatives, we do not expect plans to do so. An additional
component of the HEDIS data collection is the HOS that NCQA administers
in partnership with CMS. This year's HOS survey administration was
scheduled to be from April through July 2020. Given the significant
safety concerns, similar to the ones related to the administration of
the CAHPS survey, we are moving the HOS survey administration to late
summer and will provide MA plans more information in the upcoming
months. We will continue to monitor the situation to see if any further
adjustments are needed. To prepare for the possibility that the PHE for
the COVID-19 pandemic continues and the HOS survey data cannot be
collected starting in late summer for the 2022 Star Ratings, we are
amending the regulations for the Part C 2022 Star Ratings (by adding
new Sec. 422.166(j)(2)) to allow us to use the Star Ratings and
measure scores for the 2021 Star Ratings for any measures that come
from the HOS survey; this will address any gaps in the necessary HOS
data if the HOS survey cannot be administered in 2020. The measures
from the HOS survey include the following: Improving or Maintaining
Physical Health; Improving or Maintaining Mental Health; Reducing the
Risk of Falling; Improving Bladder Control; and Monitoring Physical
Activity.
b. Adjustments to the 2021 Star Ratings Methodology Due To Lack of
HEDIS and CAHPS Data
In response to the PHE for the COVID-19 pandemic and its impact on
health care delivery and data collection, we are making a series of
adjustments to the Star Ratings methodology to protect the health and
safety of individuals who would collect the HEDIS and CAHPS data; to
allow health and drug plans and their providers to focus on caring for
Medicare beneficiaries during the PHE for the COVID-19 pandemic; and to
address the unusual, unexpected, and uncontrollable changes that this
pandemic is likely to have on the Part C and D Star Ratings. Because of
the short time frame during which information is collected, analyzed,
and used in the calculation of the Star Ratings published in October
each year, immediate action is necessary to amend the methodology as a
result of the extraordinary circumstances created by the PHE for the
COVID-19 pandemic. Data collection is currently underway for both the
HEDIS and CAHPS data, and the data are due to CMS in June 2020. A
series of adjustments to the 2021 Star Ratings are being made to
account for eliminating the need to collect and submit HEDIS and CAHPS
data for the 2021 Star Ratings.
The April 2018 final rule (83 FR 16538 through 16546) included the
measures finalized for the 2021 Star Ratings. Included in those
measures are many that use HEDIS or CAHPS as the data source. In the
2020 Star Ratings, 14 measures had HEDIS as their data source, and nine
measures had CAHPS as their data source. The measurement period for
most of the Star Ratings measures is 2019; for many of those measures,
we (or the plans) already have the data necessary to calculate a
measure score and assign a 2021 measure-level rating but validation and
analysis of those data remain to be done. For the HEDIS data source,
the measurement period finalized in the April 2018 final rule is the
calendar year 2 years prior to the Star Ratings year so for the 2021
Star Ratings, the HEDIS measurement period is the 2019 measurement
year. However, those data are collected in 2020.
Similarly, for the CAHPS data source, the measurement period
finalized for the 2021 Star Ratings is the most recent data submitted
for the survey of enrollees. In general, the most recent data would be
the survey conducted from March through the end of May each year, which
for the 2021 Star Ratings would have corresponded to March through May
2020 data collection. However, these data will not be available for
HEDIS and CAHPS measures. CMS considered if we could remove all of the
HEDIS and CAHPS measures from the 2021 Star Ratings. If we removed
these measures from the Star Ratings, we would not have enough measures
to rate plans and to have a complete picture of performance given
approximately half of the Star Ratings measures come from HEDIS and
CAHPS. Removing all of these measures would severely compromise the
integrity of the Part C and D Star Ratings and would have significant
impact on payment for MA organizations. Given measure scores and stars
do not fluctuate significantly year to year, we believe using the 2020
measure-level stars and scores for the missing HEDIS and CAHPS data
provides the best approximation of performance in 2019. This
substitution addresses the lack of HEDIS and CAHPS data that would
otherwise be used for 2021 Star Ratings while permitting us to
calculate and use reliable Star Ratings for 2021 enrollment and 2022
QBP status determinations. Given the issues related to PHE for the
COVID-19 pandemic associated with completing the HEDIS data collection
for the 2019 measurement year, we will use the HEDIS measure scores and
Star Ratings based on the 2018 measurement year (that is, the data used
for the 2020 Star Ratings) for the 2021 Star Ratings. For the 2021 Star
Ratings, given the safety concerns related to completing the CAHPS
surveys and data collection and the inability of survey vendors to
fully complete data collection for 2020, we will use the CAHPS data
submitted to CMS in June 2019. To accomplish this, we are revising
Sec. Sec. 422.166 and 423.186 to add new regulation text that the
measures calculated based on HEDIS data are calculated based on data
for the 2018 performance period and the measures calculated based on
CAHPS data are calculated based on survey data collected from March
through May 2019. Specifically, we are adding a new paragraph (j) to
each of these regulations and are codifying these specific rules about
HEDIS and CAHPS data at Sec. Sec. 422.166(j)(1)(i) and (ii) and
423.186(j)(1)(i).
The measurement period for all other measures will not change from
what was finalized in the April 2018 final rule. For both HEDIS and
CAHPS measures, we will use 2020 measure-level Star Ratings (and
associated measure-level scores) in all the Star Ratings calculations
codified at Sec. Sec. 422.160, 422.162, 422.164, 422.166, 423.180,
423.182, 423.184, and 423.186 in calculating the 2021 Star Ratings. For
the 2021 Star Ratings, there will be no changes from the prior year in
the measure-level cut points for any of the HEDIS and CAHPS measures.
We had previously announced in the April 2019 final rule that the Plan
All-Cause Readmissions measure would be moved to display for the 2021
Star Ratings due to the substantive specification change. We will
continue to exclude this measure for the 2021 Star Ratings as provided
in that final rule, so the data associated with it for the 2018
performance period (collected in spring 2019) will be posted on the
display page for 2021 ratings.
Since we will be using the 2020 Star Ratings data for the HEDIS and
CAHPS measures, we will carry forward the measure-level improvement
change score as described at Sec. Sec. 422.164(f)(4)(i) and
423.184(f)(4)(i) from the 2020 Star Ratings for all HEDIS or CAHPS
measures for the 2021 Star Ratings Part C and D improvement measure
calculations. We are codifying this at Sec. Sec. 422.166(j)(1)(iii)
and 423.186(j)(1)(ii).
Under Sec. Sec. 422.164(g)(1) and (2) and 423.184(g)(2), we reduce
HEDIS and CAHPS measures to 1 star when either
[[Page 19273]]
HEDIS measures used to populate the Star Ratings are not reported or
for failure to adhere to CAHPS reporting requirements. For the 2021
Star Ratings, we will not reduce these measures to 1 star for failure
to report the 2020 HEDIS or CAHPS data and is codifying that approach
at Sec. Sec. 422.166(j)(1)(iv) and 423.186(j)(1)(iii). We are amending
Sec. Sec. 422.166 and 423.186 by adding paragraph (j) to codify these
various special rules for the 2021 Star Ratings.
c. Use of 2020 Star Ratings To Substitute for 2021 Star Ratings in the
Event of Extraordinarily Compromised CMS Capabilities or Systemic Data
Issues
There is great uncertainty about how the COVID-19 pandemic will
evolve over the next 6 to 9 months, and the impact on the American
population and institutions resulting from the pandemic. We have
considered the normal activities required to prepare, calculate, and
publish the Star Ratings, as well as finalize the ratings to be used as
the basis for MA QBPs in the event that CMS' functions to calculate the
2021 Star Ratings are significantly impacted. The operational timelines
for calculating the Star Ratings each year are extremely tight. For
example, when we receive all of the measure-level data in early August,
we have approximately 1 month to: Review the Star Ratings measure data
for accuracy; prepare data and supportive material to provide plans
with a preview period so they can review their numeric measure scores
and raise issues to CMS; work with contractors to calculate the Star
Ratings; prepare for a second preview period for plans to see their
preliminary measure level and overall star ratings. This work must be
completed in the months of August and September so that the Star
Ratings are ready for public display on Medicare Plan Finder in early
October for the Annual Enrollment Period. If the COVID-19 pandemic or
actions necessary in connection with the PHE impact the ability of CMS
and its contractors to complete these steps to calculate the 2021 Star
Ratings, it would be impracticable and contrary to the public interest
to begin rulemaking in August to adopt a policy for how to address such
an unprecedented situation. The normal notice and comment rulemaking
process would also prevent CMS from providing quality ratings to
Medicare beneficiaries choosing a 2021 plan during the Annual
Enrollment Period beginning in October and conflict with CMS providing
MA organizations the opportunity to appeal their QBP ratings for 2022
payment in time for 2022 bid submissions. There would be insufficient
time to engage in notice and comment rulemaking to make changes to the
2021 Star Ratings methodology in time to issue the Star Ratings on
Medicare Plan Finder.
Star Ratings are used to identify which MA plans are eligible for a
QBP and for a greater percentage of the amount by which the benchmark
for the plan's service area exceeds the plan's bid for covering Part A
and Part B benefits; the quality bonus results in an increase to the
benchmark for an MA plan's service area and the percentage that
determines the amount of the beneficiary rebate. See Sec. Sec.
422.258(d)(7) and 422.260. Together, these financial consequences for a
high Star Rating, can result in higher beneficiary rebates, which are
used to pay for supplemental benefits and reductions in the Part B or
Part D premium for enrollees in the plan. Given the impact the Star
Ratings have on payment and the benefits offered to Medicare
beneficiaries, it is critical that MA organizations have certainty in
terms of how the ratings would be calculated if this situation should
occur.
Adopting a provision to address such extraordinary circumstances
before they come to pass in connection with the COVID-19 pandemic will
ensure that Medicare health and drug plans and Medicare beneficiaries
are aware of the steps CMS will take before those actions become
necessary. This advance notice will alleviate uncertainty and provide
stability for cost plans, MA organizations, and Part D sponsors so they
can focus on continuing to ensure Medicare beneficiaries have access to
needed medical care. In case the PHE for the COVID-19 pandemic gets to
a point that CMS' functions become focused on only continued
performance of essential agency functions or the agency and its
contractors do not have the ability to calculate the 2021 Star Ratings,
as part of this IFC, we are establishing rules for this circumstance.
These rules would only be implemented for the 2021 Star Ratings if the
impact of the PHE for the COVID-19 pandemic reaches a point where CMS
and its contractors are compromised to the point the 2021 Star Ratings
cannot be calculated using the methodology set forth in the April 2018
final rule and this IFC. Calculating the Star Ratings requires a full
team of staff and contractors with specialized skill sets. If the PHE
for the COVID-19 pandemic escalates, we will need to devote more
resources to activities to address essential Agency functions so that
adding staff or resources to calculate the Star Ratings would not be
appropriate.
If CMS' resources become extraordinarily compromised, we will use
the 2020 Star Ratings as the 2021 Star Ratings. This authority is
codified at Sec. Sec. 422.166(j)(1)(v) and 423.186(j)(1)(iv) and
limited specifically to the COVID-19 pandemic.
We are also concerned, given the uncertainties ahead, whether CMS
and plans will be able to safeguard against data quality issues for
non-CAHPS and non-HEDIS measures for which CMS does not already have
data for the 2021 Star Ratings. As an example, sponsors report Special
Needs Plan (SNP) Care Management and Medication Therapy Management
(MTM) data to CMS by March 2020, and these data undergo independent
data validation beginning in April. While validation activities can be
conducted remotely between the plans' staff and data validation
reviewers, there may be other difficulties in completing the work this
year on time and consistent with CMS requirements due to the
significant impact of the PHE for the COVID-19 pandemic. Normally, as
codified at Sec. Sec. 422.164(b) and 423.184(b), we review the quality
of the data before making a final determination about inclusion of the
measures in each year's Star Ratings. Given the potential for multiple
measures to have data quality issues across many plans as a result of
COVID-19, we are addressing this possibility by adopting a rule to
permit replacing the 2021 Star Ratings measure scores and stars with
the 2020 Star Ratings measures scores and stars for the impacted
measures for all plans rather than excluding multiple measures from the
2021 Star Ratings calculations. Removing multiple measures from the
Star Ratings can cause unanticipated changes in the ratings which would
create more instability for Medicare health and drug plan sponsors and
could have significant impacts on MA QBPs at a time where MA
organizations need stability in the ratings when they need to focus on
caring for those impacted by COVID-19.
To be prepared if we have data quality issues for any non-HEDIS or
non-CAHPS 2021 Star Ratings measures, we are adopting a specific rule
limited to the PHE for the COVID-19 pandemic. At Sec. Sec. 422.164(i)
and 423.184(i), we are adopting authority for CMS to substitute the
score and star for the measure used in the 2020 Star Ratings in the
calculation of the 2021 Star Ratings when there is a systemic data
quality issue for all plans as a result of the PHE for the COVID-19
pandemic. Therefore, in the above example, we would use sponsors' SNP
Care Management and MTM Program Completion Rate for Comprehensive
Medication Review measures' scores and stars from the
[[Page 19274]]
2020 Star Ratings as the sponsors' 2021 Star Ratings on those measures.
We are making these adjustments to the Star Ratings methodology
since our inability to make calculations at a late stage in the annual
Star Ratings publication process would severely jeopardize our ability
to calculate 2022 MA payments accurately and consistent with the
statutory QBP provision particularly since our ability to change other
deadlines based on availability of the Star Ratings (for example, the
bid deadline, Annual Election Period, and the start of the new plan
benefit year) is limited but the Star Ratings are an integral part of
those other activities. In extreme situations like the ones described
above, the solicitation and consideration of public comments to
establish how CMS should proceed would be impracticable since the
process could not be completed in time to issue new Star Ratings that
could be used to inform beneficiary choice during the Annual Election
Period. The MA statute, at section 1851(d) of the Act, requires that
information about plan quality and performance indicators be provided
to Medicare beneficiaries to help them make informed plan choices. In
addition, MA plans need to know their eligibility for QBPs in advance
of the bid deadline to develop their bids; the bid deadline is also set
by the statute, as the first Monday in the June prior to the coverage
year. The 2021 Star Ratings will be the basis for 2022 QBPs so
definitive Star Ratings need to be available to plans in advance of
June 2021, to accommodate bid planning and to ensure that plans have
the ability to appeal their QBP status if necessary. We understand that
MA organizations begin developing and pricing their plan benefit
packages well before the June bid deadline and depend on the release of
Star Ratings in the preceding October as a critical milestone in their
planning for an upcoming plan year. Adopting the new rule at Sec. Sec.
422.164(i) and 423.184(i) to address measure-level substitutions of
2020 scores for data quality issues that impact the availability,
accuracy, reliability and validity of the measure-level data that would
otherwise be used for 2021 ratings will provide stability and certainty
for the program. This approach will allow CMS and MA organizations to
move seamlessly to a new basis for calculating QBPs in the event that
the original one (that is, using the data about 2019 performance) is
unavailable. It will also allow MA organizations to incorporate into
their planning the possibility that they will be required to use the
2020 Star Ratings for some or all measures in developing their 2022
bids.
To codify these provisions, we are amending Sec. Sec. 422.164 and
423.184 by adding a new paragraph (i) to each section, as well as by
amending Sec. 422.166 by adding a new paragraph (j)(1)(v) and amending
Sec. 423.186 by adding a new paragraph (j)(1)(iv).
d. 2022 Star Ratings
For the 2022 Star Ratings, we expect plans to submit HEDIS data in
June 2021 and to administer the CAHPS survey in 2021 as usual. The
majority of measures for the 2022 Star Ratings are based on the 2020
measurement year, which is ongoing during the PHE for the COVID-19
pandemic. We are using the IFC to make immediate changes to the
methodology for the 2022 Star Ratings so as not to inappropriately
incentivize actions by plans and healthcare providers that are not
directly related to the PHE for the COVID-19 pandemic. By adopting
these changes immediately, Medicare health and drug plans will be
assured as quickly as possible about how performance changes driven or
caused by the COVID-19 pandemic will be addressed in the Star Ratings
that use this performance period. Except as addressed in this IFC, we
anticipate that the 2022 Star Ratings will be implemented as codified
at Sec. Sec. 422.160, 422.162, 422.164, 422.166, 423.180, 423.182,
423.184, and 423.186.
i. Guardrails
We recognize that health and drug plans and their providers are
needing to adapt their current care practices in light of the PHE for
the COVID-19 pandemic and the need to care for the most vulnerable
patients, such as the elderly and those with chronic health conditions;
these changes in how plans and providers care for Medicare
beneficiaries as a result of COVID-19 will impact performance for the
2020 measurement period which feeds into the 2022 Star Ratings. On
March 18, 2020, we issued guidance (available on the CMS website at
https://www.cms.gov/files/document/31820-cms-adult-elective-surgery-and-procedures-recommendations.pdf) to delay all non-essential planned
surgeries and procedures, including dental, until further notice.
Healthcare providers are being asked to encourage patients to remain at
home, except for emergencies, to help curb the spread of COVID-19 and
to help limit the exposure to the virus. Plans and their providers are
focused primarily on providing urgent care to Medicare beneficiaries
who may be infected by COVID-19. We realize that this will impact the
data collected during the 2020 measurement year which will impact the
2022 Part C and D Star Ratings. Thus, as part of this IFC, we are
making some adjustments to account for the potential decreases in
measure-level scores so health plans can have some degree of certainty
knowing that the Star Ratings will be adjusted and can focus right now
on patients who are most in need.
To increase the predictability of the cut points used for measure-
level ratings, we previously finalized that, starting with the 2022
Star Ratings, guardrails would be implemented for measures that have
been in the program for more than 3 years. As specified at Sec. Sec.
422.166(a)(2)(i) and 423.186(a)(2)(i), the guardrails ensure that the
measure-threshold-specific cut points for non-CAHPS measures do not
increase or decrease more than 5 percentage points from one year to the
next. As noted in the April 2019 final rule, the trade-off for the
predictability provided by the bi-directional cap is the inability to
fully keep pace with changes in performance across the industry. While
cut points that change less than the cap would be unbiased and keep
pace with changes in the measure score trends, changes in the overall
performance that are greater than the cap would not be reflected in the
new cut points. The performance that will be used for the 2022 Star
Ratings is performance in 2020, that is, during the PHE for the COVID-
19 pandemic. We anticipate that most, if not all, plans could have
performance changes on certain measures as they deal with the demands
the PHE for the COVID-19 pandemic will place on the health care system
in the United States. Guardrails that prevent the cut points for
measures from lowering, even when performance scores are lower across
the board, will result in plans having similar low measure-level
ratings even if their performance is relatively distinguishable.
Since the Star Ratings are used to calculate the payment to MA
organizations by providing an increase in the benchmark against which
MA organizations bid and in the portion of the savings between the bid
and benchmark available to MA organizations to use as rebates,
unanticipated significant declines in the Star Ratings would create
significant uncertainty in the program and potential beneficiary access
issues if ratings significantly decline across the cost plan, MA and
Part D programs. Given the enormity of this situation we believe it is
important for plans to be able to focus on patients that are in the
most need during the outbreak, and our
[[Page 19275]]
guardrails, as currently constructed, could have unintended incentives
to the contrary. In addition, adopting this policy as soon as possible
will minimize incentives for plans and providers to focus on non-urgent
care or administrative efforts, even if those issues are tied to
existing Star Ratings measures, and focus their attention on urgent
care issues. As such, in response to the PHE for the COVID-19 pandemic,
we are delaying implementation of the guardrails so that cut points can
change by more than 5 percentage points if national performance
declines as a result of the PHE for the COVID-19 pandemic. We are
modifying Sec. Sec. 422.166(a)(2)(i) and 423.186(a)(2)(i) to delay the
application of the guardrails beginning with the 2023 Star Ratings
produced in October 2022. No other aspect of the guardrails policies
finalized in the April 2019 final rule is changing with this
modification.
ii. Improvement Measure
The existing Star Ratings system and regulations include a well-
developed improvement measure and methodology for calculating and using
it. However, because we anticipate that performance during the 2020
measurement period may decline for plans across the nation, we believe
that it is appropriate to adopt a provision to minimize the negative
effect of the improvement measure and improvement scores. As with the
guardrails policy, this amendment to the existing regulations is
designed to minimize or eliminate incentives in the Star Ratings that
might be inconsistent with the steps necessary to address the COVID-19
pandemic. We are revising the methodology for the Part C and D
improvement measure for the 2022 Star Ratings to expand the hold
harmless rule to include all contracts at the overall and summary
rating levels recognizing that the PHE for the COVID-19 pandemic may
result in a decline in industry performance. Currently, for MA-PD
contracts with an overall rating of 4 or more stars, if the inclusion
of the improvement measure(s) reduces a contract's overall Star Rating,
the Part C and D improvement measures are excluded from the overall
Star Ratings calculations for that contract. Similarly, for MA-only
contracts with 4 or more stars, if the inclusion of the Part C
improvement measure reduces the Part C summary Star Rating, it is
excluded from the calculations for that contract. Our revision will
expand the current hold harmless rule and how it works to all contracts
regardless of their ratings and also apply it to the Part C and D
summary ratings for the 2022 Star Ratings only.
We are codifying a new paragraph (g)(3) at Sec. Sec. 422.166 and
423.186 and adding text at the end of the existing text in Sec. Sec.
422.166(f)(1)(i) and 423.186(f)(1)(i) to implement this new hold
harmless provision for the 2022 Star Ratings only.
iii. Categorical Adjustment Index
Beginning with the 2017 Star Ratings, we implemented the
Categorical Adjustment Index (CAI) that adjusts for the average within-
contract disparity in performance associated with the percentages of
enrollees who receive a low-income subsidy and/or are dual eligible
(LIS/DE) and/or have disability status. For the 2022 Star Ratings, we
will calculate the CAI as codified at Sec. Sec. 422.166(f)(2) and
423.186(f)(2). The CAI values will be calculated based on the 2021 Star
Ratings data which will use the older HEDIS and CAHPS data from the
2020 Star Ratings. For each measure, adjusted measure scores which are
used to construct the CAI values will be calculated using the
enrollment year associated with the year of data being used for that
measure (that is, 2018 enrollment year data for HEDIS and CAHPS
measures, 2019 enrollment year data for all other measures). Given we
are following the rules codified in regulation, there are no changes to
the regulatory text. We are providing this explanation to avoid
uncertainty on this point for Medicare health and drugs plans.
iv. QBP Calculations for New Contracts
Under Sec. 422.252, a new MA plan means an MA contract offered by
a parent organization that has not had another MA contract in the
previous 3 years. For just the 2022 QBP ratings that are based on 2021
Star Ratings, we are modifying this definition to treat an MA plan as a
new MA plan if it is offered by a parent organization that has not had
another MA contract for the previous 4 years. This change would account
for how new plans that started in 2019 would have reported HEDIS and
CAHPS data to CMS for the first time in 2020 for the 2021 Star Ratings;
because of our elimination of the HEDIS and CAHPS data submissions to
CMS, these plans will not have enough measures to calculate the 2021
Star Ratings and, consequently, the 2022 QBP rating. A new contract
with an effective date of January 1, 2019 would normally be treated as
new for purposes of QBPs for 2019, 2020, and 2021. The 2022 QBP rating
would be based on the 2021 Star Ratings which these contracts will not
have due to the elimination of HEDIS and CAHPS data.
Z. Changes To Expand Workforce Capacity for Ordering Medicaid Home
Health Nursing and Aide Services, Medical Equipment, Supplies and
Appliances and Physical Therapy, Occupational Therapy or Speech
Pathology and Audiology Services
Title XIX of the Act requires that, to receive Federal Medicaid
matching funds, a State must offer certain basic services to the
categorically needy populations specified in the Act. Home health
services for Medicaid-eligible individuals who are entitled to nursing
facility services is one of these mandatory services. Individuals
``entitled to'' nursing facility services include the basic
categorically needy populations that receive the standard Medicaid
benefit package, and can include medically needy populations if nursing
facility services are offered to the medically needy within a State.
Home health services include part-time or intermittent nursing, home
health aide services, medical supplies, equipment, and appliances, and
may include therapeutic services. Current Medicaid regulations require
an individual's physician to order home health services as part of a
written plan of care. The plan of care must be reviewed every 60 days,
except for medical supplies, equipment and appliances which must be
reviewed by a physician annually.
We recognize that increased demand on the direct care services
provided by physicians during the PHE for the COVID-19 pandemic could
cause a delay in the availability of physicians to order home health
services in the normal timeframe. In recognition of the critical need
to expand workforce capacity, we are amending 42 CFR 440.70 to allow
licensed practitioners practicing within their scope of practice, such
as, but not limited to, NPs and PAs, to order Medicaid home health
services during the existence of the PHE for the COVID-19 pandemic.
This change to Sec. 440.70 will expand the workforce and is also a
continuation of CMS' efforts to align with Medicare on who can order
medical supplies, equipment, and appliances, and allowing smoother
access to services for Medicaid beneficiaries, including those who are
dually eligible. This alignment will also eliminate administrative
burden to states and providers when dealing with inconsistencies in the
practitioners who may order these items between the Medicare and
Medicaid programs.
[[Page 19276]]
This change applies to who can order Medicaid home health nursing
and aide services, medical supplies, equipment and appliances and
physical therapy, occupational therapy or speech pathology and
audiology services covered under Sec. 440.70(b)(1), (2), (3), and (4).
This change does not expand the benefit categories where these
items can be covered. States must continue to cover and claim home
health nursing and aide services, medical supplies, equipment and
appliances, and physical therapy, occupational therapy or speech
pathology and audiology services (that are covered under the home
health benefit) under the home health benefit, unless otherwise allowed
by federal regulations.
AA. Origin and Destination Requirements Under the Ambulance Fee
Schedule
Section 1861(s)(7) of the Act establishes an ambulance service as a
Medicare Part B service where the use of other methods of
transportation is contraindicated by the individual's condition, but
only to the extent provided in regulations. We have established
regulations at Sec. 410.40 that govern Medicare coverage of ambulance
services. Under Sec. 410.40(e)(1), Medicare Part B covers ground (land
and water) and air ambulance transport services only if they are
furnished to a Medicare beneficiary whose medical condition is such
that other means of transportation are contraindicated. The
beneficiary's condition must require both the ambulance transportation
itself and the level of service provided for the billed services to be
considered medically necessary.
Under Sec. 410.40(e)(1), nonemergency transportation by ambulance
is appropriate if either the beneficiary is bed-confined, and it is
documented that the beneficiary's condition is such that other methods
of transportation are contraindicated; or, if his or her medical
condition, regardless of bed confinement, is such that transportation
by ambulance is medically required. That section further provides that
bed confinement is not the sole criterion in determining the medical
necessity of ambulance transportation but is one factor that is
considered in medical necessity determinations. For a beneficiary to be
considered bed-confined, Sec. 410.40 (e)(1) states that all of the
following criteria must be met: (1) The beneficiary is unable to get up
from bed without assistance, (2) the beneficiary is unable to ambulate,
and (3) the beneficiary is unable to sit in a chair or wheelchair.
The origin and destination requirements for coverage of ambulance
services are addressed in our regulations at Sec. 410.40(f). As
provided in that section, Medicare covers the following ambulance
transportation:
From any point of origin to the nearest hospital, critical
access hospital (CAH), or skilled nursing facility (SNF) that is
capable of furnishing the required level and type of care for the
beneficiary's illness or injury. The hospital or CAH must have
available the type of physician or physician specialist needed to treat
the beneficiary's condition;
From a hospital, CAH, or SNF to the beneficiary's home;
From a SNF to the nearest supplier of medically necessary
services not available at the SNF where the beneficiary is a resident,
including the return trip; and
For a beneficiary who is receiving renal dialysis for
treatment of ESRD, from the beneficiary's home to the nearest facility
that furnishes renal dialysis, including the return trip.
We continue to believe that our current regulatory requirements
governing coverage of ambulance services are appropriate under normal
circumstances. However, in the context of the PHE for the COVID-19
pandemic, we recognize that providers and suppliers furnishing ground
ambulance services and other health care professionals are faced with
new challenges regarding potential exposure risks, for Medicare
beneficiaries and for members of the community at large.
Therefore, on an interim basis, we will expand the list of
destinations at Sec. 410.40(f) for which Medicare covers ambulance
transportation to include all destinations, from any point of origin,
that are equipped to treat the condition of the patient consistent with
Emergency Medical Services (EMS) protocols established by state and/or
local laws where the services will be furnished. The EMS protocols are
recognized operating procedures that all emergency service
professionals such as emergency medical technicians (EMTs) and
paramedics must follow for patient assessment, treatment,
transportation and delivery to definitive care. These protocols are
designed by national, state and/or local medical authorities and
institutions. Based on these protocols, a patient suspected of having
COVID-19 that requires a medically necessary transport may be
transported to a testing facility to get tested for COVID-19 instead of
a hospital in an effort to prevent possible exposure to other patients
and medical staff.
These destinations may include, but are not limited to: Any
location that is an alternative site determined to be part of a
hospital, CAH or SNF, community mental health centers, FQHCs, RHCs,
physicians' offices, urgent care facilities, ambulatory surgery centers
(ASCs), any location furnishing dialysis services outside of an ESRD
facility when an ESRD facility is not available, and the beneficiary's
home. This expanded list of destinations will apply to medically
necessary emergency and non-emergency ground ambulance transports of
beneficiaries during the PHE for the COVID-19 pandemic. Consistent with
section 1861(s)(7) of the Act, there must be a medically necessary
ground ambulance transport of a patient in order for an ambulance
service to be covered.
We are revising, on an interim basis, Sec. 410.40 to add a new
paragraph (f)(5), to state that during the PHE for the COVID-19
pandemic only, a covered destination includes a ground ambulance
transport from any point of origin to a destination that is equipped to
treat the condition of the patient consistent with state and local EMS
protocols where the services will be furnished. These destinations
include, but are not limited to, any location that is an alternative
site determined to be part of a hospital, CAH or SNF, community mental
health centers, FQHCs, RHCs, physician offices, urgent care facilities,
ASCs, any location furnishing dialysis services outside of an ESRD
facility when an ESRD facility is not available, and the beneficiary's
home. Home may be an appropriate destination for a COVID-19 patient who
is discharged from the hospital to home to be under quarantine (as
noted above, there must be a medically necessary ground ambulance
transport of a patient in order for an ambulance service to be
covered).
BB. Merit-Based Incentive Payment System (MIPS) Updates
1. MIPS Improvement Activities Inventory Update
The CY 2018 Quality Payment Program final rule (82 FR 53660)
finalized that we would add new improvement activities or make
modifications to existing improvement activities in the Improvement
Activities Inventory through notice-and-comment rulemaking. An
improvement activity means an activity that relevant MIPS eligible
clinician, organizations and other relevant stakeholders identify as
improving clinical practice or care delivery and that the Secretary
determines, when effectively executed,
[[Page 19277]]
is likely to result in improved outcomes. We refer readers to Table H
in the Appendix of the CY 2017 Quality Payment Program final rule (81
FR 77177 through 77199), Tables F and G in the Appendix of the CY 2018
Quality Payment Program final rule (82 FR 54175 through 54229), Tables
A and B in the Appendix 2 of the CY 2019 PFS final rule (83 FR 60286
through 60303), and Tables A, B, and C in the Appendix 2 of the CY 2020
PFS final rule (84 FR 63514 through 63538) for our previously finalized
Improvement Activities Inventory. We also refer readers to the Quality
Payment Program website at https://qpp.cms.gov/ for a complete list of
the most current list of improvement activities.
The COVID-19 pandemic has been deemed a PHE by the Secretary of the
Department of Health and Human Services. Information regarding the PHE
for the COVID-19 pandemic may be found at https://www.phe.gov/emergency/news/healthactions/phe/Pages/default.aspx. In this IFC, we
are adding one new improvement activity to the Improvement Activities
Inventory for the CY 2020 performance period in response to this PHE.
We refer readers to Table 1 for a full description which includes the
type of action that would qualify for this improvement activity. This
improvement activity promotes clinician participation in a COVID-19
clinical trial utilizing a drug or biological product to treat a
patient with a COVID-19 infection.\20\ To receive credit for this
clinical improvement, clinicians must report their findings through an
open source clinical data repository or clinical data registry. When
utilizing the term ``open source'' we mean making available to the
public the results of research, including publications and scientific
data, which enables reuse, increases transparency, and facilitates
reproductibility of research results.\21\
---------------------------------------------------------------------------
\20\ For more information on the COVID-19 clinical trials we
refer readers to the U.S. National Library of Medicine website at
https://clinicaltrials.gov/ct2/results?cond=COVID-19.
\21\ More information on open source is available at https://www.nlm.nih.gov/NIHbmic/nih_data_sharing_repositories.html; https://www.phe.gov/emergency/news/healthactions/phe/Pages/default.aspx.
---------------------------------------------------------------------------
We believe that participation in this activity is likely to result
in improved outcomes by improving the collection of data clinicians use
for the care of their patients as they monitor and manage COVID-19 and
drive care improvements. We believe that encouraging clinicians to
utilize an open source clinical data repository or clinical data
registry for data reporting will bring the results of their research to
the forefront of healthcare far quicker than if it goes through the
cycle of peer review and publishing. In addition, we believe that this
could improve clinical practice and care delivery, a relevant
stakeholder donated a database for the pandemic so that health
officials/clinicians/the public could track patients and drugs that
work to better improve outcomes of COVID-19 patients.
In the CY 2019 PFS (83 FR 59778 through 59782), we provided details
regarding the Annual Call for Activities and how stakeholders submit
potential improvement activities. In general, to nominate a new
activity or request a modification to an existing improvement activity,
a stakeholder must submit a nomination form available at
www.qpp.cms.gov during the Annual Call for Activities. For this new
improvement activity, we are making a one-time exception from our
established Annual Call for Activities timeframe and processes due to
this PHE.
New improvement activities should meet one or more criteria to be
included in the Improvement Activities Inventory (82 FR 53660). We
believe that this activity meets the improvement activities submission
criteria of a ``public health emergency as determined by the
Secretary,'' which was finalized in the 2019 PFS final rule (83 FR
59779). As noted in the CY 2017 Quality Payment Program final rule, we
use the criteria for nominating new improvement activities in selecting
improvement activities for inclusion in the program (82 FR 53659). We
also clarified that those criteria are but one factor in determining
which improvement activities we ultimately proposed (83 FR 59780). For
MIPS eligible clinicians who wish to submit this new improvement
activity, we refer readers to the CY 2019 PFS final rule (83 FR 59778
through 59782) for our previously finalized improvement activities
submission requirements. Table 1 displays the new improvement activity.
Table 1--New Improvement Activity for the MIPS CY 2020 Performance
Period
------------------------------------------------------------------------
------------------------------------------------------------------------
Improvement activity
------------------------------------------------------------------------
Activity ID:...................... IA_ERP_XX.
Subcategory:...................... Emergency Response And Preparedness.
Activity Title:................... COVID-19 Clinical Trials.
Activity Description:............. To receive credit for this activity,
a MIPS-eligible clinician must
participate in a COVID-19 clinical
trial utilizing a drug or
biological product to treat a
patient with a COVID-19 infection
and report their findings through a
clinical data repository or
clinical data registry for the
duration of their study. For more
information on the COVID-19
clinical trials we refer readers to
the U.S. National Library of
Medicine website at https://clinicaltrials.gov/ct2/results?cond=COVID-19.
Weighting:........................ High.
------------------------------------------------------------------------
2. MIPS Applications for Reweighting Based on Extreme and
Uncontrollable Circumstances
As a result of the PHE for the COVID-19 pandemic, we are applying
the MIPS automatic extreme and uncontrollable circumstances policy at
Sec. 414.1380(c)(2)(i)(A)(8) and (c)(2)(i)(C)(3) to MIPS eligible
clinicians for the 2019 MIPS performance period/2021 MIPS payment year.
We believe that this application of the policy is appropriate given the
impact COVID-19 will likely have on the ability of many MIPS eligible
clinicians to complete data submission for the MIPS program for the
2019 MIPS performance period because most of those submissions will
occur during CY 2020.
Due to the timing of the PHE, we realize that there may be
scenarios where MIPS-eligible clinicians are not covered by the
automatic extreme and uncontrollable circumstances policy. For example,
as we stated in the CY 2019 PFS final rule, the automatic extreme and
uncontrollable circumstances policy does not apply to groups or virtual
groups (83 FR 59874
[[Page 19278]]
and 59875); however, under Sec. 414.1380(c)(2)(i), individual
clinicians, groups and virtual groups could submit an application for
reweighting the performance categories based on extreme and
uncontrollable circumstances. To provide additional relief to
individual clinicians, groups, and virtual groups for whom sufficient
MIPS measures and activities may not be available for the 2019 MIPS
performance period due to the PHE for the COVID-19 pandemic, we are
extending the deadline to submit an application for reweighting the
quality, cost, and improvement activities performance categories based
on extreme and uncontrollable circumstances (Sec.
414.1380(c)(2)(i)(A)(6)) and the Promoting Interoperability performance
category based on extreme and uncontrollable circumstances (Sec.
414.1380(c)(2)(i)(C)(2)) from December 31, 2019 to April 30, 2020, or a
later date that we may specify. This extended deadline of April 30,
2020 mirrors the MIPS data submission deadline extension. The extended
deadline is available only for applications that demonstrate the
clinician has been adversely affected by the PHE for the COVID-19
pandemic.
We are also modifying our existing policy for the 2019 performance
period/2021 MIPS payment year so that if a MIPS eligible clinician,
group, or virtual group submits an application for reweighting based on
the PHE for the COVID-19 pandemic by the extended deadline, any MIPS
data they have submitted or will submit would not effectively void
their application. Under Sec. 414.1380(c)(2)(i)(A)(6) and
(c)(2)(i)(C), if an application for reweighting the performance
categories based on extreme and uncontrollable circumstances is
submitted, but data on measures or activities for a performance
category are also submitted, a MIPS eligible clinician will be scored
on the submitted data, and the performance categories for which data
are submitted will not be reweighted. However, for the 2019 performance
period we believe it is appropriate to modify this policy, because we
believe it is possible that a MIPS eligible clinician, group, or
virtual group could have submitted some MIPS data prior to the PHE for
the COVID-19 pandemic, but due to circumstances related to the PHE for
the COVID-19 pandemic, are not able to complete their submission such
that the data they submitted may not reflect their actual performance
on the measures and activities. As a result, we are modifying the
policy at Sec. 414.1380(c)(2)(i)(A)(6) to create an exception for the
2019 performance period/2021 MIPS payment year only, such that if a
MIPS eligible clinician demonstrates through an application submitted
to CMS that they have been adversely affected by the PHE for the COVID-
19 pandemic, but also submits data for the quality, cost, or
improvement activities performance categories, the performance
categories for which data are submitted would still be reweighted
(subject to CMS' approval of the application), and the data submission
would not effectively void the application for reweighting. We are also
modifying the policy at Sec. 414.1380(c)(2)(i)(C) to create a similar
exception for the Promoting Interoperability performance category for
the 2019 performance period/2021 MIPS payment year only.
CC. Inpatient Hospital Services Furnished Under Arrangements Outside
the Hospital During the Public Health Emergency (PHE) for the COVID-19
Pandemic
1. Overview for Inpatient Hospital Services
For purposes of Medicare payment, section 1861(b) of the Act
defines inpatient hospital services in part as the following items and
services furnished to an inpatient of a hospital and (except as
provided in paragraph (3)) by the hospital: (1) Bed and board; (2) such
nursing services and other related services, such use of hospital
facilities, and such medical social services as are ordinarily
furnished by the hospital for the care and treatment of inpatients, and
(3) such other diagnostic or therapeutic items or services, furnished
by the hospital or by others under arrangements with them made by the
hospital, as are ordinarily furnished to inpatients either by such
hospital or by others under such arrangements.
Routine services in the hospital setting are those described in
sections 1861(b)(1) and (b)(2) of the Act. Under our current policy for
hospital services furnished under arrangements that we adopted in the
FY 2012 IPPS/LTCH PPS rulemaking (76 FR 51714), routine services cannot
be provided under arrangement outside the hospital. Only the
therapeutic and diagnostic services described in section 1886(b)(3) of
the Act can be provided under arrangement outside the hospital.
We continue to believe that our current policy prohibiting routine
services from being provided under arrangement outside the hospital is
consistent with the statute and appropriate for the reasons discussed
in the FY 2012 IPPS/LTCH PPS rulemaking. However, we wish to give
hospitals that provide services to Medicare beneficiaries flexibility
to respond effectively to the serious public health threats posed by
COVID-19. Recognizing the urgency of this situation, and understanding
that our current policy may inhibit use of capacity in settings that
might otherwise be effective in the efforts to mitigate the impact of
the pandemic on Medicare beneficiaries and the American public, we are
changing our under arrangements policy during the PHE for the COVID-19
pandemic so that hospitals are allowed broader flexibilities to furnish
inpatient services, including routine services outside the hospital.
2. Prior Rulemaking
In the FY 2012 IPPS/LTCH PPS rulemaking (76 FR 51711), we noted
that the statute specifies that ``routine services,'' for example, bed,
board, nursing and other related services, except those specified at
paragraph (3) of section 1861(b) of the Act are to be provided by ``the
hospital,'' and not just ``a hospital.'' Similarly, we noted that our
implementing regulations at Sec. 409.12 indicate that Medicare pays
for nursing and related services, use of hospital facilities, and
medical social services as inpatient hospital services or inpatient CAH
services only if those services are ordinarily furnished by the
hospital or CAH. We pointed out that, consistent with section
1861(b)(3) of the Act, only with regard to other diagnostic or
therapeutic services do the regulations at Sec. 409.16 state that
Medicare will also pay for these services if furnished ``by others
under arrangements made by the hospital or CAH.''
Under our current policy adopted in the FY 2012 IPPS/LTCH PPS
rulemaking, if routine services, that is, services described in
sections 1861(b)(1) and (b)(2) of the Act, are provided in the
hospital, they are considered as being provided ``by the hospital.'' We
stated that we believe this policy is consistent with the statute
because the statutory language specifying that the routine services
described in sections 1861(b)(1) and (b)(2) of the Act be provided ``by
the hospital'' suggests that the hospital is required to exercise
professional responsibility over the services, including quality
controls. In situations in which certain routine services are provided
through arrangement ``in the hospital,'' for example, contracted
nursing services, we stated that we believe the arrangement generally
results in the hospital exercising the same level of control over those
services as the hospital does in situations in
[[Page 19279]]
which the services are provided by the hospital's salaried employees.
Therefore, if routine services are provided in the hospital to its
inpatients, we consider the service as being provided by the hospital.
However, if these services are provided to its patients outside the
hospital, the services are considered as being provided under
arrangement, and not by the hospital. Therefore, consistent with the
statute, we stated that only therapeutic and diagnostic services can be
provided under arrangement outside the hospital.
Some commenters during the FY 2012 IPPS/LTCH PPS rulemaking stated
that our policy to limit the services a hospital may provide under
arrangements is not required by the statute or regulations. Some
commenters also believed that CMS' proposed reading of the statutory
definition of inpatient hospital services is only one possible
interpretation of the statute.
In our response to these comments, we noted that we focused on
section 1861(b) of the Act because it provides the statutory basis for
our policy to limit the services that may be furnished under
arrangement. As we noted in that rulemaking, the reference to
diagnostic or therapeutic items or services in section 1861(b)(3) of
the Act is to services furnished by the hospital or by others under
arrangements. Therefore, we stated that we believe it is consistent
with the statutory language to limit the services that may be furnished
outside of a hospital under arrangement to only diagnostic and
therapeutic services.
We noted that our policy does not alter the definition of inpatient
hospital services, but instead limits the services a hospital may
provide under arrangements outside the hospital. If a patient of
Hospital A is in Hospital B receiving routine services, the patient
will still be an ``inpatient,'' but the services will not be considered
``inpatient hospital services'' furnished by the hospital for purposes
of payment for services defined under section 1861(b) of the Act. If
the patient is admitted to Hospital B, then the patient would be an
``inpatient'' of Hospital B and the routine services furnished to that
individual would meet the definition of ``inpatient routine services''
under section 1861(b) of the Act.
We also discussed in the FY 2012 IPPS/LTCH PPS rulemaking the
policy considerations supporting this change. We stated that we became
aware that some hospitals were furnishing certain routine services,
including ICU services, under arrangement. For example, under certain
arrangements, if an inpatient of an IPPS-excluded hospital (``hospital
A'') required ICU services, and the IPPS-excluded hospital could not
provide these services, the patient was moved to an IPPS hospital
(``hospital B'') that could furnish the ICU services. In these
situations, the patient was not transferred to hospital B but was moved
from an inpatient bed of hospital A to an inpatient bed of hospital B.
However, the IPPS-excluded hospital treated these services as being
provided under arrangement and included the cost of those services on
its cost report. We found it problematic that the patient was, at all
times, considered an inpatient of hospital A even though the patient
occupied an inpatient bed at hospital B.
Because the two hospitals in the example above are under two
different payment systems, we stated that we believe this arrangement
can result in inappropriate and potentially excessive Medicare
payments. The IPPS-excluded hospital, hospital A, is paid on a
reasonable cost basis, subject to a ceiling. In most cases, this
payment is greater than if the hospital were paid under the IPPS for
the same patient. Furthermore, although there is a ceiling on the
amount of Medicare payment for hospital A, there are also provisions
that allow hospital A to receive adjustments to its ceiling in certain
circumstances, which in the absence of our policy could allow payment
to hospital A above those allowed by its ceiling. Therefore, in the
absence of our policy these arrangements could allow hospital A to
request an adjustment to its ceiling because its ICU costs had
increased beyond what is allowed. In that case, hospital A would
receive additional payments beyond its ceiling. We stated that we
believe that by limiting the furnishing of routine services under
arrangements to situations in which the services are furnished in
hospital A, we reduce the opportunity for gaming. In these more limited
situations, hospital A exercises sufficient control over the use of
hospital resources when furnishing these services such that the
services are appropriately included in hospital A's cost report.
Under our current policy adopted in that rulemaking, if hospital A
did not have the resources to treat a patient, it would transfer the
patient to hospital B for ICU services, and hospital B would bill
Medicare consistent with the IPPS provisions. Hospital A would be paid
for an inpatient discharge.
3. Inpatient Hospital Services Furnished Under Arrangements Outside the
Hospital During the PHE for the COVID-19 Pandemic
As noted earlier in this section, we continue to believe that our
current policy is consistent with the statute and appropriate for the
reasons discussed in the FY 2012 IPPS/LTCH PPS rulemaking. However, we
wish to give hospitals that provide services to Medicare beneficiaries
additional flexibilities to respond effectively to the serious public
health threats posed by the spread of COVID-19. Recognizing the urgency
of this situation, and understanding that some pre-existing Medicare
payment rules may inhibit use of capacity that might otherwise be
effective in the efforts to mitigate the impact of the pandemic on
Medicare beneficiaries and the American public, we are changing our
under arrangements policy during the PHE for the COVID-19 pandemic
beginning March 1, 2020, so that hospitals are allowed broader
flexibilities to furnish inpatient services, including routine services
outside the hospital.
We believe that our concerns articulated in the FY 2012 rulemaking
regarding gaming of routine services provided outside the hospital for
payment reasons are significantly mitigated by the existence of the
PHE. Hospitals would be treating patients in locations outside the
hospital for a variety of reasons, including limited beds and/or
limited specialized equipment such as ventilators, and for a limited
time period. We do not expect that during the PHE for the COVID-19
pandemic hospitals would be treating patients outside the hospital for
gaming reasons.
As noted, we continue to believe that our current policy of
limiting the services that may be provided under arrangements outside
of the hospital to therapeutic and diagnostic items and services is
consistent with the statute and supported by the policy considerations
discussed in the FY 2012 IPPS/LTCH PPS final rule. However, we do not
believe that the statute would preclude this change in policy to allow
routine services to also be provided under arrangements outside the
hospital, in light of the compelling circumstances and the need for
additional, short-term flexibility during the current PHE for the
COVID-19 pandemic. Consistent with this, and as previously summarized
in section II.BB.2 of this IFC, we note that we received comments
during the FY 2012 rulemaking that our policy to limit the services a
hospital may provide under
[[Page 19280]]
arrangements is not required by the statute and that CMS' reading of
the statutory definition of inpatient hospital services is only one
possible interpretation of the statute.
While we are changing our under arrangements policy during the PHE
for the COVID-19 pandemic to allow hospitals broader flexibilities in
furnishing inpatient services, we emphasize that we are not changing
our policy that a hospital needs to exercise sufficient control and
responsibility over the use of hospital resources in treating patients,
as discussed in the FY 2012 IPPS/LTCH PPS final rule and Section 10.3
of Chapter 5 of the Medicare General Information, Eligibility, and
Entitlement Manual (Pub. 100-01). Nothing in the current PHE for the
COVID-19 pandemic has changed our policy or thinking with respect to
this issue and we are making no modifications to this aspect of the
policy. Hospitals need to continue to exercise sufficient control and
responsibility over the use of hospital resources in treating patients
regardless of whether that treatment occurs in the hospital or outside
the hospital under arrangements. If a hospital cannot exercise
sufficient control and responsibility over the use of hospital
resources in treating patients outside the hospital under arrangements,
the hospital should not provide those services outside the hospital
under arrangements.
For the reasons set forth above, effective for services provided
for discharges for patients admitted to the hospital during the PHE for
COVID-19 beginning March 1, 2020, if routine services are provided
under arrangements outside the hospital to its inpatients, these
services are considered as being provided by the hospital.
DD. Advance Payments to Suppliers Furnishing Items and Services Under
Part B
In an effort to be able to be more responsive to situations in
which Part B suppliers could request advance payments from CMS, we are
making modifications to existing advance payments rules found in 42 CFR
421.214. Currently, Sec. 421.214 limits CMS' ability to make advance
payments in situations where a CMS contractor is unable to process
claims within established time limits. In light of the PHE Declaration
related to COVID-19 and the inability to project the impact it may have
in the future on CMS' abilities to ensure timely payment and the
potential challenges for suppliers to prepare and submit claims to CMS
contractors, we are revising the definition of advance payment in Sec.
421.214(b). Currently, paragraph (b) defines advance payment as a
conditional partial payment made by the carrier in response to a claim
that it is unable to process within established time limits. We are
revising this definition to state that the conditional partial payment
will be made by the ``contractor'' (not the carrier) except as provided
in paragraph (j). We are also adding language to permit payments under
an exception at Sec. 421.214(c). In addition, we are also adding
paragraph (j) to specifically address emergency situations in which it
will be able to make advance payments. Additionally, existing rules
limit CMS to no more than 80 percent of the anticipated payment for
that claim based upon the historical assigned claims payment data for
claims paid to the supplier. Under exceptional circumstances as
outlined in paragraph (j), we are increasing this limit to 100 percent
of the anticipated payment for that claim based upon the historical
assigned claims payment data for claims paid to the supplier in
paragraph (f)(1)(i). We are also adding a criterion to Sec. 421.214
that suppliers in bankruptcy would not be eligible to receive advance
payments to ensure that, with such expanded authority, CMS is able to
appropriately pay and recover advance payments made to Part B
suppliers.
III. Waiver of Proposed Rulemaking
We ordinarily publish a notice of proposed rulemaking in the
Federal Register and invite public comment on the proposed rule before
the provisions of the rule take effect, in accordance with 5 U.S.C.
553(b) of the Administrative Procedure Act (APA) and section 1871 of
the Act. Specifically, section 553(b) of the APA requires the agency to
publish a notice of the proposed rule in the Federal Register that
includes a reference to the legal authority under which the rule is
proposed, and the terms and substance of the proposed rule or a
description of the subjects and issues involved. Section 553(c) of the
APA further requires the agency to give interested parties the
opportunity to participate in the rulemaking through public comment
before the provisions of the rule take effect. Similarly, section
1871(b)(1) of the Act requires the Secretary to provide for notice of
the proposed rule in the Federal Register and a period of not less than
60 days for public comment. Section 553(b)(3)(B) of the APA and section
1871(b)(2)(C) of the Act authorize the agency to waive these
procedures, however, if the agency finds good cause that notice and
comment procedures are impracticable, unnecessary, or contrary to the
public interest and incorporates a statement of the finding and its
reasons in the rule issued.
Section 553(d) of the APA ordinarily requires a 30-day delay in the
effective date of a final rule from the date of its publication in the
Federal Register. This 30-day delay in effective date can be waived,
however, if an agency finds good cause to support an earlier effective
date. Section 1871(e)(1)(B)(i) of the Act also prohibits a substantive
rule from taking effect before the end of the 30-day period beginning
on the date the rule is issued or published. Section 1871(e)(1)(B)(ii)
of the Act permits a substantive rule to take effect before 30 days if
the Secretary finds that a waiver of the 30-day period is necessary to
comply with statutory requirements or that the 30-day delay would be
contrary to the public interest. Furthermore, section 1871(e)(1)(A)(ii)
of the Act permits a substantive change in regulations, manual
instructions, interpretive rules, statements of policy, or guidelines
of general applicability under Title XVIII of the Act to be applied
retroactively to items and services furnished before the effective date
of the change if the failure to apply the change retroactively would be
contrary to the public interest.
The nation is experiencing an emergency of unprecedented magnitude.
Ensuring the health and safety of Medicare beneficiaries, Medicaid
recipients, and healthcare workers is of primary importance. As this
IFC directly supports that goal by offering healthcare professionals
flexibilities in furnishing services while combatting the COVID-19
pandemic and ensuring that sufficient health care items and services
are available to meet the needs of individuals enrolled in the Medicare
and Medicaid programs, it is critically important that we implement
this IFC as quickly as possible. As we are in the midst of a PHE, we
find good cause to waive notice and comment rulemaking as we believe it
would be contrary to the public interest for us to undertake normal
notice and comment rulemaking procedures. For the same reasons, because
we cannot afford any delay in effectuating this IFC, we find good cause
to waive the 30-day delay in the effective date and, moreover, to make
this IFC effective as of March 1, 2020--the date the President of the
United States declared to be the beginning of the national emergency
concerning the COVID-19 outbreak.
On January 30, 2020, the International Health Regulations Emergency
Committee of the World Health
[[Page 19281]]
Organization (WHO) declared the outbreak of the 2019 Novel Coronavirus
(COVID-19) to be a Public Health Emergency of International
Concern.\22\ On January 31, 2020, Health and Human Services Secretary
Alex M. Azar II declared a Public Health Emergency (PHE) \23\ under
section 319 of the Public Health Service Act (42 U.S.C. 247d), in
response to COVID-19. On March 11, 2020, the WHO publicly declared
COVID-19 to be a pandemic.\24\ On March 13, 2020, the President
declared that the COVD-19 outbreak in the United States constitutes a
national emergency,\25\ beginning March 1, 2020. This declaration,
along with the Secretary's January 30, 2020 declaration of a PHE,
conferred on the Secretary certain waiver authorities under section
1135 of the Act. On March 13, 2020, the Secretary authorized waivers
under section 1135 of the Act, effective March 1, 2020.\26\
---------------------------------------------------------------------------
\22\ https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-
(2005)-emergency-committee-regarding-the-outbreak-of-novel-
coronavirus-(2019-ncov).
\23\ https://www.phe.gov/emergency/news/healthactions/phe/Pages/2019-nCoV.aspx.
\24\ https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
\25\ https://www.whitehouse.gov/presidential-actions/proclamation-declaring-national-emergency-concerning-novel-coronavirus-disease-covid-19-outbreak/.
\26\ https://www.phe.gov/emergency/news/healthactions/section1135/Pages/covid19-13March20.aspx.
---------------------------------------------------------------------------
In support of the imperative to contain and combat the virus in the
United States, this IFC will give health care workers and hospitals
additional flexibility to respond to the virus and continue caring for
patients while minimizing exposure. CDC guidelines are clear that
public exposure greatly increases the overall risk to public health and
they stress the importance of containment and mitigation strategies to
minimize public exposure and the spread of COVID-19. As of March 29th,
the CDC reports 122,653 cases of COVID-19 in the United Sates and 2,112
deaths.\27\ Individuals such as healthcare workers who come in close
contact with those infected with COVID-19 are at an elevated risk of
contracting the disease. To minimize these risks, the CDC has urged
healthcare professionals to make every effort to distance themselves
from those who are potentially sick with COVID-19 by using modalities
such as telephonic interviews, text monitoring systems, or video
conference.\28\ As the healthcare community works to establish and
implement infection prevention and control practices, CMS is also
working to revise and implement regulations that function in concert
with those healthcare community infection prevention and treatment
practices.
---------------------------------------------------------------------------
\27\ https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html.
\28\ https://www.cdc.gov/coronavirus/2019-ncov/php/guidance-evaluating-pui.html.
---------------------------------------------------------------------------
This IFC offers flexibilities in certain Medicare and Medicaid
regulations that support measures to combat the COVID-19 pandemic and
safeguard all interests by protecting healthcare providers and
vulnerable beneficiaries. The provisions of this IFC better enable and
facilitate physicians and other clinicians, to focus on caring for
these beneficiaries during this PHE for the COVID-19 pandemic and
minimize their own risks to COVID-19 exposure. For example, by
increasing access to telehealth and testing in a patient's home, and
improving infection control, this IFC will provide flexibilities for
Medicare beneficiaries to be able to receive medically necessary
services without jeopardizing their health or the health of those who
are providing those services, in turn minimizing public exposure and
the overall risk to public health. Moreover, changes to Medicare
payment rules will confer on practitioners and other healthcare
providers the broadest flexibility to use remote communications
technology to avoid exposure risks to themselves, their patients, and
communities. These changes include greater flexibilities to use
communications technology to interact with patients directly and to
supervise care directly provided by other clinicians. This IFC alters
the applicable payment rules to provide specimen collection fees for
independent laboratories collecting specimens from beneficiaries who
are homebound or inpatients (not in a hospital) for COVID-19 testing.
Additionally, certain new model-specific requirements for Innovation
Center Models and program-specific requirements for the Quality Payment
Program will reduce or prevent practices that might inappropriately
incentivize cost considerations over patient safety. Changes to the
calculation of the 2021 and 2022 Part C and D Star Ratings will address
the expected disruption to data collection and measure scores posed by
the COVID-19 pandemic, and amendments to the Medicaid home health
regulations will enable other licensed practitioners to order services,
equipment, and therapy they otherwise could not.
We believe it would be contrary to the public interest for us to
undertake normal notice and comment procedures and to delay the
effective date of this IFC. We find good cause to waive notice of
proposed rulemaking under section 553(b)(3)(B) of the APA and section
1871(b)(2)(C) of the Act, and, for the reasons stated, we find that it
would be contrary to the public interest to delay the effective date of
this IFC, under section 553(d) of the APA and section 1871(e)(1)(B)(i)
of the Act.
Furthermore, the President declared that the COVID-19 outbreak in
the United States constituted a national emergency beginning March 1,
2020. To ensure the consistent availability throughout the national
emergency period of measures we are taking to address the COVID-19
pandemic, we believe it is vital that the effective date of this IFC
align with the first day of the national emergency. It is also
important to ensure the health care providers that acted expeditiously
to implement appropriate physical and operational changes to their
practices to adapt to emergency conditions, even in the absence of
changes in our policies to address them, are not disadvantaged relative
to other health care providers, and will not be discouraged from taking
similar appropriate actions in the future. March 1, 2020 precedes the
date of publication of this IFC in the Federal Register, which means
this rule has a retroactive effect. However, section 1872(e)(1)(A)(ii)
of the Act permits the Secretary to issue a rule with retroactive
effect if the failure to do so would be contrary to the public
interest. As we have explained above, we believe it would be contrary
to the public interest not to implement this IFC as soon as we are
authorized to do so under the authority of section 1871(e)(1)(A)(ii) of
the Act, that is, retroactively to March 1, 2020. We are providing a
60-day public comment period for this IFC as specified in the DATES
section of this document.
IV. Collection of Information Requirements
For IFC changes to the MA and Part D Star Ratings program, the
elimination of the requirement to collect and submit data for OMB
control numbers 0938-1028 (HEDIS) and 0938-0732 (CAHPS) will reduce
some burden. Those collections are approved for 164,200 hours and
123,375 hours annually, respectively. Due to the ongoing nature of
these information collections, it is difficult to determine the extent
of the burden. However, the burden estimates for the HEDIS and CAHPS
information collection requests are approved
[[Page 19282]]
through November 30, 2020 and April 30, 2021, respectively. Upon
resubmission for OMB approval, we will revise both information
collections to more accurately account for the burden decreases.
V. Response to Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
VI. Regulatory Impact Analysis
Executive Order 12866 and other laws and Executive orders require
economic analysis of the effects of proposed and final (including
interim final) rules.\29\ The Office of Management and Budget has
designated this rulemaking as ``economically significant'' under E.O.
12866 and also major under the Congressional Review Act. This IFC's
designation under Executive Order 13771, titled ``Reducing Regulation
and Controlling Regulatory Costs'' (82 FR 9339), which was issued on
January 30, 2017, will be informed by public comments received.
---------------------------------------------------------------------------
\29\ Section 202 of the Unfunded Mandates Reform Act of 1995
(UMRA) (Pub. L. 104-04, enacted on March 22, 1995) also requires
that agencies assess anticipated costs and benefits before issuing
any rule whose mandates require spending in any 1 year of $100
million in 1995 dollars, updated annually for inflation. In 2020,
that amount is approximately $156 million. This IFC does not
mandate, on an unfunded basis, any requirements for State, local, or
tribal governments, or for the private sector.
---------------------------------------------------------------------------
A. Statement of Need
Throughout this IFC, we discuss several changes to payment and
coverage policies intended to allow health care providers maximum
flexibility to minimize the spread of COVID-19 among Medicare and
Medicaid beneficiaries, health care personnel, and the community at
large and increase capacity to address the needs of their patients. The
flexibilities and changes contained within this IFC are responsive to
this developing pandemic emergency. Given the potentially catastrophic
impact to public health, it is difficult to estimate the economic
impact of the spread of COVID-19 under current payment rules compared
to the rules issued in this IFC.
We believe that the needs of Medicare patients will likely test the
capacity of the health care system over the coming months. Our policies
during the PHE for the COVID-19 Pandemic will allow home health
agencies and hospices more flexibility to furnish services via
telecommunications technologies to minimize exposure risks to patients,
clinicians and the general public; and there would be no change in
Medicare payment rates or change in the types of patients treated under
these policies compared to the absence of these policy changes.
Our additions to the list of Medicare telehealth services will
allow more physicians' services to be furnished in a manner that
reduces the exposure risk to patients and physicians. To the extent
that physicians utilize these new flexibilities for patients that would
have been treated in more traditional offices or hospital settings
without this policy change, given the competing demand for physicians'
services during the pandemic this additional flexibility would not
result in any significant change in aggregate Medicare payments for
physicians' services.
Still, it is possible that the flexibilities and changes contained
within this IFC would increase aggregate Medicare payments. For
example, if its protections against exposure risk are effective,
providers may maintain their own health and thus be available to
provide more medical treatment overall. Improvements in both provider
and/or patient health are intended benefits of this IFC.
We anticipate that the change in the site of service payment amount
for telehealth services under the PHE along with the changes that allow
for broader flexibilities in supervision will allow physicians and
other practitioners to better maintain overall level of needed care to
Medicare beneficiaries in the face of exposure risks and competing
demands for health care providers.
Finally, the changes to Medicaid's regulations to expand the scope
of certain providers are anticipated to eliminate some burdens on
providers and beneficiaries.
The modifications to the calculations for the 2021 and 2022 Part C
and D Star Ratings to address the expected disruption to data
collection and measure scores posed by the PHE for the COVID-19
pandemic should not have a significant impact on the distribution of
ratings across Part C and D sponsors. Consequently, there should be
negligible impacts on payments for MA organizations from these
modifications.
B. Special Requirements for Psychiatric Hospitals
In section II.P. of this final rule, we note that existing
requirements for psychiatric hospitals specify that progress notes must
be recorded by the physician(s), psychologists, or other licensed
independent practitioner(s) responsible for the care of the patient. We
believe that this provision requires clarification and revision since
the regulatory language is inconsistent with other recent changes
finalized throughout the hospital CoPs as this provision applies to
APPs, including PAs, NPs, psychologists, and CNSs.
Continued use of this outdated term may inadvertently exacerbate
workforce shortage concerns, might unnecessarily impose regulatory
burden on hospitals, especially psychiatric hospitals, by restricting a
hospital's ability to allow APPs to operate within the scope of
practice allowed by state law. We believe that the existing regulation
fails to recognize the benefits to patient care that might be derived
from fully utilizing APPs and their clinical skills to the highest
levels of their training, education, and experience as allowed by
hospital policy in accordance with state law.
Therefore, we are removing the term ``licensed independent
practitioner(s)'' from the regulations. We believe that this revision
is non-controversial, and that the public interest will be served by
permitting a greater scope of practice for professionals in the
psychiatric hospital context and further believe that these trained and
qualified practitioners, when acting in accordance with State law,
their scope of practice, and hospital policy, should have the authority
to record progress notes of psychiatric patients for whose care they
are responsible.
At Sec. 482.61(d), we are allowing NPPs, or APPs, to document
progress notes in accordance with State laws and scope-of-practice
requirements. We believe that clarification of the intent of the
regulation is necessary and will result in NPPs (specifically PAs, NPs,
and CNSs) documenting in the progress notes for patients receiving
services in psychiatric hospitals.
We estimate that MDs/DOs currently spend approximately 30 minutes
documenting progress notes in psychiatric hospitals, and that 33
percent of this time would be covered by NPPs. Of the 4,823 Medicare
participating hospitals, approximately 620 (or 13 percent) are
psychiatric hospitals. According to AHA, there were 36,510,207
inpatient hospital stays in 2017, and therefore, an estimated 13
percent of these stays were at psychiatric hospitals. The change will
result in a savings of $153.5 million (4,746,327 psychiatric hospital
stays x 2 progress notes per stay x 0.5 hours of physician/psychiatrist
time x $98 per
[[Page 19283]]
hourly wage difference between physicians/psychiatrists ($198) and NPPs
($100, the average wage between NPs and PAs) x 33 percent of physician
time spent writing progress notes covered by NPPs, or APPs).
C. Anticipated Effects of Changes to the MDPP Expanded Model
1. Effects on Beneficiaries
In section II.Q. of this IFC, we are amending the MDPP expanded
model to modify certain requirements of the model in an emergency area
during an emergency period, as those terms are defined in section
1135(g) of the Act, for which the Secretary has issued a waiver under
section 1135 of the Act. Specifically, as the Secretary has issued a
waiver under section 1135 of the Act, certain MDPP beneficiaries will
be permitted to obtain the set of MDPP services more than once per
lifetime, the number of virtual make-up sessions is increased, and
certain MDPP suppliers will be permitted to deliver time limited
virtual MDPP sessions. These changes apply only to MDPP beneficiaries
(as defined in Sec. 410.79(b)) who were receiving the MDPP set of
services during the emergency period, as defined under section 1135(g)
of the Act.
We believe that during this COVID-19 pandemic, Medicare
beneficiaries will not be able to attend in-person classes. Because we
do not want to disrupt their progress and we want to promote both MDPP
beneficiary and MDPP supplier retention, we have modified how the set
of services can be delivered to make the program accessible to
currently enrolled MDPP beneficiaries during this national emergency.
Our policies during the PHE for the COVID-19 Pandemic will allow
enrolled MDPP suppliers with active MDPP cohorts more flexibility to
furnish virtual sessions, as described by the CDC's DPRP Standards.
With the exception of the requirement for in-person attendance and
the in-person body weight measurement at the first core-session, the
in-person attendance requirements are waived. MDPP suppliers shall not
start any new cohorts with MDPP beneficiaries throughout the COVID-19
PHE period in the geographic area, as defined under section 1135(g) of
the Act, given that most beneficiaries cannot receive in-person
services right now.
During the emergency period, the number of virtual make-up sessions
is waived for MDPP suppliers, with an MDPP supplier offering MDPP
beneficiaries no more than 15 weekly virtual make-up sessions during
the core session period, no more than 6 monthly virtual make-up
sessions during the core maintenance session interval period, no more
than 12 monthly virtual make-up sessions during the ongoing maintenance
session interval periods. All flexibilities described in this IFC will
cease to be available as of the effective end date of the PHE. When in-
person classes resume, the CDC is allowing suppliers to pick up where
they left off, or to restart the program from week one. It is our
intent to conform with the CDC guidance where feasible, with the
overall intent to minimize disruption of services for MDPP suppliers
and MDPP beneficiaries; by allowing MDPP beneficiaries to maintain
their eligibility. In this IFC, we are amending the MDPP regulations to
provide for changes as described in section II.Q.1 of this IFC,
including allowing MDPP suppliers to either deliver MDPP services
virtually or suspend delivery and resume services at a later date, in
an emergency area and during this COVID-19 PHE period, as those terms
are defined in section 1135(g) of the Act, for which the Secretary has
authorized a waiver under section 1135 of the Act and the Secretary has
declared a PHE. In addition, these changes permit certain MDPP
beneficiaries to obtain the set of MDPP services more than once per
lifetime, for the limited purposes of allowing a pause in service and
allow MDPP beneficiaries to maintain eligibility for MDPP services
despite a break in service, attendance, or weight loss achievement.
These changes will have a positive impact on affected MDPP
beneficiaries, as it will allow them to maintain eligibility for the
expanded model, and request virtual make-up sessions if needed for
successful completion of attendance and weight loss milestones.
2. Effects on the Market
Currently, more than 196 organizations nationally are enrolled as
MDPP suppliers. There are approximately 798 locations. We anticipate
that of the 1,818 beneficiaries identified through our monitoring data
and the CDC's Diabetes Prevention Recognition Program (DPRP) data,
1,358 beneficiaries may be impacted by allowing both the once-per-
lifetime benefit and the minimum weight loss requirement to be waived
for those beneficiaries in the first 12 months of MDPP.
Table 2
------------------------------------------------------------------------
Recommended waivers Cost impact
------------------------------------------------------------------------
Adjust the limit to the # Virtual Make-up sessions...... $--
Waive the once per lifetime requirement................. 279,748.00
Waive the minimum weight loss requirement for OM........ 53,301.50
Waive the MDPP services time periods and intervals...... --
Average Y1 MDPP Payments (Y1) with no COVID action...... 177,898.00
---------------
Total cost of COVID-19 response..................... 333,049.50
------------------------------------------------------------------------
Assumptions:
--Average MDPP payments in Year 1: $412, assuming that beneficiaries
attended 9 sessions, and reached the 5 percent weight loss during
interval 1 of the core maintenance session
--Average MDPP payments in Year 1 with no COVID-19 action: $131,
assuming beneficiaries attended 2 ongoing maintenance sessions
D. Modification to the Extreme and Uncontrollable Circumstances Policy
Under the Shared Savings Program
In section II.V. of this IFC, we discuss a modification to the
extreme and uncontrollable circumstances policy under the Shared
Savings Program. The current Medicare Shared Savings Program extreme
and uncontrollable circumstances policy for purposes of determining an
ACO's quality score for use in determining shared savings or shared
losses applies if twenty percent or more of an ACO's assigned
beneficiaries or its legal business entity are located in an area
identified under the Quality Payment Program as being affected by an
extreme and uncontrollable circumstance, during the performance year,
including the applicable quality data reporting period for the
performance year if, the quality reporting period is not extended. In
response to the National Emergency for
[[Page 19284]]
the COVID-19 pandemic declared on March 13, 2020, we have determined
that the 2019 MIPS data submission deadline will be extended by 30 days
until April 30, 2020, to give eligible clinicians more time to report
quality and other data for purposes of MIPS. This extended timeline
also applies to Shared Savings Program ACOs because they are required
to report quality data via the CMS Web Interface and we align the
Shared Savings Program data submission timeline with the timeline for
MIPS data submission. As currently written, our extreme and
uncontrollable circumstances policy cannot be applied to waive the
quality reporting requirements under the Shared Savings Program because
the quality data submission period has been extended.
The PHE for the COVID-19 pandemic applies to all counties in the
United States, and we think it is appropriate to offer relief under the
Shared Savings Program extreme and uncontrollable circumstances policy
to all Shared Savings Program ACOs that are unable to completely and
accurately report quality for 2019 by the extended deadline.
Accordingly, in this IFC, we are revising the regulation at Sec.
425.502(f) to remove the restriction which prevents the application of
the Shared Savings Program extreme and uncontrollable circumstances
policy for disasters that occur during the quality period if the
reporting period is extended, to offer relief under the Shared Savings
Program to all ACOs that may be unable to completely and accurately
report quality for 2019 due to the PHE for the COVID-19. As currently
written, our extreme and uncontrollable circumstances policy cannot be
applied to waive the quality reporting requirements under the Shared
Savings Program because the quality data submission period has been
extended.
The PHE for the COVID-19 pandemic applies to all counties in the
United States, and we think it is appropriate to offer relief under the
Shared Savings Program extreme and uncontrollable circumstances policy
to all Shared Savings Program ACOs that are unable to completely and
accurately report quality for 2019 by the extended deadline,
Accordingly, in this interim final rule, we are revising the regulation
at Sec. 425.502(f) to remove the restriction which prevents the
application of the Shared Savings Program extreme and uncontrollable
circumstances policy for disasters that occur during the quality period
if the reporting period is extended, in order to offer relief under the
Shared Savings Program to all ACOs that may be unable to completely and
accurately report quality for 2019 due to the PHE for the COVID-19
pandemic.
We estimate based on patterns evident in the financial
reconciliation for performance year 2018 that this change would allow
roughly 100 ACOs that achieve savings either to qualify to receive
shared savings or to receive a higher effective sharing rate. We
estimate the average resulting benefit to such ACOs ranging from
$150,000 to $200,000 per ACO. The total impact of extending the extreme
and uncontrollable circumstances policy despite the extension of the
quality reporting period for 2019 is therefore estimated to be $20
million with a range of uncertainty in such estimate spanning $15
million to $25 million.
E. Anticipated Effects of Changes to the Quality Payment Program
Since it is not possible to comprehensively predict the impact of
the evolving PHE for the COVID-19 pandemic at this time, the Office of
the Actuary was unable to calculate a discrete impact estimate for the
effect of extending CJR PY 5 an additional 3 months. However, given the
previous estimate for PY 5 in the ``Comprehensive Care for Joint
Replacement Model Three-Year Extension and Changes to Episode
Definition and Pricing'' proposed rule (CMS-5529-P), we anticipate the
impact of the additional 3 months could range between $0 and $1.2
million. We will continue to refine this analysis and will provide a
more detailed estimate in the final rule if available. Table 3
summarizes the financial impact of extending PY 5 an additional 3
months. Table 3 includes the full amount of FFS episode payments and
also includes any reconciliation payments related to the model. Table 3
also shows costs/savings (costs are represented as positive amounts and
savings as negative amounts) imposed on non-federal entities (that is,
participating medical facilities), as well as net transfers of federal
funds (that is, increases in Medicare program expenditures are
indicated as positive amounts and decreases in Medicare program
expenditures are indicated as negative amounts).
Table 3--Financial Impact of Extending PY 5 an Additional 3 Months
------------------------------------------------------------------------
Transfers
Scenario Costs/benefits (millions)
------------------------------------------------------------------------
Net financial impact of extending CJR .............. 1.2
model PY 5 by 3 additional months.....
------------------------------------------------------------------------
F. Overall Impact
The RFA requires agencies to analyze options for regulatory relief
of small entities, if a rule has a significant impact on a substantial
number of small entities. The great majority of hospitals and most
other health care providers and suppliers are small entities, either by
being nonprofit organizations or by meeting the SBA definition of a
small business (having revenues of less than $8.0 million to $41.5
million in any one year). Individuals and states are not included in
the definition of a small entity. As its measure of significant
economic impact on a substantial number of small entities, HHS uses an
adverse change in revenue of more than 3 to 5 percent. We do not
believe that this threshold will be reached by the provisions in this
IFC.
In addition, section 1102(b) of the Act requires us to prepare a
regulatory impact analysis if a rule may have a significant impact on
the operations of a substantial number of small rural hospitals. This
analysis must conform to the provisions of section 604 of the RFA. For
purposes of section 1102(b) of the Act, we define a small rural
hospital as a hospital that is located outside of a metropolitan
statistical area and has fewer than 100 beds. This IFC will not have a
significant impact on the operations of a substantial number of small
rural hospitals.
Executive Order 13132 establishes certain requirements that an
agency must meet when it issues a proposed rule that imposes
substantial direct requirement costs on state and local governments,
preempts state law, or otherwise has federalism implications. This IFC
does not have a substantial direct cost impact on state or local
governments, preempt state law, or otherwise have federalism
implications.
Under the Congressional Review Act (5 U.S.C. 801 et seq.), the
Office of Information and Regulatory Affairs designated this rule as a
major rule, as
[[Page 19285]]
defined by 5 U.S.C. 804(2). As such, this rule has been transmitted to
the Congress and the Comptroller General for review.
List of Subjects
42 CFR Part 400
Grant programs--health, Health facilities, Health maintenance
organizations (HMO), Medicaid, Medicare, Reporting and recordkeeping
requirements.
42 CFR Part 405
Administrative practice and procedure, Diseases, Health facilities,
Health insurance, Health professions, Medical devices, Medicare,
Reporting and recordkeeping requirements, Rural areas, X-rays.
42 CFR Part 409
Health facilities, Medicare.
42 CFR Part 410
Diseases, Health facilities, Health professions, Laboratories,
Medicare, Reporting and recordkeeping requirements, Rural areas, X-
rays.
42 CFR Part 412
Administrative practice and procedure, Health facilities, Medicare,
Puerto Rico, Reporting and recordkeeping requirements.
42 CFR Part 414
Administrative practice and procedure, Biologics, Diseases, Drugs,
Health facilities, Health professions, Medicare, Reporting and
recordkeeping requirements.
42 CFR Part 415
Health facilities, Health professions, Medicare, Reporting and
recordkeeping requirements.
42 CFR Part 417
Administrative practice and procedure, Grant programs--health,
Health care, Health insurance, Health maintenance organizations (HMO),
Loan programs--health, Medicare, Reporting and recordkeeping
requirements.
42 CFR Part 418
Health facilities, Hospice care, Medicare, Reporting and
recordkeeping requirements.
42 CFR Part 421
Administrative practice and procedure, Health facilities, Health
professions, Medicare, Reporting and recordkeeping requirements.
42 CFR Part 422
Administrative practice and procedure, Health facilities, Health
maintenance organizations (HMO), Medicare, Penalties, Privacy,
Reporting and recordkeeping requirements.
42 CFR Part 423
Administrative practice and procedure, Emergency medical services,
Health facilities, Health maintenance organizations (HMO), Health
professionals, Medicare, Penalties, Privacy, Reporting and
recordkeeping requirements.
42 CFR Part 425
Administrative practice and procedure, Health facilities, Health
professions, Medicare, Reporting and recordkeeping requirements.
42 CFR Part 440
Grant programs--health, Medicaid.
42 CFR Part 482
Grant programs--health, Hospitals, Medicaid, Medicare, Reporting
and recordkeeping requirements.
42 CFR Part 510
Administrative practice and procedure, Health facilities.
For the reasons set forth in the preamble, the Centers for Medicare
& Medicaid Services amends 42 CFR chapter IV as set forth below:
PART 400--INTRODUCTION; DEFINITIONS
0
1. The authority citation part 400 is revised to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh, and 44 U.S.C. Chapter 35.
0
2. Section 400.200 is amended by adding the definition of ``Public
Health Emergency'' in alphabetical order to read as follows:
Sec. 400.200 General definitions.
* * * * *
Public Health Emergency (PHE) means the Public Health Emergency
determined to exist nationwide as of January 27, 2020, by the Secretary
pursuant to section 319 of the Public Health Security Act on January
31, 2020, as a result of confirmed cases of COVID-19, including any
subsequent renewals.
* * * * *
PART 405--FEDERAL HEALTH INSURANCE FOR THE AGED AND DISABLED
0
3. The authority citation part 405 continues to read as follows:
Authority: 42 U.S.C. 263a, 405(a), 1302, 1320b-12, 1395x,
1395y(a), 1395ff, 1395hh, 1395kk, 1395rr, and 1395ww(k).
0
4. Section 405.2416 is amended by adding paragraph (a)(5) to read as
follows:
Sec. 405.2416 Visiting nurse services.
(a) * * *
(5) During a PHE, as defined in Sec. 400.200 of this chapter, an
area typically served by the RHC, and an area that is included in the
FQHC's service area plan, is determined to have a shortage of home
health agencies, and no request for this determination is required.
* * * * *
PART 409--HOSPITAL INSURANCE BENEFITS
0
5. The authority citation for part 409 continues to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh.
0
6. Section 409.43 is amended by revising paragraph (a)(3) to read as
follows:
Sec. 409.43 Plan of care requirements.
(a) * * *
(3) The plan of care must include the identification of the
responsible discipline(s) and the frequency and duration of all visits,
as well as those items listed in Sec. 484.60(a) of this chapter that
establish the need for such services. All care provided must be in
accordance with the plan of care. During a PHE, as defined in Sec.
400.200 of this chapter, the plan of care must include any provision of
remote patient monitoring or other services furnished via a
telecommunications system and such services must be tied to the
patient-specific needs as identified in the comprehensive assessment,
cannot substitute for a home visit ordered as part of the plan of care,
and cannot be considered a home visit for the purposes of patient
eligibility or payment. The plan of care must include a description of
how the use of such technology will help to achieve the goals outlined
on the plan of care.
* * * * *
PART 410--SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS
0
7. The authority citation for part 410 continues to read as follows:
Authority: 42 U.S.C. 1302, 1395m, 1395hh, 1395rr, and 1395ddd.
0
8. Section 410.27 is amended by revising paragraphs (a)(1)(iv)(D) and
(E) to read as follows:
[[Page 19286]]
Sec. 410.27 Therapeutic outpatient hospital or CAH services and
supplies incident to a physician's or nonphysician practitioner's
service: Conditions.
(a) * * *
(1) * * *
(iv) * * *
(D) For pulmonary rehabilitation, cardiac rehabilitation, and
intensive cardiac rehabilitation services, direct supervision must be
furnished by a doctor of medicine or a doctor of osteopathy, as
specified in Sec. Sec. 410.47 and 410.49, respectively. For purposes
of this section, direct supervision means that the physician or
nonphysician practitioner must be immediately available to furnish
assistance and direction throughout the performance of the procedure.
It does not mean that the physician or nonphysician practitioner must
be present in the room when the procedure is performed. During a Public
Health Emergency, as defined in Sec. 400.200 of this chapter, the
presence of the physician includes virtual presence through audio/video
real-time communications technology when use of such technology is
indicated to reduce exposure risks for the beneficiary or health care
provider; and
(E) For nonsurgical extended duration therapeutic services
(extended duration services), which are hospital or CAH outpatient
therapeutic services that can last a significant period of time, have a
substantial monitoring component that is typically performed by
auxiliary personnel, have a low risk of requiring the physician's or
appropriate nonphysician practitioner's immediate availability after
the initiation of the service, and are not primarily surgical in
nature, Medicare requires a minimum of direct supervision during the
initiation of the service which may be followed by general supervision
at the discretion of the supervising physician or the appropriate
nonphysician practitioner. Initiation means the beginning portion of
the nonsurgical extended duration therapeutic service which ends when
the patient is stable and the supervising physician or the appropriate
nonphysician practitioner determines that the remainder of the service
can be delivered safely under general supervision. During a Public
Health Emergency, as defined in Sec. 400.200 of this chapter, Medicare
requires a minimum level of general supervision for the entire service;
and
* * * * *
0
9. Section 410.28 is amended by revising paragraph (e)(1) to read as
follows:
Sec. 410.28 Hospital or CAH diagnostic services furnished to
outpatients: Conditions.
* * * * *
(e) * * *
(1) For services furnished directly or under arrangement in the
hospital or in an on-campus or off-campus outpatient department of the
hospital, as defined in Sec. 413.65 of this chapter, ``direct
supervision'' means that the physician must be immediately available to
furnish assistance and direction throughout the performance of the
procedure. It does not mean that the physician must be present in the
room where the procedure is performed. During a Public Health
Emergency, as defined in Sec. 400.200 of this chapter, the presence of
the physician includes virtual presence through audio/video real-time
communications technology when use of such technology is indicated to
reduce exposure risks for the beneficiary or health care provider.
* * * * *
0
10. Section 410.32 is amended by revising paragraph (b)(3)(ii) to read
as follows:
Sec. 410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and
other diagnostic tests: Conditions.
* * * * *
(b) * * *
(3) * * *
(ii) Direct supervision in the office setting means the physician
must be present in the office suite and immediately available to
furnish assistance and direction throughout the performance of the
procedure. It does not mean that the physician must be present in the
room when the procedure is performed. During a PHE, as defined in Sec.
400.200 of this chapter, the presence of the physician includes virtual
presence through audio/video real-time communications technology when
use of such technology is indicated to reduce exposure risks for the
beneficiary or health care provider.
* * * * *
0
11. Section 410.40 is amended by adding paragraph (f)(5) to read as
follows:
Sec. 410.40 Coverage of ambulance services.
* * * * *
(f) * * *
(5) During a Public Health Emergency, as defined in Sec. 400.200
of this chapter, a ground ambulance transport from any point of origin
to a destination that is equipped to treat the condition of the patient
consistent with any applicable state or local Emergency Medical
Services protocol that governs the destination location. Such
destinations include, but are not limited to, alternative sites
determined to be part of a hospital, critical access hospital or
skilled nursing facility, community mental health centers, federally
qualified health centers, rural health clinics, physician offices,
urgent care facilities, ambulatory surgical centers, any location
furnishing dialysis services outside of an ESRD facility when an ESRD
facility is not available, and the beneficiary's home.
* * * * *
0
12. Section 410.67(b) is amended in paragraphs (3) and (4) of the
definition of ``Opioid use disorder treatment service'' by adding a
sentence at the end of each paragraph to read as follows:
Sec. 410.67 Medicare coverage and payment of Opioid use disorder
treatment services furnished by Opioid treatment programs.
* * * * *
(b) * * *
Opioid use disorder treatment service * * *
(3) * * * During a Public Health Emergency, as defined in Sec.
400.200 of this chapter, where audio/video communication technology is
not available to the beneficiary, the counseling services may be
furnished using audio-only telephone calls if all other applicable
requirements are met.
(4) * * * During a Public Health Emergency, as defined in Sec.
400.200 of this chapter, where audio/video communication technology is
not available to the beneficiary, the therapy services may be furnished
using audio-only telephone calls if all other applicable requirements
are met.
* * * * *
0
13. Section 410.78 is amended by--
0
a. Adding paragraph (a)(3)(i) and reserved paragraph (a)(3)(ii); and
0
b. Revising paragraph (b) introductory text.
The additions and revision read as follows:
Sec. 410.78 Telehealth services.
(a) * * *
(3) * * *
(i) Exception. For the duration of the Public Health Emergency as
defined in Sec. 400.200 of this chapter, Interactive
telecommunications system means multimedia communications equipment
that includes, at a minimum, audio and video equipment permitting two-
way, real-time interactive communication between the patient and
distant site physician or practitioner.
(ii) [Reserved]
* * * * *
(b) General rule. Medicare Part B pays for covered telehealth
services included
[[Page 19287]]
on the telehealth list when furnished by an interactive
telecommunications system if the following conditions are met, except
that for the duration of the Public Health Emergency as defined in
Sec. 400.200 of this chapter, Medicare Part B pays for office and
other outpatient visits, professional consultation, psychiatric
diagnostic interview examination, individual psychotherapy,
pharmacologic management and end stage renal disease related services
included in the monthly capitation payment furnished by an interactive
telecommunications system if the following conditions are met:
* * * * *
0
14. Section 410.79 is amended by adding paragraph (e) to read as
follows:
Sec. 410.79 Medicare Diabetes Prevention Program expanded model:
Conditions of coverage.
* * * * *
(e) MDPP expanded model emergency policy. (1) Notwithstanding
paragraphs (a) through (d) of this section, the policies described in
this paragraph (e) apply during the Public Health Emergency (PHE), as
defined in Sec. 400.200 of this chapter.
(2) MDPP requirement changes described in paragraph (e)(1) of this
section are applicable to:
(i) Organizations that are enrolled as an MDPP supplier as defined
in paragraph (b) of this section, as of March 1, 2020; and
(ii) MDPP beneficiaries as defined in paragraph (b) of this
section, who are receiving the MDPP set of services as of March 1,
2020.
(3) The following changes apply under this paragraph (e):
(i) The in-person attendance requirements of paragraphs
(c)(1)(ii)(A), (c)(1)(iii)(A), and (c)(3)(ii) of this section are
waived. MDPP suppliers shall not start new cohorts with MDPP
beneficiaries who are unable to attend the first core session in-
person;
(ii) The limit described in paragraphs (d)(2) and (d)(3)(i) and
(ii) of this section to the number of virtual make-up sessions is
waived for MDPP suppliers with capabilities to provide services
virtually so long as the provision of virtual services complies with
the following:
(A) The curriculum furnished during the virtual make-up session
must address the same CDC-approved DPP curriculum topic as the
regularly scheduled session;
(B) The MDPP supplier furnishes to the MDPP beneficiary a maximum
of one session on the same day as a regularly scheduled session;
(C) The MDPP supplier furnishes to the MDPP beneficiary a maximum
of one virtual make-up session per week;
(D) Virtual make-up sessions must be furnished in a manner
consistent with the DPRP standards for virtual sessions;
(E) Virtual make-up sessions can only be furnished to achieve
attendance goals and cannot be furnished to achieve weight-loss goals;
(F) An MDPP supplier can only offer virtual make-up sessions upon
an individual MDPP beneficiary's request; and
(G) An MDPP supplier can offer to an MDPP beneficiary:
(1) No more than 15 virtual make-up sessions offered weekly during
the core session period, months 1 through 6 of the MDPP services
period;
(2) No more than 6 virtual make-up sessions offered monthly during
the core maintenance session interval periods, months 7 through 12 of
the MDPP services period; and
(3) No more than 12 virtual make-up sessions offered monthly during
the ongoing maintenance session interval periods, months 13 through 24;
(iii) The once per lifetime requirement as described in paragraph
(c)(1)(i)(B) of this section is waived to permit MDPP beneficiaries
whose sessions were paused or cancelled due to the PHE to obtain the
set of MDPP services more than once per lifetime by electing to restart
the MDPP set of services or resume with the most recent attendance
session of record;
(iv) The minimum weight loss requirements for beneficiary
eligibility in the ongoing maintenance session intervals described in
paragraphs (c)(1)(ii)(B) and (c)(1)(iii)(B) of this section are waived;
and
(v) MDPP suppliers may pause or delay the delivery of the MDPP set
of services and subsequently resume services on a delayed schedule. The
time periods and intervals must be consistent with the MDPP
requirements as described in paragraphs (c)(1)(i)(B), (c)(1)(ii)(A),
(c)(1)(iii)(A), (c)(2)(i)(A) and (B), and (c)(3)(i) and (ii) of this
section.
PART 412--PROSPECTIVE PAYMENT SYSTEMS FOR INPATIENT HOSPITAL
SERVICES
0
15. The authority citation for part 412 continues to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh.
0
16. Section 412.29 is amended by revising paragraph (e) to read as
follows:
Sec. 412.29 Classification criteria for payment under the inpatient
rehabilitation facility prospective payment system.
* * * * *
(e) Have in effect a procedure to ensure that patients receive
close medical supervision, as evidenced by at least 3 face-to-face
visits per week by a licensed physician with specialized training and
experience in inpatient rehabilitation to assess the patient both
medically and functionally, as well as to modify the course of
treatment as needed to maximize the patient's capacity to benefit from
the rehabilitation process, except that during a Public Health
Emergency, as defined in Sec. 400.200 of this chapter, such visits may
be conducted using telehealth services (as defined in section
1834(m)(4)(F) of the Act).
* * * * *
0
17. Section 412.622 is amended by revising paragraphs (a)(3)(iv) and
(a)(4)(ii) introductory text to read as follows:
Sec. 412.622 Basis of payment.
(a) * * *
(3) * * *
(iv) Requires physician supervision by a rehabilitation physician.
The requirement for medical supervision means that the rehabilitation
physician must conduct face-to-face visits with the patient at least 3
days per week throughout the patient's stay in the IRF to assess the
patient both medically and functionally, as well as to modify the
course of treatment as needed to maximize the patient's capacity to
benefit from the rehabilitation process, except that during a Public
Health Emergency, as defined in Sec. 400.200 of this chapter, such
visits may be conducted using telehealth services (as defined in
section 1834(m)(4)(F) of the Act). The post-admission physician
evaluation described in paragraph (a)(4)(ii) of this section may count
as one of the face-to-face visits.
(4) * * *
(ii) A post-admission physician evaluation that meets all of the
following requirements, except for the duration of the Public Health
Emergency, as defined in Sec. 400.200 of this chapter--
* * * * *
PART 414--PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES
0
18. The authority citation for part 414 continues to read as follows:
Authority: 42 U.S.C. 1302, 1395hh, and 1395rr(b)(l).
0
19. Section 414.1380 is amended by--
0
a. Revising paragraphs (c)(2)(i)(A)(6) and (c)(2)(i)(C) introductory
text; and
0
b. Adding paragraph (c)(2)(i)(C)(11).
[[Page 19288]]
The revisions and addition read as follows:
Sec. 414.1380 Scoring.
* * * * *
(c) * * *
(2) * * *
(i) * * *
(A) * * *
(6) Beginning with the 2020 MIPS payment year, for the quality,
cost, and improvement activities performance categories, the MIPS
eligible clinician demonstrates through an application submitted to CMS
that they were subject to extreme and uncontrollable circumstances that
prevented the clinician from collecting information that the clinician
would submit for a performance category or submitting information that
would be used to score a performance category for an extended period of
time. Beginning with the 2021 MIPS payment year, in the event that a
MIPS eligible clinician submits data for the quality, cost, or
improvement activities performance categories, the scoring weight
specified in paragraph (c)(1) of this section will be applied and its
weight will not be redistributed, unless an exception applies.
Exception: for the 2021 MIPS payment year only, if a MIPS eligible
clinician demonstrates through an application submitted to CMS that
they have been adversely affected by the Public Health Emergency for
the COVID-19 pandemic and also submits data for the quality, cost, or
improvement activities performance categories, the preceding sentence
will not apply.
* * * * *
(C) Under section 1848(o)(2)(D) of the Act, a significant hardship
exception or other type of exception is granted to a MIPS eligible
clinician based on the following circumstances for the Promoting
Interoperability performance category. Except as provided in paragraphs
(c)(2)(i)(C)(10) and (11) of this section, in the event that a MIPS
eligible clinician submits data for the Promoting Interoperability
performance category, the scoring weight specified in paragraph (c)(1)
of this section will be applied and its weight will not be
redistributed.
* * * * *
(11) For the 2021 MIPS payment year only, the MIPS eligible
clinician demonstrates through an application submitted to CMS that
they have been adversely affected by the Public Health Emergency for
the COVID-19 pandemic.
* * * * *
PART 415--SERVICES FURNISHED BY PHYSICIANS IN PROVIDERS,
SUPERVISING PHYSICIANS IN TEACHING SETTINGS, AND RESIDENTS IN
CERTAIN SETTINGS
0
20. The authority citation for part 415 continues to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh.
0
21. Section 415.172 is amended by revising paragraphs (a) introductory
text, (a)(2), and (b) to read as follows:
Sec. 415.172 Physician fee schedule payment for services of teaching
physicians.
(a) General rule. If a resident participates in a service furnished
in a teaching setting, physician fee schedule payment is made only if a
teaching physician is present during the key portion of any service or
procedure for which payment is sought. During the Public Health
Emergency, as defined in Sec. 400.200 of this chapter, if a resident
participates in a service furnished in a teaching setting, physician
fee schedule payment is made if a teaching physician is present during
the key portion of the service using interactive telecommunications
technology for any service or procedure for which payment is sought.
* * * * *
(2) In the case of evaluation and management services, the teaching
physician must be present during the portion of the service that
determines the level of service billed. (However, in the case of
evaluation and management services furnished in hospital outpatient
departments and certain other ambulatory settings, the requirements of
Sec. 415.174 apply.) During a Public Health Emergency, as defined in
Sec. 400.200 of this chapter, the teaching physician may be present
during the portion of the service that determines the level of service
billed using interactive telecommunications technology. (However, in
the case of evaluation and management services furnished in hospital
outpatient departments and certain other ambulatory settings, the
requirements of Sec. 415.174 apply.)
(b) Documentation. Except for services furnished as set forth in
Sec. Sec. 415.174 (concerning an exception for services furnished in
hospital outpatient and certain other ambulatory settings), 415.176
(concerning renal dialysis services), and 415.184 (concerning
psychiatric services), the medical records must document the teaching
physician was present at the time the service is furnished. The
presence of the teaching physician during procedures and evaluation and
management services may be demonstrated by the notes in the medical
records made by the physician or as provided in Sec. 410.20(e) of this
chapter. During a Public Health Emergency, as defined in Sec. 400.200
of this chapter, except for services furnished as set forth in
Sec. Sec. 415.174 (concerning an exception for services furnished in
hospital outpatient and certain other ambulatory settings), 415.176
(concerning renal dialysis services), and 415.184 (concerning
psychiatric services), the medical records must document if the
teaching physician was physically present or if the teaching physician
was present through interactive telecommunications technology at the
time the service is furnished. The presence of the teaching physician
during procedures and evaluation and management services may be
demonstrated by the notes in the medical records made by the physician
or as provided in Sec. 410.20(e) of this chapter.
* * * * *
0
22. Section 415.174 is amended by adding paragraph (b) to read as
follows:
Sec. 415.174 Exception: Evaluation and management services furnished
in certain centers.
* * * * *
(b) During a Public Health Emergency, as defined in Sec. 400.200
of this chapter, carriers may make physician fee schedule payment for a
service furnished by a resident if the teaching physician is present
through interactive telecommunications technology.
0
23. Section 415.180 is revised to read as follows:
Sec. 415.180 Teaching setting requirements for the interpretation of
diagnostic radiology and other diagnostic tests.
(a) General rule. Physician fee schedule payment is made for the
interpretation of diagnostic radiology and other diagnostic tests if
the interpretation is performed or reviewed by a physician other than a
resident. During a Public Health Emergency, as defined in Sec. 400.200
of this chapter, physician fee schedule payment may also be made for
the interpretation of diagnostic radiology and other diagnostic tests
if the interpretation is performed by a resident when the teaching
physician is present through interactive telecommunications technology.
(b) [Reserved]
0
24. Section 415.184 is revised to read as follows:
Sec. 415.184 Psychiatric services.
To qualify for physician fee schedule payment for psychiatric
services furnished under an approved GME
[[Page 19289]]
program, the physician must meet the requirements of Sec. Sec. 415.170
and 415.172, including documentation, except that the requirement for
the presence of the teaching physician during the service in which a
resident is involved may be met by observation of the service by use of
a one-way mirror, video equipment, or similar device. During a Public
Health Emergency, as defined in Sec. 400.200 of this chapter, the
requirement for the presence of the teaching physician during the
service in which a resident is involved may be met by direct
supervision by interactive telecommunications technology.
0
25. Section 415.208 is amended by revising paragraph (b)(2)
introductory text to read as follows:
Sec. 415.208 Services of moonlighting residents.
* * * * *
(b) * * *
(2) Services of residents that are not related to their approved
GME programs and are performed in an outpatient department or emergency
department of a hospital in which they have their training program are
covered as physician services and payable under the physician fee
schedule if criteria in paragraphs (b)(2)(i) through (iii) of this
section are met. During a Public Health Emergency, as defined in Sec.
400.200 of this chapter, the services of residents that are not related
to their approved GME programs and are furnished to inpatients of a
hospital in which they have their training program are covered as
physician services and payable under the physician fee schedule if
criteria in paragraphs (b)(2)(i) through (iii) of this section are met.
* * * * *
PART 417--HEALTH MAINTENANCE ORGANIZATIONS, COMPETITIVE MEDICAL
PLANS, AND HEALTH CARE PREPAYMENT PLANS
0
26. The authority citation for part 417 is revised to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh, and 300e, 300e-5, and
300e-9, and 31 U.S.C. 9701.
0
27. Section 417.472 is amended by revising paragraphs (i) and (j) to
read as follows:
Sec. 417.472 Basic contract requirements.
* * * * *
(i) HMOs and CMPs. The HMO or CMP must comply with the requirements
at Sec. 422.152(b)(5) and (6) of this chapter.
(j) Coordinated care and cost contracts. Subject to paragraph (i)
of this section, all coordinated care contracts (including local and
regional PPOs, contracts with exclusively SNP benefit packages, private
fee-for-service contracts, and MSA contracts), and all cost contracts
under section 1876 of the Act, with 600 or more enrollees in July of
the prior year, must contract with approved Medicare Consumer
Assessment of Healthcare Providers and Systems (CAHPS) survey vendors
to conduct the Medicare CAHPS satisfaction survey of Medicare plan
enrollees in accordance with CMS specifications and submit the survey
data to CMS.
* * * * *
PART 418--HOSPICE CARE
0
28. The authority citation for part 418 continues to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh.
0
29. Section 418.22 is amended by--
0
a. Redesignating the text of paragraph (a)(4) as paragraph (a)(4)(i);
and
0
b. Adding paragraph (a)(4)(ii).
The addition reads as follows:
Sec. 418.22 Certification of terminal illness.
(a) * * *
(4) * * *
(ii) During a Public Health Emergency, as defined in Sec. 400.200
of this chapter, if the face-to-face encounter conducted by a hospice
physician or hospice nurse practitioner is for the sole purpose of
hospice recertification, such encounter may occur via a
telecommunications technology and is considered an administrative
expense. Telecommunications technology means the use of interactive
multimedia communications equipment that includes, at a minimum, the
use of audio and video equipment permitting two-way, real-time
interactive communication between the patient and the distant site
hospice physician or hospice nurse practitioner.
* * * * *
0
30. Section 418.204 is amended by adding paragraph (d) to read as
follows:
Sec. 418.204 Special coverage requirements.
* * * * *
(d) Use of technology in furnishing services during a Public Health
Emergency. When a patient is receiving routine home care, during a
Public Health Emergency as defined in Sec. 400.200 of this chapter,
hospices may provide services via a telecommunications system if it is
feasible and appropriate to do so to ensure that Medicare patients can
continue receiving services that are reasonable and necessary for the
palliation and management of a patients' terminal illness and related
conditions. The use of such technology in furnishing services must be
included on the plan of care, meet the requirements at Sec. 418.56,
and must be tied to the patient-specific needs as identified in the
comprehensive assessment and the plan of care must include a
description of how the use of such technology will help to achieve the
goals outlined on the plan of care.
PART 421--MEDICARE CONTRACTING
0
31. The authority citation for part 421 is revised to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh.
0
32. Section 421.214 is amended by--
0
a. Revising paragraphs (b) and (c) introductory text;
0
b. Adding paragraph (d)(5);
0
c. Revising paragraph (f)(1)(i); and
0
d. Adding paragraph (j).
The revisions and additions read as follows:
Sec. 421.214 Advance payments to suppliers furnishing items and
services under Part B.
* * * * *
(b) Definition. As used in this section, advance payment means a
conditional partial payment made by the contractor in response to a
claim that it is unable to process within established time limits
except as provided in paragraph (j) of this section.
(c) When advance payments may be made. Unless otherwise qualified
under paragraph (j) of this section, an advance payment may be made if
all of the following conditions are met:
* * * * *
(d) * * *
(5) Is in bankruptcy.
* * * * *
(f) * * *
(1) * * *
(i) Unless otherwise qualified under paragraph (j) of this section,
a contractor must calculate an advance payment for a particular claim
at no more than 80 percent of the anticipated payment for that claim
based upon the historical assigned claims payment data as defined in
paragraph (f)(1)(ii) of this section for claims paid to the supplier.
For suppliers qualifying and approved for advance payments under
paragraph (j) of this section, a contractor may calculate an advance
payment for a particular claim at up to 100 percent of the anticipated
payment for that claim based upon the historical assigned claims
payment data as defined in paragraph (f)(1)(ii) of this section for
claims paid to the supplier.
* * * * *
[[Page 19290]]
(j) Advanced payments in exceptional circumstances. CMS may
approve, in writing to the contractor, the making of advance payments
during the period of a Public Health Emergency, as defined in Sec.
400.200 of this chapter, or during the period under a Presidential
Disaster Declaration, under the following exceptional conditions:
(1) The contractor is unable to process the claim timely, or is at
risk of being untimely in processing the claim; or
(2) When the supplier has experienced a temporary delay in
preparing and submitting bills to the contractor beyond its normal
billing cycle.
PART 422--MEDICARE ADVANTAGE PROGRAM
0
33. The authority citation for part 422 continues to read as follows:
Authority: 42 U.S.C. 1302 and 1395hh.
0
34. Section 422.152 is amended by adding paragraph (b)(6) to read as
follows:
Sec. 422.152 Quality improvement program.
* * * * *
(b) * * *
(6) For 2021 Star Ratings only, MA organizations are not required
to submit HEDIS and CAHPS data that would otherwise be required for the
calculation of the 2021 Star Ratings.
* * * * *
0
35. Section 422.164 is amended by adding paragraph (i) to read as
follows:
Sec. 422.164 Adding, updating, and removing measures.
* * * * *
(i) Special rule for 2021 Star Ratings only. In the event that the
threat to health and safety posed by the COVID-19 pandemic compromises
the quality of the data, or ability to validate such data for all plans
used to calculate a particular measure, CMS will substitute and use the
2021 Star Ratings measure score and Star Rating with the 2020 Star
Ratings measure score and Star Rating.
0
36. Section 422.166 is amended--
0
a. By revising paragraph (a)(2)(i);
0
b. In paragraph (f)(1)(i), by adding a sentence to the end of the
paragraph; and
0
c. By adding paragraphs (g)(3) and (j).
The revision and additions read as follows:
Sec. 422.166 Calculation of Star Ratings.
(a) * * *
(2) * * *
(i) The method maximizes differences across the star categories and
minimizes the differences within star categories using mean resampling
with the hierarchal clustering of the current year's data. Effective
for the Star Ratings issued in October 2022 and subsequent years, CMS
will add a guardrail so that the measure-threshold-specific cut points
for non-CAHPS measures do not increase or decrease more than the value
of the cap from one year to the next. The cap is equal to 5 percentage
points for measures having a 0 to 100 scale (absolute percentage cap)
or 5 percent of the restricted range for measures not having a 0 to 100
scale (restricted range cap). New measures that have been in the Part C
and Part D Star Rating program for 3 years or less use the hierarchal
clustering methodology with mean resampling with no guardrail for the
first 3 years in the program.
* * * * *
(f) * * *
(1) * * *
(i) * * * For the 2022 Star Ratings only, since all contracts may
have the improvement measure(s) excluded in the determination of their
highest rating and summary rating(s), each contract's weighted variance
and weighted mean are calculated both with and without the improvement
measures.
* * * * *
(g) * * *
(3) For 2022 Star Ratings only, CMS runs the calculations twice for
the highest rating for each contract-type (overall rating for MA-PD
contracts and Part C summary rating for MA-only contracts) and Part C
summary rating for MA-PDs with all applicable adjustments (CAI and the
reward factor), once including the improvement measure(s) and once
without including the improvement measure(s). In deciding whether to
include the improvement measures in a contract's highest and summary
rating(s), CMS applies the following rules:
(i) For MA-PDs and MA-only contracts, a comparison of the highest
rating with and without the improvement measure is done. The higher
rating is used for the highest rating.
(ii) For MA-PDs, a comparison of the Part C summary rating with and
without the improvement measure is done. The higher rating is used for
the summary rating.
* * * * *
(j) Special rules for 2021 and 2022 Star Ratings only. (1) For the
2021 Star Ratings:
(i) The measures calculated based on HEDIS data are calculated
based on data from the 2018 performance period.
(ii) The measures calculated based on CAHPS data are calculated
based on survey data collected from March through May 2019.
(iii) The measure-level change score calculation described at Sec.
422.164(f)(4)(i) is not applied for HEDIS and CAHPS measures and the
measure-level change score used for the 2020 Star Ratings is applied in
its place for all HEDIS and CAHPS-based measures.
(iv) The provisions of Sec. 422.164(g)(1) and (2) are not applied
for the failure to submit HEDIS and CAHPS-based measures.
(v) In the event that there are extraordinary circumstances
resulting from the COVID-19 pandemic that compromise CMS resources to
the extent that CMS cannot calculate or issue 2021 Star Ratings by
October 2020, CMS will adopt the 2020 Star Ratings as the 2021 Star
Ratings.
(2) For the 2022 Star Ratings:
(i) In the event that the threat to health and safety posed by the
COVID-19 pandemic compromises the ability to collect the Health
Outcomes Survey in 2020, CMS will adopt the 2021 Star Ratings and
measure scores for the measures that come from the Health Outcomes
Survey as the 2022 Star Ratings and measures scores for the measures
that come from the Health Outcomes Survey.
(ii) [Reserved]
0
37. Section 422.252 is amended by revising the definition of ``New MA
plan'' to read as follows:
Sec. 422.252 Terminology.
* * * * *
New MA plan means a MA contract offered by a parent organization
that has not had another MA contract in the previous 3 years. For
purposes of 2022 quality bonus payments based on 2021 Star Ratings
only, new MA plan means an MA contract offered by a parent organization
that has not had another MA contract in the previous 4 years.
* * * * *
PART 423--VOLUNTARY MEDICARE PRESCRIPTION DRUG BENEFIT
0
38. The authority for part 423 continues to read as follows:
Authority: 42 U.S.C. 1302, 1395w-101 through 1395w-152, and
1395hh.
0
39. Section 423.156 is amended by adding a sentence at the end of the
paragraph to read as follows:
Sec. 423.156 Consumer satisfaction surveys.
* * * Part D sponsors are not required to submit CAHPS data that
would otherwise be required for the calculation of the 2021 Star
Ratings.
[[Page 19291]]
0
40. Section 423.182 is amended by adding paragraph (c)(3) to read as
follows:
Sec. 423.182 Part D Prescription Drug Plan Quality Rating System.
* * * * *
(c) * * *
(3) For 2021 Star Ratings only, Part D sponsors are not required to
submit CAHPS data that would otherwise be required for the calculation
of the 2021 Star Ratings.
0
41. Section 423.184 is amended by adding paragraph (i) to read as
follows:
Sec. 423.184 Adding, updating, and removing measures.
* * * * *
(i) Special rule for 2021 Star Ratings only. In the event that the
threat to health and safety posed by the COVID-19 pandemic compromises
the quality of the data, or ability to validate such data, for all
plans, used to calculate a particular measure, CMS will substitute and
use the 2021 Star Ratings measure score and Star Ratings with the 2020
Star Ratings measure score and Star Rating.
0
42. Section 423.186 is amended--
0
a. By revising paragraph (a)(2)(i);
0
b. In paragraph (f)(1)(i), by adding a sentence to the end of the
paragraph; and
0
c. By adding paragraphs (g)(3) and (j).
The revision and additions read as follows:
Sec. 423.186 Calculation of Star Ratings.
(a) * * *
(2) * * *
(i) The method maximizes differences across the star categories and
minimizes the differences within star categories using mean resampling
with the hierarchal clustering of the current year's data. Effective
for the Star Ratings issued in October 2022 and subsequent years, CMS
will add a guardrail so that the measure-threshold-specific cut points
for non-CAHPS measures do not increase or decrease more than the value
of the cap from one year to the next. The cap is equal to 5 percentage
points for measures having a 0 to 100 scale (absolute percentage cap)
or 5 percent of the restricted range for measures not having a 0 to 100
scale (restricted range cap). New measures that have been in the Part C
and D Star Rating program for 3 years or less use the hierarchal
clustering methodology with mean resampling with no guardrail for the
first 3 years of the program.
* * * * *
(f) * * *
(1) * * *
(i) * * * For the 2022 Star Ratings only, since all contracts may
have the improvement measure(s) excluded in the determination of their
highest rating and summary rating(s), each contract's weighted variance
and weighted mean are calculated both with and without the improvement
measures.
* * * * *
(g) * * *
(3) For 2022 Star Ratings only, CMS runs the calculations twice for
the highest rating for each contract-type (overall rating for MA-PD
contracts and Part D summary rating for PDPs) and Part D summary rating
for MA-PDs with all applicable adjustments (CAI and the reward factor),
once including the improvement measure(s) and once without including
the improvement measure(s). In deciding whether to include the
improvement measures in a contract's highest and summary rating(s), CMS
applies the following rules:
(i) For MA-PDs and PDPs, a comparison of the highest rating with
and without the improvement measure is done. The higher rating is used
for the highest rating.
(ii) For MA-PDs, a comparison of the Part D summary rating with and
without the improvement measure is done. The higher rating is used for
the summary rating.
* * * * *
(j) Special rules for 2021 Star Ratings only. (1) For the 2021 Star
Ratings:
(i) The measures calculated based on CAHPS data are calculated
based on survey data collected from March through May 2019.
(ii) The measure-level change score calculation described at Sec.
423.184(f)(4)(i) is not applied for CAHPS measures and the measure-
level change score used for the 2020 Star Ratings is applied in its
place for all CAHPS-based measures.
(iii) The provisions of Sec. 423.184(g)(2) are not applied for
failure to submit CAHPS-based measures.
(iv) In the event that there are extraordinary circumstances
resulting from the COVID-19 pandemic that compromise CMS resources to
the extent that CMS cannot calculate or issue 2021 Star Ratings by
October 2020, CMS will adopt the 2020 Star Ratings as the 2021 Star
Ratings.
(2) [Reserved]
PART 425--MEDICARE SHARED SAVINGS PROGRAM
0
43. The authority citation for part 425 continues to read as follows:
Authority: 42 U.S.C. 1302, 1306, 1395hh, and 1395jjj.
Sec. 425.502 [Amended]
0
44. Section 425.502 is amended in paragraph (f) introductory text by
removing the phrase ``if the quality reporting period is not
extended''.
PART 440--SERVICES: GENERAL PROVISIONS
0
45. The authority citation for part 440 is revised to read as follows:
Authority: 42 U.S.C. 1302.
0
46. Section 440.70 is amended by revising paragraphs (a)(2),
(b)(1)(ii), and (b)(3)(iii) and (iv) to read as follows:
Sec. 440.70 Home health services.
(a) * * *
(2) On his or her physician's orders as part of a written plan of
care that the physician reviews every 60 days for services described in
paragraphs (b)(1), (2), and (4) of this section, or, for the period of
the Public Health Emergency, as defined in Sec. 400.200 of this
chapter, orders written by an other licensed practitioner of the
healing arts acting within the scope of practice authorized under State
law, as part of a written plan of care that the ordering practitioner
reviews every 60 days for services described in paragraphs (b)(1), (2),
and (4) of this section.
(b) * * *
(1) * * *
(ii) Receives written orders from the patient's physician or, for
the period of the Public Health Emergency, as defined in Sec. 400.200
of this chapter, other licensed practitioner of the healing arts acting
within the scope of practice authorized under State law;
* * * * *
(3) * * *
(iii) A beneficiary's need for medical supplies, equipment, and
appliances must be reviewed by a physician or, for the period of the
Public Health Emergency, as defined in Sec. 400.200 of this chapter,
an other licensed practitioner of the healing arts acting within the
scope of practice authorized under State law, annually.
(iv) Frequency of further physician or, for the period of the
Public Health Emergency, as defined in Sec. 400.200 of this chapter,
an other licensed practitioner review of a beneficiary's continuing
need for the items is determined on a case-by-case basis based on the
nature of the item prescribed.
* * * * *
PART 482--CONDITIONS OF PARTICIPATION FOR HOSPITALS
0
47. The authority citation for part 482 continues to read as follows:
[[Page 19292]]
Authority: 42 U.S.C. 1302, 1395hh, 1395rr, and 1395lll unless
otherwise noted.
0
48. Section 482.61 is amended by revising paragraph (d) to read as
follows:
Sec. 482.61 Condition of participation: Special medical record
requirements for psychiatric hospitals.
* * * * *
(d) Standard: Recording progress. Progress notes for the patient
must be documented, in accordance with applicable State scope-of-
practice laws and hospital policies, by the following qualified
practitioners: Doctor(s) of medicine or osteopathy, or other licensed
practitioner(s), who is responsible for the care of the patient;
nurse(s) and social worker(s) (or social service staff) involved in the
care of the patient; and, when appropriate, others significantly
involved in the patient's active treatment modalities.
The frequency of progress notes is determined by the condition of
the patient but must be recorded at least weekly for the first 2 months
and at least once a month thereafter and must contain recommendations
for revisions in the treatment plan as indicated, as well as precise
assessment of the patient's progress in accordance with the original or
revised treatment plan.
* * * * *
PART 510--COMPREHENSIVE CARE FOR JOINT REPLACEMENT MODEL
0
49. The authority citation of part 510 is revised to read as follows:
Authority: 42 U.S.C. 1302, 1315a, and 1395hh.
0
50. Section 510.2 is amended by revising the definition of
``Performance year'' to read as follows:
Sec. 510.2 Definitions.
* * * * *
Performance year means one of the years in which the CJR model is
being tested. Performance years for the model correlate to calendar
years with the exceptions of performance year 1, which is April 1, 2016
through December 31, 2016 and performance year 5, which is January 1,
2020 through March 31, 2021.
* * * * *
Sec. 510.200 [Amended]
0
51. Section 510.200 is amended in paragraph (a) by removing the phrase
``before December 31, 2020'' and adding in its place the phrase
``before March 31, 2021''.
0
52. Section 510.305 is amended by adding paragraphs (k)(3) and (4) to
read as follows:
Sec. 510.305 Determination of the NPRA and reconciliation process.
* * * * *
(k) * * *
(3) The following is an extreme and uncontrollable circumstances
adjustment for 2019 Novel Coronavirus (previously referred to as 2019-
nCoV, now as COVID-19):
(i) The episode spending adjustments specified in paragraph (k)(4)
of this section apply for a participant hospital that has a CCN primary
address that is located in an emergency area during an emergency
period, as those terms are defined in section 1135(g) of the Act, for
which the Secretary issued a waiver or modification of requirements
under section 1135 of the Act on March 13, 2020.
(ii) [Reserved]
(4) For a fracture or non-fracture episode with a date of admission
to the anchor hospitalization that is on or within 30 days before the
date that the emergency period (as defined in section 1135(g) of the
Act) begins or that occurs through the termination of the emergency
period (as described in section 1135(e) of the Act), actual episode
payments are capped at the target price determined for that episode
under Sec. 510.300.
Dated: March 24, 2020.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
Dated: March 26, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2020-06990 Filed 3-31-20; 4:15 pm]
BILLING CODE 4120-01-P
